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· Abstract 
Novel pyrrolidine, indolizidine and azepine ring systems have been prepared via the 
palladium catalysed [3+2] cycloaddition of cyclic imines with vinylcyclopropanes. The 
reaction of simple cyclic imines with various functionalised vinylcyclopropanes, 
provided a range of bicyclic systems, as potential scaffolds for further elaboration. The 
application of functionalised cyclic imines derived from enecarbamates was limited due 
to difficulties generating the imine bond. The developed methodology was also 
employed in the formation of pyrrolooxazinone products, as templates for 
functionalised proline syntheses. 
A synthetic sequence based on palladium-catalysed transformations was developed 
towards the Stemona alkaloid (±)-stemoamide. Palladium [3+2] cycloaddition of a 
suitable acyclic imine, and tert-butyl ester substituted vinylcyclopropane, followed by 
an intramolecular Heck cyclisation yielded the azepine core present in the natural 
product. Lactonisation procedures were investigated to install the final ring of the 
tricyclic core, however due to time restraints, this work remains incomplete. 
ii 
Title page 
Abstract 
Table of contents 
List of abbreviations 
Acknowledgments 
Introduction 
Chapter One 
Contents 
1.1 Pyrrolizidine and Indolizidine Alkaloids 
1.1.1 Introduction to the Pyrrolizidine Alkaloids 
1.1.2 Syntheses of the Pyrrolizidine and Indolizidine Alkaloids 
1.2 Stemona Alkaloids 
1.2.1 Introduction to the Stemona Alkaloids 
1.2.2 Syntheses of the Stemona Alkaloids 
1.3 Cyclopropanes in Synthesis 
ii 
iii 
vii 
ix 
2 
14 
15 
1.3.1 Bonding in Cyclopropanes 34 
1.3.2 Nucleophilic Addition to Cyclopropanes 35 
1.3.3 Transition Metal-assisted reactions of Cyclopropane derivatives 39 
1.3.4 Palladium Catalysed [3+2] Cycloadditions with Pd- 42 
Trimethylenemethane complexes 
1.3.5 Transition Metal-assisted reactions of Vinylcyclopropanes 
1.3.6 Previous work within the Group 
44 
51 
iii 
Results and Discussion 
Chapter Two 
2.1 Preparation and Reactions of Vinylcyclopropanes 
2. I. I Synthesis of Vinylcyclopropanes 
2.2 Preparation of Cyclic !mines 
2.2.1 Synthesis of 5-membered Cyclic Imines 
2.2.2 Synthesis of 6-membered Cyclic !mines 
2.2.3 Synthesis of7-membered Cyclic Imines 
2.3 Palladium Catalysed [3+2] Cycloadditions with Cyclic Imines 
2.3. I Formation of novel Pyrrolizidine derivatives 
2.3.2 Formation of novel Indolizidine derivatives 
2.3.3 Formation of novel Azepine. derivatives 
2.3.4 Synthesis of Crispine A derivatives 
2.3.5 Optimal conditions for Palladium [3+2] Cycloadditions 
2.4 The use ofFunctionalised Vinylcyclopropanes 
2.4. I Variation at the vinyl terminus 
2.4.2 Variation at the Malonic position 
2.4.3 Use of Activated Bicyclic Vinylcyclopropam;s 
Chapter Three 
3.1 Preparation of functionalised imines 
3. I. I Quarternary Substitution on the Cyclic !mines 
3. I .2 Anti-substituted Cyclic !mines from 3-Pyrroline 
3. I .3 Syn-substituted Cyclic !mines from 3-Pyrroline 
3. I .4 Cyclic !mines from 4-hydroxy piperidine 
3.2 New methods towards Imine bond formation 
3.2.!1n situ generation of the Cyclic Imine 
3.2.2 Cyclic !mines from Enecarbamates 
3.2.3 Cyclic !mines from y,8-Unsaturated Nitriles 
3.3 Conclusion 
55 
59 
6I 
62 
63 
65 
68 
69 
73 
74 
77 
78 
82 
84 
87 
91 
93 
94 
101 
102 
iv 
Chapter Four 
4.1 New Routes to Functionalised Pralines 
4.1.1 Proline as a Building block 
4.1.2 Oxazinones in synthesis 
4.1.3 Formation of Oxazinones via Oxazoles 
4.1.4 Alternative Route to Oxazinones using Lead Acetate 
4.1.5 Palladium [3+ 2] cycloadditions with oxazinones 
4.1.6 Electron deficient quaternary imine bonds 
4.1. 7 Controlling the stereochemistry at C-9 
4.1.8 Electron-rich Cyclic !mines 
4.2 Conclusion 
Chapter Five 
5.1 Application to Natural Products 
5.1.1 Retrosynthesis ofstemoamide 
5.2 Formation offunctionalised Pyrrolidine intermediate 
5 .2.1 Synthesis of substituted Vinylcyclopropane 
5.2.2 Synthesis of Acyclic Imine 
5.2.3 Palladium Catalysed [3+2] Cycloaddition to functionalised 
Pyrrolidines 
5.3 Investigations into C-ring closure 
5.3.1 Radical methods for C-ring closure 
5.3.2 Halogen-Metal exchange methods for C-ring closure 
5.3.3 Heck coupling methods for C-ring closure 
5.3.4 Tandem Palladium catalysed Azepine formation 
5.4 Investigation into direct lactonisation of Z-458b 
5.5 Selective reduction ofthe exocyclic double bond 
5. 6 Palladium catalysed [3+ 2] cycloadditions of isocyanates 
Chapter Six 
6.1 Conclusion and future work 
104 
109 
Ill 
113 
115 
120 
123 
124 
127 
129 
130 
131 
133 
135 
136 
138 
142 
144 
146 
149 
150 
V 
Chapter Seven 
7.1 General information 
7.1.1 Solvents and reagents 
7 .1.2 Chromatographic procedures 
7.1.3 FT-IR 
7.1.4 1HNMR 
7.1.5 13C NMR 
7.1.6 Mass spectra 
7.1.7 Other data 
7.2 Experimental procedures 
Chapter Eight 
8.1 References 
Chapter Nine 
9.1 Appendix 
154 
154 
155 
155 
155 
156 
156 
157 
213 
218 
VI 
Abbreviations 
AIBN Azobis(isobuyronitrile) 
Ar Aromatic 
Bn Benzyl 
Boc tert-Butoxycarbonyl 
br Broad 
cat. Catalytic 
CAN Ceric ammonium nitrate 
Cbz Benzyloxycarbonyl 
d Doublet 
dba Dibenzylideneacetone 
DBU I ,8-diazabicyclo[2.2.2]undecane 
DCM Dichloromethane 
DDQ 2,3-Dichloro-5,6-dicyano-1 ,4-benzoquinone 
DEPT Distortionless Enhancement by Polarisation Transfer 
DIAD Diisopropyl azodicarboxylate 
DIDAL Diisobutylaluminium hydride 
DMAP 4-(Dimethylamino )pyridine 
DMF N,N-Dimethylformamide 
DMPU N,N'-Dimethylpropyleneurea 
DMS Dimethyl sulphide 
DMSO Dimethyl sulfoxide 
DMTSF Dimethylsulfonium tetrafluoroborate 
El Electron ionisation 
ES Electron spray 
EWG Electron withdrawing group 
FAB Fast atom bombardment 
HMPA Hexamethylphosphoramide 
HMQC Heteronuclear Multiple Quantum Coherence 
HOMO Highest occupied molecular orbital 
IR Infra-red 
J Coupling constant (NMR spectroscopy) 
KHMDS Potassium hexamethyldisilazide 
vii 
LDA 
LC-MS 
m 
m-CPBA 
MEM 
mp 
Ms 
m/z 
NCS 
NMR 
nOe 
0 
p 
P.E. 
PMB 
PPTS 
q 
RAMP 
Red-AI 
RT 
s 
SAMP 
str 
t 
TBAF 
TBS 
TBDMS 
TBS 
TFA 
TIPS 
TLC 
TMSCI 
Ts 
Lithium diisopropyl amide 
Liquid chromatography-Mass spectrometry 
M eta 
meta-Chloroperoxybenzoic acid 
Methoxymethyl 
Melting point 
Mesyl 
Mass to charge ratio 
N-Chlorosuccinimide 
Nuclear magnetic resonance 
Nuclear Overhauser effect 
Ortho 
Para 
Petroleum ether ( 40-60) 
para-Methoxybenzene 
Pyridinium p-toluenesulfonate 
Quartet 
(R)-1-Amino-2-methoxymethylpyrrolidine 
Sodium bis(2-methoxyethoxy)aluminium hydride 
Room temperature 
Singlet 
(S)-l-Amino-2-methoxymethylpyrrolidine 
Stretch 
Triplet 
Tetrabutylammonium fluoride 
tert-Butyldimethylsilyl 
tert-Butylsimethylsilyl 
Triisobutylsilyl 
Trifluoroacetic acid 
Tri isopropylsi lyl 
Thin layer chromatography 
Trimethylsilyl chloride 
para-Tolunenesulfonyl 
viii 
Acknowledgements 
I would like to thank everybody who has contributed towards my PhD experience. 
Without the help and support of the people around me, these three years would have 
been endured, rather than enjoyed. Firstly, to all the people I've encountered in FOO I -
Farah, KC, Celine, Poults, Ritz, Lummers, Carole, Prof. X, Yohan, Claire, Woz:za, 
Hayley, Laura- never a dull moment was had!! To other members of the department-
Young Paul, Lou, Kate, Tobs, DuffY, Jaime, Amber, Jo, Ben, Sean, Gav, Stanny, 
Jonker Shaw, Mark- thanks for all your help. 
To the Pritchard group past and present- The Prof (for taking me to the board), Chef (I 
think that was his name), Eric (hey! mate mate), Wenson (for the Barnsdale Close 
Rumble in the Jungle), Jess (for not letting me sleep in my corner), Curls (uuurrgh)-
thanks for the memories. 
A special thank you to Dr. G. J. Pritchard for the opportunity to undertake this project. 
The steady stream of help, advice and suggestions certainly kept me busy for three 
years. Also to my industrial supervisor and sponsors, Dr R. E. Rathmell (Eii Lilly), 
thanks for everything. 
Finally- to my family. Explaining 'Novel Palladium Catalysed [3 + 2] Cycloadditions 
Towards Functionalised Aza-Bicycles' over the telephone was always a challenge, but 
now I have something to physically show you for my troubles! I appreciate the support 
and encouragement you have given me throughout my life and this thesis is dedicated 
to you. 
ix 
Introduction. : .. 
Chapter One 
Alkaloids containing the l-aza[(2+n).3.0]bicyclic framework have a wide and varied 
distribution in nature (Figure 1.01). Pyrrolizidine (n=l), indolizidine (n=2) and azepine 
(n=3) ring systems are the central building blocks to many natural products, and many 
serve as key synthetic intermediates for more complex molecules. This thesis examines 
the development of a general method towards these structures, with the ultimate aim of 
applying this methodology to target synthesis. A brief overview of the therapeutic 
properties associated with these natural alkaloids, and previous studies in their 
syntheses follows. 
CQ 
n = 1, Pyrrolizidine 
n = 2, lndolizidine 
n = 3, Azepine 
Figure 1.01 The l-aza[2+n.3 .O]bicyclic framework 
1.1 Pyrrolizidine and lndolizidine Alkaloids 
1.1.1 Introduction to the Pyrrolizidine Alkaloids 
There are a vast number of naturally occurring pyrrolizidine and indolizidine alkaloids, 
varying from relatively simple polyhydroxylated systems such as retronecine, 
lentiginosine and swainsonine, to the more complex polycyclic systems such as 
mitomycin A, tylophorine and alkaloid-2058 (Figure 1.02). 1 Amphibians have 
provided a remarkable array of biologically active compounds, which on secretion from 
the skin can serve to protect the amphibian from predators and in the case of some 
peptides, protect from bacterial or protozoan infections. 
n = 1, pyrrolizidine 
n = 2, indolizidine 
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Figure 1.02 A selection of naturally occurring pyrrolizidine and indolizidine alkaloids 
The glycosidase inhibitory activity of the indolizidine alkaloids has been extensively 
studied, and together with related alkaloids of the pyrrolizidine, piperidine, pyrrolidine 
and nortropane families, they are revered as potential therapeutics. The wide-ranging 
physiological responses associated with these compounds, has generated much interest 
in their synthetic study, and also elucidation of their mode of action. Glycosidases are 
of paramount importance in processes such as intestinal digestion, post-translational 
treatment of glycoproteins and the lysomal catabolism of glycoconjugates. For these· 
reasons, this diverse group of alkaloids are highly regarded as possible treatments for 
diabetes, cancer and viral infections? 
1.1.2 Syntheses of the Pyrrolizidine and Indolizidine Alkaloids 
West et al. describe a novel ring expansion of azetidinium ylides to synthesise 
stereoisomers turneforcidine and platynecine (Scheme 1.01).3 They prepare 
azitidinecarboxylate esters of type 1 and effect metal-catalysed decomposition of the 
diazo-group, to yield transient spirocyclic ylides 2. These in turn undergo a Stevens 
[ l ,2]-shift leading to fused ring systems 3. 
2 
6-co2Me ~C02Me [1,2) Stevens Me02C H 0 Mln shift (f)), N 0 N ~ Qe 
N2 0 
1 (m, n = 1-3) 2 3 
Scheme 1.01 West's novel ring expansions of azetidinium ylides 
Reductive debenzylation of azitidinecarboxylate ester 4 using transfer hydrogenation 
conditions, followed by immediate coupling with 4-bromo-1-diazobutan-2-one 5 lead 
to key intermediate 6 (Scheme 1.02). Treatment with Cu(acac)2 or Rh2(0Ac)4 gave an 
inseparable mixture of diastereoisomers 7 and 8. Other soluble copper(II) catalysts can 
be used with comparable rates of turnover, but no improvement of diastereoselectivity 
was observed. This mixture of isomers was then reduced under standard hydrogenation 
conditions, to give ester 9 and lactone 10, which were easily separable. The synthesis of 
racemic turneforcidine and platynecine was completed by LiAIH4 reduction ofthe ester 
functionality. Preliminary studies suggest that this protocol can also be applied to the 
indolizidine alkaloids. 
7 8 
+ 
platynecine turneforcidine 9 10 
e 
f 
Scheme 1.02 Reagents: (a) Pd/C, NH4C02H, MeOH; (b) 5, DIPEA, MeCN (96% 2 steps); (c) 
10 mol% Cu(acac)z, toluene, reflux (82%, inseparable mixture 7:8, 3.6:1); (d) Pt02, H2, MeOH 
(9 (88%), 10 (71%)); (e) LiAIH4, THF (91%); (f) LiAlH~. THF (94%). 
3 
Angle et al. exploited the chiral pool in their use of a-amino acids in the synthesis of 
enantiopure indolizidine 167B, an alkaloid found within the skin secretions of 
neotropical frogs (Scheme 1.03).4 The N-benzoyl-protected ethyl ester of D-norvaline 
was reduced with DIBAL-H before Grignard addition of vinyl magnesium chloride to 
give alcohol 12 as a mixture of diastereoisomers. Lithium aluminium hydride reduction 
of the amide followed by N-alkylation with phenyl a-bromoacetate resulted in 
lactonisation to give tertiary amine 13. Reaction with TIPSOTf and triethylamine 
generated key intermediate 14. Subsequent lreland-Claisen rearrangement gave TIPS-
ester 15, which was reduced with LiAIH4 immediately to primary alcohol 16. The 
minor diastereoisomer of the silyl ketene acetal 14 failed to undergo Ireland-Claisen 
rearrangement, leading to exclusively one isomer of alcohol 16. Swern oxidation, 
followed by Horner-Emmons-Wadsworth homologation with triethyl 
phosphonoacetate, afforded alkene 17 as a mixture of geometrical isomers. The EIZ 
mixture was subjected to hydrogenolysis using Pearlman's catalyst, and ring closure 
with trimethyl aluminium lead to lactam 18. Reduction with LiAIH4 afforded (-)-
indolizidine 167B. 
a b,c l ____ o o 
n-Pr'"" .• lN) 
d 
I 
11 12 Bn 13 
e 
P '"" .... ON ·--.... , f. 9 n- r I I 
Bn OH 
14 15 16 
H H Q=( 
h-Pr 0 
Cb 
ii-Pr 
17 18 (-)-indolizidine-1678 
Scheme 1.03 Reagents: (a) DIBAL-H, DCM, -78°C: then CH2CH2MgBr (53%, 8:1); (b) 
LiAIH4, THF, ooc (82%); (c) BrCH2C02Ph, i-PrNEt2, MeCN, ooc (60%); (d) TIPSOTf, NEt3, 
benzene, RT; (e) LiAIH4, ooc (79% 2 steps); (f) (COCI)2, DMSO, NEt3, -78°C; (g) KH, 
(EtOhP(O)CH2C02Et, THF, -78°C (66% 2 steps); (h) H2, Pd(OH)2/C, EtOH, 60°C; (i) Me3AI, 
benzene, 0°C to reflux (55% 2 steps); (j) LiAIH~. Et20, ooc (78%). 
4 
-
Enders et al. made use of (S)/(R)-1-amino-2-methoxymethylpyrrolidine 
(SAMPIRAMP)-hydrazones in the enantioselective synthesis of dendrobatid alkaloid 
indolizidine 2091 (Scheme 1.04).5 This method involved the use of chiral amines 
arising from the stereoselective reduction of SAMPIRAMP-hydrazones. Reaction of 1-
pentanal with RAMP gave chiral hydrazone 20, which was a-alkylated with 21 to give 
a 90% d.e of the desired acetal 22. Hydrazine 23 was obtained by reaction of an 
organocerium reagent derived from 3-tert-butyldimethylsiloxypropyl lithium, with 
complete asymmetric induction. Cleavage of the N-N bond was achieved with borane, 
followed by N-protection, and silyl deprotection with TBAF. Mesylation of the 
resulting alcohol was followed by ring-closure with potassium t-butoxide to give 
compound 24. Hydrogenolysis using Pearlman's catalyst, removed theN-benzyl ester, 
and acetal deprotection gave the aldehyde. Subsequent closure of the 6-membered ring 
was followed by in situ reduction of the imine with potassium cyanide, to give amino 
nitrile 25. The synthesis of indolizidine 2091 was completed by alkylation with n-propyl 
bromide and reduction with NaBH4. 
0 
n-Pr0 
H 
19 
n-Pr 
22 
~0 o~ n-Pr 0 _) OBn 
24 
a 
j. k 
/NQ b,c N ' n-Pr~ ~-oMe 
H ~ 
d 
20 
M eO~ 
(~::BS 
n-Pr 
<±> 
CN 
25 
n-Pr 
23 
1-n Cb 
Pr 
indolizidine 2091 
e-i 
Scheme 1.04 Reagents: (a) RAMP, THF, RT(90-IOO%); (b) LOA, THF, ooc; (c) 21, THF, 
-100°C (81% 2 steps); (d) TBSO(CH2 ) 3Li, CeCI3, THF, -100°C (82%); (e) excess BH3.THF, 
reflux; (t) CIC02Bn, Et20, ooc; (g) TBAF (72% 2 steps); (h) MsCI, NEt3, THF, ooc; (i) KOt-
Bu, THF, 0°C (70% 2 steps); U) H2, Pd(OH)2/C, MeOH; (k) HCI, KCN, pH = 4 (91%); (I) 
LOA, THF, ooc; (m) n-propyl bromide, THF, 0°C, (n) NaBH4, THF, RT (88-89% 3 steps). 
5 
Angle et al. have developed a diastereoselective synthesis of highly functionalised 3-
hydroxyproline benzyl esters from a-alkoxy N-protected aminoaldehydes and benzyl 
diazoacetate.6 Key intermediate 30 was made starting from di-0-isopropylidene-D-
mannitol 26 (Scheme 1.05). Stereospecific deoxygenation of the vicinal diol was 
achieved using mild conditions developed by Hanessian to give alkene 27.7 Removal of 
the acetonides using Amberlyst-15™, followed by bis-tosylation of the primary 
alcohols via a bis(dibutylstannylene acetal) intermediate furnished compound 28. Silyl 
protection of the secondary alcohols was achieved with TBDMSOTf, and then reaction 
of the ditosylate with NaNHTs gave 29, which was oxidatively cleaved with ozone to 
give key intermediate 30. This sequence of reactions was appealing, as one molecule of 
D-mannitol 26 could be converted into two molecules of chiral aldehyde. 
a, b c-e 
26 27 
NHTs 
OTBDMS 
h 
TBDMSO 
TsHN 
29 
OTs 
HO 
TsO 
28 
OTBDMS 
~0 
NHTs 
30 
OH 
f, g 
Scheme 1.05 Reagents: (a) CH(OMe)2NMe2, DCM, RT; (b) Mel, toluene, RT to reflux (86% 2 
steps); (c) Amberlyst-15, MeOH, RT (83%); (d) Bu2Sn0, toluene, reflux; (e) TsCI, RT (66% 2 
steps); (f) TBDMSOTf, 2,6-lutidine, DCM, 0°C (92%); (g) NaNHTs, DMSO, 80°C (72%); (h) 
0 3, DCM, -78°C; then thiourea ooc (81 %). 
Aldehyde 30 was reacted with benzyl diazoacetate and BF3.0Et2 and the free hydroxy-
group protected with MEMCI to give enantiopure proline derivative 31 (Scheme 1.06). 
Reduction with NaBH4 gave a primary alcohol that was displaced with iodide, followed 
by radical reaction with methyl acrylate to give methyl ester 32. Treatment with 
magnesium ribbon in MeOH gave lactam 33, with concomitant N-detosylation and 
6 
cyclisation. LiAIH4 reduction of the lactam and cleavage of the silyl ether, followed by 
removal of the MEM ether using CBr4 gave (-)-lentiginosine 34. 
OTBDMS 
~0+ 
NHTs 
30 
a,b 
OTBDMS A ..... "OMEM 
Ts~-{ 
C02Bn 
31 
H OMEM 
c;-b-·OTBDMS 
0 
33 
g,h 
c-e 
H OH (b-.. OH 
34 
Scheme 1.06 Reagents: (a) BF3.0Et2, DCM, -78°C (65%); (b) MEMCI, DIPEA, CHCh, reflux 
(78%); (c) NaBH4, EtOH, RT (88%); (d) PPh3, h, imidazole, DCM, reflux (86%); (e) methyl 
acrylate, Bu3SnH, AIBN, benzene, reflux (57%); (t) Mg, MeOH, RT (75%); (g) LiAIH4, THF, 
reflux; (h) CBr4, MeOH, reflux (54% 2 steps). 
Montgomery et al. report the stereoselective sythesis of (+)-allopumiliotoxin, by means 
of a nickel-catalysed, triethylsilane-mediated, reductive cyclisation of ynals (Scheme 
1.07). Oxazolidinone 35 was prepared from the methyl ester of L-proline using the 
Overmann protocol.8 Hydrolysis of the oxazolidinone ring was achieved with 
potassium hydroxide, followed by propargylation with enantiopure 36, to give 
compound 37. Benzylation of the tertiary alcohol followed by deprotection of the 
primary alcohol and oxidation lead to key intermediate 40. Cyclisation was induced 
with catalytic Ni(COD)2, triethylsilane and tributylphosphine, to give exclusively one 
diastereoisomer of bicycle 41. Deprotection of the silyl ether with HF.pyridine and the 
benzyl ether with lithium in ammonia afforded (+)-allopumiliotoxin 267A. 
7 
eR 
OSEM a 
35 
Br~+ /"'-.... /"'-.... 
36 y '-.,/ ........ 
r 
<=&;OR' 
37 R1 = H R2 = SEM bl ' ' 
L_ 38, R1 = Bn, R2 = SEM 
c L 39, R1 = Bn, R2 = H 
9 
r 
__ d_ .... Cko e 
OBn 
40 
f I 41, R=TES 
L_ 42, R= H 
(+)-allopumiliotoxin 267A 
Scheme 1.07 Reagent: (a) i. KOH, EtOH; ii. 36, DIPEA, THF (74% 2 steps); (b) BnBr, KH, 
THF (83%); (c) TBAF, Mol. Sieves, THF (94%); (d) (COCI)2, DMSO, NEt3 (93%); (e) Et3SiH, 
Ni(COD)l, PBu3, THF (95%); (f) HF.pyr, THF (92%); (g) Li/NH3, THF (88%). 
Brandi et al. made use of the I ,3-dipole of pyrroline-N-oxide derived from enantiopure 
malic acid, and reacted this with methylenecyclopropane to form novel indolizidinol 52 
(Scheme 1.08).9 The secondary alcohol of the diethyl ester ~f L-malic acid was 
protected with 2-methylpropene, and the esters reduced with LiAIH4, before bis-
mesylation of the primary alcohols gave 46. Reaction with hydroxylamine resulted in 
cyclisation to give compound 47. The key nitrone 48 was made after oxidation of the 
hydroxylamine with mercury(II)oxide. The oxidation reaction provided two 
regioisomers of the nitrone product, but compound 48 was the major isomer (9: I). The 
key step involved the 1,3-dipolar cycloaddition of nitrone 48 with 
methylenecyclopropane 49, to give a mixture of regioisomers. The major isomer 50 
underwent thermal rearrangement in xylenes to give indolizidinone 51. Reduction of 
the carbonyl group followed by deprotection of the alcohol gave (IS,7S,8aR)-
octahydro-1,7-dihydroxyindolizidine 52. This novel and unnatural indolizidine was 
targeted, due to the common occurrence of hydroxylated indolizidines at the C-1 and C-
7 position. Unfortunately the biological activity of this compound was not reported. 
8 
43 
0 1Bu 0 
I 
OH 
47 
otsu 
ctro 
51 
a 
e 
h, i 
44 
0 1Bu ~ 
d 
N+ 
I 
0-
48 
OH 
Cb-OH 
52 
b 0 1Bu d 
RO J ~OR 
9 
50 
Scheme 1.08 Reagents: (a) 2-Methylpropene, Amberlyst-HIS, n-hexane (91%); (b) LiAIH4, 
Et20, reflux (83%); (c) MsCI, NEt3, DCM (97%); (d) NH20H (85%); (e) HgO, DCM, 0°C 
(90%); (f) 49, benzene, RT (70%); (g) Xylenes, 140°C; (h) NaBH4, ethanol, 0°C (90%); (i) 
CF3COOH, RT (70%). 
Cha et al. use the coupling reactions of in situ generated dialkoxytitanacyclopropanes 
and carbonyl groups (Scheme 1.09), to access novel pyrrolizidine and indolizidine 
compounds, as well as the core of mitomycin derivatives. 10 The reaction involves the 
coupling of esters to dialkoxytitanacyclopropanes of type 53, in a formal double 
alkylation to afford oxygen-substituted cyclopropanes. 
a 
~R 
53 
i-PrO Oi-Pr 
\ / 
Ti 
~R 
53 
Oi-Pr 
0 
__ T'i-oi-Pr 
R1)_/-R 
R20 . 
Proposed 
intermediate 
Scheme 1.09 Reagents: (a) c-C5H9MgCI, CITi(Oi-Pr)3, DCM, 17 h. 
9 
The synthetic potential of the proposed reaction intermediate was unlocked in work 
towards mitomycin derivatives. Starting from o-imidostyrene 54, obtained from 
acylation with succinic acid of the o-aminostyrene, reaction with cyclopentane 
magnesium chloride and triisopropoxy titanium chloride gave the key dialkoxytitanium 
intermediate 55 (Scheme 1.10). Depending on how the reaction was quenched, the 
tricyclic cores 56 and 57 were obtained. The crucial primary alcohol required for 
further elaboration to mitomycin derivatives, was introduced by simply bubbling 
oxygen through the metallo intermediate. This is a powerful method for accessing a 
range of mitomycin antibiotics, and also novel bicyclic systems. 
R~ l(\ 0 
R' p 
0 
54, R' = OMe, R = H 
a 
R 
0 
55 
56 
Ryq]C.H~H 
I# 
N 
R' 
0 
57 
Scheme 1.10 Reagents: (a) c-C5H9MgCI, CITi(Oi-Pr)3; (b) 0 2 (60%); (c) H20 (42%). 
To date there have been several synthetic routes to the mitomycin antibiotics, however 
the majority of these have lead to non-racemic products. Sulikowski et al. have 
described a chemoselective carbon-hydrogen insertion reaction of a metal carbene, to 
access I ,2-aziridinomitosene products with high levels of optical purity (Scheme 1.11). 
Pyrrolidine 58 was silylated, then the Boc-protection removed to give azido compound 
59 with an enantiomeric excess of 95%. A Buchwald-Hartwig cross-coupling of 2-
bromoiodobenzene with 59 gave aryl bromide 61, 11 which was coupled with silyl 
ketene acetal 62 in the presence oftributyltin fluoride to give acetate 63. Hydrogenation 
of the azido group followed by acetylation and desilylation yielded amide alcohol 64. 
Mesylation followed by treatment with DBU gave oxazoline product 65. They reversed 
the trans stereochemistry of azido ether 63 to the cis-stereochemistry of oxazoline 65 to 
theoretically improve the efficiency of the key carbene insertion step. Hydrolysis of 65 
followed by tosylation, treatment with phosgene and methanolysis gave carbamate 67. 
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This in turn underwent diazotransfer using para-nitrobenzenesulfonyl azide to give 
diazoester 68. Optimal regioselectivity of the carbene insertion reaction was achieved 
using the copper(!) complex derived from ligand 69, with a 9:1 ratio in favour of 
regioisomer 70. The aziridomitosene core 71 was completed by hydrolysis of the 
oxazinone, mesylation and final aziridine formation with DBU. 
HO.UN3 
N 
Boc 
58 
TBDPSO\--(N3 
a,b () 
N 
H 
59 
Q-sr 
----=---y~ 
I ····•N3 
r(Y ~OTBS 
~Br OTBDPS O'Bu 
60 61 
q-s 
OTBDPS 
63 
71 
Scheme 1.11 Reagents: (a) TBDPSCI, imidazole; DMF; (b) TFA, DCM (95% 2 steps); (c) 60, 
Pd2(dba)J, BINAP, NaO'Bu, toluene, 80°C (66%); (d) 62, Pd(TohP)2Ciz (3 mol%), Bu3SnF, 
benzene, reflux (43-53%); (e) H2, Pd/C, EtOAc; (f) (CF3CO)z0, Et3N, DCM; (g) TBAF, THF 
(80% 3 steps); (h) MsCI, Et3N, DCM, ooc; (i) DBU, 23°C (94% 2 steps); (j) K2C03 , MeOH-
H20; (k) p-TsCI, Et3N, DCM, ooc (85% 2 steps); (I) ClzCO, pyr, DCM, 0°C; (m) MeOH, 
PTSA, reflux (97% 2 steps); (n) NaHMDS, -78°C; (o) PNBSA, -78°C toRT (67% 2 steps) (p) 
Cu(I)OTf, DCM, 69 (73% 9:1 ratio); (q) DCM-MeOH-H20, K2C03 (97%); (r) MsCI, Et3N, 
DCM, ooc (72%); (s) DBU, THF, ooc (82%). 
Smith et al. drew upon the pioneering work carried out by Corey and Seebach on 
dithiane chemistry, 12 in their synthesis of (-)-indolizidine 223AB (Scheme 1.12). 13 
Dithianes act as important umpolung reagents in organic synthesis, and form one ofthe 
components in this convergent strategy. Lithiation of dithiane 72, followed by addition 
of epoxide 73 and then aziridine 74 containing HMPA, effects a solvent controlled 
Brook rearrangement to yield compound 75. Bisdesilylation with TBAF, afforded the 
I 1 
diol 76, which was bismesylated, and detosylated in one pot, to effect cyclisation to 
indolizidine 77. Interestingly the dithiane moiety aids the cyclisation step, presumably 
via the Thorpe-lngold effect. Removal ofthe dithiane group was achieved with Raney-
Ni, completing the synthesis of (-)-indolizidine 223AB. 
(l 73 
sys o 
TBSO' ..... 
TBS 
'-------72 
s OH 
'\;S~ 
~ HO~ 1 76 
S OTBS 
I ~"""-<1Ts 1-a-_c_'\;S~ 
_e,f_'\;SYD 
77 I 
~ TBsl 
'I 75 
g 
d 
(-)-indolizidine 223AB 
Scheme 1.12 Reagents: (a) t-BuLi, Et20, -78°C to -45°C; (b) 73, Et20, -78°C to -25°C; (c) 
74, HMPA/Et20, -78°C to 0°C (56% 3 steps); (d) TBAF (98%); (e) MsCJ, Et3N, THF, RT; (f) 
K2C03, MeOH, RT, 3 h; then 5% Na-Hg, Na2HP04, RT (95% 2 steps); (g) Raney-Ni, EtOH, 
Hz, RT (69%). 
Katsuki et al. prepared (-)-swainsonine by means of a chiral Mn(III)-salen mediated 
desymmetrisation of 3-pyrroline 78 (Scheme 1.13). 14 N-Protection via the carbamate 
followed by dihydroxylation and acetonide protection gave the symmetrical compound 
79. The key step in this asymmetric synthesis used a chiral Mn(III)-salen catalysed 
oxidative desymmeterisation with PhiO, to give an alcohol in 71% ee which was then 
oxidised to the lactam 80 with PCC. In situ generation ofthe Grignard reagent derived 
from CI(CH2)4Mg8r and reaction with the lactam gave the chloro amine 81, which 
underwent base mediated deprotection and cyclisation to give chloro imine 82. Heating 
in toluene effected cyclisation to give a bicyclic iminium salt, which was subjected to 
base to generate the enamine. This was then hydroborated with an oxidative work up to 
give a hydroxy group, and final acetonide removal yielded (-)-swainsonine. 
12 
oxo 
d,e 
oxo 
f 0 a-c HttH nH N 
H N 0 N 
Boc Boc 
78 79 80 
NHBoc 
><:0 g ><:l{JCI h-k 8:5" ... ,,,OH 
0 
81 82 (-)-swainsonine 
Scheme 1.13 Reagents: (a) Boc20, Et3N, DMAP, DCM, RT, 12 h; (b) K20s04.2H20, 
K3Fe(CN)6, KzC03, DABCO, CH3SOzNHz, t-BuOH, H20, RT, 15 h; (c) (CH3)2C(0Me)2, p-
TsOH, DMF, RT, 20 h (75% 3 steps); (d) Chiral Mn(III)-salen, PhiO, PhCI, -25°C, 25 h; (e) 
PCC, DCM, RT, 8 h (56% 2 steps); (f) Br(CH2) 4Cl, Mg, THF, -78°C, 1.5 h (71 %); (g) 
TMSOTf, PhSH, DCM, 0°C, 1.5 h (83%); (h) toluene, reflux, 16 h; (i) t-BuNH2, KHMDS, 
toluene, 2 h; (j) BH3.THF, THF, RT, 10 h; then NaOAc, H20 2, RT, 12 h (67% 3 steps); (k) 
PPTS, MeOH, RT, 65 h (45%). 
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1.2 Stemona Alkaloids 
1.2.1 Introduction to the Stemona Alkaloids 
The Stemona alkaloids are a structurally diver e class of alkaloids isolated from the 
roots and rhizomes of the Stemonacae plant family (Figure 1.03). The extracts of 
several plants of this family (Stemona and Croomia genera) have been used in 
traditional Chine e and Japanese folk medicine as treatments for bronchitis, 
tuberculosis, pertussis and as anti-helmintics. 15•16 These alkaloids also show 
extraordinary in ecticidal activity. 17 Although the specific biological activities of the 
individual members of this alkaloid family are quite limited, it i known that the 
extracts consist of a eries of structurally related alkaloids thought to be re pon ible 
for their medicinal properties. The 60 known Stemona alkaloids have been classed 
into six groups depending on structural criteria. The structures of 20 of these, 
including stenine, stemoamide, stemo pironine, croomme, stemoamine, 
parvistemoline and stemofoline (Figure 1.04) have been conftrmed by X-ray analyses 
whilst the remaining alkaloids have been detennined from spectroscopic data and/or 
by chemical correlation. 16 
Figure 1.03 The foliage of a member of the Stemonaecae Croomia genera 
Common to five of the six groups is a central l-azabicyclo[5.3 .0]decane y tern as the 
most characteristic structural feature. However y-butyrolactones are al o common 
occurring as trans- ci - and spiro-fused ystems. The ixtb miscellaneous group of 
the Stemona alkaloids arises from cleavage of the basic 1-azabicyclo[5.3 .0]decane 
ring system. 
14 
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1-azabicyclo[5.3.0) 
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0}---te 
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OMe H 
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Figure 1.04 A selection of Stemona alkaloids and the 
l-azabicyclo[5.3.0]decane skeleton 
1.2.2 Syntheses of the Stemona Alkaloids 
Williams et al. achieved the first synthesis of a Stemona alkaloid in 1989, in the 
enantiocontrolled synthesis of (+)-croomine (Scheme 1.13).18 Consecutive ring 
closures arose from the preliminary construction of a branched acyclic carbon 
framework. The terminal acetylene 83 was acylated with methyl chloroformate, 
before copper-catalysed conjugate Grignard addition of BnO(CH2)4MgBr, and 
subsequent DIBAL-H reduction gave allylic alcohol 85. Sharpless asymmetric 
epoxidation followed by Swern oxidation of the allylic alcohol, allowed 
homologation following a Wittig protocol with a suitable phosphorous ylide, yielding 
vinyl epoxide 87. Reduction of the ester using LiBH4, followed by hydrogenation of 
the alkene using rhodium on alumina gave the saturated alcohol, which was protected 
as the benzoate ester before addition of lithium azide and DMPU to give azido 
alcohol 88. Reaction with boron trifluoride etherate generated the saturated dioxepine 
ring, then ester hydrolysis and Swern oxidation gave an aldehyde which was reacted 
with the chiral ylide 86 to give alkene 89 exclusively as the (Z)-isomer. Acid 
hydrolysis of the dioxepine acetal and basic saponification yielded a trio! which was 
oxidised to the lactone ring using Jones' reagent. Esterification of the terminal 
carboxylic acid using diazomethane generated butyrolactone 90. Removal of the 
15 
benzyl ether followed by oxidation gave an azido aldehyde which was reacted with 
triphenylphosphine to generate an aza-ylide. Subsequent intramolecular Wittig 
condensation produced a seven-membered imine, which was reduced to azepine 91 
with sodium borohydride. The final two ring-closures were accomplished in a single 
iodoamination step to give synthetic (+)-croomine. 
' R MEMO~ 
a I 83R=H . 
l-. 84 R=C02Me 
91 
b,c 
HO 
d-f 
85 
(+)-croomine 
0 
87 
90 
BnO 
• ~OBz 
Ph3P 
86 
g-j 
s-u 
Scheme 1.14 Reagents: (a) n-BuLi, THF, -78°C to ooc; then CIC02Me, -78°C (63%); (b) 
BnO(CH2)4MgBr, Me2S.CuBr, TMEDA, Et20, -78°C (95%); (c) DIBAL-H, DCM, -78°C 
(98%); (d) Ti(i-Pr0)4 (cat.), D-DIPT (cat.), t-BuOOH, 4A MS, DCM, -50°C (83%); (e) 
(COCI)z, DMSO, NEt3, DCM, -78°C to 0°C; (f) Ph3P=CHCOMe, ooc to RT (89% 2 steps); 
(g) LiBH4, Et20, MeOH, ooc (81%); (h) 5 % Rh/AI20 3 , H2, THF (62%); (i) BzCI, NEt3, 
DCM, 0°C toRT (97%); U) LiN3, DMPU, ll0°C, (94%); (k) BF3.Et20, DCM, 0°C (81 %); (I) 
LiOH, THF, aq. MeOH (97%); (m) (COCI)2, DMSO, NEt3, -78°C toRT (91%); (n) 86, 
THF, -10°C (70-81%); (o) aq. HBF4, MeOH (74%); (p) LiOH, THF, aq. MeOH, 22°C 
(86%); (q) Jones' reagent, THF, ooc; (r) CH2N2, DCM, Et20 (72% 2 steps); (s) BCI3, DCM, 
-78°C to 0°C; then MeOH, -78°C (77%); (t) (COCI)2, DMSO, NEt3, -78°C to RT (92%); 
(u) Ph3P, THF, 22°C; then NaBH4, MeOH (90%); (v) 12, DCM, Et20, 22°C (25%). 
The first total synthesis of racemic stenine was achieved by Hart et al., utilising an 
intramolecular Diels-Aider reaction to construct the indolizidine core of the 
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molecule.19 It relies on the synthesis of key intermediate 98 starting from (E)-3,5-
hexadienol 92 (Scheme 1.15). Esterification with (E)-2,4-pentadienoyl chloride 93 
gave the precursor for the Diets-Alder reaction, which was promoted by Lewis acid to 
give bicycle 94. Ring-opening of the lactone with hydrazine, followed by exhaustive 
methylation and acylation of the primary alcohol gave aminimide 95. This underwent 
an aminimide variant of the Curtius rearrangement in refluxing mesitylene to give an 
intermediate isocyanate, which was quenched with methanol to give carbamate 96. 
Hydroboration using sodium perborate as oxidant, and mesylation gave compound 
97, which was cyclised using two equivalents of methyl lithium to key intermediate 
98. 
( ·~0 
o? ~ 93 Cl 
92 OH 
H 
ct:~Me 
i H 
AcO • 
-....__/ 96 
g,h 
a, b ~ ~0 
94 
H 
~ OMs O:::,Me 
~ H 
A eO~ 
97 
95 
H 
-W ~ H C02Me HO = 
-....__/ 98 
Scheme 1.15 Reagents: (a) n-BuLi (100%); (b) Et2AICI, CHCb, 85°C (67%); (c) NH2NH2, 
MeOH (87%); (d) Mel (100%), K2C03 ; (e) CH3COCI (lOO%); (f) mesitylene, reflux, MeOH 
quench (94%); (g) 9-BBN, NaB03.4H20 (95%) (h) MsCI, Et3N (100%); (i) MeLi (2 equiv.) 
(94%). 
The next step m the synthesis involved oxidation of 98 to the acid 99, and 
iodolactonisation in a biphasic system to give 100. Dehydrohalogenation with DBU, 
reductive cleavage of the lactone and selective protection ofthe primary alcohol with 
TBSCI gave 101. Reaction of the secondary alcohol with amide acetal 
MeC(OMe)2NMe2, lead to an intermediate which underwent a Claisen rearrangement 
to yield compound 102. Iodolactonisation to form the lactone ring present in stenine, 
was accompanied by desilylation of the silyl ether. Keck allylation proceeded with 
excellent diastereoselectivities, presumably because of steric effects to give 105.20 a-
Methylation of the lactone ring, Swern oxidation of the primary alcohol and Wittig 
homologation, gave a conjugated diene which was selectively reduced using Red-Al. 
Removal of the carbamate protection was achieved \~ith trimethylsilyl iodide to give 
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compound 105. The tetra cyclic core of stenine was completed after refluxing in 
mesitylene, and the allylic alkene oxidised using Johnson-Lemieux conditions. 
Finally, to introduce the pendant ethyl group and remove the amide carbonyl, reaction 
with 1,2-ethanedithiol and Lawesson's reagent gave thioketal 107, which was 
desulfurised using Raney-nickel to give racemic stenine (Scheme 1.16). 
a 
98 
0 }-~ H 
om·w ~.... :: 
X ' N, ~ H C02Me HO~ 
n,o 
he 103, X= I 
0 ~H 
0, ' " 
- p,q 
0 \:J=o 
106 107 (±)-stenine 
Scheme l.l6 Reagents: (a) Cr03, H2S04 (83%); (b) 12, NaHC03(aq) (95%); (c) DBU (98%); 
(d) NaBH4 (lOO%);( e) K2C03, TBSCI (100%); (f) MeC(OMe)2NMe2 (93%); (g) 1z (75%); (h) 
n-Bu3SnCH2CH=CH2. AIBN, benzene, reflux (83%); (i) LOA, THF, Mel (87%); U) Et3N, 
DMSO, (COCI)2 (99%); (k) Ph3P=CHC02Et (91 %); (I) Red-A!, Cu(I)Br (85%); (m) Me3Sil, 
CH2Ch, RT (94%); (n) Mesitylene, reflux (91%); (o) Os04 (cat.), Nal04 (84%); (p) 
HSCH2CH2SH, SiOrSOCh (100%); (q) (p-MeOC6H4PS2)2 (100%); (r) Raney-Ni, EtOH 
(75%). 
In 1998 Rigby et al. reported a novel strategy to the azepinoindole skeleton present in 
stenine, neotuberostemonine and tuberostemonol (Scheme 1.17).21 The key step 
makes use ofa [1+4] cycloaddition between vinyl isocyanate 108 and the 1,1-dipole 
equivalent present in alkyl isocyanide 109, to give hydroindolone 110. Routine 
enamide alkylation with 1,4-diiodobutane gave alkylated hydroindolone 111, which 
was cyclised to the tricyclic enamide 112, using ethyl magnesium bromide and 
diglyme. Hydrolysis of the enamine was achieved using an aqueous solution of oxalic 
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acid dihydrate to give the hydroisatin derivative 113, existing primarily in the enol 
form. Oxidation with m-CPBA resulted in functionalisation at the y-position of the 
extended enol to give oxidation product 114, containing ring fusion patterns 
consistent with tuberostemonol. 
Q + Cy-N=C: ______:__ 
NCO 
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114 
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Scheme 1.17 Reagents: (a) Xylene, reflux (83%); (b) NaH, DMF, ooc; then I2(CH2) 4 (56% 2 
steps); (c) EtMgBr, diglyme, 120°C (70o/D); (d) (COOH)2, THF/H20 (60%); (e) m-CPBA, 
CHCb, -l5°C (93%). 
Padwa et al. describe the total synthesis of (±)-stenine, which relies on an 
intramolecular [4+2]-cycloaddition of a 2-methylthio-5-am'ido furan (IMDAF) to 
create the azepinoindole skeleton (Scheme 1.18).22 This approach differs from most, 
as the azepine ring system was introduced at an early stage, acting as a template for 
stereochemical manipulation later in the synthesis. Caprolactam 115 was subjected to 
an. aldol reaction with bis-(methylsulfanylacetaldehyde ), then acetic anhydride 
quench to give amide 116. Acylation with trans-5-chlorocarbonyl-pent-3-enoic acid 
methyl ester gave imide 117. Methyl sulfonylation of one ofthe methylthio groups of 
117 with dimethyl(methylthio)sulfonium (DMTSF) induced thionium-promoted 
cyclisation. The resulting dihydrofuran readily lost acetate to furnish the desired furan 
118. This compound rapidly rearranged at room temperature via the IMDAF 
mechanism, resulting in azepinoindole 119. Removal of the methylthio group was 
achieved with Raney nickel, and subsequent Luche reduction of the ketone afforded 
alcohol 120 as a single diastereoisomer. Stereoselective hydrogenation was achieved 
by [lr(cod)pyr(PCy3)]PFJCH2Cb, a catalyst described by Crabtree et a/.,23 to give 
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exclusively the syn-anti conformation at the ring fusion sites. Regioselective 
dehydration was achieved by converting the alcohol to the mesylate before treatment 
with DBU to give compound 121. Hydrolysis of the methyl ester followed by 
iodolactonisation formed the lactone 122. Final conversion to (±)-stenine was 
accomplished using a Keck allylation with allyltributyl-stannane?0 Johnson-Lemieux 
oxidation afforded the desired aldehyde,24 which was treated with 1,2-ethanedithiol. 
Conversion of the amide to the thioamide was done using Lawesson's reagent, 
followed by desulfurisation with Raney-Nickel and methylation of the lactone enolate 
with methyl iodide to give racemic stenine. 
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Scheme 1.18 Reagents: (a) LOA; (b) (MeS)2CHCHO; (c) Ac20, (80%, 3steps); (d) 
Me02CCHzCH=CHCH2COCI, (85%); (e) DMTSF, NEt3, (80%); (f) Raney-Ni, EtOH, (92%) 
(g) NaBH4, CeCh, MeOH, (77%), (h) Crabtree's catalyst, Hz, CH2C)z; (i) MsCI, NEt3, OBU, 
(64%, 2 steps); (j) LiOH, H20; (k) 12, MeCN; (60%, 2 steps); (I) CH2=CHCH2SnBu3, AIBN, 
(62%); (m) Os04, Nal04; (n) HSCH2CH2SH, BF3.Et20, (48%, 2 steps); (o) Lawesson's 
reagent (73%); (p) Raney-Ni; (q) LOA, HMPA, Mel (93%, 2 steps). 
Wipf et al. have developed a general methodology towards the azepinoindole core 
with Cbz-L-tyrosine 123 acting as the key building block. They have used this 
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protocol in the synthesis of stenine, 25·26 and also (-)-tuberostemonine (Scheme 
1.19).27 Bicycle 125 was obtained by treating Cbz-L-tyrosine 123 with 
iodobenzenediacetate and NaHC03 in a one-pot procedure before benzoylation of the 
tertiary alcohol, followed by reduction of the en one using Luche conditions. Reaction 
with Pd2(dba)2.CHCh gave a 1r-allyl intermediate which was reduced in situ using 
formic acid to give 125. Silylation ofthe alcohol was followed by deprotection ofthe 
carbamate, before cinnamylation and subsequent fluoride-induced desilylation to give 
alcohol128. Ruthenium tetroxide oxidation ofthe secondary alcohol was followed by 
a stereoselective alkylation of the enolate generated from reaction with KHMDS to 
give pre-cyclisation compound 129. Ring closing metathesis was carried out using 
Grubbs catalyst 130 to give azepinoindole 131. Thiophenol was used as a transient 
protection of the enone double bond to allow reduction of the azepine alkene with 
Wilkinson's catalyst. The thiophenol was removed with DBU, and 1,2-reduction of 
the enone was followed by silyl protection to give 132. The ester was then converted 
to the Weinreb amide 133 which was added to the lithium anion of ortho ester 134 to 
give ketone 135. Reduction of the ketone with L-selectride, followed by acidic 
removal of the ortho ester and silyl ether protecting groups lead to cyclised lactone 
136 as a single diastereoisomer. ' 
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Scheme 1.19 Reagents:(a) Phi(OAc)2. NaHC03, MeOH (20-60%); (b) Bz20, NEh; (c) 
NaBH4, CeCb.7HzO (89% 2 steps); (d) Pdz(dba)z.CHCb, NEt3, HCOOH, PBn3, THF, 65°C 
(93%); (e) TBDMSCl, imidazole, DMAP, DCM (97%); (f) Et3SiH, Pd(OAc)2, NEt3, DCM, 
RT (90%); (g) cinnamyl bromide, K2C03, toluene, 60°C (96%); (h) TBAF, THF, RT (96%); 
(i) TPAP, NMO, DCM (88%); (j) KHMDS, allyl iodide, -90°C (66%); (k) cat. 130, DCM, 
reflux (92%); (I) PhSH, NEt3, DCM, (91 %); (m) (PPh3) 3RhCl, H2, EtOH/DCM, RT; (n) 
DBU, DCM, RT (89% 2 steps); (o) CeCl3.7H20, NaBH4, THF/MeOH, ooc (71%); (p) 
TBDMSCI, imidazole, DMAP, DCM, RT (79%); (q) (Me)(OMe)NH.HCI, Me2AlCI, DCM, 
RT (94%); (r) 134, LiDBB; then 133 (95%); (s) L-Selectride, THF, -78°C (80%); (t) TsOH, 
MeOH (70%). 
The introduction of the final lactone ring began by Claisen rearrangement using N,N-
dimethylacetamide dimethyl acetal to give 137 (Scheme 1.20).28 
Selenolactonisation29 followed by Keck allylation20 and a-methylation of the fused 
lactone ring with methyl iodide gave tetracycle 140. Chain contraction of the allyl 
group was achieved first by isomerisation of the double bond using allyltritylamine 
and Grubbs 2nd generation catalyst 130, before ethylene cross-metathesis with catalyst 
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143 gave compound 142. The synthesis of tuberostemonine was completed by 
hydrogenation using palladium on carbon. 
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Scheme 1.20 Reagents: (a) N,N-Dimethylacetamide dimethyl acetal, xylenes, 135°C (78%); 
(b) PhSeCl, MeCN/H20, ooc (67%); (c) AIBN, allyltriphenyltin (neat), 95°C (70%); (d) 
LOA, HMPA, THF, -78°C, Mel (76%); (e) 130, allyltritylamine, DIPEA, toluene, ll0°C 
(85%); (f) TsOH, 143, DCM, reflux, ethylene (81%); (g) Pd/C, H2 (l atm), MeOH (97%). 
Kende et al. have addressed the structurally demanding spirocyclic core of 
stemonamide. A fifteen step total synthesis of stemonamide and isostemonamide has 
been reported.30 They both contain a characteristic tetra cyclic core, with two 
contiguous spirocyclic centres differing in relative stereochemistry at the quaternary 
centres. The heteroatoms are in an anti relationship in stemoamide, but syn in 
isostemonamide (Figure 1.05). 
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stemonamine isostemoamine 
Figure 1.05: Stemonamine and isostemonamine.4 
Their route involved a divergent parallel synthesis from identical starting materials. 
Grignard addition to PMB protected succinimide 144, resulted in a hemiaminal that 
was protected as the methoxy derivative 145, then hydrogenolysis ofthe benzyl group 
afforded the spiro compound 146. Addition of siloxyfuran 147 to the N-acyliminium 
ion generated from 146 generated the first quaternary centre as a mixture of 
diastereomeric alcohols 148. Swem oxidation afforded aldehydes, which were 
cyclised with DBU to give the tricyclic products, and further oxidised under Swem 
conditions to a separable mixture of tricyclic ketones 149 and 150. The desired 
enones were synthesised by first generating the silyl enol ether with tert-
butyldimethylsilyl triflate, the oxidation with Pd(OAc )2 produced en ones 151 and 
152, setting the platform for the parallel synthesis of both stemonamine and 
isostemonamide (Scheme 1.21). 
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Scheme 1.21 Reagents: (a) BnO(CH2) 3MgBr, Et20, reflux 30 min; (b) PPTS, MeOH, RT, 30 
min (90%, 2 steps); (c) H2, 5% Pd/C, 3 h (90%); (d) 147, BF3.Et20, CH2C]z, RT, 40 min 
(82%); (e) (COCI)2, DMSO, Et3N, CH2C)z; (f) DBU, CH2CI2, 12 h, RT; (g) (COCI)2, DMSO, 
Et3N, CH2C]z (70%, 3 steps); (h) TBDSOTf, collidine, toluene, 7 h, 0°C-RT (149, 80% and 
150, 68%); (i) Pd(OAc)2. 02. DMSO, 80°C, 24-48 h (151, 93% and 152, 89%). 
The total synthesis of (±)-stemonamide was achieved by conjugate addition of the 
necessary Grignard reagent to isomer 152 in the presence ofCuBr-Me2S, which gave 
predominantly anti addition with respect to the C-N bond (Scheme 1.22). The 
exocyclic double bond was introduced by firstly a Mannich reaction with 
dimethylmethyleneammonium trifluoroacetate to install the a-methyl group followed 
by olefination and treatment with KH to give compound 153. Removal of the PMB 
groups with eerie ammonium nitrate yielded the unprotected lactam, which was 
treated with RhCb to effect isomerisation of the exo-double bond to an endo position 
as in 154. Azepine ring closure was achieved by nucleophilic displacement of the 
mesylate with Nal to afford (±)-stemonamide. An identical approach was used 
starting from tricyclic ketone 152 in the synthesis of (±)-isostemonamide. 
25 
0 
q,c((OM• tx~ N 0 
I 
PMB 
152 
a 
0 
155 
0 
b c,d 
OPMB 
153 154 
e, f 
(±)·stemonamide 
Scheme 1.22 Reagents: (a) PMBO(CH2) 4MgBr, 5% CuBr-Me2S, TMSCI, HMPA, THF,-
78°C, 30 min (74%, 6.4:1, a:fJ); (b) KH, Me2N=CH/CF3Coo·, THF, 12 h (67%); (c) CAN, 
CH3CN-H20, 2 h (80%); (d) RhCh.H20, EtOH/H20 (10:1), reflux, 36 h (66%); (e) MsCl, 
DMAP, pyridine, CH2C}z, 0°C, I h; (f) NaH, THF, RT, 30 h (33%, 2 steps). 
Williams et al. carried out the first synthesis of stemoamide in 25 steps in 1994.31 
Since then Narasaka, Mori, Jacobi and most recently Somfai in 2007 have attempted 
to construct the tricyclic core and control the stereochemistry of its four chiral 
centres.32"35 Jacobi et al. have previously prepared racemic stemoamide in an elegant 
synthesis consisting of only 7 steps.34 They have further refined this procedure and 
describe a novel synthesis of (-)-stemoamide containing a key (Diels-Alder)-(retro-
Diels-Aider) sequence to construct the core system (Scheme 1.23). Starting from L-
pyroglutamic ·acid, esterification to the methyl ester followed by reduction with 
NaBH4 gave lactam 157. Protection of the primary alcohol with vinyl ethyl ether was 
followed by alkylation with oxazole 160 and removal of the alcohol protection using 
TsOH to give compound 161. Swern oxidation gave the unstable aldehyde 162, which 
was reacted immediately with the Gilbert-Seyferth reagent to give alkyne 163. 
Methylation ofthe alkyne terminus lead to key intermediate 164. The (Diels-Aider)-
(retro-Diels-Aider) reaction was promoted in refluxing diethyl benzene, with 
spontaneous loss of acetonitrile to form enantiomerically pure butenolide 165. The 
26 
correct stereochemistry found in (-)-stemoamide was established using the nickel 
boride catalyst derived from NaBHJNiCb.36 
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Scheme 1.23 Reagents: (a) SOCh, MeOH, RT (90%); (b) NaBH4, MeOH, RT (92%); (c) 
vinyl ethyl ether, CI,CC02H, CHCI,, RT (93%); (d) 160, NaH, DMF, 0°C (67%): (e) TsOH, 
MeOH (83%); (f) (COCI)z, DMSO, NEt3, -78°C ; (g) (Me0)2P(O)CHN2, 'BuOK, THF, 
-78°C (65% 2 steps); (h) LDA, -78°C; then Me! (32%); (i) Diethylbenzene, 182°C; (j) H20, 
(52%, 2 steps); (k) NaBH4, NiCh, MeOH, -30°C, (73%). 
Olivio et al. report the total synthesis of (-)-stem?amide using a MgBr2-catalysed 
stereoselective anti-aldol reaction of a N-acyl thiazolidinethione (Scheme 1.24).37 
Addition of the titanium enolate derived from 4R-phenyl thiazolidinethione with the 
iminium ion formed from a suitable pyrrolidinone precursor, gave the correct 
diastereomeric product 166 in good yield. Evans has extensively researched the use of 
chiral thiazolidinethione auxiliaries in diastereoselective aldol reactions, and in this 
case the anti-aldol product was formed, facilitated by silylation with TMSCI and 
catalytic amounts of MgBr2.0Et2• Crucially, this key intermediate now possessed 
three of the required stereocentres present in the natural product. The aldol product 
was protected as the triethylsilyl ether 167 in quantitative yield. All attempts to 
partially reduce the chiral thiazolidinethione failed, so the auxiliary was removed 
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reductively to give the alcohol 168, which was then oxidised to aldehyde 169 with 
perruthenate. Wittig reaction with the necessary phosphonium ylide, gave an 
inseparable E,Z-mixture ofmethylvinyl ethers. Acidic removal ofthe silyl protection, 
hydrolysis of the methylvinyl ether and oxidation of the residual lactol with PCC 
gave the desired lactone 170. Ring-closing-metathesis was achieved with Grubbs 
second generation catalyst in refluxing 1 ,2-dichloroethane. The synthesis was 
completed by palladium-catalysed hydrogenation of the unsaturated azepine 171, 
followed by stereoselective methylation32 from the least hindered face of the lactone 
to give (-)-stemoamide. 
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Scheme 1.24 Reagents: (a) TiCI4, DIPEA, DCM, -78°C (92%); (b) cinnamaldehyde, cat. 
MgBr2.0Et2, RT; then TMSCI, Et3N, EtOAc, HCI (74%); (c) TESOTf, 2,6-lutidine, 0°C, 
DCM (99%); (d) NaBH4, -50°C, EtOH (96%); (e) TPAP, NMO, DCM (90%); (t) 
Ph3P=CHOCH3, THF, -78°C (76%); (g) p-TsOH, THF/H20, reflux (88%); (h) PCC, NaOAc 
(87%); (i) 130 (cat.), (CICH2)z, reflux (60%); U) H2, Pd/C, MeOH (99%); (k) LiHMDS, THF, 
Mel, -78°C (70%). 
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To date there have been far more syntheses of both racemic and natural (-)-
stemoamide/1-34'38 but increasingly more attention is being focused on the preparation 
of analogues ofstemoamide. Khim et al. report an efficient synthesis of(-)-9,10-epi-
stemoamide via a sequential asymmetric Birch reduction-alkylation, lithium 
hydroxide-promoted fragmentation and a 7-exo-trig radical cyclisation (Scheme 
1.25). Birch reduction of compound 173 provided a chiral enolate, which was then 
alkylated in situ with methyl iodide to give cyclohexadiene 174 as a single 
diastereoisomer. The enol ether was hydrolysed using 6 M HCl to give p,y-enone 175. 
Iodolactonisation gave the enantiomerically pure carbolactone 176, which was then 
fragmented with lithium hydroxide monohydrate to give the requisite key 
intermediate 177. The butenolide carboxylic acid 177 was reduced to the primary 
alcohol using borane-tetrahydrofuran complex, and subsequent Mitsunobu reaction 
with succinimide gave imide 178. The carbinol lactam 179 was achieved by NaBH4 
reduction, and this in turn was reacted with PhSH in the presence of p-TSA to give 
the thiophenyl radical precursor 181. Radical reaction with Bu3SnH and AIBN (cat.) 
resulted in ring-closure, to give an inseparable mixture of (-)-9,10-epi-stemoamide 
and 182 in a 10:1 ratio respectively. The mixture was epimerised using K2C03 in 
MeOH, resulting in exclusively the more thermodynamically stable (-)-9,10-epi-
stemoamide. 
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Scheme 1.25 Reagents: (a) K, NH3, THF, t-BuOH (I equiv), -78°C, piperylene, Mel; (b) 6 
M HCI, MeOH, RT; (c) 12, THF/HzO (1:1), RT (81% 3 steps); (d) LiOH.H20, THF/H20 
(10:1), RT (41%); (e) BH3.THF, THF, -30°C (92%); (f) succinimide, Ph3P, DEAD, THF, RT 
(92%); (g) NaBH4, MeOH, -10°C (88%); (h) PhSH, TsOH.H20, benzene, ooc (70%); (i) 
Bu3SnH, AIBN (cat.), benzene (3.5 mM), reflux, 24 h; (j) K2C03, MeOH, RT (74% 2 steps). 
Cossy et al. recently reported a similar free-radical approach to the tricyclic core of 
stemoamide and its analogues (Scheme 1.26).39 They utilised the 7-exo-trig radical 
cyclisation previously seen, in the synthesis of (±)-9, I 0-bis-epi-stemoamide, which 
controlled three of the four contiguous stereocentres in one step. Diol183 was doubly 
protected with TBSCI, and the primary silyl ether selectively deprotected using 
ammonium fluoride to give 185. Substitution of the primary hydroxyl with 
succinimide was carried out using a Mitsunobu-type reaction to give imide 186. This 
in turn was selectively reduced using Super Hydride®, to give compound 187 which 
was treated with PhSH in the presence of p-TSA to give the thiophenyl radical 
precursor 188. These acidic conditions also cleaved the silyl ether, which was 
subsequently reacted with methylacrylic acid to give ester 189. The lactone ring was 
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installed using a ring closing metathesis reaction with second generation Grubbs 
catalyst, to give the key intermediate 190. The crucial 7-exo-trig radical cyclisation 
occurred using Bu3SnH and catalytic AIBN to give (±)-9, 1 0-bis-epi-stemoamide as a 
single diastereoisomer, in a disappointing final-step yield of an unoptimised 20%. 
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Scheme 1.26 Reagents: (a) TBSCI, imidazole, DCM (93%); (b) NH4F, MeOH, 65°C (58%); 
(c) succinimide, DIAD, Ph3P, THF (91%); (d) LiBEt3H, THF, -78°C (96%); (e) p-TSA 
(cat.), PhSH (87%); (t) methylacrylic acid, DCC, DMAP (cat.), DCM (86%); (g) Grubbs 11 
(10 mol%), DCM, 40°C, 3 h (79%); (h) Bu3SnH, AIBN, benzene (~5 mM), 80°C (20%). 
Gurjar et al. have reported a formal synthesis of (-)-stemoamide using a 
carbohydrate-based approach.38 Their method involves the elaboration of o-glucose 
and a stereocontrolled allylation under Barbier conditions. A ring closing metathesis 
approach forms the integral azepine ring system (Scheme 1.27). Starting material 
191, obtainable from D-glucose diacetonide in three steps, was subjected to Swern 
oxidation conditions to form an unstable aldehyde, which was immediately reacted 
with allyl bromide in the presence of activated zinc. This Barbier-type reaction 
yielded exclusively stereoisomer 192, arising from a 7-membered zinc-chelated 
transition state. Hydroboration-oxidation of 192 followed by a protection-
deprotection sequence furnished the mesylate and treatment with NaN3 afforded the 
azido alcohol. Swern oxidation followed by reaction of NaC102 with the resulting 
aldehyde gave the azido acid and after esterification. The methyl ester 193 was 
obtained. Hydrogenation of 193 with palladium on carbon resulted in cyclisation to 
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give the 2-pyrrolidine ring, and phase transfer N-allylation in a biphasic system gave 
compound 194. Selective deprotection of the 5,6-acetonide moiety using H2S04 in 
MeOH, bismesylation of the resultant diol and elimination with sodium iodide gave 
the desired precyclisation intermediate 195. The azepine ring was completed using 
Grubbs ring closing metathesis. Hydrogenation of the double bond and treatment with 
Amberlyst-15 afforded the methyl glycoside P-isomer 197. Deoxygenation of the C-2 
hydroxyl was achieved using Barton's radical deoxygenation procedure.40 Treatment 
with thiocarbonyl diimidazole and in situ addition of n-Bu3Sn, AIBN (cat.) afforded 
198. Finally they-lactone was installed using Grieco's procedure to give compound 
199.41 Methylation using LDA and methyl iodide lead to the total synthesis of(-)-
stemoamide. 
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Scheme 1.27 Reagents: (a) (COCih, DMSO, Et3N, -78°C, I h (80%); (b) allyl bromide, Zn, 
sat. NH4CI, THF, 30 min (81%); (c) BH3.(CH3) 2S, THF, 0°C-RT, I h, then NaOAc, H20 2, 30 
min (65%); (d) TBSCI, imidazole, CH2CI2, RT, I h (90%) then MsCI, Et3N, CH2Cl2, 0°C-RT, 
30 min (85%); (e) NaN3, DMF, 75-85°C, 32 h (77%); (f) (COCI)2 , DMSO, Et3N, -78°C, I h 
(80%) then NaCI02, DMSO, NaH2P04, H20, 0°C-RT, I h (95%) then CH2N2, 50% KOH 
soln., Et20, -20°C, 5 min (94%); (g) 10% Pd/C, H2, MeOH, RT, 6 h (87%); (h) allyl 
bromide, 50% KOH soln, C6H6 , TBAI, RT, 2 h (74%); (i) 0.8% H2SO~. MeOH, RT, 8 h 
(84%); (j) MsCI, Et3N, CH2Cb, 0°C, 10 min (70%); (k) Nal, ethylmethyl ketone, reflux, 4 h 
(66%); (I) 130 (cat.), CH2Cb, reflux, 12 h (83%); (m) 10% Pd/C, H2, MeOH, RT, 6 h (85%); 
(n) Amberlyst-15, MeOH, reflux, 3 h (70%); (o) Im-CS-Im, toluene, reflux, 6 h; then 
Bu3SnH, AIBN, toluene, reflux, 12 h (45%, 2 steps); (p) m-CPBA, BF3.0Et2, CH2Ch, 0°C-
RT, 12 h (30%); (q) LOA, HMPA, Me! (93%, 2 steps). 
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Mori et al. use a novel ruthenium-catalysed enyne metathesis reaction in their 
synthesis of (-)-stemoamide (Scheme 1.28).33 Pyrrolidinone 200, derived from 
pyroglutamic acid, was N-alkylated with 5-bromo-1-pentene, and the ethoxyethyl 
protection removed with acidic methanol to give 201. Swern oxidation and Corey-
Fuchs homologation with CBr4 and Ph3P in the same pot resulted in the 
dibromoalkene, which was subjected to butyl lithium to give the enyne 202. 
Treatment with LDA deprotonated at the tenninal alkyne position and subsequent 
reaction with ClCOOMe gave conjugated enyne 203. Ring closing metathesis with 
ruthenium catalyst 204 gave the cyclised product 205. The important characteristic of 
this reaction is that the carbon-carbon bond fonnation between the alkene and alkyne 
occurs to give the cyclisation product, with concomitant migration of the alkylidene 
part of the alkene to the alkyne carbon. 
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Scheme 1.28 Reagents: (a) NaH, DMF, CH2=CH(CH2) 3Br (89%); (b) TsOH, MeOH (91%); 
(c) (COCI)2. DMSO, Et3N; (d) CBr4 , Ph3P (87%, 2 steps); (e) BuLi, THF, -98°C (72%); (f) 
LOA, HMPA, CICOOMe (68%); (g) 204 (cat.), (4-5 mol%), CH2CI2, RT (87%); (h) NaBH~, 
MeOH, (85%); (i) NaOH, MeOH/H20 U) CuBr2 on Al20 3 (8, 25% and 9, 31 %); (k) NEt3; (I) 
NiCh.6H20, NaBH4, MeOH, (76%). 
1 ,4-Reduction of the a,fi-unsaturated system, followed by hydrolysis of the ester and 
a bromolactonisation reaction, gave the two products 207 and 208. Compound 207 
was easily converted into compound 208 by treatment with NEt3• The total synthesis 
was completed via stereoselective reduction using NaBH4 and NiCb.6H20 to give 
(-)-stemoamide. 
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1.3 Cyclopropanes in Synthesis 
1.3.1 Bonding in Cyclopropanes 
Cyclopropane derivatives are capable of ring-opening reactions under the influence of 
many different reacting species, including electrophilic, nucleophilic, and radical 
reagents, as well as external physical forces such as heat or light. Unlike other 
aliphatic hydrocarbons, the c-c single bond of the cyclopropane resembles that of a 
C=C double bond. It is the strained nature of the three-carbon unit and the subsequent 
relief of the strain during ring opening, which provides the crucial thermodynamic 
driving force for the reaction.42 
The arrangement of carbon atoms in cyclopropanes results in significant angular 
(Bayer) strain, where the bond angles must deviate to 60° from the ideal 109.5° for 
sp3 -hybridised systems. Additional torsional (Pitzer) strain is observed, as the 
coplanar nature of the carbon atoms requires the C-H bonds to be eclipsed. However, 
thermochemical considerations alone are insufficient to explain the remarkable 
reactivity seen in cyclopropanes, and numerous bonding models have been proposed. 
The Coulson-Moffit model assumes three sp3 -hybridised CH2-groups results in a 
reduction of effective orbital overlap, by a deviation of ea. 22° from the imaginary 
c-c bond, attributing to the angular strain in the system (Figure 1.06).43 
Figure 1.06. The Coulson-Moffitt model 
Variations of this model suggest sp2, sp3 and sp5-hybridised orbitals may explain the 
greater p-character and similarity to olefin reactivity. Indeed, the Walsh model 
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suggests three sp2 -hybridised carbon nuclei, with the hybrid orbitals orientated 
radially towards the centre of the ring (Figure 1.07).44 
Another interesting approach as expressed by Dewar,45 proposes the notion of "cr-
conjugation", and how a cyclic array of 6 electrons, according to the 4n + 2 rule, 
suggests aromaticity in the cyclopropane ring. cr-Aromaticity can explain previously 
considered anomalies in cyclopropanes, such as; the actual lower strain energy 
observed in comparison to the theoretical value calculated from bending force 
constants; the observed upfield shifts of the cyclopropane protons explained by ring 
current effects; and the reactivity of cyclopropanes towards electrophiles as seen in 
Freidel-Craft type reactions. 
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Figure 1.07 The Walsh model 
1.3.2 Nucleophilic Addition to Cyclopropanes 
In direct analogy with reactions of olefins, cyclopropanes are susceptible to addition 
reactions. The major difference is the presence of an extra carbon, the "synthetic 
wedge", which improves the number of rearrangement pathways threefold compared 
to those available to alkenes. Disconnections of similarly functionalised alkenes and 
cyclopropanes via donor and acceptor interactions, lead to a resonance form in the 
case of the alkene, and a new compound being formed in the cyclopropane case 
(Figure 1.08).42 
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Figure 1.08 Illustration of the "synthetic wedge" concept 
In 1895 Bone and Perkin discovered that cleavage ofthe cyclopropane bond was only 
possible in the presence of an electron-withdrawing group on the ring.46 Best and eo-
workers found activated cyclopropane 209 undergoes 1,5 ring opening with diethyl 
malonate to form the tetraester 210, with subsequent intramolecular cyclisation to 
form the cyclopentanone product 211 (Scheme 1.29).47 
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Scheme 1.29 Best's ring-opening of activated cyclopropanes 
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The geminally placed activating groups observed in many nucleophilic openings of 
this type, help doubly stabilise the anion formed upon ring fission. However, vigorous 
reaction conditions are still required to effect ring opening with nucleophiles such as 
. 48 49 I . 46 5o d · 51 • I ammes, mercaptans, ma onate Ion, cuprate an enammes, exposmg t 1e 
difficulty in cleaving the strained c-c single bond (Scheme 1.30). 
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Scheme 1.30 Various nucleophiles for ring-opening 
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Linstead and eo-workers applied this methodology to vinyl analogues and reported 
both 1,5 and 1,7 modes of ring opening.52 The major product of the reaction with 
diethyl malonate was cyclopentanone 212, with trace amounts of the 1,7-ring opened 
alkene 213 formed, before suitable treatment of the tetraester gave suberic acid 
(Scheme 1.31). 
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Scheme 1.31 Linstead' s I ,5 and I, 7 modes of ring-opening 
The chemical properties of cyclopropanes drastically change upon the incorporation 
of a neighbouring n-system. In 1960, Vogel reported the thermal conversion of 
vinylcyclopropane 214 to cyclopentene 215 (Scheme 1.32).53 The mechanism and 
stereochemistry of this rearrangement has been discussed extensively, and the 
majority of these are thought to proceed via biradical intermediates, although some 
concerted processes have been reported. This reaction has become important for the 
incorporation of cyclopentene structural units into many complex natural products. 54 
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Scheme 1.32 Vogel's thermal conversion ofvinylcyclopropane to cyclopentene 
The extension of conjugation seen in vinylcyclopropanes was harnessed by Burgess, 
who reported a milder and selective ring opening reaction using catalytic amounts of 
a palladium(O) source (Scheme 1.33).55 The ratio ofmoho- and bis-alkylated products 
216 and 217, depends not only on the concentration of starting materials, but also the 
nature of the electron-withdrawing-groups (EWG) present on the vinylcyclopropane 
and the nucleophile. It was established that the stabilising effect of the EWG on the 
cyclopropane must be greater or comparable to that of the EWG on the nucleophile. 
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Scheme 1.33 Burgess' Palladium catalysed nucleophilc addition to vinylcyclopropanes 
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1.3.3 Transition Metal-assisted reactions of Cyclopropane derivatives 
The true potential of these small ring systems, and the plethora of possible structural 
transformations was only unlocked with the advent of transition metal catalysis. Up 
until this point, transition metal-assisted transformations of small rings were limited 
to the synthesis of stoichiometric organometallic complexes. The application of 
transition metal chemistry in the reactions of cyclopropane derivatives has for a long 
time been a powerful method for exploiting the versatility of these systems. Three 
classes of small ring that enjoying a renaissance of exploration were cyclopropenes 
218, methylenecyclopropanes 219 and vinylcyclopropanes 220 (Figure 1.09).56 
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Figure 1.09 Various cyclopropane derivatives 
Each of these derivatives possess significant strain, which increases the potential 
energy stored within the molecule and explains their unusually high reactivity. The 
cyclopropene scaffold has increased n-density on its double bond, which makes it an 
attractive substrate for n-philic transition metals. Cyclopropenes participate in a 
whole host of reactions of a similar type to olefins, including carbometalation, 
cycloadditions, cross-coupling, substitution and cycloisomerisation. Meijere et al. 
demonstrated one example where cyclopropenes were used in a palladium-catalysed 
allylic alkylation (Scheme 1.34).57 The n-allylpalladium intermediate 223, generated 
from a variety of primary and secondary cyclopropenylmethyl esters 221, underwent 
selective alkylation at the a-position to produce cyclopropenylmethyl derivatives 222. 
No allylic transposition or ring-opened products were detected during this 
transformation. 
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EWG = C02Me, S02Ph 
a 
Scheme 1.34 Reagents: Pd(dba)z/dppb, THF, RT. 
R~ 
223 Pdln 
Methylenecyclopropane is the smallest carbocycle with an exo-methylene group. The 
inherent rigidity and symmetry observed within this molecule confers its unique 
reactivity. The exocyclic double bond enforces additional strain on the three 
membered ring by increasing the nearby bond angle and therefore lengthening the 
opposing bond 225 (Figure 1.10).58 
-
1.510 A 1.541 A 
224 225 
Figure 1.10: Cyclopropane and methylene cyclopropane derivatives. 
Methylenecyclopropanes participate in reactions that are characteristic of olefins e.g. 
electrophilic additions, radical additions, addition to carbenes and nitrenes, various 
thermally activated cycloadditions or in the presence of strong electron withdrawing 
groups. However, the key to their synthetic versatility is their ability to act as building 
blocks in [3+2]-cycloaddition reactions catalysed by transition metals such as Ni(O) 
and Pd(O) under mild conditions.59-6 1 
Initial work by Binger and Noyori describe possible mechanisms for the two reaction 
pathways in which the metal-catalysed cycloaddition can proceed to afford 
regioisomeric products (Scheme 1.35).59,61 
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Scheme 1.35: Mechanism of the two possible metal-catalysed cycloaddition reaction 
pathways. 
X 
The transition metal can oxidatively insert into the distal bond 227. Subsequent 
carbometallation onto the double bond and reductive elimination afford cyclopentane 
226, inserting a two-carbon unit in the distal position to the double bond. 
Alternatively the proximal cleavage leads to isomeric metallacyclobutane 228 with 
the two-carbon unit being introduced in the proximal position to the exocyclic double 
bond. Both regioisomeric cyclopentenes 226 and 229 can be isolated in the presence 
of Ni(O), whereas only type 226 can be isolated when the reaction is catalysed by 
Pd(O). 
The regia-chemical outcome of the reactions is highly dependent on the nature of the 
metal and its associated ligands. The ability to control both the regia and 
stereochemical outcome suggests this might provide a powerful cycloaddition process 
for natural product synthesis. 
Although cyclopropenes have a wide-ranging scope of potential transformations, 
methylenecyclopropanes have enjoyed far more attention in the literature because of 
their ability to ring-open under transition metal catalysis, forming reactive 
trimethylenemethane (TMM) complexes. 
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1.3.4 Palladium Catalysed [3+2] Cycloadditions with Pd-trimethylenemethane 
complexes 
Trost and eo-workers report the use of a stabilised trimethylenemethane (TMM) 
molecule, activated with palladium(O), as a valuable reagent in [3+2] 
cycloadditions.62-64 In 2-[(trimethylsilyl)methyl]-allyl ester 230, the silyl and acetate. 
groups act as carbanionic and carbocationic equivalents respectively. Other more 
reactive sulfonates or chlorides can be used as well as the acetate leaving group. 
Formation of a n-allylpalladium complex and subsequent elimination of the silyl 
group, furnishes a dipolar species 231, reactive enough to attack electron-deficient 
double bonds (vinyl esters, nitriles, sulfones and any activated alkenes in terms of a 
conjugate method). Trost showed the formation ofthe fused cyclopentanoid 232 was 
possible using an intramolecular version of this reaction (Scheme 1.36). 
;:·' [ _I\:' l A PdL4 -TMSOAc OAc OAc ---~ ~+ ~ 
PdL2 PdL2 
230 231 
Pd(O)/dppe 
232 
Scheme 1.36 General mechanism of [3+ 2] cycloadditon of Pd-TMM complexes 
The Pd-TMM complex generated in situ from 230, reacts with a variety of electron 
deficient alkenes. Interestingly, the [3+2] cycloaddition proves to be stereoselective 
upon reaction with trans-alkenes such as dimethyl fumarate, whereas ci.\"-alkene 
dimethyl maleate produces a cisltrans mixture of methylenecyclopentane products 
233a and 233b (Scheme 1.37). 
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Scheme 1.37 Stereoselective addition of electron-deficient alkenes to Pd-TMM complexes 
The lack of stereospecificity observed with cis-alkenes, suggests a stepwise 
mechanism involving an intramolecular nucleophilic addition step, where the reacting 
intermediate 234 has time to rearrange to the more stable trans conformer (Scheme 
1.38). 
EWG 
8NG~Cz 
234 233a 
Scheme 1.38 Proposed mechanism for observed stereochemistry 
When the substitution patterns on the TMM compound are considered, some 
interesting regiochemical information can be deduced.65 Depending on the position of 
the methyl-substituent in 235a or 235b, two regioisomeric Pd-complexes 236a and 
236b are formed which could undergo subsequent cycloadditions with an electrophile 
such as cyclopentenone to give cycloadducts 237a-c. However, it is observed that the 
same ratio of cycloadducts are formed irrespective of the substitution on the Pd-TMM 
complex, suggesting equilibration of 236a and 236b, occurs faster than the rate of 
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addition of trapping reagent. Estimation of thermodynamic stability verifies complex 
236a as the more stable of the two conformers (Scheme 1.39).66 
236a 
236b 
MeySiMe3 
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Scheme 1.39 Regioselective addition of substituted Pd-TMM complexes 
1.3.5 Transition Metal-assisted reactions of Vinylcyclopropanes 
Vinylcyclopropanes are yet another versatile strained compound, as the pronounced 
cyclopropyl Walsh-type ··banana-shaped'' HOMO can conjugate with the 
neighbouring n-orbitals of the double bond. 56 Electronic analysis suggests the cr-bond 
connecting the cyclopropyl and vinyl group has increased double-bond character by 
13-15%, significantly shortening the cr-bond.67'68 Sarel et al. carried out the first 
investigations into the field of transition metal-assisted reactions of 
vinylcyclopropanes in 1965.69 They used iron carbonyl complexes in stoichiometric 
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amounts to effect transformations such as (a) creation of n-complexes 238 and 239 
via interaction of the double bond with the metal centre; 70 (b) isomerisation by ring-
opening the cyclopropane 240 to give 1,3-dienes 241;69 (c) photoinduced 
carbonylative insertion to give cyclohexeneones 242,71 and (d) simultaneous carbonyl 
insertion and metal interaction to give metal acyl complexes 243 (Figure 1.11).72 
(a) Creation of pi-complexes 
~ \ 
238 Fe(C0)4 
(b) Isomerisation to 1,3-dienes R 
Fe(C0)5 h'L ~ heat \I Fe (COh 241 
(c) Photoinduced 1 ,5-carbonylation 
~ 
Fe(C0)5 
"Y hv 
R 0 
(d) Metalloacyl complexes 242 
~ Fe(C0)5 (0~ hv 
243 0 
Figure 1.11 The origins ofTransition-Metal assisted reactions 
After the initial potential of this type of methodology was realised, the scientific 
community showed a great deal of interest in transition metal catalysed reactions of 
vinylcyclopropanes. Over the next few decades a range of different catalysts was 
developed, including iron, cobalt, nickel, rhodium, platinum and most recently 
palladium based complexes. As the work reported in this thesis is focussed on 
palladium catalysed ring openings of vinylcyclopropanes, we shall take a systematic 
look at how the method used within the group evolved. 
Vinylcyclopropanes easily form complexes with palladium compounds. The 
substitution of 244 with ethylene from the palladium complex PdCb(C2H4)2 results in 
45 
a labile intermediate, which under 1H NMR analysis showed a broad singlet in the 
region of 1.5 ppm. The intermediate complex was thought to exist as several species, 
equilibrating through 2,3-hydride shifts (Scheme 1.40).73·74 
~' '•PdCI2 
-- ~Pd~l2 
[>----! PdCI2(CzH4h 11 
244 CI2Pd~ CI2Pd'"'~ --
Scheme 1.40 2,3-Hydride shifts of Palladium on vinylcyclopropane 
Heck et al. investigated the effect of palladium salts on vinylcyclopropanes 
containing electron-withdrawing substituents. 75 They found that after initial 
complexation of the olefinic double bond with the metal ion, rearrangements occured 
with opening of the cyclopropane ring to give 1t-allyllic complexes 246. Various 
products were formed depending on the structure of the vinylcyclopropane derivative 
(Scheme 1.41). 
a Ph~C02Et+ 
/P<)< C02Et 
crx 
2 
246 
Scheme 1.41 Reagents: (a) Li2PhPdCI3, Et3N, MeCN, 0°C, RT (37%). 
Mechanistic studies involving deuterium labelled vinylcyclopropane 247, showed 
migration of one of the benzylic deuterium atoms from C-1 to C-4 to give 1t-allyllic 
complex 248 (Scheme 1.42). They proposed a mechanism involving elimination to an 
alkenylpalladium derivative, followed by a palladium hydride elimination and 
readdition sequence, which resulted in this intruiging deuterium shift. 
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Scheme 1.42 Mechanistic studies involving deuterium labelled vinylcyclopropane 
Backvall et al. reported a stereochemical and mechanistic diagnosis of the 
palladium(II)-induced chloro- and oxypalladation reactions of (+)-carene.76 Reaction 
of the enantiomerically pure carene with PdClz(MeCN)2 in non-nucleophilic solvents, 
lead to chloropalladation and two (n-allyl)palladium complexes 249 and 250. 
(Scheme 1.43). However, upon the incorporation of nucleophilic solvents, a range of 
oxypalladation reactions occurred to give complexes 251-254, and small amounts of 
the chloropalladation adduct 249. Interestingly, in the oxypalladation reaction none of 
the seven-membered ring complex 250 was ever observed. 
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Scheme 1.43 Palladium(II)-induced chloro- and oxypalladation reactions of ( + )-carene 
In an attempt to prove the stereochemical configuration of the (rr-allyl)palladium 
complexes, they were reduced with LiAl~ and LiAlD4, to give reduction products 
255 and 256 as a 4: I mixture and 255-d1 and 256-d1 in a similar ratio (Scheme 1.44). 
Reduction with LiAlH4 showed the methyl group of 256 to be cis to the isopropyl 
group. Importantly the deuterium in 255-d1 was found to be trans to the isopropyl 
group. It was known at the time that LiAlH4 cleaves (rr-allyl)palladium bonds with 
retention of configuration,77 so it was deduced that the palladium species inserts with 
inversion of stereochemistry to place it trans to the chloroisopropyl group. 
a 
+ 
249 255 X=H 256 X=H 
255-d1 X= D 256-d1 X= D 
Scheme 1.44 Reagents: (a) LiAIH4 or LiAID4, THF, -78°C. 
48 
Morizawa et al. were the first group to report a palladium(O) catalysed [3+2] 
cycloaddition of a vinylcyclopropane (Scheme 1.45).78 The use of I ,3-dipolar species 
in the construction of ring systems was accepted as a viable approach, however, at the 
time there was no simple way to prepare these synthons. They proposed a 
rearrangement which proceeds through nucleophilic attack of Pd(O) to the dienic 
group of 257 to form a zwitterion consisting of a n-pentadienylpalladium species and 
doubly-stabilized anion. The intermediate cyclised to form cyclopentene derivative 
259, with the new C-C bond formation exclusively producing a five-membered ring, 
and not a seven-membered one. They suggest the regioselectivity arises from the 
preferred W-type conformation of the pentadienyl group in 258. 
a 
257 259 
1 
Scheme 1.45 Reagents: (a) 10 mol% Pd(PPh3) 4, DMSO, 50°C (87%). 
Tsuji et al. also recognised the potential of these types of zwitterionic species in the 
preparation of functionalised cyclopentanes.79 They report an intermolecular reaction 
between the (n-allyl)palladium zwitterion 260, derived from vinylcyclopropane 259, 
with methylacrylate to form functionalised 261 (Scheme 1.46). 
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Scheme 1.46 Reagents: (a) 10 mol% Pd(PPh3) 4, DMSO, 80°C (84%). 
Similarly to Morizawa, Tsuji believed the palladium to be oxidatively inserting into 
the vinyl group, with concomitant ring-opening. The I ,3-dipole that results is 
stabilised by the two electron-withdrawing groups at the malonate centre. Tsuji 
extended this procedure by recognising the zwitterion to be an intermolecular 
trapping reagent, and reported the successful trapping of a variety of activated 
alkenes. The use of aryl isocyanate 262 leads to the generation of a y-lactam 263, 
using similar a similar catalytic system (Scheme 1.47). However the major drawback 
ofthis procedure was the use of highly toxic hexamethylphoshoramide (HMPA), and 
also the fact that two equivalents of isocyanate were required for the reaction to 
proceed. 
.yO 
~--.. -JC02Me o:N-:::-C 
· V'co2Me + I 
MeO ~ 2 equiv. 
259 262 
a [ ~C02Mel .· ~~-· -C0
2
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Scheme 1.47 Reagents: (a) 10 mol% Pd2(dba)3.CHCI3, Bu3P, HMPA, 25°C (86%). 
Recent work by Polhaus et al. has shown the usefulness of mild Lewis catalysed 
conditions in the ring opening of aryl-substituted cyclopropanes 264 (Scheme 1.48). 80 
Mild conditions using catalytic amounts of Sn(OTf)2 generated a stabilised I ,3-
dipole, which was subsequently trapped with a range of electron-rich aldehydes. 
Excellent diastereoselectivities were observed when using benzaldehyde, with 
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exclusively the syn-2,5-disubstituted tetrahydrofuran 265 being formed. In the case of 
other electron-rich aldehydes, mixtures of diastereoisomers were observed, but the 
syn isomer was always the major product. This method outlines the importance of 
Lewis acids as potential reagents for ring-opening reactions of cyclopropanes. 
264 
\ RO 
:~H 6=\ 
Ph 
a 
265 
I 
Scheme 1.48 Reagents: (a) Sn(OTf)2 (5 mol%), DCM, RT, 2.5 h (100%). 
1.3.6 Previous work within the Group 
The groundbreaking work carried out by Tsuji has provided our own research group 
with some valuable insight into the reactions of vinylcyclopropanes. Tang began 
researching possible variations of Tsuji's conditions in an attempt to apply it to 
heterocycle formation, but using milder conditions. 
Tang reported a variety of novel palladium catalysed [3+2]-cycloadditions using the 
versatile doubly activated vinylcyclopropane and a Lewis acid.81 A variety of 
trapping agents were explored affording a selection of tetrahydrofurans and 
pyrrolidines when reacted in conjunction with their respective aldehydes and imines. 
The respective tetrahydrofurans and pyrrolidines appeared as a pair of 
diastereoisomers. Careful optimisation led to excellent yields under mild reaction 
conditions (Scheme 1.49). 
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Scheme 1.49: Synthesis of 5-membered heterocycles.45 
Tang concluded that the inclusion of a Lewis acid resulted in a marked increase in 
yield. The optimum conditions included a stoichiometric amount of the 
vinylcyclopropane and electrophile, 10 mol% Pd(PPh3) 4 and two equivalents of ZnBr2 
in THF at room temperature. 
It is possible to propose a reaction mechanism that takes into the account the affects 
of the palladium(O) catalyst, Lewis acid. As the reaction only requires a catalytic (1 0 
mol%) amount of palladium(O) reagent the implication is a catalytic cycle is set up 
regenerating the palladium(O) species during the [3+2]-stepwise cycloaddition, which 
results in the formation of the 5-membered heterocyclic product. An oxidative 
addition of the palladium(O) catalyst to the vinyl cyclopropane generates a zwitterion 
that subsequently undergoes nucleophilic attack on the electrophilic substrate 
affording a second transient zwitterion. The resultant alkoxide/amide moiety 
subsequently displaces the palladium reagent from the Jr-allyl site with concomitant 
reductive elimination ofthe transition metal catalyst to give the required heterocycle. 
It is thought that the Lewis acid sits in between the geminal ester groups, further 
stabilising the transient zwitterion (Scheme 1.50). 
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Scheme 1.50: General palladium catalysed cyclisation with vinylcyclopropane 
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Tang also reported the successful trapping of a cyclic imine with vinylcyclopropane 
259.81 This is the first and only reported use of a cyclic imine in the above reaction 
sequence. This thesis will investigate the use of a variety of conformationally locked 
cyclic cis-imines as potential trapping agents in the palladium catalysed [3+2] 
cycloaddition step. This would allow a bicyclic ring system to be accessed in one step 
with the option of functional group elaboration at a later stage. Depending on the ring 
size of the imine, a range of stereocontrolled, fused nitrogen heterocycles can 
potentially be synthesised (Scheme 1.51). 
Pd(O) 
+ 
Lewis acid 
259 [ n = 1, 2, 3} 
Scheme 1.51 Proposed palladium catalysed [3+ 2] cycloaddition step 
This introduction has shown the widespread occurrence of these sorts of bicyclic 
systems within nature. As such, the development of methods for the asymmetric 
synthesis of ring-fused derivatives such as pyrrolizidines, indolizidines, and azepines 
remains an area of current interest. Our ultimate aim was to generate the azepine core 
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present in the Stemona alkaloids, by the successful trapping of a cyclic seven-
membered imine. The incorporation of functionality on the cyclic imine substrate was 
also investigated, as this would act as a handle to gain access to a range of natural 
compounds (Scheme 1.52). ·The stereochemical outcome of the reaction may be 
affected by the size of the cyclic imine ring, making it possible to control two 
stereogenic centres in one step. 
+ 
259 
t~ /+Jn 
( n = 1, 2, 3} 
Pd(O) 
Lewis acid 
Scheme 1.52 Proposed palladium catalysed [3+2] cycloaddition step with functionalised 
imines 
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Results and Discussion 
Chapter Two 
2.1 Preparation and Reactions of Vinylcyclopropanes 
2.1.1 Synthesis ofVinylcyclopropanes 
Naturally occurring vinylcyclopropanes have attracted considerable interest among 
organic chemists. Carenes, sesquicarenes, sirenine, dictyopterenes and pyrethroids all 
contain such functionality, 82 resulting in numerous total syntheses being developed 
for these compounds (Figure 2.01).83-85 In addition, vinylcyclopropanes are vital 
synthetic intermediates, justifying the widespread interest shown by the scientific 
community. 
"'9 Me (+)-carene 
H ~'··-..~ Me~M H e 
(±)-sesquicarene 
pyrethroids 
H HO~·'-~ 
I Me~OH Me H 
(±)-sirenine 
(+)-dictyopterene A 
Figure 2.0 I Naturally occurring vinylcyclopropanes 
There have been various methods for synthesising cyclopropanes documented in the 
literature. A recognized route to cyclopropanes involves the use of carbene 
intermediates such as the Simmons-Smith reagent.86 In this reaction, a geminal 
dihalogen species reacts with reducing zinc metal in solution. The mechanism is not 
fully clarified, but pure carbenes can be excluded and the existence of a carbenoid is 
thought to be the reactive intermediate. Reaction of these electrophilic carbenoids 
with alkenes generates cyclopropanes (Scheme 2.01). 
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Scheme 2.01 Reagents: (a) Zn/Cu couple, Et20. 
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Paquette et al. reported several methods for generating bifunctional 1-(trimethylsilyl)-
substituted cyclopropanes.87 The methyl bromide 267 generated from Simmons-Smith 
cyclopropanation of alkene 266 and bromination with phosphorus tribromide, is 
shown to be very reactive to SN2 displacement, and therefore easily transformed into 
a variety of other derivatives including phenyl sulfides and phenyl sulfones (Scheme 
2.02). 
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Scheme 2.02 Reagents: (a) Mg turnings, CH20, Et20; (b) CH212, EtZnl; (c) PBr3 ; (d) 
PhS02Na, DMF; (e) PhSH, NaH. 
Backvall et al. employ a palladium-catalysed route to bicyclic vinylcyclopropanes 
using 1-acetoxy-4-chloro-2-alkenes as starting materials. 88 Reaction of alkenes of the 
type 268 with base followed by palladium(O) catalyst (Pd(dppe)2, Pd(dba)2/dppe and 
Pd(OAc)2/dppe were all used), results in a formal SN2' cyclisation and formation of 
the desired vinylcyclopropanes, with high levels of relative stereochemistry between· 
the cyclopropane ring and the double bond being attained. Indeed, bicyclic 
vinylcyclopropanes can be generated using this method also (Scheme 2.03). 
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Scheme 2.03 Backvall's palladium-catalysed route to vinylcyclopropanes 
A method used within the Pritchard group to access the above bicyclic 
vinylcyclopropanes involves the modification of a procedure developed by Livant et 
al. 89 Rhodium catalysts such as Rh2(0Ac )4 have become the catalyst of choice for 
many cyclopropanations of aromatic alkenes. It is the ability of rhodium to stabilise 
carbenes. such as that generated from dimethyl diazo malonate, which made the 
bicyclic vinylcyclopropanes 269, 270, and 271 accessible (Scheme 2.04). 
a 
+ 
Scheme 2.04 Reagents: (a) Rh2(0Ac)4, DCM, reflux, 3 h. 
n = 0, 269 (52%) 
= 1, 270 (51%) 
= 2, 271 (39%) 
Our method of choice for accessing vinylcyclopropane 259 involved the double 
displacement of trans-1 ,4-dibromobut-2-ene with malonic acid dimethyl ester in the 
presence of sodium methoxide in good yield (82%) (Scheme 2.05).55 
0 0 
MeO~OMe + Br ~Br 
a 
Scheme 2.05 Reagents: (a) NaOMe, MeOH, reflux, 24 h (90%). 
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57 
The mechanism proceeds via the deprotonation ofthe activated methylene component 
of the malonic acid dimethyl ester, followed by an internal SN2' displacement to form 
the cyclopropane ring (Scheme 2.06). 
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Scheme 2.06 Mechanism ofvinylcyclopropane formation 
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2.2 Preparation of Cyclic /mines 
2.2.1 Synthesis of 5-membered Cyclic !mines 
The 5-membered cyclic imine 1-pyrroline 272, has been proposed as an intermediate 
in the biosynthesis of phenanthroindolizidine alkaloids such as septicine and 
tylophorine, and has also been used in the biomimetic syntheses of these alkaloids 
(Figure 2.07).90 
OMe OMe 
M eO M eO 
0 --
-
272 M eO M eO 
OMe OMe 
septicine tylophorine 
Figure 2.07 1-Pyrroline as a precursor to natural compounds 
However, its application in organic synthesis is limited due to its volatility and its 
tendency to rapidly trimerise at room temperature in neutral or basic solutions. 
Previous work by Parsons et al. describes the cracking of the triazine 273 in boiling 
THF to give the monomer, which could then be eo-distilled with THF and trapped at 
-78°C. This was trappe~ with triethylamine and propionyl chloride to obtain the 
protected enamine 274 as a precursor in their rapid synthesis of racemic brevioxime 
(Scheme 2.08).91 
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Scheme 2.08 Reagents: (a) Na2S20 8, NaOH, cat. AgN03, H20; (b) Crack in THF, trap 
monomer@ -79°C; (c) NEt3, CH3CH2COCI, -78°C, (15% overall). 
The problem of trimerisation was easily overcome by Robins et al. who report the 
stabilisation of 1-pyrroline with zinc iodide, to generate a stable crystalline complex, 
which can be easily regenerated for the preparation of various pyrrolidine 
derivatives.92 It was with this method we decided to prepare 1-pyrroline-zinc halide 
complexes 275 and 276 (Scheme 2.09). Addition of a zinc halide to 1-pyrroline was 
envisaged to enhance its effectiveness as a trapping reagent towards 
vinylcyclopropane 259. Not only do these complexes introduce an intrinsic Lewis 
acid into the reaction mixture for the [3+ 2] cycloaddition, the Lewis acid should draw 
electron density away from the heteroatom, making the imine bond more susceptible 
to nucleophilic attack. 
This method involved acid hydrolysis of 4-aminobutanal diethylacetal in an 
intramolecular cyclisation step followed by extraction of the basified solution with 
ether to give the highly volatile and trimerisable free 1-pyrroline, which was not 
isolated. This was stabilised by the addition of anhydrous zinc iodide and bromide to 
form the desired pyrroline zinc halide complexes 275 and 276. 
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Scheme 2.09 Reagents: (a) 2 M HC1, Et20, 0°C, 20 min; (b) ZnX2, Et20, 0°C-RT, I h (275 
(15%), 276 (26%)). 
This reaction proved to be problematic with the reaction temperature needing to be 
carefully monitored at OOC to minimise losses of the pyrroline by evaporation. 
Attempts to repeat the 60% yield of zinc iodide complex quoted by Robins,92 were 
fruitless, illustrating the capricious nature of the reaction. However, the products 275 
and 276, once isolated, proved to be air stable at room temperature, and a convenient 
precursor for subsequent reactions with vinylcyclopropane 259. Examination of the 
1H NMR spectrum of 275 and 276, taken in CDCh, showed all proton signals were 
shifted downfield 0.1 - 0.4 ppm relative to the signals of the free 1-pyrroline sample. 
2.2.2 Synthesis of 6-membered Cyclic Imines 
Scully et al. reported the use of 1-piperideine 277 as a precursor for the synthesis of 
complex piperidine alkaloids.93 Synthesis of2-substituted piperidines have commonly 
involved either: (a) cyclisation of an appropriately constructed acyclic precursor and 
(b) alkylation of a pyridine followed by reduction of the aromatic heterocycle. These 
methods suffer from too many steps, lack of generality, or low yields. They 
anticipated C-alkylation of the corresponding cyclic imine precursor, could prove 
valuable in the synthesis of larger piperidine alkaloids. N-Chlorination of an ethereal 
solution of piperidine, followed by reaction with potassium superoxide and a catalytic 
amount of 18-crown-6, resulted in the free 1-piperideine 277. The reaction was 
complete when the yellow superoxide colour had faded to beige. The free imine 277, 
is known to possess similar trimerisation properties as its pyrroline counterpart, so in 
a modification of Scully's method, the reaction mixture was filtered, and anhydrous 
zinc iodide was introduced to the filtrate to form the zinc iodide complex 278 in good 
yields (Scheme 2.10). Attempts to complex zinc bromide and chloride under the same 
conditions failed. 
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I 
Cl 
b 
- 0 N c -
277 278 
Scheme 2.10 Reagents: (a) t-BuOCI, Et20, 30 min, RT; (b) K02, 18-crown-6, EtzO, RT, 21 
h; (c) Znlz, RT, 1 h (80% 3 steps). 
The chlorinating reagent !-butyl hypochlorite was generated from the reaction of 2-
methyl-propan-2-ol with bleach (Scheme 2.11). 
7(0H a 7(0CI 
Scheme 2.11 Reagents: (a) NaOCl, CH3C02H, H20, RT, 5 min (80%). 
Chlorination of piperidine proved to be quite capricious. The chlorinating agent must 
be added slowly to form a white gelatinous precipitate to signify the formation of the 
N-chloramine. This free imine precursor can then be formed by elimination of HCI 
via potassium superoxide in the presence of 18-crown-6. Successful complexation 
was once again verified by a downfield shift of all proton signals. 
2.2.3 Synthesis of 7-membered Cyclic Imines 
In a method identical to that used for the synthesis of the 6-membered cyclic imines, 
homopiperidine, was used to generate the zinc iodide complex 279, in moderate 
yields (Scheme 2.12). 
0 
I, /1 
a 0 b 0 c ZoTO) 
~ I N Cl 
2 
279 
Scheme 2.12 Reagents: (a) t-BuOCI, Et20, 30 min, RT; (b) K02, 18-crown-6, Et20, RT, 21 
h; (c) Znl2, RT, I h (40% 3 steps). 
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2.3 Palladium Catalysed [3+ 2] Cycloadditions with Cyclic 
/mines 
2.3.1 Formation of novel Pyrrolizidine derivatives 
Work began on the pyrrolizidine derivatives by reaction of complex 276 with 
vinylcyclopropane 259 in the presence of 10 mol% tetrakis(triphenylphosphine) 
palladium(O) in DMF at room temperature for upto 68 hours (Scheme 2.13), 
conditions outlined by Tang.81 
a 
259 276 280 
Scheme 2.13 Reagents: (a) 10 mol% Pd(PPh3) 4, DMF, RT, 20 h (27%). 
The expected pyrrolizidine 280 was isolated in moderate yield (27%) from the 1-
pyrroline zinc iodide complex. 1H NMR analysis of the crude reaction mixture 
showed a greater proportion of product than was ever isolated after column 
chromatography. For this reason, water washes were carried out on the crude reaction 
mixture to remove DMF, before an acid wash extracted the product into the aqueous 
layer, and subsequent basification and re-extraction into EtOAc gave the desired 
product. Attempts to perform the same cycloaddition with the zinc bromide complex 
failed. Significantly, two dimensional 1 H NMR and nOe experiments confirmed the 
pyrrolizidine 280 was isolated as one diastereomer, with the two ring protons 
adopting a (H,H)-anti relative stereochemistry (Figure 2.08). 
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~ nOe effects 
280 
Figure 2.08 NOe interactions of pyrrolizidine 280 
A similar mechanism for the [3+2] cycloaddition to vinylcyclopropane 259 can be 
applied to the cyclic imines as for the acyclic imine substrates. Oxidative addition of 
palladium(O) into the vinylic double bond effects ring opening of the cyclopropane 
ring, and generates a zwitterionic species. The zinc iodide may not only help activate 
the imine bond, but once dissociated from the imine also act as an intrinsic Lewis acid 
stabilising the zwitterion. Subsequent [3+ 2] cycloaddition of the imine reductively 
eliminates the palladium(II) species generating the palladium(O) species in a catalytic· 
cycle and accessing the desired pyrrolizidine (Scheme 2.14). 
Reductive elimination 
~OMo 0 (M' 
Oxidative insertion 
~~eoyol + 
~v--{0 
OMe 
Znl2 
+2L 11-2L 
PdL2 M eO 
L2Pd 
) OMe 
~OMo~/1 
L,PV 0 ~ OMo Zo(o ), 
Scheme 2.14 Proposed catalytic cycle for cyclic imine addition to vinylcyclopropane . 
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2.3.2 Formation of novel lndolizidine derivatives 
Attempts to gain access to the indolidizine core began with reaction of complex 278 
with vinylcyclopropane 259 in the presence of I 0 mol% palladium(O) under various 
conditions (Table 2.01). The best conditions were refluxing MeOH, which afforded 
indolizidine 281 in modest yields (21%). These conditions involved water and brine 
washes of the crude reaction mixture before column chromatography, instead of acid 
washes. The importance of column type was not as important as with the 
pyrrolizidine derivatives, as both silica and neutral alumina gave the desired product. 
However, crude 1H NMR data suggested there is more of the desired product present 
than purification would indicate, so it can be assumed material is once again being 
lost on the column. Various palladium catalysts were tried and tested, as catalyst 
suitability can vary from one system to another. Pd(PPh3)4 is a coordinatively 
saturated palladium(O) complex, and although the Pritchard group has witnessed 
much success with this catalyst for simple [3+2] cycloadditions, sometimes over-
ligation can hinder the coordination of some reactants. The highly coordinatively 
unsaturated PdCBu3P)2 was tried as this is a stable palladium(O) complex in solid state 
and commercially available.94 The stability of this unsaturated phosphine complex is 
certainly due to the bulkiness of its ligands. This complex is a very active catalyst in 
some reactions, however failed to produce a result in this system.95 
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''zriro), 1J02Me ~C02Me Pd(O) . C02 Me + H C02Me Solvent 
259 278 281 
Pd Catalyst Solvent Temperature Time (h) Product yield(%) 
Pd(PPh3)4 DMF RT I7 7 
Pd(PPh3)4 MeOH RT I7 IO 
-
DCM RT I7 SM 
Pd(PPh3)4 THF RT 46 2 
Pd2(dba)3 MeOH RT 69 II 
Pdz(dba)J THF RT 69 SM 
Pdz(dba)J DMF RT 69 3 
Pd('Bu3P)z MeOH RT 20 SM 
Pd(PPh3)4 MeOH Reflux I 2I 
THF:MeOH 
Pd(PPh3)4 Reflux 3 Degraded after 3h (1: I) 
THF:MeOH 
Pd(PPh3)4 Reflux 30min 0 (1: I) 
Table 2.01 
In all cases where the product was isolated, one diastereomer was formed exclusively 
from the reaction mixture. Two dimensional 1 H NMR and nOe experiments 
confirmed the indolizidine 281 adopts a (H,H)-anti relative stereochemistry with 
respect to the protons on the newly formed chiral centres (Figure 2.09). 
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Figure 2.09 NOe interactions ofindolizidine 281 
When refluxing in MeOH, a major by-product accounting for -50% of the crude 
reaction mixture was alkene 282. Vinylcyclopropane 259 is stable in refluxing 
methanol, however it is the presence of palladium(O) that causes the unwanted by-
product. This is produced by methanol acting as a nucleophile towards the 
zwitterionic species formed after palladium insertion into the double bond of 
vinylcyclopropane 259 (Scheme 2.15). 
a 
259 282 
Scheme 2.15 Reagents: (a) 10 mol% Pd(PPh3) 4, MeOH, reflux, I h (80-95%). 
To establish whether the addition of methanol to vinylcyclopropane was reversible, 
alkene 282 was stirred with the good aldehyde trapping-reagent, 4-nitrobenzaldehyde, 
in the presence of I 0 mol% palladium (0) in an attempt to form the furan 283 
(Scheme 2.16). If palladium could re-insert into the alkene bond, eliminate the 
methoxy group and generate the reactive zwitterion, then it could be possible to form 
five membered heterocycles directly from the straight chain alkene instead of 
vinylcyclopropane. 
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Me0~C02Me + 
C02Me 
282 
a 
X 
Scheme 2.16 Reagents: (a) 10 mol% Pd(PPh3) 4, MeOH, RT, 19 h. 
283 N02 
The reaction failed to progress, suggesting the alkene 282 was not reversible towards 
palladium catalysed [3+2] cycloaddition using these conditions. 
Although refluxing methanol appeared to give the best yield of indolizidine 281, it 
also hindered the reaction. This outlined the importance of solvent interaction in this 
reaction, and suggested the use of non-nucleophilic solvents may prevent this 
unwanted pathway from occurring. 
2.3.3 Formation of novel Azepine derivatives 
A cursory glance at the azepine core began with reaction of complex 279 with 
vinylcyclopropane 259 in the presence of 1 Omol% palladium(O) using the most 
favourable conditions observed for the generation of indolizidine 281 (Scheme 2.17). 
1 'zri~( ~ yoo,Me ~C02 Me 
'0 a C02Me N H + C02 Me 
2 
259 279 284 
Scheme 2.17 Reagents: (a) 10 mol% Pd(PPh3)~. MeOH, reflux, 1.5 h (19%). 
The desired azepine 284 was synthesised in modest yield. Water and brine washes 
were carried out before a column was performed. However, by 1 H NMR the washes 
didn't seem to have much of an effect on the crude mixture, and a slight reduction to 
the overall yield could be attributed to this fact. Critically 20 1 H NMR and nOe data 
suggested one diastereisomer was formed exclusively in the reaction, with a (H,H)-
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syn relative stereochemistry with respect to the protons on the newly formed chiral 
centres (Figure 2.11). This is converse to the findings reported for indoloizidine 281 
and pyrrolizidine 280. A possible explanation of this result could be attributed to 
steric factors, arising from ring puckering effects of the incoming cyclic imine. In 
turn this could determine the axial or equatorial orientation of the bulky vinyl 
substituent. 
C02Me 
~ nOe effects 
284 
Figure 2.11 NOe interactions of azepine 284 
2.3.4 Synthesis of Crispine A derivatives 
Extracts of the Carduus crispus plant have been used in Chinese folk medicine for the 
treatment of cold, stomach ache and rheumatism. Moreover, studies by Zhao and eo-
workers have revealed significant cytotoxicity in these extracts. Phytochemical 
studies on C. er is pus have isolated the two pyrrolo[2, 1-a ]isoquinoline alkaloids 
crispine A and crispine B along with three bicyclic isoquinoline alkaloids (Figure 
2.12).96 
Crispine A Crispine B 
Figure 2.12 Extracts of the Carduus crispus plant 
Knolker et al. recently reported the total synthesis of the antitumour active 
pyrrolo[2, 1-a]isoquinoline alkaloid (±)-crispine A in three steps (overall yield 24%) 
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(Scheme 2.18).97 Lewis acid promoted addition of 3-trimethylsilylpropargyl 
magnesium bromide to 285 revealed that the allene 287 was formed as a by-product 
(2% yield) along with the propargyl derivative 286 (6I% yield). Silver(I)-promoted 
oxidative cyclisation of 286 provided the tricyclic core 288. The unexpected Grignard 
product 287 was converted into the same product using slightly different oxidative 
conditions. Chemoselective hydrogenation of the pyrrole ring was achieved with 
rhodium on activated charcoal in acetic acid/methanol (I: I) to give crispine A. 
M eO M eO Me OX)() a,b + I N M eO M eO MeO ~ fi 
285 
TMS 
' l 
d 
M~~ e M~~ I# N I# N 
MeO ~ ~ M eO 
288 crispine A 
Scheme 2.18 Reagents: (a) Et20.BF3, THF, -23°C, 30 min; (b) Me3SiCCCH2MgBr, Et20,-
23°C, 15 h (286 (61%) and 287 (2%)); (c) AgOAc, DCM, RT, 14 h (58%); (d) AgOAc, 
Me2CO, 56°C, 6-14 h (43%); (e) 5% Rh/C, H2, HOAc/MeOH (1:1), RT, 8 d (66%). 
It was reasoned that our palladium catalysed [3+2] cycloaddition methodology could 
be used to generate the tricyclic parent framework of crispine A in one step. It would 
also be an opportunity to try the cycloaddition of another conformationally locked 6-
membered cis-imine. 
Commercially available 6, 7-dimethoxy-3,4-dihydro isoquinoline, HCI hydrate 289 
was reacted with vinylcyclopropane 259 in the presence of I Omol% palladium(O) and 
Lewis acid under different conditions (Table 2.02), failing to give the desired 
isoquinoline 290. 
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-Cl Lewis acid 
~C02Me + ((XOMe Pd(O) HN I OMe 
C02Me ~ OMe Solvent 
OMe 
259 289 290 
Lewis 
:.J>t:!)duct yield(%) Pd Catalyst Solvent Tern perature Time (h) 
acid ' .<~' '' ' ,' ' 
···"'· 
··I ·~···:.2; .·· 
ZnCh Pd(PPh3)4 THF RT 20 SM 
ZnCh Pd(PPh3)4 DCM RT 21 SM 
ZnCh 
-
DCM RT 20 SM 
Table2.02 
Previous work within the Pritchard group has shown cyclisations worked in DCM, in 
the absence of palladium(O) catalyst, and rely solely on Lewis acid interactions.98 
These conditions were tried without success. 
In light of the successful cyclisations using zinc iodide complexes, the zinc halide 
isoquinoline complex 291 was formed by complexation of zinc iodide to 6,7-
dimethoxy-3,4-dihydro isoquinoline, HCl hydrate 289 in diethyl ether in excellent 
yield (81%) (Scheme 2.19). 
Cl 
(XX~ OMe HN I ~ OMe 
a 
289 291 
Scheme 2.19 Reagents: (a) Zn)z, Et20, RT, I h (81%). 
Complexation was unsuccessful when ZnBr2 and ZnCh were used as Lewis acid. 1H 
NMR can easily verify a successful complexation, as a switch in the peak positions of 
the I O-CH2 and methoxy protons occurs. 
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The isoquinoline complex 291 was then reacted with vinylcyclopropane 259 in the 
presence of 10 mol% palladium(O),using different conditions (Table 2.03). 
'v~ ) Pd(PPh3)4 ~C02Me '.~OM• OMe + 
C02 Me Solvent OMe 2 OMe 
259 291 290 
Pd Catalyst Solvent. Temperature Time (h) ··. :\Product yield(%) . 
Pd(PPh3)4 THF RT 63 8 
Pd(PPh3)4 DMF RT 19 22 
Table 2.03 
The cyclised isoquinoline 290 was isolated in modest yields (22%) as an inseperable 
mixture of diastereoisomers. The importance of workup on the reaction mixture was 
paramount, as column chromatography failed to isolate any product if no reaction 
workup was performed. It was thought that residual Lewis acid interfered with 
purification by column chromatography. For this reason, the crude reaction mixture 
was extracted into aqueous HCl, before basification and re-extraction into ethyl 
acetate to give a crude material suitable for column chromatography. Despite the 
modest yield, it was pleasing to construct the tricyclic core of the crispine alkaloids 
using our methodology. 
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2.3.5 Optimal conditions for Palladium [3+2] Cycloadditions. 
It was pleasing to isolate various novel compounds using our methodology, however 
poor yields limited the synthetic utility of the reaction. One final solvent study made 
use of dimethylsulfoxide, a solvent known to greatly enhance the reactivity of ionic 
reagents due to its excellent solvating power. An improvement in yield was observed 
for all cycloadducts 280, 281, 284 and 290, with conversion occurring within an hour. 
(Table 2.04). 
a 
Cyclised product 
259 
Cyclic imine Cyclised Product Yield(%) 
lj C02Me 
>n+0), &co,Mo 65 H 
276 280 
,';Zn·{O), lj C02Me OCO,Mo 42 H 
278 281 
H C02Me 
',)n·{()), 'l"'Oco,Mo N H 90 
279 284 
C02Me 
Cl- ~OMe C02 Me 59 HN I H OMe 
0-.. I N ~I (1 :1 diastereoisomers) OMe 290 0-.. 
289 OMe 
Table 2.04 Reagents: (a) 10 mol% Pd(PPh3) 4 , DMSO, 80°C, I h. 
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Once again, compounds 280, 281 and 284 were all isolated exclusively as one 
diastereoisomer, confirmed by nOe experiments. In the case of the pyrrolizidine and 
indolizidine compounds, the relative stereochemistry of the protons on the newly 
formed chiral centres was (H, H)-anti. However, conversely to this, the azepine ring 
system sets up a (H, H)-syn relationship. The cyclised product 290 was formed as a 
mixture of syn and anti products. Reaction workup was key with water washes carried 
out on the crude reaction mixtures to remove DMSO, before acid washes extracted 
the product into the aqueous layer, and subsequent basification and re-extraction into 
EtOAc gave the desired products. Purification of the aza-bicycles 280, 281, 284 and 
290 with silica or alumina lead to the majority of the compound being lost on the 
column, presumably due to the presence of the highly basic tertiary amine 
functionality. Yields reported in the table are therefore without column 
chromatography. 
Interestingly, the commercially available isoquinoline hydrochloride salt used to 
generate compound 290 did not require any Lewis acid for the reaction to work. The 
zinc iodide is essential for the stabilisation of the readily trimerisable simple cyclic 
imines, but may not necessarily play a further role in the cycloaddition reaction. 
2.4 The use of Functionalised Vinylcyclopropanes 
2.4.1 Variation at the vinyl terminus 
In an attempt to improve the scope of the reaction, the introduction of an electron-
withdrawing group on the vinyl terminus of the vinylcyclop.ropane was explored. This 
would create a handle for further elaboration of the molecule at a later stage if 
required. It would also give some insight into the palladium-catalysed insertion 
reaction, by gauging the effect of substitution on the alkene bond. Ethyl ester 
substituted vinylcyclopropane 294 was synthesised (Scheme 2.20). The first step 
involved stirring acrolein with dimethyl bromomalonate in the presence of potassium 
carbonate in a high boiling solvent such as dimethylformamide for 17 hours?J The 
reaction proved to be quite problematic, with initially very sluggish yields recorded. 
dimethoxyethane was tried as an alternative solvent, but to no avail. It was found that 
the order in which the reagents were added, was crucial to the success of the reaction. 
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The dimethyl bromomalonate must be added to a stirred solution of acrolein and 
potassium carbonate for the reaction to form the aldehyde 292 in temperamental 
yields ranging from 5-60%. Stirring the dimethyl bromomalonate with base prior to 
the addition of acrolein, lead to dimerisation to give unwanted tetra-ester by-products. 
0 ( a 
Scheme 2.20 Reagents: (a) DMF, K2C03, RT, 17 h (5-60%); (b) n-BuLi, THF, 0°C, 10 min 
(90%). 
The temperamental nature of the reaction leading to aldehyde 292 resulted in other 
routes being investigated. It was found that ozonolysis of vinylcyclopropane 259 
worked far more effectively and reproducibly to give aldehyde 292 (Scheme 2.21). 
a 
292 
Scheme 2.21 Reagents: (a) 0 3, DCM, -78°C, I h; then DMS quench (90%). 
The aldehyde 292 in turn underwent a Wittig reaction, with commercially available 
(carbethoxymethyl)triphenylphosphonium bromide, to form the substituted 
vinylcyclopropane 294 in good yield exclusively as the E-isomer. 100 We hoped to 
discover whether the electron deficient alkene would have an effect on the cyclisation 
of simple cyclic imines, using our recently developed palladium cyclisation 
conditions. Cyclisations worked with consistently good yields to give the 
pyrrolizidine, indolizidine and azepine products 295, 296, 297 and 298 (Table 2.05). 
It was observed that the pyrollizidine and indolizidine products were isolated as 
mixtures of ring diastereoisomers. NOe experiments confirmed the same relative 
stereochemistry of the 7-membered cyclisation product, as for the unsubstituted 
product 284. In later work it was discovered that the problem of ring diastereoisomer 
formation could be circumvented by modifying the order in which reagents were 
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added (pg. 134). This was unknown at the time this stage of the research was being 
carried out. It is therefore not unreasonable to assume that such a modification could 
lead to improved stereocontrol for the compounds isolated as diastereoisomers. 
a 
Cyclised product 
294 
Cyclic imine Cyclised Product Yield(%) d.r 
~O,Mo 
>'00), Et02C C02Me 60 1 :1 H. 
276 295 
::z,·(O), EIO CY'·tf'"' 2 -:;/" C02 Me 55 1 :1 N H 
278 296 t40,Mo ',~""{0), Et02Cy''··· C02 Me 65 H . 
279 297 
0 2Me 
Cl- roOMe H 
C02Me 
HN I H OMe /"' 69 1 :1 :::..._ I N I OMe 298 
Et02C 
:::..._ 
289 OMe 
Table 2.05 Reagents: (a) 10 mol% Pd(PPh3 ) 4 , DMSO, 80°C, I h. 
Once again 1 H NMR analysis of the crude reaction mixtures showed a greater 
proportion of product than was ever isolated after column chromatography. Water 
washes were carried out on the crude reaction mixtures to remove DMSO, before acid 
washes extracted the product into the aqueous layer, and subsequent basification and 
re-extraction into EtOAc gave the desired products. Purification of the aza-bicycles 
295-298 with silica or alumina lead to the majority of the compound being lost on the 
column, presumably due to the presence of the highly basic tertiary amine 
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functionality. Yields reported m the table are therefore without column 
chromatography. 
This result of an electron-withdrawing group at the vinyl terminus appeared to have 
no detrimental effect on the efficiency of the reaction, with an improvement in yield 
observed in some cases. It was considered whether an aromatic ring in the same 
position would affect the reaction. Attempts to form the phenyl-substituted 
vinylcyclopropane 299 from the Wittig reagent benzyl triphenylphosphonium 
bromide, failed using the standard Wittig reaction conditions and no further work was 
carried out in this area (Scheme 2.22). 
C02Me 0~co2Me 
292 
a 
299 
Scheme 2.22 Reagents: (a) Ph3P+CH2PhBr-, n-BuLi, THF, RT, 17 h. 
2.4.2 Variation at the Malonic position 
To establish whether different electron-withdrawing substituents attached to the 
cyclopropane ring have any effect on its ring opening, the dicyano vinylcyclopropane 
300 was synthesised (Scheme 2.23). The superior electron-withdrawing nature of the 
cyano groups would theoretically aid ring opening and make the molecule more 
reactive. Formation of vinylcyclopropane 300 proved to be very capricious, with two 
different routes being investigated. The first, a procedure utilised by Tang, 81 involved 
adding malononitrile to a stirred solution of trans-bromobut-2-ene and sodium 
hydride in THF. The reaction was extremely exothermic with a vigorous reaction 
taking place. The reaction mixture was then poured into EtOAc and ice water, 
followed by a unpleasant extraction, in which a very poor separation was observed. 
This resulted in poor yields of the desired vinylcyclopropane. The alternative route as 
used by Ali involved the use of potassium tert-butoxide as the base, in a methanolic 
solution.101 Once again, a difficult extraction followed by column chromatography 
resulted in poor yields. In both cases the desired product was not stored for longer 
than 2 days, as it degraded quite readily 
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~Br + 
_;- NC'-../CN 
Br 
a orb CN 
~CN 
300 
Scheme 2.23 Reagents: (a) NaH, THF, RT, 4 h (5%); (b) KOt-Bu, MeOH, reflux, 17 h (5%). 
The reaction was performed on a large enough scale to yield enough 
vinylcyclopropane 300 for a few attempted cyclisations (Scheme 2.24). 
I H I t;rCN CN 1-Zn(Q), a CN ~CN H + 
n 
300 n = 1, 276 n=1,301 
n = 2, 278 n = 2, 302 
Scheme 2.24 Reagents: (a) Pd(PPh3)4 (10 mol%), DMSO, 80°C, I h (301 80%,302 75%). 
Although the reactions were only performed using 25 mg of vinylcyclopropane 300, 
1H NMR data clearly showed the formation of the desired aza-bicycles 301 and 302. 
However since such small amounts ofthe products were isolated, full characterisation 
was not possible. The stability of the cyclised products was also very poor. Further 
work needs to be carried out on the reaction work-up in the generation of 
vinylcyclopropane 300, to generate enough material for cyclisation. 
2.4.3 Use of Activated Bicyclic Vinylcyclopropanes 
Previous work within the group has investigated the rhodium-stabilised carbenoid 
reaction of diazo-carbonyl compounds and I ,3-cyclodienes, to form activated bicyclic 
vinylcyclopropanes 303 of varying ring size (Scheme 2.25). These types of 
compound are known to undergo palladium catalysed [3+2] cycloadditions with a 
variety of imine and aldehyde trapping reagents, furnishing bicyclic heterocycles 304. 
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Pd(O)L4 cat. ~ 6 RI(R Rh2(0Ac)4 trxR LewisAcid + ---------- R1 N2 R X 
~ H [ n = 1 ,2,3 or 4 ) R=C02Me 303 R 304 
C02 Et 
S02Ph X= 0 orNR 
Scheme 2.25 Rhodium-catalysed vinylcyclopropane synthesis and their reactions 
The bicyclic vinylcyclopropane compounds are known to be less reactive than the 
simpler vinylcyclopropanes 259 and 294.98 To improve the scope of our reaction, the 
[ 4.1.0] activated bicyclic vinyl cyclopropane 307 was reacted with a range of cyclic 
imines, to hopefully access a range of novel tricyclic compounds. Regitz et al. have 
reported the use of diazo transfer groups such as mesyl azide in the formation of 
dimethyl diazomalonate. 102•103 Preparation of the diazo transfer compound 305, 
introduces the diazo functionality in a single step. Mesyl azide was therefore 
synthesised in excellent yields form mesyl chloride and sodium azide in acetone 
(Scheme 2.26).104 The diazo group is transferred by a donor (mesyl azide) to an 
acceptor (acidic malonate centre). 
0 
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-g-N=N=N 
Scheme 2.26 Reagents: (a) Acetone/water, reflux, 2 h (99%) 
305 
0 j 11 - + 
-S-N-N:::N 
11 
0 
Diazo dimethylmalonate 306 was synthesised by reacting dimethyl malonate, mesyl 
azide 305 and triethylamine in acetonitrile, in a moderate yield (Scheme 2.27). 
0 
11 + -
-S-N=N=N 
11 
0 
305 
0 0 
+ MeO~OMe a 
Scheme 2.27 Reagents: (a) Et3N, MeCN, RT, 4 h (54%). 
0 0 
MeOVOMe 
Nz 
306 
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With the dimethyl diazomalonate 306 in hand, rhodium(II) catalysed thermal 
decomposition with 1 ,3-cyclohexadiene gave the [ 4.1.0]activated bicyclic 
vinylcyclopropane 307 (Scheme 2.28). The schematic shows how thermal 
decomposition of the diazo compound leads to a carbene at the malonate centre, 
which can be stabilised by the rhodium. Aware that diazo carbonyl compounds can be 
potentially explosive, the reaction mixture was kept reasonably dilute (0.1 M of diazo 
dimethylmalonate 306 in CH3CN, 5 ml). 
0 0 
Me0¥0Me 
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Scheme 2.28 Reagents: (a) Rh2(0Ac)4 (10 mol%), MeCN, reflux, 3 h (41%) 
The reaction progressed in moderate yield, yielding the bicyclic vinylcyclopropane 
307, which was reacted with a variety of cyclic imines. It was hoped tricyclic ring 
systems could be set up in one step. Bicyclic vinylcyclopropane 307 was reacted with 
zinc complexes 276 and 278 under palladium catalysis (Scheme 2.29). 
H 
~C02Me + 
~C02Me 
H 
307 
1, I 
(bJ 
2 
a 
Scheme 2.29 Reagents (a) Pd(PPh3)~ (10 mol%), DMSO, 80°C, 24 h 
none isolated 
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In each case, an unidentified product was isolated, but 1 H NMR and IR spectra did 
not suggest any of the desired heterocycles had been made. Bicyclic 
vinylcyclopropane 307 was stirred with Pd(PPh3)4 in DMSO at 80°C, to ascertain 
whether a rearrangement of the vinylcyclopropane was occurring. However, only 
starting material was recovered, suggesting the cyclic imines do play a role in the 
reaction. 
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Chapter Three 
3.1 Preparation offunctionalised imines 
3.1.1 Quarternary Substitution on the Cyclic Imines 
Commercially available 2-methyl-1-pyrroline was used as the cyclic imine substrate, 
to ascertain whether a quarternary centre in the a-position poses any steric restraints 
upon reaction with vinylcyclopropane 259. The methyl-substituted imine is less prone 
to trimerisation than its unsubstituted 1-pyrroline counterpart, meaning the free imine 
could be reacted directly with the vinylcyclopropane. Various conditions were 
explored (Table 3.01). 
259 
Lewis 
Pd Catalyst Solvent 
acid 
ZnCb Pd(PPh3)4 THF 
ZnCb Pd(PPh3)4 DMF 
ZnClz Pd(PPh3)4 THF 
- Pd(PPh3)4 THF 
- Pd(PPh3)4 DMF 
ZnBr2 Pd(PPh3)4 THF 
ZnCb Pd2(dba)3 THF 
Lewis acid 
Pd(O) 
Solvent 
Temperature 
RT 
RT 
Reflux 
RT 
RT 
RT 
RT 
Table 3.01 
.Time (h) 
60 
21 
16 
60 
21 
19 
19 
308 
Product yield(%) 
3 
6 
No product isolated 
SM 
No product isolated 
No product isolated 
SM 
Despite doubling the equivalents of Lewis acid, the yield of the desired pyrrolizidine 
308 remained unchanged. This reaction proved to be quite problematic as only small 
amounts of the cyclised product were present in the crude reaction mixture by 1H 
NMR, the majority of which was vinylcyclopropane 259. It is possible the presence 
of the quartemary C-centre on the imine may cause a steric restraint on the 
nucleophilic addition of the zwitterionic species. Closer inspection of 1H NMR data 
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for the crude reaction mixtures clearly showed the unreacted imine peaks are 
broadened, possibly because of its complexation to the Lewis acid, suggesting the 
affinity of the imine for the Lewis acid may hinder the reaction. 
The basic tertiary amine constituent of pyrrolizine 308 made this compound difficult 
to purify through silica flash chromatography, and mobile phase modifiers such as 
triethylamine were required. Neutral alumina was used in an attempt to isolate the 
desired product, but yields were still very poor. Interestingly, 20 1H NMR and nOe 
experiments confirmed one diastereomer was formed exclusively in this reaction. 
2-Methyl-1-pyrroline was complexed with zinc iodide successfully to form the 
complex 309 as a cream powder in good yields (Scheme 3.01). Successful 
complexation can be confirmed by an upfield shift (~O.lppm) in the proton shifts of 
protons adjacent to the nitrogen atom. 
a 
309 
Scheme 3.01 Reagents: (a) Znl2. Et20, 0°C, 1 h (85%). 
Vapour diffusion from DCM and hexane gave crystals, which X-ray crystallographic 
data showed to be tetrahedral about the zinc metal centre, with the imines sitting in 
orthogonal planes to one another (Figure 3.01). 105 
Figure 3.01 X-ray structure of309 
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The zinc iodide complex 309 was subsequently reacted with vinyl cyclopropane 259 
and I 0 mol% palladium(O), using various conditions (Table 3.02). 
I,~(N6 ), C02Me Pd(O) ~co2Me ~C02Me + Me C02 Me Solvent 
259 309 308 
none isolated 
Complex 309 ·. Time 
Solvent Pd Catalyst Temperature 
present (y/n) : 
Product yield (%) 
• (h) 
DMF Pd(PPh3)4 RT y 68 None isolated 
THF Pd(PPh3)4 RT y 18 None isolated 
MeCN Pd(PPh3)4 RT y 18 None isolated 
MeCN Pd(PPh3)4 RT N 22 SM 
Table 3.02 
The small amounts of cyclised product apparently present in the crude reaction 
mixture were lost in the purification process. The use of acetonitrile as solvent 
appears to give numerous by-products by TLC, with one product appearing to 
account for 50% of the crude material. However, it was difficult to determine a single 
compound by 1H NMR data. Interestingly, for the complex mixture of products to be 
observed, the imine complex 309 must be present. 
3.1.2 Anti-substituted Cyclic Imines from 3-Pyrroline 
After the success observed with simple cyclic imines our attention was drawn to 
imines containing a degree of functionalisation. Davis et al. recently reported the use 
of novel cyclic sugar imines as carbohydrate mimics for the creation of aza-sugars. 106 
Polyhydroxylated nitrogen heterocycle aza-sugars are considered to be sugar mimics, 
by virtue of the ring oxygen being substituted for a nitrogen atom. These compounds 
possess potent inhibitory activity towards carbohydrate-processing enzymes and can 
be applied to a wide range of therapies including the treatment of viral infections, 
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cancer, diabetes, tuberculosis, lysomal storage diseases and parasitic protazoa. In their 
method, simple or polyhydroxylated pyrrolidine or piperidine imines are used as 
scaffolds to diversely functionalised aza-sugars through highly diastereoselective 
organometallic additions (Scheme 3.02). 
R'-M 
-
Scheme 3.02 General scheme for the creation of aza-sugars 
Interestingly, in the few cases that sugar imines have been formed, they have shown 
enhanced inhibitory properties over their fully reduced counterparts. 107 The 
introduction of hydrophobic substituents onto these cyclic sugar mimics, leads to an 
enhanced potency and bioavailability in carbohydrate-processing systems. 108 
Typically, the introduction of such groups has taken place at an early stage in the 
synthesis of sugar mimics, however Davis et al. have developed a late stage 
diversification using regioselective C=N imine formation, followed by organometallic 
addition to these late stage cyclic imine intermediates. 
It was decided to construct one of these five membered, dihydroxylated imine 
intermediates, whose preparation involved 7 steps (Scheme 3.03). The synthesis of 
imine 315 began with benzyl chloroformate protection of the secondary amine of 
commercially available 3-pyrroline. Epoxidation using m-CPBA proceeded only after 
addition of two separate portions of peracid. Acid-catalysed ring opening of the 
epoxide proved to be very problematic. Vigorous stirring was required to mix the 
biphasic system, but the epoxide proved difficult to break, with the reported yield for 
this step calculated from recovered starting material. The concentration of acid was 
increased to 3 M with no effect, and any attempt to further increase the concentration 
was avoided, as cleavage of the benzyl protecting group was possible. The reaction 
was repeated several times to acquire enough of the protected diol 312 for the 
remaining steps. tert-Butyldimethylsilyltrifluoromethanesulfonate was used as the 
silicon-protecting group and was introduced with no problems. 
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H 
6 a 
oyo~Ph 
H TBDMSO OTBDMS 
313 
oyo~Ph OyO~Ph 
6 b Q 
310 
e 
0 
311 
_Q 
TBDMSO OTBDMS 
314 
f, g 
OyO~Ph 
c H d 
HO OH 
312 
A TBDMSO OTBDMS 
315 
Scheme 3.03 Reagents: (a) Benzyl chloroformate, 3M aq. NaOH, toluene, RT, I h (83%); (b) 
m-CPBA, DCM, RT, 25 h (44%); (c) 2M aq. H2S04, Et20, RT, 2.5 d (62%); (d) 
TBDMSOTf, pyr, DCM, RT, 2 h (69%); (e) H2, Pd/C, MeOH, RT, 5 h (83%); (t) NCS, Et20, 
RT, 19 h; (g) DBU, Et20, RT, 5 h (34% for two steps). 
Palladium on carbon hydrogenolysis, deprotected the nitrogen atom in good yields to 
give the silicon protected amine 314, before N-chlorination using N-
chlorosuccinimide and elimination with diazabicycloundecane gave the target anti-
imine 315 in 4.4% overall yield. 
After this process only a small amount of the imine was isolated, and only one 
reaction was attempted with vinylcycloproane 259. The free imine was complexed to 
zinc iodide in ethereal solution, and unlike the zinc complexes 276, 278 and 279, 
which precipitated out of solution; the zinc iodide appeared to dissolve, suggesting 
the zinc iodide complex 316 was soluble in ether (Scheme 3.04). This enhanced 
solubility in an aprotic solvent such as Et20, could potentially increase the reactivity 
of the imine with the vinylcyclopropane reactant. 
I 
I A _a_ I-Zn(.NQOTBDMS) 
TBDMSO OTBDMS OTBDMS 2 
315 316 
Scheme 3.04 Reagents: (a) Znlz, Et20, RT, I h (87%). 
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The complex 316 was added to a solution ofvinylcyclopropane 259 in both THF and 
DMSO with I 0 mol% palladium(O) (Table 3.03). No desired product was formed, 
and both the vinylcyclopropane and imine were recovered after purification with 
silica gel. 
259 
Pd Catalyst 
Pd(PPh3)4 
Pd(PPh3)4 
Pd(PPh3)4 
1\. /1 
Zn(N~OTBDMS) 
'oTBDMS 2 
316 
Solvent Temperature 
'. 
THF RT 
THF RT 
DMSO RT-Heflux 
Table3.03 
C02 Me 
C02 Me 
10 mol% Pd(O) 
'OTBDMS 
solvent OTBDMS 
none isolated 
Time (h) Product yield (%). 
20 SM 
21 SM 
20 Complex mixture 
3.1.3 Syn-substituted Cyclic lmines from 3-Pyrroline 
It was hypothesized that substituents at the C-3 and C-4 position on the 5-membered 
cyclic imine, may have a directing effect on the [3+2] cycloaddition step, and hence 
control the sterechemical outcome of the indolizidine product. It was reasoned that 
the syn-imine . derivative 320 could be synthesised using an osmium-catalysed 
dihydroxlation step in a modification ofDavis' procedure (Scheme 3.05). 
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H 
OYO ............... Ph OYO ............... Ph 
6 a 6 b ~ c 
HO OH 
310 317 
OYO ............... Ph 
~ 
TBDMSO . OTBDMS 
d ~ 
TBDMSO OTBDMS 
e, f Q 
TBDMSO OTBDMS 
318 319 320 
Scheme 3.05 Reagents: (a) Benzyl chlorofonnate, 3M aq. NaOH, toluene, RT, I h (83%); (b) 
AD-mix-p, methane sulfonamide, t-Bu0H:H20 (1:1), 0°C, 19 h (73%); (c) 
TBDMSOTf, pyr, DCM, RT, 2 h (70%); (d) H2, Pd!C, MeOH, RT, 5 h (82%); (e) NCS, Et20, 
RT, 19 h; (t) DBU, EtzO, RT, 5 h (33% for two steps). 
Poor yields were initially observed in the dihydroxylation step. The addition of AD-
mix-P to a solution of N-protected-3-pyrroline in tert-butanol:water (I: I) gave an 
unacceptable 29% yield of diol 317. The step had to be optimised for this to be a 
viable route toward the syn-imine 320. The AD-mix formulation consists of 0.6% by 
weight of (DHQD)2-PHAL ligand and Os04, blended into the bulk ingredients 
ferricyanide and carbonate, providing a convenient yellow powder. Sharpless and eo-
workers found that addition of methane sulfonamide to this mixture is recommended 
for all non-terminal olefins, as an enhanced rate of ester hydrolysis is thought to 
occur.
109 
With this in mind, the N-protected-3-pyrroline was reacted with AD-mix-P in tert-
butanol:water (l: I) at 0°C, and methane sulfonamide added to the slurrying mixture. 
The workup involved the addition of sodium sulfite and extraction into DCM. The 
eventual yield of the dihydroxylation step increased to 73%, making this early stage 
in the process a lot more efficient. Subsequent silicon-protection, hydrogenation, N-
chlorination and elimination steps were performed with no problems to give the target 
syn-imine 320 in 11% overall yield. 
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As a greater quantity of the .syn-imine 320 was prepared a few different conditions 
were tried in the cycloaddition reaction with vinylcyclopropane 259. Firstly, the free 
imine was reacted with vinylcyclopropane, using different conditions (Table 3.04). 
259 
Lewis 
acid 
Pd Catalyst 
ZnCh Pd(PPh3)4 
ZnBrz Pd(PPh3)4 
- Pd(PPh3)4 
ZnCh Pd(PPh3)4 
ZnCh Pd(PPh3)4 
NQOTBDMS 
OTBDMS 
320 
10 mol% Pd(O) 
solvent 
Solvent Temperature Time (h) 
THF RT 20 
THF RT 21 
THF RT~reflux 20 
DMF Reflux 19 
DMSO RT~reflux 19 
Table 3.04 
C02 Me 
C02 Me 
O[Si] 
O(Si] 
none isolated 
.. 
Product yield (%) 
SM 
SM 
Complex mixture 
SM 
Complex mixture 
Analysis of the crude reaction mixtures suggested the presence of only starting 
materials in most cases. However, when no Lewis acid was used, the reaction mixture 
was stirred for 18 hours at room temperature, and TLC suggested no reaction had 
occurred. The mixture was then heated to reflux for 2 hours resulting in a complex 
mixture of products, which appeared to contain a cyclisation product due to the 
characteristic proton peaks at 6.00 ppm. Purification by column chromatography 
appeared to isolate one spot by TLC, but complicated 1 H NMR data suggested a 
mixture of compounds, one of which a possible cyclisation product. 
The free imine 320 was complexed to zinc iodide to give the zinc iodide complex 321 
in good yield (Scheme 3.06). 
89 
Q 
TBDMSO OTBDMS 
a l'zn(<QOTBDMS) 
OTBDMS 
2 
320 321 
Scheme 3.06 Reagents: (a) Zn}z, Et20, RT, 1 h (70%). 
Complex 321 was subsequently reacted with vinylcyclopropane 259 in DMSO at 
room temperature with 10 mol% tetrakis(triphenylphosphine) palladium(O) but again 
no desired pyrollizidine was observed and the starting materials were recovered 
(Scheme 3.07). 
\tQ-OTBDMS) 
i1o2Me a C02 Me 
~C02Me 
+ 
* C02Me 
OTBDMS 
OTBDMS 2 OTBDMS 
259 321 none isolated 
Scheme 3.07 Reagenfs: (a) Pd(PPh3) 4 (10 mol%), DMSO, 80°C, 24 h. 
This was quite a disheartening stage of the research, as a better result was envisaged 
with the use of these functionalised imines. For this reason, an alternate protecting 
group was investigated. It was decided 2,2-dimethoxypropane would be used to 
protect the cbz-protected syn-diol 317, as it would be able to withstand the 
hydrogenation conditions needed to cleave the cbz-group later in the synthesis of the 
imine, and would also alleviate the problem ofC-Si bond lability (Scheme 3.08). 
OlO~Ph 
H 
~ a, b H c, d H HO OH oxo oxo 
317 322 
Scheme 3.08 Reagents: (a) Acetone, 2,2-dimethoxypropane, PTSA, RT, 19 h (77%); (b) H2, 
Pd/C, MeOH, RT, 20 h (90%); (c) NCS, Et20, RT, 19 h; (d) DBU, Et20, RT, 5 h (15%, 2 
steps). 
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The DMP protection progressed well, as well as hydrogenation of the cbz-group. 
However, the last step to form the imine with NCS and DBU was very disappointing, 
with only 15% of the product possibly being the desired imine 322, by 1H NMR data. 
It was decided to use this crude product in a cyclisation with vinylcyclopropane 259. 
The reaction was carried out on the free imine with Lewis acid in THF at room 
temperature with I 0 mol% tetrakis(triphenylphosphine) palladium(O) (Scheme 3.09). 
No desired cyclised pyrrolizidine product was observed, and only unreacted 
vinylcyclopropane was present in crude 1H NMR spectra. 
H ~02Mo a ~C02 Me )( COzMe + C02 Me oxo 0 
of--
259 322 
none isolated 
Scheme 3.09 Reagents: (a) Pd(PPh3) 4, THF, ZnBr2, RT, 19 h. 
3.1.4 Cyclic Imines from 4-hydroxy piperidine 
Having exerted much time and effort in the unsuccessful trapping of functionalised 
imines 315 and 320 it was decided to try alternative functionalised imines. Possible 
reasons for this lack of reactivity of the aforementioned imines could be attributed to 
steric or stereoelectronic influences of the proximal silyl ether functionality, 
hindering the attack of an incoming nucleophile on the imine bond. For this reason, it 
was envisaged that a 6-membered cyclic imine, with para-substitution, would 
eliminate the possibility of steric/stereoelectronic interference. 4-Hydroxy piperidine 
was protected with TBDMSOTf and pyridine in DCM. The reaction progressed 
smoothly with the silyl ether 323 being isolated in good yield (Scheme 3.10). 
OH OTBDMS 
6 a 6 
H H 
323 
Scheme 3.10 Reagents: (a) TBDMSOTf, pyr, DCM, RT, 24 h (71 %). 
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The silyl ether 323 could then be N-chlorinated using NCS, then DBU used to 
eliminate HCI to form the cyclic imine 324. However, real problems were 
encountered with this reaction. 1H NMR data clearly showed the presence of the 
downfield imine proton, but this rapidly disappeared, possibly due to trimerisation. 
Potassium superoxide was also used as an alternative reagent, as once the reaction 
had finished, the remaining solid potassium superoxide could be filtered off, 
removing the majority of impurities. Once again the characteristic imine proton 
quickly disappeared with time (Scheme 3.11). 
OTBDMS OTBDMS 
6 a,b 6 N 
H 
323 324 
Scheme 3.11 Reagents: (a) NCS, Et20, RT, 19 h; (b) DBU or K~2, 18-crown-6. 
By introducing a Lewis acid, such as Zn}z, it was hoped the imine complex 325 could 
be isolated as a stable powder, suitable for use in cyclisation reactions. Upon addition 
of the Lewis acid to the colourless solution, a deep red colour was observed. The 
reaction mixture was filtered, leaving a pale yellow solid, in poor yield. 1 H NMR and 
IR data proved to be inconclusive as to whether the complex formation was a success. 
The material obtained from the complexation reaction was reacted with 
vinylcyclopropane 259, under palladium catalysis, using a variety of conditions 
(Table 3.05). However, in each case unreacted vinylcyclopropane was recovered. The 
poor yields and uncertainty as to whether the cyclic imine had been formed at all, was 
certainly a contributing factor to the failure of this reaction. 
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~C02Me + 
V "C02Me 
259 
Solvent 
DMSO 
DMSO 
DMSO 
MeOH 
325 
Temperature Time 
CO C) (h) 
80 1 
80 4 
. 100 
0.2 
(mirowave) 
Reflux I 
Table3.05 
solvent 
o~~,:: 
OTBDMS 
none isolated 
Product yield(%) 
•• 
SM 
SM 
SM 
SM 
3.2 New methods towards imine bond formation 
3.2.1 In situ generation of the Cyclic Imine 
The application of cyclic imines in organic synthesis is limited due to their volatility 
and tendency to rapidly trimerise at room temperature in neutral or basic solution. 110 
As a possible solution to this, other than introducing a Lewis acid, we hoped 
generating the imine directly from its N-chloramine derivative in the presence of a 
palladium(O) source, would bypass the problem oftrimerisation. 
Homopiperidine was used, as the azepine ring system forms more readily than its 
pyrrolizidine and indolizidine counterparts. N-Chlorination of homopiperidine was 
carried out with NCS in ethereal solution, with the reaction being stirred overnight 
(Scheme 3.12). 
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0 
I 
H 
a 
Scheme 3.12 Reagents: (a) NCS, Et20, RT, 24 h. 
0 
I 
Cl 
326 
The reaction was monitored by TLC, with the majority of starting material being 
consumed. Water and brine washes were performed, and the organic fractions dried 
over MgS04. IR spectroscopy confirmed the absence of a N-H stretch in the region 
3400-31 OOcm-1• TheN-chloramine 326 was used immediately upon its formation, and 
reacted with vinylcyclopropane 259, in the presence of base and 10 mol% 
tetrakis(triphenylphosphine) palladium(O) (Scheme 3.13). 
0 /'~Oo,M. ~C02Me a -::?' C02Me + N H C02 Me I 
Cl 
259 326 284 
Scheme 3.13 Reagents: (a) Pd(PPh3) 4, DBU, DMSO, 80°C, 1.5 h (19%). 
Encouragingly, the azepine 284 was formed in modest yield, as exclusively one 
diastereoisomer. This showed that in situ generation of the imine could be a viable 
route towards these sorts of compounds. The reaction was carried out just one time, 
so there is possibly some scope for further optimisation of the reported yield. 
3.2.2 Cyclic Imines from Enecarbamates 
Carreira et al. report the first total synthesis of (±)-strychnofoline, a class of natural 
product isolated from the leaves of Strychnos usambarensis, which displays 
antimitotic activity in cultures of mouse melanoma and Ehrlich tumour cells. The 
prominent structural feature of this group of alkaloids is the spiro[pyrrolidin-3,3 '-
oxindole] nucleus, which they construct with a ring-expansion reaction of a spiro-
[cyclopropan-1,3'-oxindole] and a cyclic imine (Scheme 3.14). 111 The cyclisation 
step occurs via a Mgh mediated process. 
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+ 
HO 
strych nofoline 
Scheme 3.14 Mgl2 mediated cyclisation in the synthesis of strychnofoline 
They reported a mild and convenient synthesis of cyclic imines from Hoc-protected 
enamine 327, upon treatment with TMSOTf/NE!J at -20°C, with aqueous workup 
(Scheme 3.15). They refer to the cyclic imines lack of stability, and for this reason no 
purification was carried out before its subsequent cyclisation. 
0 
t-BuO)lN~ VR 
327 
b 
Scheme 3.15 Reagents: (a) TMSOTf, Et3N, DCM, -78°C ~ -20°C; (b) aq. NaHC03 
quench, -78°C. 
For this route to be viable, a range of functionalised enecarbamates 327 must be 
easily accessible from cheap and readily available starting materials. Accordingly we 
turned our attention to a protocol by Yu et a!, in which they report a general one-pot 
synthesis of cyclic enecarbamates. 112 Their approach in the preparation of a drug 
candidate involved the reduction of lactam carbamate 328 with Super Hydride to 
lactamol derivative 329, which without quench or isolation was treated directly with 
trifluoroacetic anhydride, diisopropylethylamine and a catalytic amount of DMAP. 
The dehydration occured in good yield at room temperature, to give the enecarbamate 
330 (Scheme 3.16). 
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i 
! 
a b 
328 329 330 
Scheme 3.16 Reagents: (a) LiBHEt3, toluene, -70°C, 30min; (b) TFAA/DIPEA cat. DMAP, 
-70°C---+ RT, 2 h (70% 2 steps). 
Four different enecarbamates were synthesised from the respective carbamates 328, 
331, 332 and 333 following the described procedure, to explore the possibility of 
whether this synthetic route could be applied to our research. The unfunctionalised 
enecarbamate 334, after imine formation, would hopefully give a direct comparison 
with our own method for the preparation of pyrrolizidine 280. The methyl, and ethyl 
ester versions 328, 332 and aromatic 333 were chosen in an effort to introduce some 
simple functionality onto the ring (Table 3.06). 
Carbamate Enecarbamate Isolated yield(%) (2 steps) 
0 Boo,N6 Boc,N~ 66 
331 334 
0 
""'6 soc,O 70 Me02C Me02C 332 335 
0 
""'6 soc,O 72 Et02C 328 Et02C 336 
ro N 0 CO N 60 
I I 
Boc 333 Boc 337 
Table 3.06 
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With this selection of enecarbamates at hand, we decided to apply Carreira's protocol 
to form the cyclic imines 272, 338, 339 and 340 (Table 3.07) 
0 )l 
t-BuO N~ V-'-R a b 
Enecarbamate Cyclic imine 
Enecarbamate Cyclic imine 
Boc,N~ N:) 
334 272 
soc,O 
Me02C 335 
0 
Me02C 338 
soc,O 0 Et02C 336 Et02C 339 
00 CO N N I 
Boc 337 340 
Table 3.07 Reagents: (a) TMSOTf, Et3N, DCM, -78°C- -20°C; (b) aq. NaHC03 quench, 
-78°C. 
It is important to note that no yields were reported, as the material taken through for 
cyclisations was always crude, due to the general instability of the cyclic imines. 1 H 
NMR data of the crude imines showed the characteristic imine proton to be present, 
and was a key indication of a successful reaction. In the case of the simple cyclic 
imine 272, the crude reaction material was immediately reacted with 
vinylcyclopropane 259, under palladium catalysis to give the previously synthesised 
pyrrolizidine 280 exclusively as one diastereoisomer, in a lower yield of 19% 
(Scheme 3.17). 
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a b 
334 272 
H 
~ C02Me 
280 
C02 Me 
H 
Scheme 3.17 Reagents: (a) TMSOTf, EhN, DCM, -78°C---+ -20°C; then aq. NaHC03 
quench, -78°C; (b) 259, Pd(PPh3) 4 (10 mol%), DMSO, 80°C, 24 h (19% 2steps). 
This was quite a promising result, as no attempt had been made to stabilise the readily 
trimerisable cyclic imine prior to its cyclisation, and it illustrates Carreira's chemistry 
could possibly be applied to our own. However, attempts to cyclise functionalised 
versions 338-340 were unsuccessful under identical conditions. In fact, the only 
product isolated from the reaction was, surprisingly, the enecarbamates 335-337. 
Heating the crude imines in DMSO for one hour was enough to c~nvert them back to 
their respective enecarbamate precursors. This unwanted reaction occurs due to the 
impure nature of the cyclic imines. Different solvents were used in an attempt to stop 
this reaction occurring and to isolate the desired cyclised products (Table 3.08). 
Trace amounts ofpyrrolizidine 341 were observed using THF as solvent. 
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+ Cyclised Product 
Solvent 
Cyclic imine 
Cyclic imine Sovent Temperature Cyclised product Yield(%) (OC) bo,Mo 
No 80°C 
C02 Me 
DMSO N 19 
272 280 
DMSO 80°C ~co,Me 0 C02 Me none DCM Reflux N isolated 
Me02C Me02C 338 THF Reflux 
~C~Me 0 Reflux C02Me trace THF N amounts 
Et02C 
339 Et02C 341 ;pco,Me 
CO C02Me THF Reflux N none isolated N '\ 
340 
Table 3.08 
Two major side-products observed when using DCM and THF, were straight chain 
alkenes 342 and 343 (Figure 3.02). 
~C02Me 
C02 Me 
342 
C02Me ~C02Me 
Me02C C02Me 
343 
Figure 3.02 
The his-alkene 342 is thought to arise via an oxidation pathway, whereas the Iris-
alkene 343 is the by-product arising from Et3N reacting with vinylcyclopropane 259 
in a dimerisation reaction. The presence of surplus Et3N in the crude imine caused 
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real problems with the subsequent cyclisation reaction. When isolating the imine, 
saturated aqueous NaHC03 and brine washes were performed, but prolonged contact 
with aqueous solvent lead to a reduction in the yield of the imine, presumably through 
hydrolysis of the imine bond. However carefully the work-up was performed, 
significant quantities of EhN were left in the imine residue. Attempts to purity the 
imine by column chromatography failed, with nothing being isolated from the 
column. Polymer bound diethylamine was used in an attempt to eliminate the 
problem, with the intention of filtering off the polymer to leave the clean imine. 
However, solid-supported reagents can behave very differently under similar reaction 
conditions, and the reaction failed to work. 
Lewis acids such as zinc iodide have previously been used to stabilise simple cyclic 
imines,92 so upon isolation of the crude imine, zinc iodide was introduced into an 
ethereal solution ofthe imine 339. A precipitate initially appeared to form in solution, 
however, as soon as the precipitate was filtered appeared to become wet. It can be 
assumed the complex 344 is much more hygroscopic than previously isolated zinc 
complexes. The wet solid isolated from .this reaction was still reacted with 
vinylcyclopropane 259, under palladium catalysis in DMSO (Scheme 3.18). 
a c 
336 339 
H 
~'''''1t· C02Me :?' C02Me N H 
EI02C 
341 
Scheme 3.18 Reagents: (a) TMSOTf, Et3N, DCM, -78°C ---+ -20°C; then aq. NaHC03 
quench, -78°C; (b) Znl2, Et20, RT, I h; (c) 259, Pd(PPh3) 4 (10 mol%), DMSO, 80°C, 24 h 
(10% 3 steps). 
The reaction was only attempted one time, with crude 1 H NMR data showing the 
presence of a possible cyclisation product resembling compound 341. After column 
chromatography, cyclised product 341 was isolated in modest yield (1 0%), with nOe 
data suggesting the one diastereoisomer being formed. This avenue needs to be re-
visited with an aim to modifying the comp1exation procedure, possibly with more 
stringent, anhydrous conditions in place. 
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3.2.3 Cyclic !mines from y,o-Unsaturated Nitriles 
Fry et a/ report the addition of Grignard reagents to ffi-bromonitriles and y,o-
unsaturated nitrites to effect ring closure, forming cyclic imines 345 and 346 in good 
overall yields (Scheme 3.19). 113 
OTMS 
~CN RMgX lMSOn 
Br N R 
345 
OTMS T:n nN i.RMgX ii. NBS Br ....-:: N R 
346 
Scheme 3.19 Grignard additions to ro-bromonitriles and y,o-unsaturated nitriles 
Previous work has failed in the cyclisation of imine bonds bearing quartemary 
centres, due to steric hindrance. In a modification of Fry's procedure, it was 
envisaged the Grignard reagent could be replaced by a hydride source to give 
unsubstituted, fundionalised imines 347 (Scheme 3.20). 
OTMS 
~CN 
Br 
TMSOD Super Hydride 
·········--·------ ..0 
THF N 
347 
Scheme 3.20 Proposed modification of Fry's procedure 
Fry reports the synthesis of the bromonitrile precursor following a synthetic sequence 
involving alkylation of acetonitrile with allyl bromide followed by epoxidation and 
subsequent ring cleavage of the 2-cyanoethyl epoxide with trimethylsilyl bromide 
(Scheme 3.21 ). 
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~CN 
Br 
c 0 ~CN 
a,b d 
OTMS 
~CN 
Scheme 3.21 Reagents: (a) i. n-BuLi, THF, -78°C. ii. allyl bromide; (b) m-CPBA, DCM; (c) 
TMSBr, 0 --t 25°C; (d) i. n-BuLi, THF, -78°C; ii. acrolein, iii. TMSCI. 
Attempts to synthesise the bromonitrile failed with problems encountered with the 
initial alkylation step. Although the desired alkylation product appeared to be present 
in the crude reaction mixture, upon careful purification with column chromatography, 
a close running impurity could not be removed. This in turn hindered the epoxidation 
step, and none of the desired epoxide could be isolated. It was decided to terminate 
this section of research at this stage. 
3.3 Conclusion 
Good progress has been made in the reaction of simple and functionalised 
vinylcyclopropane derivatives with a variety of simple cyclic imines (Scheme 3.22). 
R~EWG + 
V 'EWG 
R = H, EWG = C02Me ( n = 1, 2 or 3) 
R=H, EWG=CN 
R = C02Et, EWG = C02Me 
a 
RQEWG 
N EWG 
n 
R = H, EWG = C02Me 
R=H, EWG=CN 
R = C02Et, EWG = C02Me 
Scheme 3.22 Reagents: (a) Pd(PPh3) 4 (10 mol%), DMSO, 80°C, I h. 
Although the introduction of di-cyano functionality onto the cyclopropane ring was 
difficult, initial experiments suggested, the cyclisation reaction works well with the 
superior elecron-withdrawing nature of the cyano group. Introduction of functionality 
onto the double bond still gave a compound susceptible to palladium insertion and 
subsequent ring formation. It has been shown that there is scope for wide variation of 
the vinylcyclopropane derivative in its reaction with simple cyclic imines. 
Major problems have been encountered in the use of more functionalised cyclic 
imines with simple vinylcyclopropane (Scheme 3.23). The generation of a whole host 
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of functionalised cyclic imines has lead to problems with their isolation, due to the· 
reactivity of the imine bond. For this reason, numerous different reaction sequences 
have been explored in an attempt to gain access to functionalised imines. Trace 
amounts of cyclised products have been isolated suggesting the reactions have the 
potential to work, but a more robust method for the stabilisation of the cyclic imines 
is required for future success. 
259 
Scheme 3.23 Failed reactions of functionalised cyclic imines 
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Chapter Four 
4.1 New Routes to Functionalised Prolines 
4.1.1 Proline as a Building block 
Peptide-derived chemotherapeutics have attracted a great deal of interest in recent 
years and has heightened the importance of viable synthetic routes towards rare and 
nonproteinogenic enantiomerically pure amino acids. 114 Consequently, expeditious 
preparations of these types of compound have become increa~ingly prevalent in the 
literature. The importance of making enantiomerically pure compounds cannot be 
emphasized enough and the current interest in this field has been brought about by (a) 
the enantioespecificity shown by most biological systems in their responses to drugs, 
(b) the regulatory pressure on the pharmaceutical industry to market chiral drugs as 
single enantiomers, and (c) the strong drive for synthetic efficiency.115 
. Particular attention has been devoted to asymmetric syntheses of heterocyclic 
compounds, due to their presence in nature and specific biological activities. 
Researchers in this field have relied heavily on enantiospecific processes proceeding 
from the chiral pool to gain access to this broad class of compounds.116 The most 
significant contribution from the chiral pool arises from amino acids, due to their 
versatility and have been the most extensively used for the synthesis of chiral, 
enantiomerically pure heterocycles. The proteinogenic amino acids possess a limited 
but significant number of diverse functional groups, which help facilitate numerous 
synthetic transformations; their protection-deprotection and activation chemistry is 
thoroughly documented and they are readily available commercially, usually in both 
enantiomeric forms. 
Proline continues to be a favorite starting material for the construction of the 
pyrrolizidine alkaloids. Mulzer et al. recently reported a synthesis of the necine base 
(-)-petasinecine using the highly stereoselective Ireland-Ciaisen rearrangement to 
create two of the three chiral centers present in the molecule (Scheme 4.01). 117 The 
required allyl ester 349 was rapidly prepared from allyl alcohol 348, in turn obtained 
via Horner-Emmons homologation of Boc-prolinal. Reaction of 349 with lithium 
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hexamethyldisilazide and trimethylsilyl chloride gave the Ireland-Ciaisen precursor, 
which after rearrangement was cyclised to 350. Ozonolysis and reduction gave the 
primary alcohol 351 which was reduced using borane.THF complex and debenzylated 
using hydrogenolysis conditions. 
0 
OH BnoJ0 ~OBc ~ a ~ b, c d, e c c 
348 349 350 0 
351 352 
Scheme 4.01 Reagents: (a) BnOCH2COCI, pyr, RT, 5 h (98%); (b) LiHMDS, TMSCI, THF, 
-Il0°C, 2 h, then 5 hat ooc; (c) F3CC02H, BuOH. -20°C, I h, RT, I6 h, 60°C, 48 h (82%); 
(d) 0 3, MeOH, -78°C, IO ruin; (e) NaBH4, MeOH, -78°C, I6 h (92%); (f) BH3.THF, THF, 
60°C, 48 h; (g) IO% Pd/C, H2, MeOH, RT, I bar, 48 h (98%). 
In a further example that extends the usefulness of the anodic methoxylation of 
pro lines, alkynylsubstituted proline ester 355 (prepared by acylation of prolinol 353, 
followed by oxidation and esterification) was submitted to an anodic oxidation-
iminium ion cyclization sequence to afford indolizinedione 357, which was ultimately 
transformed into the angiotensin-converting enzyme inhibitor A58365A (Scheme 
4.02). 118 
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c5~:H a-c M•c"~ca,Me d 
353 0 354 355 ~ ~ Me Me 
Me"N~O C02Me 
y 356 
OMe ~ 
e, f Mea,~ CO, Me 
Me 
0 
357 
Meo,~CO,Me ----Ho,~co,H 
0 OH 
358 A-58365A 
g,h 
Scheme 4.02 Reagents: (a) 354, Me3Al, benzene, reflux, 1.5 h; (b) Jones reagent, acetone, 
RT, 4 h; (c) Me2NCH(OMe)z, toluene, reflux (36% 3 steps); (d) carbon anode, Pt cathode, 
0.03 M Et4NOTs in MeOH, undivided cell, 36.0 mA, 6.5 F/mol (83%); (e) TiCI4 , DCM, 
-78°C ~ RT; (t) i. 0 3, MeOH, -78°C, ii. Zn, HOAc, -78°C ~ RT (72% 2 steps); (g) 
TIPSOTf, Et3N, benzene, 0°C ~ RT; (h) DDQ,p-dioxane, reflux (51% 2 steps); (i) 0.01 M 
HCI in 1:1 MeOH/H20 (48%). 
Jacobi et al. have used an intramolecular Diels-Aider cycloaddition of an acetylenic 
oxazole derived from proline dipeptide 359 to synthesise the complex tetracyclic 
alkaloid (-)-norsecurinine (Scheme 4.03). Dipeptide 359 was converted to the oxazole 
pyrrolidine derivative 360 by cyclodehydration followed by catalytic hydrogenation. 
The protected enynone 361 underwent rapid I ,4-addition with the secondary amine to 
give acetylenic ketone 362, which without purification was converted to the 
furanoketone 363, by brief thermolysis in mesitylene. Reduction with sodium 
borohydride and elimination using Martin's reagent ([PhC(CF3)20]2SPh2) led to the 
introduction of the double bond in the seven-membered ring. Deprotection of 363, 
followed by hydrolysis with Nal/TiCI4,. afforded the butenolide alcohol 364 as a 
single isomer. Finally, mesylation and subsequent transannular alkylation with 
potassium hexamethyldisilazide gave ( -)-norsecurinine. 119 
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Scheme 4.03 Reagents: (a) POCh, reflux, 4 h;,(b) Pd!C, H2, MeOH, RT, 19 h (65% 2 steps); 
(c) 361, MeCN, 50°C, 2 h; (d) Reflux, mesitylene, 6 h (50% 2 steps); (e) NaBH4, THF, 
-30°C; (f) [PhC(CF3)20hSPh2, DCM, RT (60% 2 steps); (g) TBAF, THF, RT (90%) (h) 
Nal, TiC14, H20, 65°C (75%); (i) MsCl, DMAP cat., Et3N, RT, 2 h (98%); (j) KHMDS, THF, 
-78°C, 1 h (69%) 
These are all examples of protocols taking advantage of proline as a building block 
towards more complex molecules. Synthetic sequences towards more complex 
proline templates are becoming increasingly commonplace, as precursors for more 
diverse molecule formation. An example of this is the synthesis of trans-(2S,4R)-4-
hydroxy-L-proline 369 (L-Hyp), a non-essential amino acid found in a number of 
secondary metabolites such as echinocandins and etamycin. With its two chiral 
centers, L-Hyp is the molecule of choice for access to numerous multifunctionalised 
pyrrolidine ring compounds. 120 Takano et a/ recently prepared L-Hyp in a ten-step 
sequence starting from (S)-0-benzylglycidol (Scheme 4.04). Acetylenic substitution 
of epoxide 365 and subsequent reduction of the resulting pentynol compound, then 
Mitsunobu reaction with phthalimide gave derivative 366. Reaction with hydrazine 
and benzoylation gave compound 367, which cyclised in the presence of iodine to 
obtain 4-b~nzoate-2-prolinol 368, which was Hoc-protected, oxidized, and further 
deprotected to give 369 in 25% overall yield. 121 
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H 
~OBn 
0 
365 
a-c ~OBn 
PhtN H 
366 
PhOCQ 
Ch ~ OBn g-k 
368 
NHCOPh 
d,e Osn 
367 
Scheme 4.04 Reagents: (a) C2H2, NaH, DMSO; (b) H2, Pd/CaC03 cat.; (c) Phthaliniide, 
PPh3, DEAD (61% 3 steps); (d) N2H4, EtOH; (e) BzC1, EhN (87% 2 steps); (f) Jz, H20/THF 
(78%); (g) Boc20, Et3N, DCM; (h) K2C03; (i) H2, Pd(OH)z; (j) RuCh, Na104; (k) TFA (61% 
5 steps). 
L-Hyp acts as a more functionalised analogue of proline, and allows access to a large 
variety of chiral molecules such as glutamic acids analogues, kainic acids, arginine 
analogues, carbapenems, natural products such as lycoperdic acid, bulgecins, 
echinochandins or didemnins, and also fully synthetic piperidines and pyrrolidines, 
benzodiazepins, puromycin analogues, baclofen, quinolones and naphthyridones 
(Figure 4.01). 120•122 
H 
HO,C1AO .. /~CO,H 
~C02H 
H 
acromelic acid 
lycoperdic acid 
OH NaOjS~~.:Zl-.co H 
I N 2 
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OHH Me 
MeA-~ S-aCONMe2 
N !J NH 
0 
C02H 
meropenem 
Figure 4.0 I Examples of natural products based on L-Hyp 
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The pursuit for general methodology towards various functionalised proline 
derivatives can only enhance the efficiency with which complex molecules can be 
constructed. As such, we decided to expand the potential synthetic utility of the 
palladium [3+2]. cycloaddition, in an attempt to form novel proline compounds as 
templates for further elaboration. 
We turned our attention to the use of oxazinones 370 within the reaction. Oxazinones 
offer an alternative form of cyclic imine, with a highly electrophilic imine bond, 
caused by the electron-withdrawing lactone portion of the ring. This improved 
environment is conducive towards nucleophilic attack from vinylcyclopropane 259, to 
give intermediary bicycles 371 as templates for functionalised proline syntheses 
(Scheme 4.05). The relatively simple preparation of oxazinones from amino alcohols, 
allows us the opportunity to screen numerous different substrates, and also take 
advantage ofthe chiral pool presented by amino acid derivatives. The ultimate aim of 
this project was to gain total control of the two stereogenic centres created in the 
cycloaddition step, leading to an enantioselective route towards functionalised 
pro lines. 
C02Me 
Co2Me N~O Pd(O) :ft CO Me 
C02Me ·R~O - N 2 ~ R-{_c0 0 -
259 370 371 
Scheme 4.05 Proposed route to novel functionalised prolines 
4.1.2 Oxazinones in synthesis 
The use of oxazinones (or glyoxylate imines) is widespread in the literature, 
particularly as electrophilic chiral glycine equivalents. 123 Molinski et a! reported an 
unexpected rearrangement route towards these types of compounds. 124 Starting from 
2-substituted oxazolines, a novel reverse-Beckmann type rearrangement occurred 
after oxidation of the a-carbon by selenium dioxide, followed by P-cleavage by I ,2-
migration and concomitant ring expansion (Scheme 4.06). 
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Oxazole 
i. R' = H, R = i-Pr 
ii. R' = H, R =Ph 
iii. R' = Ph, R =Ph 
iv. R' = Ph, R = i-Pr 
a 
Oxazinone 
i. R' = H, R = i-Pr (75%) 
ii. R' = H, R =Ph (72%) 
iii. R' = Ph, R =Ph (94%) 
iv. R' =Ph, R = i-Pr (74%) 
Scheme 4.06 Reagents: (a) Se02, dioxane, reflux, 1 h. 
The proposed reaction mechanism proceeds through a Lewis acid-catalysed 
rearrangement of a 2-acyloxazoline intermediate (Scheme 4.07). Allylic oxidations 
are known to occur in the presence of Se02 and for this reason it was considered that 
2-acyloxazoline 372 was a reasonable intermediate. In the presence of Lewis acid, 
compound 372 is unstable and undergoes rapid ring opening leading to a conjugated 
nitrilium ion. It was reasoned that sources of Lewis acid in this reaction might arise 
from selenium-containing by-products formed in the reduction of Se02• The cationic 
nitrilium intermediate then rearranges via a 1,2-shift to an acylium ion, followed by 
ring closure to give oxazinone 373. 
R'~{~R 
Oxazole 
R = H or Ph 
LA 
I 
0 
0 ,)_ ~N R R'~+ 
'Nitrilium-acylium' 
rearrangement 
a 
LA 
I 
~~)-R 
R' 
Scheme 4.07 (a) Se02, dioxane, reflux, I h 
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Lewis Acid 
Oxazinone 
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Chen et at were one of the first groups to harness this reaction in, their 
diastereoselective synthesis of arylglycine derivatives, via TF A-promoted Freidel-
Crafts reactions of phenols with cyclic glyoxylate imines. 125 They report the use of a 
diphenyl substituted glyoxylate imine 374 as an electrophile in the reaction with 
phenol 375, to give a mixture of ortho and para adducts. These adducts were 
subsequently treated with Pearlman's catalyst [Pd(OH)2/C] and TFA in a 
hydrogenolysis reaction to remove the chiral template and form the free amino acid 
without notable racemisation (Scheme 4.08). 
OH o~ 
.o ·0\)~o a 0 go o)··''' ... R- ~ ·· ... ,,,0-....::::: 
...-::; 
+ 
374 375 
b 
Scheme 4.08 Reagents: (a) TFA, DCM, 0°C; (b) Pd(OH)2/C, TFA H2 (latm), MeOH:H20 
(20:1). 
4.1.3 Formation of Oxazinones via Oxazoles 
Oxazoles 376-380 were prepared following the protocol of Meyers et a/, in which a 
selection of racemic and chiral amino alcohols were condensed with commercially 
available ethyl iminoacetate hydrochloride. 126 The oxazoles were then subjected to 
Se02 forming the corresponding oxazinones (Scheme 4.09). 
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RYNH2 + NH.HCI __ a_ ... 
l._OH ~OEt ---{~ N R 
Oxazole Oxazinone 
Amino alcohol R Oxazole Oxazinone 
0 H 
(S)- ---('N~H /'''tN Phenylalaninol Bn Ph ''··. :L 
I 376 381 Ph 0 0 (70%) (60%) 
(±)-Valinol i-Pr 
-<Z\-- ~":L 382 377 
(60%) 0 0 (60%) 
0 ~~H H (S)-Leucinol Y't":L 2-methyl- N~ propyl 
378 0 0 383 
(40%) (32%) 
0 H 
(R)- Ph ~~H PhtN:L 
Phenylglycinol N .,., 379 384 Ph (85%) 0 0 (15%) 
0 /''(:La (±)-2-Amino-1- Et ---('N~ butanol 
380 385 
(45%) (30%)' 
Scheme 4.09 Reagents: (a) DCM, 0°C---+RT, 18 h; (b) Se02. dioxane, reflux, 1 h. 
Oxazoles 376-380 were synthesised in average to good yields (40-85%) from 
phenylalaninol, valinol, leucinol, phenylglycinol and 2-amino-butanol. Kuglerohr 
distillation of the oxazole products was necessary to obtain optical purities 
comparable to those reported in the literature, however, water washes were sufficient 
to isolate oxazole products in good yields, suitable for the oxidative rearrangement 
reaction. In most cases the commercially available amino alcohol was purchased 
directly, however, (S)-phenylalaninol 386 was prepared via the reduction of (S)-
phenylalanine with lithium borohydride/TMSCI (Scheme 4.10). 
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a 
(S)-Phenylalanine 
~ H_ ,NH2 
~OH 
(S)-Phenylalaninol 
386 
Scheme 4.10 Reagents: (a) LiBH4, TMSCI, THF, 2 h (95%). 
The best yield obtained in the Se02 promoted rearrangement reaction was for benzyl-
substituted oxazole 376, affording oxazinone 381 in 60% yield. The reaction 
appeared to be sensitive to the quality of Se02 used, and the reduction in yield for 
oxazinones 383-385 was a possible indication of this. The oxazinones were isolated 
as viscous oils after column chromatography, and showed no signs of degradation on 
silica. Surprisingly, these types of imines were also stable to hydrolysis through 
aqueous work-up. The inherent stability of these compounds removed the 
requirement for any stabilisers (such as Lewis acid). Previous work with simple 
cyclic imines has shown the incorporation of zinc iodide to be crucial to inhibit 
trimerisation. 
4.1.4 Alternative Route to Oxazinones using Lead Acetate 
An alternative route to access oxazinones involved the double displacement of phenyl 
a-bromoacetate with amino alcohols using Hilnigs base, to form secondary amines 
387 and 388 (Scheme 4.11). 127 Oxidation of the secondary amines with lead 
tetraacetate, directly lead to the formation of an imine bond. Phenyl and benzyl 
substituted oxazinones 381 and 384 were synthesised from phenylalaninol and 
phenylglycinol in moderate yields. Temperatures were kept below 40°C to avoid the 
formation of a dimeric species. Once oxazinones 381 and 384 were prepared, they 
were reacted in the next step immediately. 
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Scheme 4.11 Reagents: (a) DIPEA, MeCN, RT, 17 h (387 (27%), 388 (56%)). 
The oxidation reaction with lead tetraacetate was then carried out to form oxidised 
oxazinones 387 and 388 in good yields (Scheme 4.12). The convenient synthesis 
involved stirring the secondary amine and lead tetraacetate in acetonitrile. The 
reaction mixtures turned bright orange upon addition of the lead reagent and went to 
completion once this colour faded to pale yellow. The reaction mixture could then be 
filtered through celite, and reduced in vacuo, to give the oxidised products. The only 
other contaminant present was acetic acid arising as a by-product of lead tetraacetate 
oxidation. Surprisingly, the oxazinones isolated were very stable to aqueous work-up 
and column chromatography, and were purified by the latter method in good yield. 
R .. t~l 
0 0 
R =Ph, 387 
R = Bn, 388 
a RlN1 
0 0 
R =Ph, 381 
R = Bn, 384 
Scheme 4.12 Reagents: (a) Pb(OAc)4, MeCN, 14 h (381 (85%), 384 (92%)). 
The inherent drawback involved with this route was the use of the heavy metal lead 
and the associated health and safety implications. As numerous different oxazinones 
were required on a frequent basis, it was decided to avoid this method and use 
Molinski's oxidative rearrangement methodology. 
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4.1.5 Palladium [3+2] cycloadditions with oxazinones 
The varying degrees of substitution on the oxazinone products were chosen to assess 
the effect of both straight and branched chain substituents and also phenylic/benzylic 
functionalisation on the eventual cycloaddition reaction. The various substituents 
could potentially direct the approach of the incoming imine on vinylcyclopropane 259 
and hence determine the stereoselectivity of the reaction. To further increase the level 
of stereocontrol, it was envisaged the use of chiral starting materials would make for 
an enantioselective process. 
With these oxazinones in hand, we attempted the palladium catalysed [3+2] 
cycloadditions under a variety of conditions initially on benzyl-substituted oxazinone 
384 (Table 4.01). In all cases where product was isolated, a mixture of inseparable 
diastereoisomers 389a and 389b was observed, the relative stereochemistry 
confirmed by nOe experiments. Surprisingly, the syn-conformer 389a (in relation to 
the ring protons) was the major isomer in all cases, suggesting formation of the 
kinetic product was favoured over the more thermodynamically stable anti-conformer 
389b, under this set of conditions. THF appeared to give the best yield of 
cycloadducts (78%) used in conjunction with Pd(PPh3) 4, although superior d.e's were 
observed using Pd(P[2-furylh)2 generated in situ from palladium acetate. In the 
examples where the palladium catalyst was generated in situ, I 0 mol% palladium 
acetate and 20 mol% of the corresponding ligand were allowed to preform in THF at 
50°C for I 0 minutes before addition ofvinylcyclopropane 259. 
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Catalyst' , '$olvent 
c ' ' '- ,,, 
Pd(OAc)2/ 
P(2-furylh 
Pd(OAc)2/ 
P(o-tolh 
THF 
THF 
THF 
THF 
THF 
DMA 
DCM 
I,4-
Dioxane 
DMF 
10 mol% Pd 
T T (h)· 
RT 48 
RT 48 
RT 48 
RT 48 
RT I7 
RT 48 
RT 48 
RT 48 
RT 48 
Table 4.01 
Yield. 
(%) 
IO 
75 
40 
20 
<5 
62 
22 
40 
26 
3 : I 
2: I 
3: I 
5 : I 
5:4 
4: I 
3 : I 
5:3 
A further set of experiments was carried out at higher temperatures to see if any 
improvement in yield could be obtained. A range of solvents was explored including 
ionic liquids, which have attracted increasing interest as an environmentally benign 
reaction media, suitable for a range of palladium reactions. However, in the majority 
of cases, the oxazoline was being recovered at the end of the reaction, with trace 
amounts of the desired cyclised product (Table 4.02). 
116 
10 mol% Pd 
259 384 
Cataly~t Solvent Lewis T t (h) Acid ,,, 
Pd(PPh3)4 THF reflux 17 
Pd(PPh3)4 [bmim]BF4 80°C 1 
Pd(PPh3)4 [bmim]BF4 110°C 1 
Pd(PPh3)4 DMSO 90°C 17 
Pd(PPh3)4 DMF ZnCh 90°C 17 
Pd(PPh3)4 DMF 90°C 17 
Pd(PPh3)4 DMF 150°C 
microwave 
Pd(PPh3)4 THF 90°C 0.2 
microwave 
Pd(PPh3)4 MeOH reflux 17 
Pd2(dba)J THF reflux 3 
Pd(PPh3)4 THF 1oooc 0.25 
micowave 
Pd(PPh3)4 THF ZnCh 90°C 0.25 
microwave 
Pd(PPh3)4 DMSO 110°C 0.25 
microwave 
Table 4.02 
H C02Me _f1"'"~· C02Me 
H N H 
Ph, .>\__··· 0 ........ , ... \ 
0 
389a: 389b 
syn: anti 
. Yield d.r 
(%) (389a: 389b) 
. : 
15 4: 1 
SM 
SM 
Complex 
mixture 
<5 
SM 
SM 
30 7:5 
0 
<5 
19 1 : 1 
SM 
<5 
At high temperatures vinylcyclopropane 259 was not recovered from the reaction 
mixture. To ascertain what side reaction was happening, the reaction was followed by 
LC-MS, and revealed a strong [M+Ht peak at 369, and a smaller peak at 553. These 
peaks indicate the formation of a dimer and trimer of vinylcyclopropane 259. 
Tentative 1H NMR analysis of the isolated compounds suggested the formation of 
dimer 390 and trimer 391 (Figure 4.02). 
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390 391 
Figure 4.02 Polymeric reaction by-products 
The best results at high temperature were observed using THF as solvent, giving a 
mixture of diastereoisomers 389a and 389b. An optimum d.r of 4: 1 (389a: 389b) was 
observed when the reaction was heated thermally to reflux temperature. When 
microwave energy was used to surpass the natural reflux temperature of THF, a 
gradual decrease in d.e was observed. In conclusion, the yields of the desired 
cycloadducts were poor when the reaction temperatures were raised, presumably due 
to the increased rate of dimerisation and trimerisation ofvinylcyclopropane 259. This 
unwanted side reaction hindered the cyclisation of oxazinone 384 and outlined the 
importance of using lower temperatures to avoid this phenomenon. 
Having obtained promising results with benzyl-oxazinone 384, isopropyl-oxazinone 
382 was investigated (Table 4.03). Interestingly, pyrrolo-oxazinone 392 was isolated 
exclusively as the theoretically more stable thermodynamic anti-product, under one 
set of conditions. A more acceptable yield was observed using THF at room 
temperature, giving a 5:4 d.r in favour of the syn diastereoisomer. 
10mol% Pd 
259 382 
Catalyst Solvent Lewis T Acid 
Pd(PPh3)4 THF reflux 
Pd(PPh3)4 Toluene reflux 
Pd(PPh3)4 THF/DMF ZnCb II0°C (3 : I) 
Pd(PPh3)4 THF RT 
Table 4.03 
t (h) 
17 
17 
17 
48 
H C02Me 
C02 Me -;::::;'''···~-
>,. .. ..jN HO 
H1 \_o 
392a: 392b 
syn: anti 
Yield d.r 
(%) (392a: 392b) 
SM 
SM 
15 1:0 
54 5:4 
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Leucinol-oxazinone 383 was then investigated, to explore the effect of an additional 
methylene group spacer between the i-Pr substituent and the ring, on the 
stereochemical outcome of the reaction (Scheme 4.13). Pyrrolo-oxazinone 393, was 
clearly made in the reaction (approx. 15% yield by NMR), however after column 
chromatograpghy, TLC and LC-MS experiments confirmed the desired product was 
eo-eluting with unwanted by-product dimer 390. Preparative HPLC was carried out 
on the 20 mg sample obtained after column chromatography. The separation proved 
to be quite difficult, and most of the sample was lost on the HPLC column. As a 
result, full data for the desired cycloadduct 393 has not been reported. 1H NMR data 
of the mixture clearly showed the cycloadduct had been formed in a 1: 1 mixture of 
diastereoisomers, evidently showing the stereochemical outcome of the cyclisation to 
be substrate dependant, as well as temperature dependant. 
a 
259 383 393 
Scheme 4.13 Reagents: (a) Pd(PPh3) 4, THF, RT, 18 h. 
(±)-2-Amino-1-butanol was used as the amino alcohol to introduce an ethyl group in 
oxazinone 385. This was successfully cyclised with vinylcyclopropane 259 using 
microwave conditions, yielding the cycloadduct 394 as a I: 1 mixture of 
diastereoisomers in poor yield (17%) (Scheme 4.14). The reaction has still to be 
attempted at room temperature, and we would hope that an improvement in yield 
would be observed, due to reduced rate of by-product formation, and also greater 
control over the stereochemical outcome. 
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C02Me ~C02Me + 
259 385 
a 
394a: 394b 
Scheme 4.14 Reagents: (a) Pd(PPh3) 4 (10 mol%), THF, 90°C, 11-wave, 10 min (17%, 1:1 
syn:anti). 
Finally, (R)-phenylglycinol was used to access phenyl-oxazinone 384. This was 
successfully cyclised yielding pyrrolo-oxazinone 395a and 395b as an inseparable 
mixture of diastereoisomers (I: 1, 395a: 395b) (Scheme 4.15). The ultimate aim of 
this project was to remove the chiral auxiliary, furnishing the functionalised proline 
amino acid. We were hopeful that the phenyl-oxazinone 384 would work well in the 
cyclisation, as hydrogenolysis to remove the benzyl protection and hydrolysis to 
cleave the lactone would provide a two-step deprotection route to our desired proline 
derivative. Unfortunately, low yields thwarted the potential synthetic applicability of 
this reaction. 
C02 Me ~ + 
- V'co2Me 
a 
259 384 
_..,-,,,,H~co2Me 
-:/"" '·· 
C02 Me 
H N H 
':/ 0 
Ph''''- \_
0 
395a: 395b 
syn: anti 
Scheme 4.15 Reagents: (a) Pd(PPh3)4, THF, RT, 18 h (25%, 1:1 (syn:anti)). 
4.1.6 Electron deficient quaternary imine bonds 
To understand the stereochemical course ofthese cycloadditions, it was reasoned that 
the introduction of additional substitution on the imine bond, such as in 3,5-diphenyl-
oxazonine 396, could possibly increase stereocontrol. A relatively bulky phenyl 
substituent could affect the direction of the incoming nucleophile, and in essence 
"lock ouf' any epimers seen at C-9 in the compound 397 (Scheme 4.16) 
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PdL2 C02Me ~~tN XO'M_e ___ _ 
Ph"'" X 
0 0 
396 
H /,,~C02Me ~·····. 
C02Me 
H N 9 Ph 
Ph'>\_o. o 
397 
Scheme 4.16 Locking out epimers at C-9 
Previous work has unsuccessfully evaluated the use of quaternary centres on simpler 
cyclic imines. An explanation of this result is the sterically demanding environment 
associated with the formation of two adjacent quaternary centres. Although 3,5-
diphenyl-oxazonine 396 still had the unfavourable steric environment to contend 
with, we were hopeful that the electron-withdrawing lactone group would render the 
imine bond electrophilic enough to overcome this problem. Work began by 
generating 2-phenylethyl acetimidate hydrochloride salt 398 following a procedure by 
Wenker. 128 This involved bubbling HCI gas through an ethanolic solution of benzyl 
cyanide and cooling, giving crystals of the desired product in excellent yield (90%) 
(Scheme 4.17). 
a 
/ N 
Ph 
Scheme 4.17 Reagents: (a) HCI(gl• EtOH, I h (90%). 
NH.HCI foEt 
Ph 
398 
Acetimidate 398 was reacted with (R)-phenylglycinol, to give diphenyl oxazole 399 
in good yield, followed by selenium dioxide-promoted oxidative rearrangement to the 
required diphenyl-oxazoline 396 (Scheme 4.18). 
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H NH.HCI H Ph,,tNH," a 0 b ~OEt Ph~l<H Ph,,rxh 
OH Ph N ''Ph 0 0 
398 399 396 
Scheme 4.18 Reagents: (a) DCM, 0°C--+RT, 18 h (60%); (b) Se02, dioxane, reflux, 1 h 
(56%). 
Oxazinone 396 was then subjected to our palladium catalysed cyclisation reaction 
with vinylcyclopropane 259 (Scheme 4.19). Unfortunately !lOne of the desired 
product was formed, but another product was isolated in almost stoichiometric 
amounts. 
C02Me ~C02Me 
259 
a 
396 
0 0 x~h::::::...... COzMe Ph N 
H 
Me02C 
400 
Scheme 4.19 Reagents: (a) Pd(PPh3) 4 (10 mol%), THF, RT (400, 95%). 
The reaction was monitored by LC-MS and indicated total consumption of starting 
materials, and the presence of a [M+Ht peak at 436 indicating the two reactants had 
combined via an alternative pathway. Further analysis suggested the formation of 
alkylated product 400 had occured (Scheme 4.20). A possible mechanistic 
explanation of this is the abstraction the benzylic proton from oxazonine 396, by the 
nucleophilic end of the vinylcyclopropane zwitterion, forming a stabilised anion 
capable of entering into conjugation with the remainder of the molecule. This anion 
can then react with the rr-allyl portion of the zwitterion giving unexpected compound 
400; 
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396 
400 
Scheme 4.20 Possible explanation of formation of 400 by-product 
4.1.7 Controlling the stereochemistry at C-9 
The palladium cataly ed cyclisation reaction of oxazinones with vinylcyclopropane 
259 has so far lead to the generation of a mixture of diastereoisomers with i-Pr 
oxazinone 382 being the only exception. Where an excess of one diastereomer was 
observed, it was surpri singly the more strained syn kinetic product. Scheme 68 shows 
the configurational difference between the two diastereomers of benzyl-pyrrolo-
oxazinone 389 (Figure 4.03).129 
yn-product 389a 
(ki netic 
Figure 4.03 
anti-product 389b 
(thermodynamic) 
The syn product was fonn ed preferentia lly over the anti product, even though when 
all the ring proton are on the same face, the bicyclic ring system is forced into a 
strained 'boat ' arrangement. Epimerisation at C-9 would give the anti-product, 
clearly alleviating the train in the ring system (Scheme 4.21). 
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Aqueous workup 
(re-protonation to form 
thermodynamically 
more stable product) 
Scheme 4.21 Controlling the C-9 stereochemistry 
It was our intention to control the stereochemical outcome of the reaction during the 
cycloaddition step, but in the cases where mixtures of diastereomers were observed, 
we planned to exploit the enolisable nature of C-9 to switch between epimers. After 
trying bases such as sodium hydroxide and DBU, it was found that potassium 
hexamethyldisilazide deprotonated pyrollo-oxazinone 389 at -78°C, forming the 
enolate, which was subsequently re-protonated upon aqueous work-up, giving almost 
complete conversion to the more thermodynamically stable anti-isomer in good yield 
(Scheme 4.22) 
H -:;:::;'''···~· C02Me 
C02 Me 
H N H 
Ph..._ >\_··· 0 .......... ,,, 
0 
389a: 389b 
4: 1 (syn: anti) 
a 
H r''··~C02Me --:?' '•. 
C02 Me H N .. .,,,H 
Ph..._ >\_···· 0 .......,,,, 
0 
389a: 389b 
1 : 20 (syn : anti) 
Scheme 4.22 Reagents: (a) KHMDS, 1,4-dioxane, -78°C--+RT, I h: then aqueous workup 
(89%). 
This was a pleasing result, as the nature of the cyclised product allowed 
interconversion between the two diastereoisomers formed in the reaction. 
4.1.8 Electron-rich Cyclic Imines 
With the limited success observed for electron-deficient imine bonds such as those 
found in oxazinones 389, 392, 393, 394 and 395, we briefly turned our attention to 
the use of electron rich systems. We considered whether the electron-rich quaternary 
imine bond of oxazole 379 would cyclise. However, no product was isolated, 
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• 
suggesting the steric and electronic environment of the imine bond hampered the 
progress of the reaction (Scheme 4.23). 
a 
C02Me ~C02 Me 
H~o X 
Ph~ 
259 379 none isolated 
Scheme 4.23 Reagents: (a) 10 mol% Pd(PPh3) 4, THF, RT.- reflux, 20 h. 
Other more sterically accessible electron-rich systems include those found in 2-
oxazoline 401 and 2-imidazoline 402 (Figure 4.04). Imidazoline 402 was 
commercially available, and oxazoline 401 was synthesised in two steps.130 
401 402 
Figure 4.04 2-0xazoline and 2-imidazoline 
2-0xazolines have previously been prepared in the literature by Wenker, from N-
acyl-2-aminoethanols.128 N-Formyl-2-aminoethanol 403 was formed conveniently by 
heating equimolar proportions of formic acid and 2-aminoethanol to 200°C, followed 
by vacuum distillation. Compound 403 was subsequently reacted with thionyl 
chloride in a cyclisation reaction to form 2-oxazoline 401 (Scheme 4.24). 
a 0 
l!__ OH N~ 
b 
H 
403 401 
Scheme 4.24 Reagents: (a) 200°C, 4 h (59%); (b) SOCI2, ooc~RT (56%). 
125 
With our electron-rich imines in hand, the cyclisation reaction was attempted with 
vinylcyclopropane 259. However, no reaction occurred using 
tetrakis(triphenylphosphine) palladium(O) in THF at room or reflux temperature 
(Scheme 4.25). 
+ 
N-;:::'\ 
~X 
X= 0 401 
X= NH 402 
a 
)( 
[X= 0 orNH} 
Scheme 4.25 Reagents: (a) Pd(PPh3)4 (10 mol%), THF, RT or reflux, 18 h. 
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4.2 Conclusion 
Preliminary work assessed the use of functionalised oxazinones as trapping reagents 
in the palladium catalysed [3+2] cyclisation reaction with vinylcyclopropane 259. 
Starting from various amino alcohol substrates, a selection of oxazoles was made, 
which were then transformed into oxazinones and reacted with vinylcyclopropane 
259 to form pyrrolo-oxazinone products (Table 4.04). 
C02 Me ~C02Me 
259 
+ 
Oxazinone Product 
A B 
H H 
H ""'"'~""'' /'~O,M• Ph/''····t N:t C02 Me C02 Me H N H : H N ... .,,H 
Ph-......,,>\_ 0 Ph......_>\_ 0 ,,, 
381 0 0 0 0 
J_t\ 
H H /~O,M• 5.~o,Mo ,::r '•· ... 
C02 Me C02 Me 
H N H · )~~~""Ho ) .. \__0 0 . 
382 ° 
0 
H H H /"~O,M• /'~O,M• Ph •••. tN:t C02Me C02 Me 
H N H : H N .. .,,H 
>\_a Ph'>\_ O 384 0 ° Ph'' O 0 
H H 
lN:t 
/'~O,M• /'~O,M• 
C02 Me. C02 Me N . N ... ,.,H 
385 ° 
0 r-\_o Ho r-\_o o 
Table 4.04 
Conditions Yield d.r (%) A:B 
THF, RT, 48h 72 2:1 
THF, reflux, 24 h 19 4:1 
THF, 1-1-wave, 90°C, 
10min 30 7:5 
THF, 1-1-wave, 100°C, 19 1:1 
10min 
THF/DMF, 80°C, 24 h 15 1: 0 
THF, RT, 48 h 54 5:4 
THF, RT, 32 h 25 1:1 
THF,IJ-wave, 90°C, 17 1:1 
10min 
The best cyclisation yield was observed for benzyl-substituted oxazinone 381, with 
different diastereomeric ratios reported for different reaction temperatures. This 
outlined the importance of temperature on the stereoselectivity of the reaction. The 
best diastereomeric ratio observed in these . experiments was for i-Pr-substituted 
oxazinone 382, with exclusively one diastereoisomer produced. This suggested the 
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stereoselectivity to be dependant on substrate, and the steric influence of the i-Pr had 
a directing effect on the reaction. 
We have also shown that quaternary imines and elecron rich imines suffer from 
reduced reactivity, and fail to cyclise under the reaction conditions explored (Scheme 
4.26). 
~02Me Ph'CNXPh Pd(PPh3)4 C02Me 
X h C02Me 
----\_0 0 ~C02Me 0 0 THF + C02 Me 
259 N""""\ Pd(PPh3)4 ~eo, Me 
VX X 
THF ~X 
[X= 0 orNH) [X= Oor N) 
Scheme 4.26 Failed cyclisation attempts 
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Chapter Five 
5.1 Application to natural products 
5.1.1 Retrosynthesis of stemoamide 
The next stage of this project involved the application of the recently developed 
palladium [3+2] cycloaddition process to the natural product stemoamide. A brief 
introduction to the physiological properties and previous syntheses of this compound 
' has been covered in the introduction, and will not be detailed any further at this stage. 
Stemoamide is based on a tricyclic system, which after retrosynthetic analysis can be 
disconnected back to two synthons amenable to our methodology (Scheme 5.01). 
:~ OR 0 X s 
H''"". ~~ C02 Me """""c N~ V o 
stemoamide 
0 ~ 
OR ~02Me 
O C02Me 
Br + C02 Me 
~N0R R 
Scheme 5.0 I Retrosynthesis of stemoamide 
Cleavage of the lactone ring gives a functionalised azepine system. This could 
potentially arise from Heck coupling of a suitable vinyl halide tether to an a,fJ-
unsaturated group. The functionalised pyrrolidine precursor could be derived from a 
suitable substituted vinylcyclopropane, and an acyclic imine. Previous work within 
the group has investigated the use of simple acyclic imine substrates, and found 
phenyl substituted imines to be easily prepared and also relatively stable. For this 
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reason, preliminary studies towards stemoamide used an acyclic imine where R = 
phenyl. However, it was noted at this early stage that variation of the R-group could 
act as a handle to access closely related analogues of the Stemona alkaloids, such as 
stemoamide, stemonine and didehydroparvistemonine (Figure 5.01). 
0 
stemonine stemoamide 
0 
Me 
0 
didehydroparvistemonine 
0 
Figure 5.01 Synthetically versatile imine building block 
5.2 Formation offunctionalised Pyrrolidine intermediate 
5.2.1 Synthesis of substituted Vinylcyclopropane 
The first objective was to synthesise the appropriate substituted vinylcyclopropane. 
From earlier work reported within this thesis, it is known that substitution at the vinyl 
terminus with electron-withdrawing groups is possible, with no appreciable drop in 
reactivity during the [3+2] cycloaddition. It was decided to introduce the t-butyl ester 
at this position using a similar method to that used previously. Ozonolysis of 
vinylcyclopropane 259 gave aldehyde 292, which was subjected to Wittig 
homologation with (tert-butoxycarbonylmethyl)triphenylphosphonium bromide, to 
give the substituted compound 405 (Scheme 5.02). 
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C02Me ~C02Me 
259 
a C02 Me 0~COzMe 
b 
292 -...I 0 + -..?"-o~PPh3 Br 
404 
405 
Scheme 5.02 Reagents: (a) 0 3, -78°C, 2 h; then quench with DMS, RT, 12 h (80%); (b) 404, 
BuLi, THF, 0°C, 10 min (89%). 
The introduction of the t-butoxy ester at this early stage would hopefully help in the 
lactonisation step later in the synthesis. We envisaged carrying out an 
iodolactonisation to close the final lactone ring of stemoamide, and t-butoxy esters 
are known to carry out this transformation in one step, without the need to hydrolyse 
the ester first. 131 It was reasoned that this could save a step in the synthesis (Scheme 
5.03). 
C02Me 
stemoamide 
Scheme 5.03 Retrosynthesis incorporating tert-butyi ester iodolactonisation 
5.2.2 Synthesis of Acyclic Imine 
An investigation into the preparation of acyclic imine 412 had already been carried 
out within the group. 100 A linear approach was used starting from 3-butyn-1-ol 406, 
and involved bromination at the alkyne terminus, followed by selective reduction 
using diimide to give exclusively the cis-isomer 408. This in turn was mesylated, and 
transformed into the iodo-adduct 410 by Finklestein reaction with sodium iodide. The 
most problematic step involved displacement of iodine with phthalimide, to install a 
masked amine in the correct position on the acyclic chain. This was a temperamental 
step, with yields never surpassing 56%. Finally phthalimide 411 was hydrolysed 
using hydrazine monohydrate to give the free amine, which was not isolated. The 
crucial element in the amine formation was the reaction workup. Complete reaction 
131 
of the phthalimide group with the hydrazine monohydrate was signified by the 
generation of a white precipitate in the reaction mixture. The key stage in the work-up 
involved addition of aqueous 2 M HCl and refluxing of the reaction mixture for a 
further I 0 minutes. The reaction was then cooled to room temperature and the 
residual solids were filtered and washed with water. The aqueous ethanol filtrate was 
concentrated under reduced pressure before basifying with NaOH and extracting into 
diethyl ether. Any variations of the reaction workup led to only small quantities of 
amine being generated. The amine itself was relatively volatile, so removal of diethyl 
ether was done at low temperature, to give a concentrated solution to be used in the 
imine formation reaction with benzaldehyde. (Scheme 5.04). 
~OH __ a__ 
406 
Br 
~OMs 
409 
Br 
~N~Ph 
412 
d 
407 
Br 
~I 
410 
b 
e 
Br 
~OH 
408 
sr 
~NPhth 
411 
c 
f, g 
Scheme 5.04 Reagents: (a) KOH, Brz, HzQ, dark, 0°C~RT, 24 h (92%); (b) p-ToiS02N2H4, 
NaOAc, THF:H20 (I :I), 4 h (93%); (c) MsCI, Et3N, DCM, 0°C, 4 h (94%); (d) Nal, acetone, 
reflux, 18 h (82%); (e) KNPhth, 2-butanone, reflux, 24 h (54%); (f) N2H4.H20, EtOH, reflux, 
2 h; (g) PhCHO, 4 A molecular seives, Et20, RT, 18 h (74% 2 steps). 
Attempts to shorten the synthesis were investigated, with some success observed 
converting mesylate 409 directly to the phthalimide 411. Conditions were developed 
using potassium phthalimide and a catalytic amount of potassium iodide (Scheme 
5.05). The reaction worked in an improved yield of 69% for the one step in 
comparison to 68% for the two-step method. However, these conditions only ever 
worked on a scale less than 200 mg, so this route was rejected. 
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Br 
~OMs 
409 
a Br 
~NPhth 
411 
Scheme 5.05 Reagents: (a) KNPhth, KI (10 mol%), 18-crown-6, DMF, 80°C, 18 h (69%). 
Another route was also investigated starting from the commercially available 
phthalimide protected alkyne 413. Attempts to form the free phthalimide 411 failed, 
however the bromination reaction worked well, only when the product was isolated as 
the hydrochloride salt 414. The selective diimide reduction ofthe alkyne worked on 
the hydrochloride salt in a reduced yield of 54% (Scheme 5.06). The synthesis of 
imine 412 was completed as described above in an overall yield of28% for 4 steps, as 
opposed to 26% for 7 steps. A combination of both routes was used to synthesise 
reasonable quantities of the desired imine. 
~NPhth a 
413 
~NPhth 
Br == .HCI ---
b. 
414 
Br 
~NPhth 
411 
Scheme 5.06 Reagents: (a) KOH, Br2, H20, dark, ooc~RT, 24 h, acidic work-up (69%); (b) 
p-ToiS02N2H 4, NaOAc, THF:H20 (I :1), 4 h (54%). 
5.2.3 Palladium Catalysed [3+2] Cycloaddition to functionalised Pyrrolidines. 
The first key-step in the synthesis involved the cycloaddition of vinylcyclopropane 
405, with acyclic imine 412. 1H NMR analysis of the imine usually showed varying 
amounts of unreacted benzaldehyde, from the imine formation step, to be present. For 
a successful [3+2] cycloaddition to take place, it was vital to adjust the number of 
equivalents of vinylcyclopropane 405 used, as benzaldehyde itself is an excellent 
trapping reagent that forms the unwanted furan by-product. 
The cyclisation occurred in excellent yields to form the two geometric isomers 415a 
and 415b, which could be easily separated by column chromatography (Scheme 
5.07). It was deduced that after the palladium had inserted into the double bond, 
reductive elimination, coupled with bond rotation lead to the generation of these 
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isomers. Interestingly, exclusively one diastereoisomer was formed with respect to 
the ring protons, with a syn relative stereochemistry observed. This was confirmed by 
nOe experiments. 
otsu COzMe 0~COzMe 
405 
+ 
Br 
~N~Ph 
412 
a 
E-415a 
415a: 415b 
E:Z 
2.8: 1 
0 
Ao1su t ... ~rLC02Me 
Br C02Me 
U N · .. H "'ph 
Z-415b 
Scheme 5.07 Reagents: (a) Pd(PPh3) 4 (10 mol%), ZnBr2 (2 equivs), THF, RT, 18 h (90%). 
Another crucial factor for a successful cyclisation was the order in which the reagents 
were introduced to the reaction mixture. To a solution ofthe vinylcyclopropane 405, 
must be added the imine 412, and then the zinc bromide. These must then be stirred at 
room temperature for 15 minutes before addition of the palladium catalyst. Any 
variation in this sequence of events, lead to both ring diastereoisomers and 
geometrical isomers being formed. 
5.3 Investigations into C-ring closure 
Even though two geometrical isomers had been formed in the cycloaddition reaction, 
it was hoped that both compounds would still be suitable for the seven-membered 
ring closure. Initially it was reasoned that a reductive ring-closing procedure would 
be beneficial, as this would simultaneously close the ring and reduce the alkene of the 
a,fi-unsaturated system. This exocyclic carbon-carbon single bond mimics the 
arrangement found in stemoamide. Radical and halogen-metal exchange methods 
would theoretically carry out this transformation, so these were first examined 
(Scheme 5.08). 
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o1Bu 
o~ .• vvo,Me 
Br \,___}_ C02Me 
U N · .. H '>Ph 
E-415a or Z-415b 
Radical 
or 
Halogen-metal 
exchange 
0 1Bu 
0 
Scheme 5.08 Alternative methods for ring-closure 
5.3.1 Radical methods for C-ring closure. 
stemoamide 
A variety of radical conditions were explored, using either Et3B or AIBN as the 
radical initiator. (Table 5.01). In all cases starting material was recovered. The only 
curious result arose from reaction of cis-isomer 415b with Et3B in benzene. This lead 
to apparent isomerisation ofthe alkene double bond, and resulted in the trans-isomer 
415a being formed in good yield. 
E-415a or Z-415b 
Pyrrolidine Initiator Propagator 
415a E!)B Bu3SnH 
415a EhB Bu3SnH 
415a AIBN Bu3SnH 
415a AIBN Bu3SnH 
415b Et3B Bu3SnH 
415b EhB Bu3SnH 
415b AIBN Bu3SnH 
415b AIBN Bu3SnH 
Radical 
conditions 
X· 
Solvent 
Benzene 
Toluene 
CCI4 
Benzene 
Benzene 
Toluene 
CCI4 
Benzene 
Table 5.01 
0 
Temperature Time Yield (h) (%) 
RT 17 SM 
RT 17 SM 
Ioooc 17 SM 
RT 17 SM 
RT 17 SM + 415a (85%) 
RT 17 SM 
Joooc 17 SM 
RT 17 SM 
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5.3.2 Halogen-Metal exchange methods for C-ring closure. 
With no signs of the desired transformation occurring using radical means, halogen-
metal protocols were next investigated (Table 5.02). Organolithium reagents were 
first examined, with the various isomers of butyl lithium. When n-BuLi was used, 
there was a new product isolated from the reaction. However, rigorous analysis of this 
compound suggested the vinyl halide to still be present, and the !-butyl group of the 
ester had disappeared. LC-MS experiments showed the [M+Ht peak at 564, 
suggesting the double 1,2-addition of the butyl anion to the a,p-unsaturated system, to 
give the unwanted tertiary alcohol416. In an attempt to prevent the formation of this 
by-product, the more sterically demanding t-BuLi was used. However, once again the 
apparent loss of the !-butyl group of the ester was observed, suggested compatibility 
issues with this functionality. Spectral analysis was unable to determine the exact 
structure of the product. The addition of Cui in an effort to soften any nucleophilic 
attack, and stimulate 1,4 addition to the Michael acceptor also failed. To ascertain if 
the !-butyl ester was in fact at the heart of the problem, the ethyl ester derivative 417 
was syntheised, but similar compatability issues were encountered. 
The possibility of using a Grignard type addition was investigated, first by simply 
stirring the pyrrolidine E-415a with magnesium turnings. This only yielded starting 
material, and prompted a look at the literature for similar Grignard-type additions. 
Knochel et al. have recently reported the stereoselective addition of 
alkenylmagnesium reagents using i-PrMgCI.LiCI. 132 This reagent dramatically 
increased the efficiency of the halogen-magnesium exchange process. However, 
attempts to apply this to our own system failed. 
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415a, 415b or417 
Entry SM 
la 415a 
2a 415b 
3a 415a 
4a 415b 
sa 415a 
sa 415b 
6a 417 
7b 415a 
gc 415a 
9a 415a 
10 415a 
11 415a 
12 415a 
Halogen-Metal 
exchange 
X· 
R Conditions 
.. . 
t-Bu n-BuLi 
t-Bu n-BuLi 
t-Bu n-BuLi 
t-Bu n-BuLi 
t-Bu t-BuLi 
t-Bu t-BuLi 
Et n-BuLi 
t-Bu s-BuLi 
t-Bu t-BuLi, Cui 
t-Bu LOA· 
t-Bu Mg turnings 
t-Bu i-PrMgCI.LiCI 
t-Bu Me3SiSn8u3, CsF 
Solvent 
THF 
THF 
THF 
THF 
THF 
THF 
THF 
THF 
THF 
THF 
EhO 
THF 
DMF 
Temperature Time : ~Yield •• 
.. :;; .. i: :.;(%) . .. ; • 
-78°C 15 SM 
mm 
-78°C 15 SM 
m in 
-78°C- 15 SM+416 
-2ooc m in (54%) 
-78°C- 2h SM+416 RT (40%) 
-78°C- 15 Unknown 
-2ooc m in By-product 
-78°C- 2h Unknown 
-2ooc By-product 
-78°C- 15 SM +416 
-20°C m in (67%) 
-78°C- 2h SM RT 
-78°C- 1 h Unknown RT By-product 
-78°C- 3h Unknown 
reflux By-product 
Reflux 18 h SM 
-40°C- 12 h SM RT 
0°C-RT 12 h SM 
- loooc 
Table 5.02 Conditions: a THF/H20 quench; b THF/MeOH quench; c 2 M HCI quench. 
One final attempt to effect halogen-metal exchange was explored using a procedure 
by Mori et al., using a stannyl anion generated from Me3SiSnBu3 and CsF (Scheme 
5.09). 133 This method was used for 5-membered ring formation between a vinyl 
halide and an ester. It was hoped that this could be applied to carry out the same type 
of addition onto an a,,B-unsaturated system. Unfortunately, starting material was only 
ever recovered from the reaction mixture. 
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R, 
R'o;j> 
( R' = OMe or H ) Y, Y' = 0 or 
Y= OH, Y' = H 
Scheme 5.09 Mori's stannyl anion cyclisation chemistry 
What was clear from these findings was the complete lack of insertion into the vinyl 
halide bond. Chemoselectivity issues lead to unwanted side reactions occurring on the 
ester group. This fruitless stage of the research meant other avenues had to be 
explored. 
5.3.3 Heck coupling methods for C-ring closure. 
Alternative routes were explored to close the seven-membered ring, involving 
palladium catalysed Heck couplings. This method would theoretically close the ring, 
leaving an exocyclic double bond, which would require selective reduction at a later 
stage in the synthesis (Scheme 5.09). 
otsu 
0~ ...... ~o,Mo 
Br \,__!_ C02Me 
U N .. H "'ph 
E-415a or Z-415b 
otsu 
Heck 0 
E-418a or Z-418b 
Scheme 5.09 Ring-closure by Heck coupling 
Previous work within the group had isolated Heck product E-418a in an average yield 
of 42%. 100 Repetition of these conditions gave 39% of the desired product. This was a 
disappointingly low yield at a critical stage ofthe synthesis, so in light of the success 
observed using palladium catalysts with DMSO previously within this thesis, 
attempts were made to improve this yield. Satisfyingly, the Heck reaction worked in 
excellent yields using either triethylamine or sodium hydrogen carbonate as base 
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(Table 5.03). Modifications were made to the reaction conditions in an attempt to 
effect a reductive Heck cyclisation. The powerful method of reductive Heck 
couplings has been previously studied within the literature, 134 however, efforts to 
apply similar conditions to our own system failed, with only starting material being 
isolated. 
0 1Bu 
0~.._~o,Me 
Br \
1
--L_ C02Me 
U N · .. H "ph 
E-415a or Z-415b 
Pyrrolidine Catalyst Base 
415a Pd(OAc)2, DIP EA PPh3 
415a Pd(PPh3)4 El)N 
415b Pd(PPh3)4 Et3N 
415a Pd(PPh3)4 NaHC03 
415b Pd(PPh3)4 NaHC03 
Heck 
-------------------. 
Solvent 
DMF 
DMSO 
DMSO 
DMSO 
DMSO 
415a131 Pd(PPh3)4 piperidine; DMF HCOOH 
415a Pd(PPh3)4 NaHC03; DMSO HCOOH 
Table 5.03 
0 
E-418a or Z-418b 
Temperature Time Yield (h) 
RT 17 418a (39%) 
80°C 2 418a (95%) 
80°C 2 418b (90%) 
80°C 2 418a (92%) 
80°C 2 418b (96%) 
80°C 24 SM 
80°C 18 SM 
Interestingly, when the £-isomer 415a was subjected to these Heck conditions, 
geometrical isomerisation of the double bond was observed, leading to £-isomer 
418a. It is important to note that the priorities around the alkene have changed during 
this transformation. For the opposite isomer Z-415b, similar isomerisation of the 
double bond occurs. It was reasoned that after oxidative insertion of palladium into 
the vinyl halide, carbometallation occurs to give the seven-membered ring. In the/]-
hydride elimination step that follows, the palladium and hydride must be coplanar for 
the reaction to take place, as this is a syn elimination process. Bond rotation must 
therefore dictate the stereochemical outcome of this reaction (Scheme 5.10). 
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E-415a 
0 
E-418a 
Palladium insertion 
~ 
Syn B-hydride 
elimination 
~ 
0 1Bu 
~ Bond Rotation 
Scheme 5.10 Postulate for observed stereochemistry 
Crystals of E-418a have previously been grown simply by evaporation of diethyl 
ether, and the configuration confirmed by X-ray crystallographic analysis (Figure 
5.02). 100 Various different conditions were tested to grow suitable crystals of Z-418b, 
however no crystals were ever isolated. NOe experiments confirmed the relative 
stereochemistry of both isomers ofthe Heck products. 
Cl231 
Figure 5.02 Crystal structure of E-418a 
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1H NMR analysis of both 418a and 418b showed some significant differences in 
proton environments. In 418a, H-3 is deshielded by the proximal carbonyl of the tert-
butyl ester, and as such 0.91 ppm further downfield than H-3 in 418b. Conversely, H-
5 in 418b sees an even larger shift downfield because of this deshielding effect, and is 
1.20 ppm further downfield than H-5 in 418a (Figure 5.03). 
H 
418 H-3 = 4.35 ppm a H-5 = 5.99 ppm 
0 
H 
0 1Bu 
418b H-3 = 3.44 ppm H-5 = 7.19 ppm 
Figure 5.03 Deshielding effect as observed by 1H NMR 
At this stage, both Heck products 418a and 418b were recognised to be potential 
precursors to the tricyclic core of stemoamide. The arrangement of the tert-butyl ester 
in 418a meant a selective reduction of the exocyclic double bond was necessary 
before free rotation of this group would set the compound up for a lactonisation step. 
It was reasoned that the reverse stereochemistry observed in 418b, could allow the 
lactonisation to occur without the need to selectively reduce the exocyclic double 
bond. If the lactonisation were to work, an easier, non-selective alkene reduction 
would yield the desired product. The convergence of both synthetic pathways from 
different isomers to a single compound was very appealing (Scheme 5.11). 
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0 1Bu 
0 1Bu 
lodolactonisation Selective reduction 
I 
0 
0 
Hydrogenation 
' 
0 lodolactonisation 
Scheme 5.11 Convergent syntheses to iodolactonisation product 
5.3.4 Tandem Palladium catalysed Azepine formation 
At this stage it was recognised that to form azepine ring systems 418a and 418b, 
consecutive palladium catalysed processes had been employed. A short period of time 
was spent examining the possibility of carrying out a tandem [3+2] cycloaddition and 
Heck coupling process. This would in effect "zip up" the two halves ofthe molecule, 
forming three new C-C bonds, and defining two stereocentres in a single step. The 
first experiment simply combined all reagents for tlie two separate steps using 20 
mol% of the palladium catalyst (Scheme 5.12). 
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O'Bu C02Me 0~C02Me + 
405 
Br 
~N~Ph 
412 
0 1Bu 
a 0 
X 
E-418a or Z-418b 
Scheme 5.12 Reagents: (a) 20 mol% Pd(PPh3) 4, ZnBr2, NaHC03, DMSO, 80°C, 4 h. 
None of the desired product was formed, with only the vinylcyclopropane 405 being 
recovered. Importantly, the cyclisation had failed to work prompting the question 
whether the cyclisation reaction actually works in DMSO, as previously this step had 
been carried out in THF. The cyclisation reaction was attempted in DMSO, however 
the cyclisation appeared to fail at 80°C and needed to be heated to I oooc before any 
cyclisation occurred. Unfortunately the pyrrolidine isolated, existed as an ins~perable 
mixture of ring diastereoisomers, in modest yield (Scheme 5.13). 
O'Bu C02Me 0~co2Me + 
405 
Br 
~N~Ph 
412 
0 1Bu 
a 
415 
Scheme 5.13 Reagents: (a) 10 mol% Pd(PPh3 )~, ZnBr2, DMSO, 100°C, 2 h (45%, 5:6 
mixture of ring diasteroisomers ). 
The lack of stereoselectivity and apparent reduction in reaction turnover, lead to a 
switching of solvent systems during the reaction (Scheme 5.14). The cyclisation was 
carried out in THF, before evaporating off the solvent and replacing it with DMSO 
for the Heck reaction. As expected, the cyclisation worked, but Heck coupling failed 
to progress, even upon the further addition of fresh palladium catalyst. This suggested 
a possible byproduct or remnant from the cyclisation reaction was interfering with the 
progress of the Heck reaction. 
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+ Br 
~N~Ph 
412 
a b 
* 
0 1Bu 
0~H C02Me 
I C02Me N ·. H 
"-Ph 
E-418a or Z-418b 
Scheme 5.14 Reagents: (a) 10 mol% Pd(PPh3) 4, ZnBr2, THF, RT, 24 h; (b) NaHC03, DMSO 
80°C, 4 h. 
Another study simply added NaHC03 to the reaction mixture of the completed 
cyclisation reaction, but once again the Heck reaction failed to work. Closer scrutiny 
of the catalytic cycle is required to explore the range of additives or scavengers that 
could be introduced to the reaction, to make the transformation viable. 
5.4 Investigation into direct lactonisation of Z-418b · 
Over the years there have been many protocols for lactone ring formation, 135 the most 
common being halolactonisation methods. Previous syntheses of the Stemona 
Alkaloids have employed iodolactonisation and selenolactonisation methods for the 
incorporation of the crucial lactone ring, 22•29 however, these methods require at least 
two steps for the transformation. The tert-butyl ester functionality present within our 
system was designed from an early stage to carry out the iodolactonisation step, 
without the need to hydrolyse the ester first. 
The favourable conformation ofthe tert-butyl ester in Z-418b, led to efforts to form 
the final lactone ring of stemoamide prior to the reduction of the exocyclic double 
bond. The shorter bond length associated with the C=C double bond compared to that 
of a C-C single bond was considered to be a potential pitfall in the iodolactonisation. 
It was recognised that the transformation would probably be energetically less 
favourable than an iodolactonisation on a more conventional precursor, and as such 
harsher conditions may have been required. The tert-butyl ester group is known to 
carry out iodolactonisations directly, with the driving force behind the reaction being 
the loss of the stable tert-butyl cation, as proposed by Bartlett, who studied its 
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mechanism.136 Antonioletti et al. have recently developed iodolactonisation 
methodology in the diastereoselective synthesis of tetrasubstituted dihydrofurans, 131 
and it was with their conditions we decided to study our own system (Table 5.04). 
However, none of the desired product was formed, with the products isolated being 
difficult to unambiguously elucidate. The presence of the tert-butyl group by NMR 
was a key indicator that the reaction had failed to work, and as such with time 
restraints, this avenue of research was terminated. 
0 
lodolactonisation 
Z-418b none isolated 
,~" Time Yield Conditions Solvent Temperature (h) 
h, Na2C03, DCM RT 17 Complex dark131 mixture 
h, Na2C03, THF RT 17 Complex dark mixture 
h, Na2C03, DCM Reflux 17 Complex dark mixture 
h, Na2C03, THF Reflux 17 Complex dark mixture 
Table 5.04 
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5.5 Selective reduction of the exocyclic double bond 
With the failure of the iodolactonisation of Z-418b, investigations began on the 
selective reduction of the exocyclic double bond present in the other isomer E-418a. 
A successful reduction on this isomer would also be expected to work on the isomer 
Z-418b. There is a plethora of research within the literature concentrating on 
chemoselective reduction of a,p-unsaturated carbonyl compounds. Reagents which 
have previously been used for this conversion include Cui!LiAI~, homogenous 
metal hydride catalysts, Mg/MeOH, Li/EtNH2, LDA, zinc-copper couple, LiAIH4 in 
the presence of lanthanide salts, aqueous Zn-NiCh under ultrasonication and AI- . 
NiC)z. 137 
There is however far less research into a,p,y,o-unsaturated carbonyl compounds and 
their selective reduction, such as the system found in E-418a. The challenging 
problem associated with the selective reduction of these systems is enhanced because 
of three reducible positions. Birch reduction with lithium and ammonia produces p,y-
unsaturated carbonyl compounds. Hydrogenation with Ni-Ah03 targets the y,o-
unsaturated double bond, while the presence of Pb or Cd reduces the a,p-enone. 
Reduction of the a,p-double bond is also observed using a triallylsilane in the 
presence of either rhodium or platinum catalysts. The reduction of a,p,y,o-unsaturated 
carboxylic esters by trialkylsilane reagents in the presence of Wilkinson's catalyst 
provides p,y-unsaturated esters from acyclic molecules, whereas strained cyclic 
compounds, the a,p-double bond is reduced. 138 The number of different possible 
reduction pathways increases the complexity of the reaction, and the effect of the 
substrate on the chemoselectivity could potentially undermine any trend previously 
observed. A variety of selective reducing conditions were tested (Table 5.05). 138-142 
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0 1Bu 
E-418a 
Entry Conditions 
>'·· ' ... 
Ph2SiH2, 
1 Pd(PPh3)4, 
ZnCh 
2 InCh/NaBH4 
3 Rh(PPh3)3Cl, PhMe2SiH 
4 Rh(PPh3)3Cl, Et3SiH 
5 [PPh3CuH]6 
6 Li/NH3, t-BuOH 
7 Li/anthracene 
Selective 
reduction 
' ''<, 
Solvent 
CHCh 
MeCN 
THF 
Benzene 
Benzene 
THF 
THF 
0 1Bu 
0 
none isolated 
Temperatur~ Time (h)·' 
RT 17 
RT 17 
50°C 16 
RT 17 
RT 17 
-78°C I 
-78°C to 2 RT 
Table 5.05 
Yield 
SM+419 
(60%) 
SM 
SM +419 
(33%) 
SM 
SM 
SM+420 
(40%) 
421 (80%) 
Entries 1-4 show metal-catalysed methods to reduce conjugated systems. The basis of 
these methods relies on a relatively unreactive source of hydride, coupled with a 
catalytic amount of a transfer reagent, to selectively reduce various electrophilic 
functionalities. Unfortunately regioselectivity problems were encountered in the case 
of entries I and 3, with the y,o-unsaturated double bond being reduced to give 
compound 419. The use of Stryker's reagent (entry 5) appeared to have no effect 
whatsoever. In light of the relative lack of reactivity observed with metal-catalysed 
reduction systems, it was decided to subject E-418a to slightly harsher dissolving 
metal conditions. 
It is important to note that these reactions were carried out on a small scale (-0.1 
mmol), and initial experiments using lithium metal in ammonia, suffered from lack of 
precision in measuring such small amounts of the metal solution. An excess of 
lithium was no doubt added, and this would potentially affect the course of the 
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reaction. Interestingly, entry 6 appeared to reduce the conjugated system leaving a 
p,y-unsaturated ester. However, closer examination of the new product by NMR 
showed the CH2 ofthe pyrrolidine ring had lost its characteristic diastereotopic proton 
signals. Further analysis confirmed the cleavage of the pyrrolidine ring to form 
compound 420 (Figure 5.04). This was a particularly frustrating stage of the research, 
as reduction of the conjugated system only to give a p,y-unsaturated ester would 
nevertheless unveil a compound capable of being transformed into the lactone, via a 
method previously used by Mori (see Scheme 1.28).33 
0 1Bu 
419 420 
0 1Bu 
Figure 5.04 Isolated by-products from attempted selective reduction experiments 
It was decided to substitute the ammonia in the Li/NH3 system for anthracene in THF. 
These are a set of dissolving metal conditions, where lithium and anthracene are 
stirred in THF for 1-2 days, or until a deep green/blue colour is observed.142 The 
benefit of this system was that a measured solution of lithium anthacenide could be 
prepared, and stored for a couple of weeks, allowing far easier handling. Reaction of 
the lithium anthracenide with E-418a was complete after 1-2 hours, with a new spot 
by TLC forming at half the Rr value of the starting material. This was initially 
dubious, as the desired product should theoretically have a similar Rr value to that of 
the closely related starting material. Once again conjugate reduction had occurred, 
however, mass spectrometry confirmed a dimerisation process had occurred, leading 
to compound 421. Attempts were made to keep the reaction solution very dilute to 
avoid this problem, however recombination of two molecules was always observed. 
Due to time restraints, work was halted at this stage, but further work is necessary in 
order to gain more control over the course of the reaction. 
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5.6 Palladium catalysed [3+2] cycloadditions ofisocyanates 
The introduction of isocyanates into the palladium catalysed [3+2] cycloaddition 
methodology would incorporate the characteristic amide group found in stemoamide. 
To assess the tolerance ofthe palladium catalysed [3+2] cycloaddition to isocyanates, 
a range of substrates were examined (Table 5.06). Tsuji et al have previously 
observed the reaction of isocyanates with vinylcyclopropanes, however the use of 
highly toxic HMPA as reaction solvent was a major drawback. 143 
C02 Me ~C02Me + R-N=C=O 
259 [ R = Ph. Bn or Et ) 
R Conditions 
Ph Pd(PPh3)4 
Ph Pd(PPh3)4 
Bn Pd(PPh3)4 
Bn Pd(PPh3)4 
Bn Pd(PPh3)4, ZnBrz 
Et Pd(PPh3)4 
Solvent 
DMSO 
THF 
DMSO 
THF 
THF 
DMSO 
Table 5.06 
R =Ph, 422 
R= Bn 
R=Et 
Time (h) .. 
2 
2 
2 
2 
2 
2 
342 
•Yield 
422 (59%) 
+342 
SM +342 
SM +342 
SM +342 
SM +342 
SM +342 
Phenyl isocyanate was the only substrate that was successfully cyclised. The desired 
compound was stable to aqueous workup and column chromatognipghy. In all cases, 
between 5-50% of the reaction mixture was accounted for by the oxidised 
vinylcyclopropane adduct 342. Even though this was an isolated example of the 
application of isocyanates, it was a promising result. It indicated that the introduction 
of the amide portion of the pyrrolidinone ring in the cyclisation step was a real 
possibility. 
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Chapter Six 
6.1 Conclusion and Future Work 
Good progress has been made towards a general strategy for the construction of 
closely related analogues of the Stemona Alkaloids. The palladium catalysed [3+2] 
cycloaddition of functionalised vinylcyclopropane 405 and acyclic imine 412 
proceeded in good yields, to form exclusively one diastereoisomer with respect to the 
ring protons, and a mixture of geometric alkene isomers. Two avenues of research 
focussed on reductive cyclisation and Heck methods were pursued to close the seven-
membered ring. No success was seen with the reductive methods examined, however, 
this is an area of research which would benefit from more study, as this would be a 
more efficient and elegant route to the desired stemona skeleton. The Heck coupling 
worked extremely well to give 418a and 418b, which were both studied as 
intermediates for the same target molecule (Scheme 6.01). 
otsu COzMe 0~COzMe 
405 
+ 
Br 
~N~Ph 
412 
a 
0 1Bu 
O~'"·HaCOzMe 
Br C02Me 
U N .. H "'Ph 
E-415a or Z-415b 
* 
Radical 
· or 
Halogen-metal 
otsu exchange 
0~co2Me 
I C02Me N . H 
'>Ph 
0 1Bu 
b 
0~H C02Me 
'I C02Me 
I N . H 
'>Ph 
E-418a or Z-418b 
stemoamide 
Scheme 6.01 Reagents: (a) Pd(PPh3) 4 (I 0 mol%), ZnBr2 (2 equivs), THF, RT, 18 h (90%); 
(b) Pd(PPh3) 4 (10 mol%), NaHC03, DMSO, 80°C, 2 h (92-96%). 
Initial work on the selective reduction of the exocyclic double bond has proved 
problematic, with unwanted reduction pathways occurring. However, some success 
ISO 
has been seen in the conjugate reduction ofthe a,p,y,o-unsaturated ester, to give a p,y-
unsaturated dimer. Other single electron transfer processes and conditions must be 
examined to try and impede this dimerisation process, as the resultant p,y-unsaturated 
carboxylic acid would be expected to ring-close in a bromolactonisation step outlined 
by Mori et a/ (Scheme 6.02).33 
Conjugate 
reduction 
Hydrolysis 
Scheme 6.02 Possible bromolactonisation procedure 
If problems were to persist with the selective reduction of the exocyclic double bond, 
it would be theoretically possible to exploit the more accessible and reactive nature of 
the endocyclic double bond in a dihydroxylation step. The lactone ring could then be 
formed under acid catalysis (Scheme 6.03). 
OR 
0~H C02Me 
1  C02Me 
I N . H 
~Ph 
OR 
0~co2Me 
HO C02Me 
HO N \ H 
Ph 
0 
---~~----~ 0 C~~:~e 
N . H 
HO ~ 
· Ph 
Scheme 6.03 Functionalisation of the endocyclic double bond 
Until now, it can be assumed that the a-methyl group on the lactone ring, as found in 
stemoamide, could be introduced in a late stage alkylation step. However, it is 
possible that this methyl group could be introduced at a much earlier stage, and 
incorporated into the functionalised vinylcyclopropne, using a suitable Wittig reagent 
(Scheme 6.04). 
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292 
Buli 
THF 
................... 
Scheme 6.04 Introducing the a-methyl group of the lactone ring 
With the promise shown by isocyanates as trapping reagents in the palladium 
catalysed [3+2] cycloaddition, it is envisaged that a suitable acyclic isocyanate could 
be synthesised and this reacted with the methyl-substituted functionalised 
vinylcyclopropane. After further manipulation, a compound such as 423 could be 
accessed, with the possibility of carrying out a double decarbonylation of the original 
diester functionality, by virtue of the adjacent carbonyl of the amide group (Scheme 
6.05). 
+ 
423 stemoamide 
(b) W, heat Br 
I_ N, ~'C ~0 
Scheme 6.05 Reaction ofisocyanates and a potential double decarboxylation 
Further work needs to be carried out into the various groups which can be introduced 
onto the acyclic imine. Work towards stemonine would need an acyclic imine 
precursor with either the lactone ring already present, or a masked lactone, such as a 
furan, which could be readily oxidised to the desired lactone oxidation level (Scheme 
6.06). 
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0 
Me 
> 
Br rj\ ~N~c( Br H./\_ ~N~rfo 
stemonine 
0 
Scheme 6.06 Varying the acyclic imine substrate 
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Chapter Seven 
7.1 General information 
7.1.1. Solvents and Reagents 
All solvents and reagents were purified by standard techniques as reported in Perrin. 
D.D.; Armarego, W. L. F., Purification of Laboratory Chemicals, 3rd edition. 
Pergamon Press, Oxford, 1998 or as used as supplied from commercial sources as 
appropriate. 
Reagent chemicals were purchased from Aldrich Chemical Company Ltd., Lancaster 
Chemical Synthesis Ltd., Acros (Fischer) Chemicals Ltd. and Avocado . 
. Commercially available reagents were used as supplied, without further purification 
unless otherwise stated. Air- and moisture-sensitive reactions were carried out using 
glassware that had been dried overnight in an oven at 240°C. The reactions were 
carried out under a slight positive static pressure of nitrogen unless otherwise stated. 
Solvents where necessary, were dried and stored over 4A molecular sieves prior to 
use. Molecular sieves were activated at 240°C over a period of 3 days. 40-60 
petroleum ether (P.E. 40-60) refers to the fraction of the light petroleum ether which 
boils between 40-60°C. DCM, EhO, MeOH, EtOH and THF refer to 
dichloromethane, diethyl ether, methanol, ethanol and tetrahydrofuran respectively. 
7.1.2. Chromatographic Procedures 
Analytical thin layer chromatography (TLC) was conducted using aluminium or glass 
backed plates coated with 0.25 mm silica containing fluorescer. Plates were 
visualised by quenching of UV light (254 nm) as well as through staining with I% 
vw/v potassium permanganate in aqueous alkaline solution followed by heat where 
appropriate. Flash chromatography was conducted using Merck Kieslgel (70-230 
Mesh ASTM) as the stationary phase unless otherwise stated. Samples were applied 
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as saturated solutions in the appropriate solvent. Pressure was applied to the column 
by use of hand bellows. 
7.1.3. FT-IR 
Infra-red spectroscopy (IR) was conducted in the range of 4000-600 cm-1, using a 
Perkin-Elmer Fourier Transform Paragon 1000 spectrophotometer (with internal 
calibration). Samples were dissolved in appropriate solvent and applied as thin film to 
the NaCl plates. Liquid samples were applied neat to the plate and run as thin films. 
Only major absorbencies have been quoted. 
7.1.4. 1H NMR 
Proton magnetic resonance spectra eH NMR) were recorded at 250, 4QO or 500 MHz 
using a BrUker AC-250, BrUker DPX-400 or BrUker DPX-500 spectrometer as 
solutions of deuterated CDCh unless otherwise specified. Chemical shifts (oH) were 
quoted as parts per million (ppm) and are referenced to the residual solvent peak 
tetramethylsilane (TMS) as the internal standard. The following abbreviations are 
used; singlet (s), doublet (d), triplet (t), quartet (q) multiplet (m) and broad (br). 
Assignment of individual proton signals was assisted by analysis of 1 H COSY spectra 
and nOe data. Coupling constants (J values) are reported in Hertz (Hz). 
Diastereoisomer ratios were calculated from the integration of suitable peaks in the 
1 H NMR spectra 
7.1.5. Be NMR 
Carbon magnetic resonance spectra ( 13C NMR) at I 00 MHz usmg a DPX-400 
spectrometer were recorded as solutions of deuterated CDCb unless otherwise 
specified. (oH) were quoted as parts per million (ppm) and are referenced to the 
residual solvent peak tetramethylsilane (TMS) as the internal standard. Assignment of 
individual carbon signals was assisted by DEPT and HMQC data. 
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7.1.6. Mass Spectra 
Mass spectra (high/low resolution) were recorded using a Fisons VG Quattro 11 SQ 
instrument, with modes of ionisation being indicated as electron impact (El) and fast 
atom bombardment (F AB) and electron spray (ES) with only the molecular ion, 
molecular ion fragments and major peaks being reported. Accurate masses were 
recorded using a Kratos MS-80 instrument. Elemental analysis was performed by Mr 
J. Kershaw, Department of Chemistry, Loughborough University and by the ESPRC 
National mass spectrometry service in Swansea. 
7.1.7. Other Data 
Melting points where appropriate were determined using an electrical 9100 Thermal 
Melting point instrument and are uncorrected. Yields (unless otherwise stated) are 
quoted for isolated pure products. 
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7.2 Experimental procedures 
2-Vinylcyclopropane-1,1-dicarboxylic acid dimethyl ester (259)55 
5~COzMe V "co2Me 
3 
To a solution of sodium methoxide prepared from sodium (2.30 g, 100 mmol) in 
methanol (40 ml) was added dimethyl malonate (11.42 ml, 100 mmol) and a 
methanolic solution of trans-1,4-dibromobut-2-ene (10.70 g, 50 mmol in 40 ml 
methanol). The mixture was refluxed for 19 h to give a colourless solution. The 
mixture was cooled to room temperature, and the white precipitate formed (NaBr), 
filtered and discarded, before reducing the filtrate in vacuo. The residue was 
dissolved in ethyl acetate (60 ml) and washed with distilled water (3 x 60 ml) and 
saturated brine solution (20 ml), dried over MgS04 and evaporated under reduced 
pressure to give a pale yellow oil. Purification by column chromatography (Si02, 40-
60 P.E: ethyl acetate; 6: I) afforded vinyl cyclopropane 259 (8.29 g, 82%) as a 
colourless oil. Umax (thin film)/cm -I 2954s (C-H str), 1732s (C=O str), 1614m (C=C 
str), 1434s, 1334s, 1274s, 1210s, 1132s, 991m, 920m; oH (250 MHz, CDCh) 5.40-
5.30 (lH, m, 4-CH), 5.23 (IH, d, J 16.0 Hz, 5-C(H)H), 5.08 (lH, d, J 10.0 Hz, 5-
C(H)H), 3.73 (6H, s, 2 x OCH3), 2.53-2.62 (IH, m, 2-CH), 1.71 (IH, dd, J 5.0 and 7.5 
Hz, 3-C(H)H), 1.57 (1 H, dd, J 5.0 and 9.0 Hz, 3-(H)H); oc (1 00 MHz, CDCh) 170.06, 
167.83 (2 X C=O), 132.96 (4-C), 118.75 (5-C), 52.77 (OCH3), 52.64 (OCH3), 35.74 
( 1-C), 31.53 (2-C), 20.64 (3-C). 
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Bis(l-pyrroline)diiodozinc (276)92 
4-Aminobutanal diethylacetal (2.34 g, 14.5 mmol) was dissolved in 2 M HCl (20 ml) 
and diethyl ether (50 ml) was added. The mixture was stirred at 0 oc for 20 min, and 
then basified with K2C03. The aqueous layer was extracted with cold diethyl ether (3 
x 50 ml). The combined diethyl ether extracts were dried and filtered at 0 °C, and 
anhydrous zinc iodide (2.08 g, 7.2 mmol) was added. The mixture was stirred at 0 oc 
under nitrogen for 30 min. The precipitate was filtered off and washed with cold 
diethyl ether to give a cream powder (0.83 g, 26%). mp 120-124°C [lit mp 120-
1220C]; Umax (thin film)/cm-1 1636s (C=N str), 961m; OH (400 MHz, DMSO-d6) 7.77 
(1H, br s, 2-CH), 3.77-3.72 (2H, m, 5-CHz), 2.61 (2H, br t, J 8.5 Hz, 3-CH2), 1.78 
(2H, quintet, J 8.5 and 15.6 Hz, 4-CHz); 8c (100 MHz, DMSO-d6) 171.12 (2-C), 
59.93 (5-C), 36.31 (3-C), 19.84 (4-C). 
Bis (1-piperideine)diiodozinc (278) 
2 
To a stirred solution of piperidine ( 1.00 g, 11.8 mmol) in dry diethyl ether (30 ml) 
was added tert-butyl hypochlorite ( 1.17 g, 11.8 m mol) to give a colourless solution 
with small amounts of a white suspension. This was stirred for 30 min under a 
nitrogen atmosphere. 18-Crown-6 (30 mg, 0.11 mmol) in diethyl ether (I ml) and 
potassium superoxide (1.79 g, 25 mmol) were added to give a yellow slurry. This was 
stirred for 21 h resulting in a beige coloured mixture that was filtered using diethyl 
ether washings (2 x 15 ml) and to the filtrate was added zinc iodide (1.88 g, 5.89 
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mmol). The filtrate was vigorously stirred for 1 h under a nitrogen atmosphere 
yielding the zinc complex 278 (2.26 g, 80%) as a white precipitate. mp 125-129°C; 
Umax (thin film)/cm·1 2943m, 1653s (C=N str), 1445m, 1389m, 1108m, 1041m; 8H 
(250 MHz, CDCb) 8.45 (IH, s, 2-CH), 3.82-3.69 (2H, m, 6-CH2), 2.55-2.45 (2H, m, 
3-CH2), 1.79- 1.50 (4H, m, 4 and 5-CH2). 
tert-Butyl hypochlorite 
Sodium hypochlorite (200 ml) was placed in a silver-foil covered RBF. The reaction 
vessel temperature was kept below 1 ooc with rapid stirring before a solution of t-
butyl alcohol (14.8 m!, 0.16 mmol) and glacial acetic acid (9.8 m!, 0.17 mmol) was 
added in a single portion. The mixture was stirred for 5 min, poured into a separating 
funnel and the aqueous layer discarded. The oily yellow layer was washed with 10% 
Na2C03 (50 m!) aqueous solution and then distilled water (50 ml). The resultant 
yellow oil was dried over CaCb, filtered into a dark glass container with glass stopper 
(12.3 g, 80%), and used without further purification. 8H (400 MHz, CDCb) 1.35 (9H, 
s, 3 x CH3); <>c (100 MHz, CDCb) 83.93 (QCH3)), 2().80 (C(£H3)). 
Bis (1-piperideine)diiodozinc (279) 
2 
To a stirred solution of homopiperidine ( 1.00 g, I 0.1 mmol) in dry diethyl ether (30 
m!) was added tert-butyl hypochlorite ( 1.00 g, I 0.1 mmol) to give a colourless 
solution with a small amount of a white suspension. This was stirred for 30 m in under 
a nitrogen atmosphere. 18-Crown-6 (30 mg, 0.11 mmol) in diethyl ether (I m!) and 
potassium superoxide (1.80 g, 25.0 mmol) were added to give a slurrying yellow 
159 
mixture. This was stirred for 2I h resulting in a beige coloured mixture which was 
filtered and washed with diethyl ether (2 x I5 ml) and to the filtrate was added zinc 
iodide (1.88 g, 5.89 mmol). The filtrate was vigorously stirred for I h under a 
nitrogen atmosphere yielding the zinc iodide complex 279 as a cream precipitate 
(2.00 g, 40%). The product was used directly in the next step without further 
purification. mp = I4I-I44°C. 
3-Vinylhexahydropyrrolizine-1,1-dicarboxylic acid dimethyl ester (280) 
6 
Vinylcyclopropane 259 (IOO mg, 0.54 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (64 mg, 0.054 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for IO min before adding zinc complex 276 (I47 mg, 0.32 
mmol). The mixture was heated to 80°C for I h before cooling to room temperature. 
ethyl acetate (I 0 ml) was added to the mixture and this washed with distilled water (5 
x I 0 ml) and brine (2 x I 0 m I). The organic layer was separated and then partitioned 
with aqueous 2 M HCI (15 ml). The aqueous layer was basified with saturated 
NaHC03 (15 ml). Ethyl acetate (3x I 0 ml) was used to extract the product and the 
combined extracts were dried over MgS04 and concentrated to give pyrolizidine 280 
(90 mg, 65%) as an orange oil. Umax (thin film)/cm-1 2950m, 2870m (C-H str), I736m 
(C=O str), 1430m, I269s, I24Is, I200s, Il40m, IIOOm, 994w, 922m; 8H (400 MHz, 
CDCb) 5.62 (IH, ddd, .17.5, IO.O and 17.2 Hz, 9-CH), 5.I5 (IH, ddd, J 1.0, 1.7 and 
17.2 Hz, I 0-C(H)H), 4.81 (I H, ddd, J 1.0, I. 7 and I 0.0 Hz, I 0-C(H)H), 4.I8 (I H, dd, 
.I 6.8 and 9.1 Hz, 8-CH), 3.67 (6H, s, 2 x OCH3), 3.37-3.28 (I H, m, 3-CH), 2.92-2.80 
(IH, m, 5-C(H)H), 2.73-2.68 (IH, dd, J 6.0 and I2.5 Hz, 2-C(H)H), 2.61-2.58 (IH, 
m, 5-C(H)H), 2.02-1.97 (IH, dd,.J 10.0 and I2.5 Hz, 2-C(H)H), 1.90-1.69 (3H, m, 7-
C(H)H and 6-CH2), 1.38-1.35 (IH, m, 7-C(H)H); 8c (100 MHz, CDCb) 171.46, 
171.00 (2 X C=O), I40.Il (10-C), Il6.12 (11-C), 69.39 (8-C), 68.08 (3-C), 61.40 (I-
C), 52.45, 52.82 (2 x OCH3), 52.15 (5-C), 41.59 (2-C), 28.09 (7-C), 26.06 (6-C); m/z 
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(FAB+) 254 (100), 253 (21), 252 (59), 222 (19), 109 (21); HRMS found 253.1314 
[Mt, [CnH19N04t requires 253.1314). 
3-Vinylhexahydroindolizine-1,1-dicarboxylic acid dimethyl ester (281) 
6 7 
. Vinylcyclopropane 259 (100 mg, 0.54 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (64 mg, 0.054 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for 10 min before adding zinc complex 310 (144 mg, 0.32 
mmol). The mixture was heated to 80°C for 1 h before cooling to room temperature. 
Ethyl acetate (10 ml) was added to the mixture and this washed with distilled water (5 
x 10 ml) and brine (2 x 10 ml). The organic layer was separated and then partitioned 
with aqueous 2 M HCl (15 ml). The aqueous layer was basified with saturated 
aqueous NaHC03 (15 ml). Ethyl acetate (3x1 0 ml) was used to extract the product 
and the combined extracts were dried over MgS04 and concentrated to give 
indolizidine 281 (61 mg, 42%) as an orange oil. Umax (thin film)/cm-1 2949s, 2855w, 
2785w (C-H str), 1736m (C=O str), 1648w (C=C str), 1434s, 1382m, 1275s, 1245s, 
1202s, 1147m, 994m; OH (400 MHz, C6D6) 6.00 (IH, ddd, J 8.4, 10.0 and 17.2 Hz , 
10-C), 5.14 (1H, dd, J 1.6 and 17.2 Hz, 11-C(H)H), 5.09 (IH, dd, J 1.6 and 10Hz, 
11-C(H)H), 3.46, 3.43 (6H, s, 2 x OCH3), 3.15 (IH, br d, J 10.8 Hz, 5-C(H)H), 2.99 
( 1 H, dd, J 2.4 and 10.8 Hz, 9-CH), 2.90 ( 1 H, dd, J 8.4 and 13.4 Hz, 2-C(H)H), 2.67 
(l H, q, J 8.4 Hz, 3-CH), 2.32 (l H, dd, J 8.4 and 13.4 Hz, 2-C(H)H), 2.32-2.26 ( 1 H, 
m, 8-C(H)H), 1.83-1.70 (2H, m, 5-C(H)H and 6-C(H)H), 1.60-1.20 (4H, m, 6-C(H)H, 
7-CH2 and 8-C(H)H); Oc (lOO MHz, C6D6) 171.48, 170.27 (2 x C=O), 139.83 (10-C), 
116.88 (11-C), 69.18 (9-C), 68.04 (3-C), 61.01 (1-C), 51.76 (5-C), 51.68, 51.57 (2 x 
OCH3), 38.48 (2-C), 28.68 (6-C), 24.99 (8-C), 24.43 (7-C); mlz (F AB+) 267 (52), 
236 (36), 208 (31), 148 (20), 123 (57), 95 (21), 83 (22), 81 (28), 69 (33), 67 (24), 57 
(33); HRMS found 267.1468 [Mt, [C14H21N04t requires 267.1471. 
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3-Vinyl octahydropyrrolo[1,2-a )azepine-1,1-dicarboxylic acid dimethyl ester 
(284) 
7 
Vinylcyclopropane 259 (100 mg, 0.54 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (64 mg, 0.054 mmol) in anhydrous DMSO (2 m!) were stirred at room 
temperature under nitrogen for 10 min before adding zinc complex 312 (167 mg, 0.32 
mmol). The mixture was heated to 80°C for 1 h before cooling to room temperature. 
Ethyl acetate (10 ml) was added to the mixture and this washed with distilled water (5 
x 10 m!) and brine (2 x 10 m!). The organic layer was separated and then partitioned 
with aqueous 2 M HCI (15 m!). The aqueous layer was basified with saturated 
aqueous NaHC03 (15 m!). Portions of ethyl acetate (3x10 m!) were then used to 
extract the product and the combined extracts were dried over MgS04 and 
concentrated to give azepine 284 (137 mg, 90%) as an orange oil. 8H (400 MHz, 
CDCh) 5.65-5.52 (lH, ddd, J 8.0, 10.0 and 17.0 Hz, 11-CH), 5.08 (1 H, ddd, J 1.0, 2.0 
and 17.0 Hz, 12-C(H)H), 5.02 (IH, dd, J2.0 and 10.0 Hz, 12-C(H)H), 3.68, 3.65 (6H, 
2 x s, 2 x OCH3), 3.30-3.27 (IH, m, 10-CH), 2.85-2.75 (IH, m, 5-C(H)H), 2.75-2.65 
(IH, m, 3-CH), 2.41-2.31 (IH, dd, J 10.0 and 14.0 Hz, 2-C(H)H), 2.20-2.10 (2H, m, 
2-C(H)H and 5-C(H)H), 1.69-1.39 (7H, m, 6-CH2, 8-CH2, 9-CH2 and 7-C(H)H), 
1.37-1.25 (IH, m, 7-C(H)H); Oc (100 MHz, CDCh) 172.30, 170.50 (2 x C=O), 140.24 
(JJ-C), 116.99 (12-C), 68.62 (JO-C), 67.18 (3-C), 62.33 (J-C), 52.76, 52.37 (2 X 
OCH3), 51.49 (5-C), 38.86 (2-C), 31.35, 28.66, 26.04, 25.60 (6-C, 7-C, 8-C and 9-C); 
m/z (Cl+) 282 (lOO), 180 (48), 134 (26), 100 (27), 98 (49); HRMS found 282.1699 
[M+Ht, [C1sH23N04+Htrequires 282.1700. 
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8,9-Dimethoxy-3-vinyl-2,3,6,10b-tetrahydro-5H-pyrrolo[2,1-a]isoquinoline-1,1-
dicarboxylic acid dimethyl ester (290) 
Vinylcyclopropane 259 (100 mg, 0.54 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (64 mg, 0.054 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for 10 min before adding 6,7-dimethoxy-3,4-dihydro-
isoquinoline.HCl (136 mg, 0.60 mmol). The mixture was heated to 80°C for I h 
before cooling to room temperature. Ethyl acetate (10 ml) was added to the mixture 
and this washed with distilled water (5 x I 0 ml) and brine (2 x I 0 ml). The organic 
layer was separated and then partitioned with 2 M HCl (15 ml). The aqueous layer 
was basified with saturated NaHC03 (IS mi). Portions of ethyl acetate (3 x IO ml) 
were then used to extract the product and the combined extracts were dried over 
MgS04 and concentrated to give an orange oil. Purification by column 
chromatography (Si02, 40-60 P.E:ethyl acetate, 6:I) gave indolizidine 290 (120 mg, 
59%, 5:4) as an orange oil as an inseparable mixture of diastereoisomers. Umax (thin 
film)/cm-1 2999w, 2950w, 2836w (C-H str), 1737m (C=O str), 165Im (C=C str), 
I602m, 15I3s, 1434s, 1342s, I275s, Il38m, 930w; ou (400 MHz, CDCb) 6.95 (IH, 
s, 7-CH), 6.92 (IH, s, 7-CH'), 6.50 (IH, s, 10-CH'), 6.48 (IH, s, IO-CH), 5.76 (IH, 
ddd, .18.0, 10.0 and 17.0 Hz, 14-CH'), 5.69-5.6I (IH, ddd, .18.0, 10.0 and 17.0 Hz, 
14-CH), 5.24 (l H, s, 5-CH), 5.22-5.10 (4H, m, 15-CH2 and 15-CH2'), 4.06 (l H, s, 5-
CH'), 3.98-3.90 (l H, m, 3-CH), 3.79-3.74 (ISH, 6 x s, C02CH3, C02CH/, 2 x OCH3 
and 2 x OCH3'), 3.37 (3H, s, C02CH3'), 3.11 (3H, s, C02CH3), 3.18-3.09 (IH, m, 13-
C(H)H), 3.08-3.00 (l H, m, 13-C(H)H'), 3.00-2.88 (2H, m, I 3-C(H)H and 3-CH'), 
2.76-2.64 (2H, m, 13-C(H)H' and 12-C(H)H'), 2.63-2.55 (2H, m, 12-C(H)H and 2-
C(H)H), 2.50 (2H, d, .l 8.0 Hz, 2-CH2'), 2.37-2.22 (2H, m, 12-C(H)H and 12-
C(H)H'), 2.09 (I H, dd, .l 8.0 and I 3.0 Hz, 2-C(H)H); Oc (I 00 MHz, CDCb) 172.81, 
172.15, 171.05, 171.02 (2 x C=O and 2 x C=O'), 147.43, 147.28 (9-C and 9-C'), 
146.80, 146.25 (8-C and 8-C'), 139.89 (14-C') 138.08 (14-C), I28.89, I27.76, I26. 
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30, 126.10 (6-C, 11-C, 6-C' and 11-C'), 118.66 (15-C), 117.60 (15-C'), 110.95 (10-
C'), 110.83 (7-C), 110.77 (10-C), I 09.92 (7-C'), 69.65 (5-C'), 65.90 (3-C'), 65.43 (I-
C), 65.12 (5-C), 64.89 (3-C), 62.24 (IC'), 55.84, 55.69 (2 x OMe and 2 x OMe'), 
52.89, 52.85, 52.38, 52.07 (2 x C02Me and 2 x C02Me'), 45.76 (13-C), 44.19 (13-
C'), 40.34 (2-C'), 39.75 (2-C), 24.41 (12-C and 12-C'); m/z (FAB+) 376 (66), 375 
(23), 374 (58), 344 (40), 279 (27), 231 (100), 230 (48), 192 (27); HRMS found 
375.1687 [Mt, [CzoHzsN06t requires 375.1760. 
Bis (6,7-dimethoxy-3,4-dihydroisoquinoline)diiodozinc (291) 
2 
To a stirred solution of 6, 7-dimethoxy-3,4-dihydroisoquinoline HCl hydrate (200 mg, 
0.88 mol) in diethyl ether (10 ml) was added zinc iodide (140 mg, 0.44 mmol) and the 
mixture vigorously stirred at room temperature for 30 min under a nitrogen 
atmosphere. The precipitate was filtered under suction and washed with diethyl ether 
to give zinc complex 291 (211 mg, 81%) as a pale yellow powder. mp 180-182°C; OH 
(250 MHz, DMSO-d6) 8.95 (lH, s, 2-CH), 7.52 (IH, s, 4-CH), 7.18 (IH, s, 7-CH), 
3.93 (3H, s, OMe), 3.86 (2H, t, J 8.2 Hz, l0-CH2), 3.81 (3H, s, OMe), 3.07 (2H, t, J 
8.2 Hz, 9-CHz); Oc (100 MHz, DMSO-d6) 164.33 (2-C), 156.39 (5-C), 147.84 (6-C), 
133.42 (3-C), 116.70 (8-C), 115.25 (4-C), 111.52 (7-C), 56.40 (OMe), 55.86 (OMe), 
40.75 (10-C), 23.65 (9-C). 
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2-Formyl-cyclopropane-1,1-dicarboxylic acid dimethyl ester (292). (Method A)99 
To a stirred solution of acrolein (356 mg, 6.36 mmol) and potassium carbonate (1.32 
g, 9.53 mmol) in anhydrous DMF (20 m!), was added dimethyl bromomalonate 
(l.OOg, 4.76 mmol). The reaction mixture was stirred for 2 h at room temperature, 
under an atmosphere of nitrogen to give a yellow solution. Aqueous 2 M HCI was 
added to neutralise the reaction mixture, and this extracted into diethyl ether (2 x 20 
ml). The combined organic fractions were washed with distilled water (4 x 20 m!) and 
brine ( 4 x 20 ml), dried over MgS04, and evaporated under reduced pressure to give 
the cyclopropane 292 (709 mg, 60%) as a yellow oil, suitable for use without need for 
further purification. Umax (thin film)/cm-1 3012m, 2956m, 2850m (C-H str), 1734s 
(C=O str), 1437m, 1270s (C-0), 1211m, 1133m; oH (400 MHz, CDCb) 9.30 (IH, d, 
J 5.4 Hz, 4-CH), 3.71 (6H, s, 2 x OMe), 2.04-2.01 (1H, dd, J 5.4 and 8.8 Hz, 2-
C(H)H), 1.78-1.75 (IH, dd, J5.4 and 8.8 Hz, 2-C(H)H); oc (100 MHz, CDCI3) 196.32 
(4-C), 168.37, 166.44 (2 x C02Me), 53.22 (2 x OMe), 37.58 (1-C), 34.88 (3-C), 
19.71 (2-C). 
2-Formy1-cyclopropane-1,1-dicarboxylic acid dimethyl ester (292). (Method B) 
Vinylcyclopropane 259 (6.40 g, 34.8 mmol) in DCM (50 ml) was treated with ozone 
at -78°C for 2 h, or until the reaction mixture turned blue. The reaction was quenched 
with dimethylsulfoxide (13.5 g, 217 mmol), and allowed to stir open to the air, at 
room temperature overnight. The colourless oil was then dissolved in ethyl acetate 
(30 ml) and washed with water (30 ml) and brine solution (2 x 30 ml). The organic 
portion was dried over MgS04 and evaporated under reduced pressure to give the 
cyclopropane 292 (5.00 g, 77%). Data as for Method A. 
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2-(2-Ethoxycarbonylvinyl)-cyclopropane-1 ,1-dicarboxylic acid dimethyl ester 
(294)100 
To a stirred solution of carbethoxymethyl triphenylphosphonium bromide (1.60 g, 
3.72 mmol) in anhydrous THF (20 m!) at 0°C, was added n-BuLi (1.48 ml, 3.72 
mmol, 2.5 M in THF). The yellow reaction mixture was stirred under a nitrogen 
atmosphere for 10 min, before the addition of 2-formyl-cyclopropane-1,1-
dicarboxylic acid dimethyl ester 292 (350 mg, 1.86 mmol). The reaction mixture was 
allowed to warm up to room temperature and stirred for a further 2 h. The reaction 
was quenched with saturated aqueous NaHC03 (15 m!) at 0°C. Ethyl acetate (20 m!) 
was added to the biphasic system, and the organic layer extracted with distilled water 
(3 x 20 ml) and brine (3 x 20 m!). The combined aqueous fractions were back-
extracted into ethyl acetate (20 m!), and the combined organic fractions dried over 
MgS04 and evaporated under reduced pressure to give a yellow oil. Purification by 
column chromatography (SiOz, 40-60 P.E:ethyl acetate; 7:1) afforded the 
vinylcyclopropane 294 (290 mg, 61%) as a colourless oil. Umax (thin film)/cm· 1 
2982w, 2955w, 2904w, 2848w (C-H str), 1731 s (C=O), 1649m (C=C str), 143 7s, 
1380s, 1331s (C-0), 1254m, 1199s, 1131s; oH (400 MHz, CDCh) 6.41-6.34 (IH, dd, 
17.4 and 9.0 Hz, 4-CH), 6.00 (1H, d, 19.0 Hz, 5-CH), 4.13-4.08 (2H, t, 17.0 Hz, 
OCfuCH3), 3.70 (6H, s, 2 x OMe), 2.62-2.57 (IH, m, 2-CH), 1.77-1.73 (1H, dd, 17.4 
and 12.0 Hz, 3-C(H)H), 1.68-1.64 (IH, dd, 17.4 and 12.0 Hz, 3-C(H)H), 1.90 (3H, t, 
17.0 Hz, OCHzCfu); De (lOO MHz, CDCh) 169.3, 167.2, 165.6 (3 x C=O), 143.1 (4-
C), 124.4 (5-C), 60.4 (OCHzCH3), 52.9, 52.9 (2 x OMe), 36.5 (1-C), 29.8 (2-C), 21.5 
(3-C), 14.3 (OCHz~H3); HRMS found (256.0947 C12H160 6 requires 256.0946). 
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3-(2-Ethoxycarbonylvinyl)hexahydro pyrrolizine-1 ,1-dicarboxylic acid dimethyl 
ester (295) 
Vinylcyclopropane 294 (50 mg, 0.195 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (32 mg, 0.027 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for 10 min before adding bis-(1-pyrroline)diiodozinc 276 
(89 mg, 0.195 mmol). The mixture was heated to 80°C for 1 h before cooling to room 
temperature. ethyl acetate (10 ml) was added to the mixture and this washed with 
distilled water (5 x 10 ml) and brine (2 x 10 ml). The organic layer was separated and 
then partitioned with aqueous 2 M HCl (15 ml). The aqueous layer was basified with 
saturated aqueous NaHC03 (15 ml). Ethyl acetate (3 x 10 ml) was used to extract the 
product and the combined extracts were dried over MgS04 and concentrated to give 
pyrolizidine 295 (39 mg, 61%, d.r 1:1) as an orange oil. Umax (thin film)/cm-1 2953m 
(C-H str), 1731 s (C=O str), 1660w (C=C str), 1435m, 1367w, 1249m (C-O); 8H ( 400 
MHz, CDCh) 6.81-6.72 (2H, m, 9-CH and 9-CH'), 5.92 (IH, d, J 15.2 Hz, 10-CH'), 
5.91 (IH, d, J 15.2 Hz, 10-CH), 4.23-4_17 (2H, m, 8-CH and 8-CH'), 4.17-4.08 (4H, 
2 x q, J 7.0 Hz, OCfuCHJ and OCfuCH3'), 3.68, 3.67, 3.67, 3.66 (l2H, 4 x s, 2 x 
OMe and 2 x OMe'), 3.60-3.52 (2H, m, 3-CH), 2.98-2.90 (2H, m, 5-C(H)H and 5-
C(H)H'), 2.73 (2H, dd, J 6.4 and 13.6 Hz, 2-C(H)H and 2-C(H)H'), 2.54-2.48 (2H, 
m, 5-C(H)H and 5-C(H)H'), 2.05 (2H, m, 2-C(!:!)H and 2-C(H)H'), 1.90-1.71 (6H, m, 
6-CHz, 6-CHz', 7-C(H)H and 7-C(H)H'), 1.44-1.31 (2H, m, 7-C(H)H and 7-C(H)H'), 
1.22 (6H, 2 x t,.! 7.0 Hz, OCHzCfu and OCHzCfu'); 8c (lOOMHz, CDCh) 171.22, 
170.98, 170.98, 170.85, 166.45, 166.33 (3 x C=O and 3 x C=O'), 149.00 (9-C'), 
148.54 (9-C), 122.06 (10-C), 121.58 (10-C'), 69.52 (8-C'), 69.41 (8-C), 66.25 (3-C), 
66.13 (3-C'), 61.51 (1-C), 61.48 (1-C'), 60.43 (OCH2CH3 and O~_H2CH3 '), 52.90 (2 x 
OMe), 52.86 (5-C'), 52.85 (5-C), 52.60 (OMe'), 52.50 (OMe'), 41.16 (2-C and 2-C'), 
28.18 (6-C), 28.07 (6-C'), 26.56 (7-C), 26.52 (7-C), 14.10 (OCH2CH3), 13.97 
(OCHzCH3'); mlz: (FAB+) 326 (100), 325 (18), 324 (46); HRMS found 325.15254 
[Mt, [Ct6H23N06t requires 325.3577). 
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3-(2-Etho:xycarbonylvinyl)hexahyd ro indolizine-1 ,1-dicarboxylic acid dimethyl 
ester (296) 
6 
Vinylcyclopropane 294 (50 mg, 0.195 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (32 mg, 0.027 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for 10 min before adding zinc complex 278 (95 mg, 0.195 
mmol). The mixture was heated to 80°C for 1 h before cooling to room temperature. 
Ethyl acetate (1 0 ml) was added to the mixture and this washed with distilled water (5 
x 1 q ml) and brine (2 x 10 ml). The organic layer was separated and then partitioned 
with aqueous 2 M HCI (15 ml). The aqueous layer was basified with saturated 
aqueous NaHC03 (15 ml). Ethyl acetate (3x1 0 ml) was used to extract the product 
and the combined extracts were dried over MgS04 and concentrated to give 
indolizidine 296 ( 40 mg, 60%, d.r 1:1) as an orange oil. Umax (thin film)/cm" 1 2935m 
(C-H str), 1730s (C=O str), 1650m (C=C str), 1437m, 1368w, 1266m (C-0); oH (400 
MHz, CDCh) 6.86 (IH, dd, J 5.3 and 16.0 Hz, 10-CH'), 6.82 (IH, dd, J 5.3 and 16.0 
Hz, 10-CH), 5.80 (1H, d, J 16.0 Hz, 11-CH'), 5.79 (1H, d, J 16.0 Hz, 11-CH), 4.12 
(4H, 2 x q, J 7.2 Hz, OCfuCH3 and OCfuCH/), 3.66, 3.66, 3.65, 3.65 (12H, 4 x s, 2 
x OMe and 2 x OMe'), 3.50-3.45 (2H, m, 3-CH and 3-CH'), 3.0l-2.9i (2H, m, 9-CH 
and 9-CH'), 2.51-2.40 (2H, m, 5-C(H)H and 5-C(H.)H'), 2.31-2.18 ( 4H, m, 5-
C(H)H,5-C(H)H', 2-C(H)H and 2-C(H)H'), 2.00-1.88 (2H, m, 2-C(H)H and 2-
C(H)H'), 1.60-1.45 (8H, m, 6-CH2, 6-CH/, 8-CH2 and 8-CH2'), 1.42-1.30 (4H, m, 7-
CH2 and 1-CH2'), 1.23 (4H, 2 x t,J7.2 Hz, OCH2CH3and OCH2CH3'); Oc (lOO MHz, 
CDCb) 170.01, 169.87, 168.54, 168.41, 166.35, 165.94 (3 x C=O and 3 x C=O'), 
146.94 (10-C), 146.04 (10-C'), 123.71 (11-C), 123.05 (11-C'), 64.23 (9-C and 9-C'), 
61.51 (O~H2CH3), 61.43 (O~H2CH3'), (1-C not observed), 52.59, 52.53, 51.66 (2 x 
OMe and 2 x OMe'), 50.23 (5-C and 5-C'), 49.10 (3-C), 49.07 (3-C'), 30.0 I (2-C and 
2-C'), 26.30 (6-C, 6-C', 8-C' and 8-C), 24.58 7-C and 7-C'), 14.26 (OCH2CH3), 
14.26 (OCH2~H3'); m/z (FAB+) 340 (lOO), 339 (33), 338 (62), 310 (54), 308 (23), 
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240 (22), I96 (80), I54 (29), 136 (25), I22 (35); HRMS found 339.168I [Mt, 
[C11HzsN06t requires 339.3845). 
3-(2-Ethoxycarbonylvinyl)octahydro pyrrolo[1,2-a]azepine-l,l-dicarboxylic acid 
dimethyl ester (297) 
Vinylcyclopropane 294 (70 mg, 0.273 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (40 mg, 0.034 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for IO ruin before adding zinc complex 279 (I40 mg, 
0.273 mmol). The mixture was heated to 80°C for I h before cooling to room 
temperature. ethyl acetate (I 0 ml) was added to the mixture and this washed with 
distilled water (5 x IOml) and brine (2 x IO ml). The organic layer was separated and 
then partitioned with aqueous 2 M HCI (15 ml). The aqueous layer was basified with 
saturated aqueous NaHC03 (15 ml). Ethyl acetate (3 x I 0 ml) was used to extract the 
product and the combined extracts were dried over MgS04 and concentrated to give 
azepine 297 (58 mg, 60%) as an orange oil. Dmax (thin film)/cm-1 I 732s (C=O str), 
I656w (C=C str), 1436m, 1370w, 1262m, I 175m; DH (400 MHz, CDCh) 6.76-6.70 
(IH, dd, J7.6 and 15.5 Hz, 11-CH), 5.88 (1H, d, J 15.5 Hz, 12-CH), 4.15-4.10 (2H, 
q, J 7Hz, OCfuCH3), 3.68, 3.65 (6H, 2 x s, 2 x OMe), 3.43-3.38 (1H, m, 10-CH), 
3.01-2.92 (IH, m, 3-CH), 2.71-2.62 (IH, m, 5-C(H)H), 2.44-2.38 (IH, dd, J 10.0 and 
13.0 Hz, 2-C(H)H), 2.35-2.24 (I H, m, 5-C(H)H), 2.23-2.17 (I H, dd, J 6.6 and 13.0 
Hz, 2-C(H)H), 1.75-1.26 (8H, m, 6, 7, 8, 9-CHz), 1.22 (3H, t, J 7Hz, OCHzCH3); 8c 
(100 MHz, CDCb) 171.98, 169.93, 166.40 (3 x C=O), 149.50 (11-C), 122.58 (12-C), 
67.94 (10-C), 64.44 (3-C), 62.57 (1-C), 60.42 (O.CH2CH3), 52.94, 52.49 (2 x OMe), 
51.77 (5-C), 38.36 (2-C), 31.43, 28.95, 26.35, 25.37 (6, 7, 8, 9-C), 14.27 (OCH2CH3); 
m/z (F AB+) 354 ( 1 00), 353 ( 46), 352 (93), 324 (79), 294 ( 41 ), 254 ( 46), 154 (82), 138 
(35), 137 (49), 136 (86), 107 (48), 91 (44), 89 (42), 81 (41), 77 (58), 69 (61), 55 (86); 
HRMS found 354.19132 [M+Ht, [C1sH27N06+Ht requires 354.19166. 
169 
3-(2-Ethoxycarbonylvinyl)-8,9-dimethoxy-2,3,6,10b-tetrahydro-5H-pyrrolo[2,1-
a]isoquinoline-1,1-dicarboxylic acid dimethyl ester (298) 
Vinylcyclopropane 294 (100 mg, 0.39 mmol) and tetrakis(triphenylphosphine) 
palladium(O) (44 mg, 0.034 mmol) in anhydrous DMSO (2 ml) were stirred at room 
temperature under nitrogen for I 0 m in before adding 6, 7-dimethoxy-3,4-dihydro-
isoquinoline.HCI (81 mg, 0.35 mmol). The mixture was heated to 80°C for I h before 
cooling to room temperature. Ethyl acetate (1 0 ml) was added to the mixture and this 
washed with distilled water (5 x I 0 ml) and brine (2 x 10 ml). The organic layer was 
separated and then partitioned with aqueous 2 M HCI (15 ml). The aqueous layer was 
basified with saturated aqueous NaHC03 (15 ml). Ethyl acetate (3xl0 ml) was used to 
extract the product and the combined extracts were dried over MgS04 and 
concentrated to give an orange oil. Purification by column chromatography (Si02, 40-
60 P.E:ethyl acetate, 6:1) gave indolizidine 298 (130 mg, 83%, 2:1) as an inseparable 
mixture of diastereoisomers. Umax (thin film)/cm-1 2999w, 2950w, 2836w (C-H str), 
1737m (C=O str), 165lm (C=C str) 1602m, 1513s, 1434s, 1342s, 1275s, ll38m, 
930w; 8H (400 MHz, CDCI3) 6.98 (IH, s, 7-CH), 6.91 (IH, s, 7-CH'), 6.88 (IH, dd, J 
9.6 and 17.2 Hz, 14-CH'), 6.74 (IH, dd, J6.8 and 15.6 Hz, 14-CH), 6.50 (IH, s, lO-
CH'), 6.47 (I H, s, 1 0-CH), 6.00 (1 H, d, J 15.6 Hz, 15-CH), 5.95 (I H, d, J 15.6 Hz, 
15-CH'), 5.23 (1 H, s, 5-CH), 4.06 (I H, s, 5-CH'), 4.20-4.01 (6H, m, OCfuCH3, 
OCHzCH3', 3-CH and 5-CH'), 3.84, 3.79, 3.77, 3.77, 3.76, 3.74 (ISH, 6 x s, C02CH3, 
C02CH3', 2 x OCH3 and 2 x OCH3'), 3.37 (3H, s, C02CH/), 3.11 (3H, s, C02CH3), 
3.19-3.09 (IH, m, 3-CH'), 3.09-3.00 (IH, m, 13-C(H)H'), 2.99.(1H, m, 13-C(H)H), 
2.80-2.65 (2H, m, 13-C(H)H and 12-C(H)H), 2.62 (I H, dd, J 5.6 and 12.8 Hz, 2-
C(H)H), 2.60-2.48 (2H, m, 2-CH2 '), 2.35-2.25 (2H, m, 13-C(H)H' and 12-C(H)H), 
2.08 (lH, dd, J 8.8 and 12.8 Hz, 2-C(H)H), 1.29-1.18 (6H, m, OCH2Clli and 
OCHzCfu'); oc (lOO MHz, CDCb) 171.74, 171.20, 170.77, 170.47 (2 x!::_02Me and 2 
x!::_02Me'), 166.28 (!::_02Et), 166.05 (!::_02Et'), 149.41 (14-C), 147.52 (14-C'), 147.37 
170 
(8-C), 147.39 (8-C'), 146.85 (9-C), 146.28 (9-C'), 128.95 (6-C), 127.61 (6-C'), 
126.02 (11-C), 125.69 (11-C'), 124.10 (15-C'), 122.87 (15-C), 110.94 (7-C and 7-
C'), 110.76 (10-C), 110.02 (10-C'), 69.49 (5-C'), 65.37 (5-C), 65.32 (1-C), 63.18 (3-
C'), 62.88 (3-C), 62.18 (1-C'), 60.45, 60.41 (OCH2CH3 and OCH2CH3'), 55.85, 
55.73 (2 x OMe and 2 x OMe'), 52.97 (C02CH/), 52.90 (C02CH3), 52.43 
(C02CH3'), 52.12 (C02CH3), 46.30 (13-C'), 44.80 (13-C), 39.83 (2-C'), 39.36 (2-C), 
29.45 (12-C'), 24.64 (12-C), 14.24, 14.20 (OCH2£H3 and OCH2£H3'); rn/z (FAB+) 
448 (100), 447 (34), 446 (96), 416 (78), 303 (74), 230 (59), 192 (32), 83 (35), 81 (42), 
69 (67), 57 (49), 55 (63); HRMS found 448.1977 [M+Ht, [C2oH2sN06+Ht requires 
448.1971. 
Bis(2-methyl-1-pyrroline )diiodozinc (309) 
To a stirred solution of2-methyl-1-pyrroline (2.00g, 24.1 mol) in diethyl ether (50ml) 
was added zinc iodide (3.84 g, 12.1 mol) and the mixture vigorously stirred at 0 oc 
under nitrogen for 30 min. The precipitate was filtered under suction and washed with 
cold diethyl ether to give zinc complex 309 (5.18 g, 89%) as a cream powder. A 
portion of the complex was recrystallised from DCM/hexane vapour diffusion 
experiments and X-ray crystallographic data obtained (See Appendix). mp 145-
1470C; Umax (thin film)/cm-1 1635s (C=N str), 965m; OH (250 MHz, DMSO-d6) 3.80-
3.72 (2H, m, 5-CHz), 2.69 (2H, t, J 8.4 Hz, 3-CH2), 2.14 (3H, s, 6-CH3), 1.87 (2H, 
quintet, J 8.4 and 15.6 Hz, 4-CHz); De (I 00 MHz, OMSO-d6) 182.99 (2-C), 60.16 (5-
C), 39.26 (3-C), 21.26 (4-C), 19.56 (6-C). 
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1-Carboxybenzyl-3-pyrroline (310)106 
O~O~Ph 
16, 7 
'6' 
4 3 
To a stirred solution (5°C) of 3-pyrroline (4.00 g, 54.0 mmol) in toluene (I 00 ml) and 
3 M NaOH (72 ml) was added benzyl chioroformate (10.6 ml, 75.0 mmol). After I h 
TLC (I:I ethyl acetate:hexane) showed all starting material had been consumed. The 
layers were separated and the organic layer washed with distilled water (50 ml), dried 
over MgS04 and evaporated under reduced pressure to give a yellow oil. Purification 
by column chromatography (Si02, Hexane:ethyl acetate; 7:3) afforded I-
carboxybenzyl-3-pyrroline 310 (9.80 g, 83%) as a pale yellow oil. Umax (thin 
film)/cm-1 3064w, 303I w (Ar C-H str), 2952s, 2860s (C-H str), 170 Is (C=O str), 
I623m (C=C str); OH (400 MHz, CDCh) 7.39-7.26 (5H, m, 5 x Ar-CH), 5.80-5.73 
(2H, m, 3 and 4-CH), 5.16 (2H, s, 7-CHz), 4.21-4.10 (4H, m, 2 and 5-CH2); Oc (100 
MHz, CDCI3) 154.66 (6-C), 136.95 (iAr-C), 128.48, 127.95, 127.88 (5 x Ar-C), 
125.79, 125.66 (3 and 4-C), 66.79 (7-C), 53.43, 52.96 (2 and 5-C). 
1-Carboxybenzyl-3,4-epoxy-pyrrolidine (311 )106 
To 1-carboxybenzyl-3-pyrroline 310 (4.90 g, 24.1 mmol) in dry DCM (90 ml) was 
added a solution of meta-chloroperoxybenzoic acid (mCPBA) (55%, 15.1 g) in DCM 
(90 ml). The mixture was left to stir under nitrogen for I 9 h before addition of a 
second portion of mCPBA (55%, 15.0 g) in DCM (90 ml). After a total of 38 h, TLC 
( 1:1 diethyl ether:hexane) showed consumption of starting material and formation of 
a major product (Rr 0.5). The solvent was evaporated under reduced pressure and the 
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resultant white solid dissolved in diethyl ether (50 ml) and washed with aqueous 
NaHC03 (50 ml) followed by brine (3 x 50 ml). The organic layer was dried over 
MgS04, filtered and concentrated under reduced pressure to give a white solid. 
Purification by column chromatography (Si02, Hexane:ethyl acetate; 1:1) yielded 1-
carboxybenzyl-3,4-epoxy-pyrrolidine 311 (2.30 g, 44%) as a colourless oil. Umax (thin 
film)/cm-1 2950w, 2875w (C-H str), 1704s (C=O str); DH (400 MHz, CDCh) 7.35-
7.29 (5H, m, 5 x Ar-CH), 5.09 (2H, s, 7-CH2), 3.80 (IH, d, J 12.8 Hz, 5-C(H)H), 3.76 
(IH, J 12.8 Hz, 2-C(.t!)H), 3.61 (2H, dt, J 1.4 and 3.1 Hz, 3-CH and 4-CH), 3.32 
(IH, dd, J 1.4 Hz and 12.8 Hz, 5-C(H)H), 3.30 (IH, dd, J 1.4 Hz and 12.8 Hz, 2-
C(H).t!); De (100 MHz, CDCb) 155.32 (6-C), 136.55 (iAr-C), 128.24, 128.07, 127.96 
(5 x Ar-C), 67.05 (7-C), 55.54, 54.98 (2 and 5-C), 47.45, 47.18 (3 and 4-C). 
(± )-(3S,4S)-1-Carboxybenzy1-3,4-dihydroxypyrrolidine (312)106 
0~0"-./Ph 
16. 7 
N1 
HOp;H 
H OH 
1-Carboxybenzyl-3,4-epoxy-pyrrolidine 311 (1.80 g, 8,22 mmol) was dissolved in 2 
M aqueous H2S04 (!50 ml) and diethyl ether ( 150 ml). This was left to stir under 
nitrogen at room temperature for 21 h. diethyl ether (50 ml) was added and the layers 
separated. The organic layer was dried over MgS04, filtered and concentrated under 
reduced pressure giving a colourless oil. The aqueous layer was back-extracted with 
ethyl acetate (50 ml), and the organic extract dried over MgS04, filtered and 
evaporated under reduced pressure to give a colourless oil. Both products were shown 
by 1H NMR to be the diol. Purification by column chromatography (Si02, ethyl 
acetate) yielded (±)-(3S,4R)-l-carboxybenzyl-3,4-dihydroxypyrrolidine 312 ( 678 mg, 
62%) as a colourless oil. Umax (thin film)/cm- 1 3400br (OH str), 3064m, 3040m (ArC-
H str), 2949w, 2886w (C-H str), 1675s (C=O str); DH (400 MHz, CDCb) 7.31-7.23 
(5H, m, 5 x Ar-C), 5.01 (2H, s, 7-CH2), 4.05 (2H, s, 3 and 4-CH), 3.62-3.59 (2H, m, 2 
and 5-C(H)H), 3.36-3.31 (2H, m, 2 and 5-C(H)H); Oc (I 00 MHz, CDCh) 155.67 (6-
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C), 136.35 (iAr-C), 128.52, 128.11, 127.79 (5 x Ar-C), 75.19, 74.55 (3 and 4-C), 
67.21 (7-C), 51.77, 51.44 (2 and 5-C). 
( ±)-(3 S,4S)-3,4-di-0-tert-B u ty I dim eth ylsily 1-1-ca r boxy benzyl-3,4-dihyd roxy-
pyrrolidine (313)106 
O~O~Ph 
16. 7 
N1 
TBDMSOQ •. '.OTBDMS 
H H 
To a solution of 312 (678 mg, 2.86 mmol) and dry pyridine (1.40 ml, 17.3 mmol) in 
dry DCM (40 ml) was added tert-butyldimethylsilyltrifluoro methanesulphonate (1.97 
ml, 8.60 mmol) at 0 °C. The reaction mixture was stirred under nitrogen for 75 min 
before TLC (100% ethyl acetate) showed consumption of starting material. The 
reaction mixture was washed with distilled water (20 m!) followed by 1 M aqueous 
HCI (20 m!) and again by distilled water (20 m!). The aqueous extracts were back-
extracted with DCM (20 m!) and the combined organic layers dried over MgS04, 
filtered and evaporated under reduced pressure to give a yellow oil. Purification by 
column chromatography (Si02, Hexane:ethyl acetate; 17:3) afforded (±)-(3S,4S)-3,4-
di-O-tert-butyldimethylsilyl-1-carboxybenzyl-3,4-dihydroxy-pyrrolidine 313 (922 
mg, 69%) as a colourless oil. Umax (thin film)/cm- 1 2952w, 2856w (ArC-H str), 1710s 
(C=O str); oH (400 MHz, CDCb) 7.35-7.30 (5H, m, 5 x Ar-C), 5.14 (2H, s, 7-CH2), 
3.97-3.95 (2H, m, 3 and 4-CH), 3.59-3.50 (2H, m, 2 and 5-C(H)H), 3.30-3.21 (2H, m, 
2 and 5-C(H)H), 0.85 (18H, s, 2 x SiC(CH3)3), 0.06 (12H, s, 2 x Si(CH3)2); Oc (100 
MHz, CDCb) 155.32 (6-C), 137.10 (iAr-C), 128.44, 127.84, 127.71 (5 x Ar-C), 
76.51, 75.75 (3 and 4-C), 66.68 (7-C), 52.37, 52.09 (2 and 5-C), 25.73, 25.71 
(SiC(~H3)3), 17.97, 17.94 (Si~(CH3)3), -4.69, -4.75, -4.78, 4.83 (OSi(~H3)2). 
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(±)-(3S,4S)-3,4-di-0-tert-Butyldimethylsilyl-3,4-dihydroxy-pyrrolidine (314)106 
To a solution of (±)-(3S,4S)-3,4-di-O-tert-butyldimethylsilyl-1-carboxybenzyl-3,4-
dihydroxy-pyrrolidine 313 (922 mg, 1.98 mmol) in dry MeOH (35 ml) was added 
palladium on carbon (1 0% wt Pd, 10 m g). The reaction mixture was stirred under a 
hydrogen atmosphere for 19 h. TLC (1:4 ethyl acetate:hexane) showed complete 
consumption of starting materiaL The mixture was filtered through a pad of Celite 
and the filtrate evaporated under reduced pressure to yield (±)-(3S,4S)-3,4-di-0-tert"7 
butyldimethylsilyl-3,4-dihydroxy-pyrrolidine 314 (545 mg, 83%) as a colourless oil. 
Umax (thin film)/cm-1 3342br (br N-H str), 2954w, 2982w, 2886w (C-H str); OH (400 
MHz, CDCh) 3.90-3.82 (2H, dd, J 1.6 and 3.2 Hz, 3 and 4-CH), 3.03 (2H, dd, J 3.2 
and 12.0 Hz, 2 and 5-C(!:DH), 2.60 (2H, dd, J 1.6 and 12.0 Hz, 2 and 5-C(H)H), 0.82, 
(ISH, s, SiC(Cfu)3), 0.01 (12H, s, Si(Cfu)2); oc (100 MHz, CDCh) 79.28 (3 and 4-
C), 54.08 (2 and 5-C), 25.85 (SiC(CH3)3), 25.78 (Si~(CH3)3), -4.69 (0Si~H3)2). 
(±)-(3S,4S)-3,4-di-O-tert-Butyldimethylsilyl-3,4-dihydroxy-1-pyrroline (315)106 
1 
N 
TBDMSOQ •. '.OTBDMS 
H H 
To a solution of 314 (545 mg, 1.65 mmol) in dry diethyl ether (30 ml) was added N-
chlorosuccinamide (241 mg, 1.80 mmol). The reaction mixture was stirred under 
nitrogen for 19 h. TLC (I :4 ethyl acetate:hexane) showed consumption of starting 
material. The reaction mixture was diluted with diethyl ether (30 ml) and washed with 
water (3 x 20 ml). The aqueous fractions were back-extracted with diethyl ether (2 x 
20 ml) and the combined organic fractions dried over Na2S04 and filtered to give a 
solution of (±)-(3S,4S)-3,4-di-O-tert-butyldimethylsilyl-1-chloro-3,4-
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dihydroxypyrrolidine. To this solution was added DBU (273 mg, 1.82 mmol). The 
reaction mixture was stirred under nitrogen for 4 h. The reaction mixture was filtered 
through a glass sinter funnel and the solvent removed in vacuo to yield an orange oil. 
Purification by column chromatography (Si02, Hexane:ethyl acetate; 17:3) afforded 
(±)-(3S,4S)-3,4-di-O-tert-butyldimethylsilyl-3,4-dihydroxy-l-pyrroline 315 (182 mg, 
34%) as an orange oil. Umax (thin film)/cm"1 2954s, 2856s (C-H str), 1650m (C=N str); 
8H (400 MHz, CDCl3) 7J8 (IH, d, J 5.0 Hz, 2-CH), 4.42-4.45 (IH, dd, J 5.0 and 3.0 
Hz, 3-CH), 4.09-4.00 (IH, m, 4-CH), 3.87 (IH, dd, J 3.2 and 12.0 Hz, 5-C{H)H), 
3.45-3.37 (IH, m, 5-C(H)H), 0.78 (ISH, s, 2 x SiC(C.fu)3), 0.00 (12H, s, 4 x 
Si(C.fu)2); 8c (100 MHz, CDCh) 168.57 (2-C), 85.56 (3-C), 79.21 (4-C), 67.00 (5-C), 
25.77, 25.75 (2 X SiC(£H3)3), 18.08, 17.98 (2 X Si.C.(CH3)3), -4.59, -4.61, -4.66,-
4.879 ( 4 X Si(£H3)2). 
(±)-(3S,4R)-1-Carboxybenzyl-3,4-dihydroxypyrrolidine (317)106 
O~O~Ph 
16. 7 
QN 1 2 4 3 
HO : : OH 
H H 
To a solution of tert-butyl alcohol and distilled water (I: I; 30 ml) was added AD-
mix-~ ( 1.40 g) and the two phase mixture stirred at room temperature for 5 min. 
Methane sulphonamide (250 mg, 2.63 mmol) was added and the mixture cooled to 0 
oc. To this solution was added 1-carboxyybenzyl-3-pyrroline 310 (500 mg, 2.46 
mmol) and the reaction mixture stirred for 19 h. Sodium sulfite ( 1.50 g, 14.6 mmol) 
was added to give a brown solution and the reaction mixture warmed to room 
temperature. The mixture was partitioned with DCM (30 ml) and the aqueous layer 
re-extracted with DCM (3 x 15 ml). The organic layers were combined and washed 
with aqueous 2 M KOH (30 ml) and the organic layer dried over MgS04 and 
evaporated under reduced pressure to give a colourless oil. Purification by column 
chromatography (Si02, I 00% ethyl acetate) gave (±)-(3S,4R)-1-carboxybenzyl-3,4-
dihydroxypyrrolidine 317 (229 mg, 73%) as a colourless oil. Umax (thin film)/cm· 1 
3405br (O-H str), 3032w (C-H str), 2951 w, 2887w (C-H str), 1683s (C=O str); 8H 
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(400 MHz, CDCb) 7.33-7.27 (5H, m, 5 x Ar-CH), 5.08 (2H, 2 x s, 7-CH2), 4.14 (2H, 
s, br, 3 and 4-CH), 4.00 (IH, br s, OH), 3.77 (1H, br s, OH), 3.58-3.55 (2H, m, 2 and 
5-C(H)H), 3.41-3.36 (2H, m, 2 and 5-C(H)H); oc (100 MHz, CDCb) 155.24 (6-C), 
136.48 (iAr-C), 128.50, 128.08, 127.84 (5 x Ar-C), 71.11, 70.39 (3 and 4-C), 67.09 
(7-C), 50.48, 50.34 (2 and 5-C). 
(±)-(3S,4R)-3,4-di-O-tert-Butyldimethylsilyl-1-carboxybenzyl-3,4-
dihydroxypyrrolidine (318)106 
O~O~Ph 
16. 7 
N' 
TBDMSO~OTBDMS 
H H 
To a solution of 317 (1.50 g, 6.33 mmol) and dry pyridine (3.07 ml, 37.9 mmol) in 
dry DCM (90 ml) was added tert-butyldimethylsilyltrifluoro methanesulphonate (4.35 
ml, 19.0 mmol) at 0 °C. The reaction mixture was stirred under nitrogen for 75 min. 
TLC (1 00% ethyl acetate) showed consumption of starting material. The reaction 
mixture was washed with distilled water (30 ml) followed by 1 M aqueous HCI (30 
ml) and again by distilled water (30 m1). The aqueous fractions were back-extracted 
with DCM (30 ml) and the combined organic layers dried over MgS04, filtered and 
evaporated under reduced pressure to give a ~yellow oil. Purification by column 
chromatography (Si02, Hexane:ethyl acetate; 17:3) afforded (±)-(3S,4R)-3,4-di-0-
tert-butyldimethylsilyl-l-carboxybenzyl-3,4-dihydroxy-pyrrolidine 318 (2.04 g, 70%) 
as a colourless oil. Umax (thin film)/cm-1 2955w, 2851 w (ArC-H str), 1711 s (C=O str); 
811 (400 MHz, CDCb) 7.29-7.18 (5H, m, 5 x Ar-CH), 5.06 (2H, s, 7-CH2), 4.02-4.00 
(2H, m, 3 and 4-CH), 3.41-3.39 (2H, m, 2 and 5-C(H)H), 3.30-3.25 (2H, m, 2 and 5-
C(H)H), 0.84 ( 18H, s, 2 x SiC(CH3)3), 0.02 (6H, s, Si(CH3)2), 0.0 I (6H, s, Si(CH3)z); 
Oc (100 MHz, CDCb) 155.15 (6-C), 136.98 (iAr-C), 128.45, 127.90, 127.84 (5 x Ar-
C), 72.64, 72.05 (3 and 4-C), 66.73 (7-C), 50.80, 50.64 (2 and 5-C), 25.84, 25.70, 
25.66 (2 X SiC(~H3h), 18.23, 18.22 (2 X Si~(CH3h), -4.55, -4.59, -4.83, -4.99 (4 X 
0Si(~H3)z). 
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(±)-(3S,4R)-3,4-di-0-tert-Butyldimethylsilyl-3,4-dihydroxypyrrolidine (319)106 
H 
N TBDMSO~OTBDMS 
To a solution of (±)-(3S,4R)-3,4-di-0-tert-butyldimethylsilyl-1-carboxybenzyl-3,4-
dihydroxy-pyrrolidine 318 (1.02 g, 2.19 mmol) in dry MeOH (30 ml) was added 
palladium on carbon (10% wt Pd, 100 mg). The reaction mixture was stirred under a 
hydrogen atmosphere for 19 h. TLC (1 :4 ethyl acetate:hexane) showed complete 
consumption of starting material. The mixture was filtered through a pad of Celite 
and the filtrate evaporated under reduced pressure to yield (±)-(3S,4R)-3,4-di-O-tert-
butyldimethylsilyl-3,4-dihydroxy-pyrrolidine 319 (595 mg, 82%) as a colourless oil. 
Umax (thin film)/cm-1 3403br (br N-H str), 2926w, 2855w, 2882w (C-H str); OH (400 
MHz, CDCh) 3.97-3.95 (2H, m, 3 and 4-CH), 2.90-2.81 (2H, m, 2 and 5-C(H.)H), 
2.79-2.75 (2H, m, 2 and 5-C(H)H), 0.84 (ISH, s, 2 x SiC(Cfu)J), 0.02 (6H, s, 
(Si(Cfu)2), 0.01 (6H, s, (Si(CH3)2); Oc (100 MHz, CDCh) 74.06 (3 and 4-C), 51.57 (2 
and 5-C), 26.09, 25.98, 25.94, 25.87, 25.78, 25.74 (2 x SiC(CH3)3), 18.32, 18.28 (2 x 
Si~(CHJ)J), -4.51, -4.80, -4.85, -5.08 (4 X 0Si(~H3)2). 
(± )-(38,4 R)-3,4-di-0-tert-Bu tyldimethylsilyl-3,4-dihydroxy-1-pyrroline (320) 106 
1 
N TBDMSO~OTBDMS 
To a solution of 344 ( 1.13 g , 3.41 mmol) in dry diethyl ether (60 ml) was added N-
chlorosuccinamide (566 mg, 1.99 mmol). The reaction mixture was stirred under 
nitrogen for 19 h. TLC ( 1:4 ethyl acetate:hexane) showed consumption of starting 
material. The reaction mixture was diluted with diethyl ether (30 ml) and washed with 
water (3 x 20 ml). The aqueous fractions were back-extracted with diethyl ether (2 x 
20 ml) and the combined organic fractions dried over Na2S04 and filtered to give a 
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solution of ( ± )-(3 S,4 R)-3 ,4-di-0-tert -butyldimethylsilyl-1-chloro-3,4-
dihydroxypyrrolidine. To this solution was added DBU (0.74 ml, 4.93 mmol). The 
reaction mixture was stirred under nitrogen for 4 h. The reaction mixture was filtered 
through a glass sinter funnel and the solvent removed in vacuo to yield an orange oil. 
Purification by column chromatography (Si02, Hexane:ethyl acetate; 17:3) afforded 
(±)-(3 S,4R)-3,4-di-O-tert-butyldimethylsilyl-3,4-dihydroxy-1-pynoline 320 (373 mg, 
33%) as an orange oil. Umax (thin film)/cm-1 2952w, 2853w (C-H str), 1652m (C=N 
str); 8H (400 MHz, CDCb) 7.50 (1H, d, J 5.0 Hz, 2-CH), 4.40-4.37 (1H, m, 3-CH), 
4.14-4.11 (IH, m, 4-CH), 3.81-3.75 (IH, m, 5-C{H)H), 3.69-3.60 (1H, m, 5-C(H)H), 
0.82 {9H, S, {SiC{CH3)3), 0.80 {9H, S, {SiC{CH3)3), 0.09 {12H, S, 4 X Si{CH3)2); be 
(100 MHz, CDCb) 169.13 (2-C), 81.53 (3-C), 71.87 (4-C), 67.49 (5-C), 26.07, 25.99, 
25.97, 25.92, 25.85, 25.68 (2 X SiC~H3)3), 18.23, 18.15 (2 X SiC(CH3)3), -4.32, -
4.39, -4.50, -4.61 (4 X Si(h.H3)2). 
4-(tert-Butyl-dimethyl-silanyloxy)-piperidine (323) 
OTBDMS 
To a stirred solution of 4-hydroxypiperidine (1.00 g, 9.89 mmol) in DCM (50 ml), 
was added pyridine (2.4 ml, 29.6 mmo1) and TBDMSOTf (3.5 ml, 14.8 mmol). The 
reaction mixture was stirred at ooc for 24 h under a nitrogen atmosphere. The solvent 
was evaporated under reduced pressure to give a pale yellow oil. Purification by 
column chromatography (Si02, 40-60 P.E:ethyl acetate; 2:1) afforded the protected 
piperidine 323 (1.5 g, 71%) as a colourless oil. Umax (thin film)/cm-1 3499s (N-H str), 
2955m, 1615m (N-H bend), 1471m, 1259s, 1169s, 1030s; OH (CDCb, 400 MHz) 
4.05-4.00 (I H, m, 4-CH), 3.35-3.27 (2H, m, 6-C(H)H and 2-C(H)H), 3.22-3.16 (2H, 
m, 6-C(H)H and 2-C(H)H), 2.00-1.89 (2H, 5-C(H)H and 3-C(H)H), I. 72-1.61 (2H, 
m, 5-C(H)H and 3-C(H)H), 0.82 (9H, s, SiC(Cfu)J), 0.00 (6H, s, Si(Cfu)2); 8c (I 00 
M~z, CDCb) 62.51 (4-C), 40.43 (2-C and 6-C), 30.32 (3-C and 5-C), 25.69 
(SiC(~H3)3), 17.90 (SiQCH3)J), -4.72, -5.06 (Si(CH3)2); mlz (El+) HRMS found 
216.1777 [M+Ht, [C11 H2sNOSi+Ht requires 216.1778. 
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5-0xopyrrolidine-1,2-dicarboxylic acid-1-tert-butyl ester-2-ethyl ester (328)112 
To a stirred solution of ethyl-(s)-(+)-2-pyrrolidinone-5-carboxylate (1.25 g, 7.95 
mmol) in DCM (25 ml) was added di-tert-butyl dicarbamate (2.09 g, 9.54 mmol) and 
DMAP (1 00 m g). The reaction mixture was stirred for 24 h under a nitrogen 
atmosphere resulting in a yellow solution. This was evaporated under reduced 
pressure and the yellow oil filtered through a plug of silica ( 100% ethyl acetate) 
affording the lactam carbamate 328 (1.85 g, 91%) as a colourless oil. [a]0 20 +27.5 (c 
0.0112 in CHCb); Umax (thin film)/cm-1 2978w, 2940w (C-H str), 1792s, 1750s, 
1712s (C=O str), 1340m, 1312s (C-0), 1157s; oH (400 MHz, CDCb) 4.54-4.51 (lH, 
dd, J 3.3 and 10.0 Hz, 5-CH), 4.16 (2H, q, J 7Hz, OCfuCH3), 2.57-2.52 (1H, m, 3-
C(H.)H), 2.45-2.39 (IH, m, 3-C(H)H), 2.30-2.26 (IH, m, 4-C(H)H), 1.98-1.89 (lH, m, 
4-C(H)H.), 1.49 (9H, s, C(CH3)3), 1.22 (3H, t, J 7 Hz, OCH2C!:b); 8c (1 00 MHz, 
CDCb) 173.4 (O(C=O)N), 171.3 (C=O ester), 149.2 (2-C=O), 83.4 (~(CH3)3), 61.6 
(OCH2CH3), 58.9 (5-C), 33.0 (3-C), 28.0, 27.8, 27.6 (C(CH3)3), 21.4 (4-C), 14.1 
(OCH2CH3). 
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5-0xopyrrolidine-1,2-dicarboxylic acid-1-tert-butyl ester-2-methyl ester (332)112 
0 Bocjj, 
Me02C [ 4 . 
H 
To a stirred solution of methyl-(s)-(+)-2-pyrrolidinone-5-carboxylate (1.00 g, 6.99 
mmol) in DCM (25 ml) was added di-tert-butyl dicarbamate (1.83 g, 8.38 mmol) and 
DMAP (1 00 mg). The reaction mixture was stirred for 24 h under a nitrogen 
atmosphere resulting in a yellow solution. This was evaporated under reduced 
pressure and the yellow oil filtered through a plug of silica (I 00% ethyl acetate) 
affording the lactam carbamate 332 (1.65 g, 95%) as a white, waxy solid. mp 70.8-
71.40C [lit mp 7l-73°C]; 21.5 (4-C); [a]0 20 +40.4 (c 0.0110 in CHCh); Umax (thin 
film)/cm-1 1792s, 1748s, 1714s (C=O str), 1370m, 1314s (C-0), 1257m, 1211m, 
1152s; oH (400 MHz, CDCh) 4.65-4.62 (1H, dd, J3.0 and 9.5 Hz, 5-CH), 3.79 (3H, s, 
OMe), 2.66-2.59 (1H, m, 3-C(IDH), 2.54-2.51 (1H, m, 3-C(H)ill, 2.38-2.32 (IH, m, 
4-C(H)H), 2.07-2.04 (IH, m, 4-C(H)H), 1.49 (9H, s, C(CH3)3); Oc (100 MHz, CDCh) 
173.4 (O(C=O)N), 171.9 (C=O ester), 149.2 (2-C=O), 83.6 (C(CH3)3), 58.8 (5-C), 
52.6 (O~H3), 31.1 (3-C), 27.9 (C(CH3)3). 
2-0xo-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester (333) 112 
6 4 7ax5 3 
I 2 
8 // 
1o N 0 
9 I 1 
Boc 
To a stirred solution of3,4-dihydro-2(1H)-quinolinone (500 mg, 3.40 mmol) in DCM 
(20 ml) was added di-tert-butyl dicarbamate (891 mg, 4.08 mmol) and DMAP (50 
mg). The reaction mixture was stirred for 24 h under a nitrogen atmosphere resulting 
in a yellow solution. This was evaporated under reduced pressure and the yellow oil 
filtered through a plug of silica (100% ethyl acetate) affording the lactam carbamate 
333 (900 mg, 100%) as a colourless oil. Umax (thin film)/cm-1 2976w, 2938w (C-H 
181 
str), I79Is, I75Is, I7I8s (C=O str), 1336m, 1313s (C-0), II57s; 8H (400 MHz, 
CDCh) 7.I8-7.08 (2H, m, 9-CH and 6-CH), 7.02-6.96 (IH, m, 8-CH), 6.89-6.85 (IH, 
d, J 7 Hz, 7-CH), 2.90-2.85 (2H, m, 3-CH2), 2.6I-2.57 (2H, m, 4-CH2), 1.53 (9H, s, 
C(CH3)3); 8c (IOO MHz, CDCh) I69.3 (2-C), I51.8 (C=O ester), 137.I (10-C), I28.0 
(6-C), I27.3 (8-C), I25.9 (5-C), I24.1 (7-C), II7.0 (9-C), 85.0 (£(CH3)3), 32.3 (3-C), 
27.7 (C(£H3)3), 25.5 (4-C). 
2,3-Dihydropyrrole-1-carboxylic acid tert-butyl ester (334) 112 
soc.........._01 2 
N ~ 3 
5 
4 
To a stirred solution of 1-(tert-butoxycarbonyl)-2-pyrrolidinone (500 mg, 2.80 mmol) 
in dry toluene (20 m!) at -78°C, was carefully added Super Hydride (3.II m!, 3.IO 
mmol, I M in THF). After stirring under a nitrogen atmosphere for I h, 
diisopropylethylamine (2.8I ml, I6.0 mmol), a catalytic amount of DMAP (6 mg, 
0.04 mmol) and trifluoroacetic anhydride (0.48 m!, 3.36 mmol) were sequentially 
added. The reaction mixture was allowed to warm up to room temperature, and stirred 
for 2 h. Distilled water (20 m!) was added to the reaction, the organic layer separated, 
and washed with further portions of distilled water (2 x 20 m!). The organic fraction 
was dried over MgS04 and evaporated under reduced pressure to give a yellow oil. 
Purification by column chromatography (Si02, 40-60 P.E:ethyl acetate; 6:1) afforded 
the enecarbamate 334 (300 mg: 66%) as a colourless oil. Umax (thin film)/cm-1 2974m, 
2930m, 2863m (C-H str), 1702s, (C=O str), 1617m (C=C str), 14 77m, l450m, 1134s 
(C-0); 8H (400 MHz, DMSO, lOO 0 C) 6.45 (IH, m, 3-CH), 4.91 (IH, m, 2-CH), 
3.68-3.57 (2H, m, 4-CH2), 2.62-2.50 (2H, m, 5-CH2), 1.41 (9H, s, C(CH3)3); 8c (I 00 
MHz, CDCh) 151.6 (C=O), 129.8 (2-C), I 07.5 (3-C), 80.0 (~(CH3)3), 44.7 (5-C), 
28.7 (4-C), 28.4 (C(~H3)3). 
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2,3-Dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
(335)112 
BocD1 2 N ~ 
3 
5 
Me02C ~ 4 
H 
To a stirred solution oflactam carbamate 332 (2.91 g, 12.6 mmol) in dry toluene (50 
ml) at -78°C, was carefully added Super Hydride™ (13.9 ml, 13.9 mmol, 1.0 M in 
THF). After stirring under a nitrogen atmosphere for 1 h, diisopropylethylamine (12.5 
ml, 71.8 mmol), a catalytic amount of DMAP (30 mg, 0.20mmol) and trifluoroacetic 
anhydride (2.15 ml, 15.1 mmol) were sequentially added. The reaction mixture was 
allowed to warm up to room temperature, and stirred for 2 h. Distilled water (30ml) 
was added to the reaction, the organic layer separated, and washed with further 
portions of distilled water (2 x 30 ml). The organic fraction was dried over MgS04 
and evaporated under reduced pressure to give a yellow oil. Purification by column 
chromatography (Si02, 40-60 P.E:ethyl acetate; 10:1) afforded the enecarbamate 335 
(2.00 g, 70%) as a colourless oil. [a]0 20 +81.2 (c 0.0104 in CHCb); Umax (thin 
film)/cm-1 2976m, 2932m, 2876m (C-H str), l755s, l703s (C=O str), 1623m (C=C 
str), l402s, 1367s, 1204s, 1180s, 1137s; ()H (400 MHz, DMSO, 100 °C) 6.53 (1H, m, 
2-CH), 5.00 (1H, m, 3-CH), 4.62-4.57 (1H, dd, J 4.6 and 11.7 Hz, 5-CH), 3.70 (3H, s, 
OMe), 3.10-3.02 (IH, m, 4-C(H)H), 2.62-2.55 (IH, m, 4-C(H)H), 1.43 (9H, s, 
C(CH3)3); <>c (1 00 MHz, CDCh) 172.1 (O(C=O)N), 151.0 (C=O ester), 130.1 (2-C), 
105.9 (3-C), 80.7 (C(CH3)3), 58.5 (5-C), 52.2 (O~H3), 34.9 (4-C), 28.4 (C~H3)3). 
183 
2,3-Dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester (336)112 
To a stirred solution oflactam carbamate 328 (1.70 g, 6.90 mmol) in dry toluene (30 
ml) at -78°C, was carefully added Super Hydride™ (7.60 ml, 7.60 mmol, I M in 
THF). After stirring under a nitrogen atmosphere for I h, diisopropylethylamine (6.90 
ml, 39.6 mmol), a catalytic amount ofDMAP (20 mg, 0.13 mmol) and trifluoroacetic 
anhydride (I.20 ml, 8.43 mmol) were sequentially added. The reaction mixture was 
allowed to warm up to room temperature, and stirred for 2 h. Distilled water (30 ml) 
was added· to the reaction, the organic layer separated, and washed with further 
portions of distilled water (2 x 30 ml). The organic fraction was dried over MgS04 
and evaporated under reduced pressure to give a yellow oil. Purification by column 
chromatography (Si02, 40-60 P.E:ethyl acetate; IO: I) afforded the enecarbamate 336 
(1.13 g, 72%) as a colourless oil. [a]0 20 +I09.I (c O.Oil in CHCh); Umax (thin 
film)/cm-1 2977m, 2933m, 2867m (C-H str), I753s, I707s (C=O str), I623m (C=C 
str), I478m, I456m, I404s, 1386m, I133s, II93s, II35s; oH (400 MHz, DMSO-d6, 
100 °C) 6.54 (IH, m, 2-CH), 5.00 (IH, m, 3-CH), 4.59-4.55 (IH, dd, J 4.7 and Il.8 
Hz, 5-CH), 4.20-4.I4 (2H, q, J 7Hz, OCHzCH3), 3.II-3.02 (I H, m, 4-C(H)H), 2.6I-
2.54 (1 H, m, 4-C(H)H.), 1.45 (9H, s, C(CH3)3), 1.24 (3H, t, J 7 Hz, OCHzCH3); oc 
(I 00 MHz, CDCh) I71.6 (O(C=O)N), 151.3 (C=O ester), I30.I (2-C), I 05.8 (3-C), 
80.6 (C(CH3)3), 61.0 (OCHzCH3), 58.5 (5-C), 35.0 (4-C), 28.4 (C(~H3)3 ), I4.3 
(OCHz~H3). 
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4H-Quinoline-1-carboxylic acid tert-butyl ester (337)112 
6 4 
7CO~s 
1
3 
8 ~ 1 2 
10 N 
9 I 
Boc 
To a stirred solution oflactam carbamate 333 (1.70 g, 6.90 mmol) in dry toluene (30 
ml) at -78°C, was carefully added Super Hydride™ (7.60 ml, 7.60 mmol, I M in 
THF). After stirring under a nitrogen atmosphere for I h, diisopropylethylamine (6.90 
ml, 39.6 mmol), a catalytic amount ofDMAP (20 mg, 0.13 mmol) and trifluoroacetic 
anhydride (I.20 ml, 8.43 mmol) were sequentially added. The reaction mixture was 
allowed to warm up to room temperature, and stirred for 2 h. Distilled water (30 ml) 
was added. to the reaction, the organic layer separated, and washed with further 
portions of distilled water (2 x 30 ml). The organic fraction was dried over MgS04 
and evaporated under reduced pressure to give a yellow oil. Purification by column 
chromatography (Si02, 40-60 P.E:ethyl acetate; IO: I) afforded the enecarbamate 337 
(1.13 g, 72%) as a colourless oil. Umax (thin film)/cm-1 2975w, 2929w (C-H str), 
I714s (C=O str), I664 (C=C str), 1488m, 1368s, 1340s (C-0); 8H (400 MHz, CDCb) 
7.82 (IH, d, 17Hz, 9-C), 7.15-7.08 (lH, m, 7-CH), 7.00-6.96 (2H, m, 6-CH and 8-
CH), 6,84-6.80 (IH, dt, 17Hz and 0.8 Hz 2-CH), 5.21-5.I8 (lH, m, 3-CH), 3.26-3.23 
(2H, m, 4-CH2), 1.53 (9H, s, C(CH3)3); 8c (lOO MHz, CDCb) 151.7 (C=O ester), 
137.0 (10-C), 128.2 (6-C), 128.0 (5-C), 127.3 (2-C), 126.1 (8-C), 124.5 (7-C), 121.8 
(9-C), l 08.6 (3-C), 81.9 (.G(CH3)3), 28.3 (C(CH3)3), 27.6 ( 4-C). 
Formation of imines 272, 338, 339 and 340 from enecarbamates 334, 335, 336 
and 337.111 
To a stirred solution of enecarbamate 334, 335, 336 or 337 (2.16 mmol) and 
triethylamine (21.6 mmol) in DCM (10 ml) at -78°C was added TMSOTf (15.1 
mmol) dropwise. The reaction was warmed to -20°C and stirred under an atmosphere 
of nitrogen for 2 h. The reaction was quenched with saturated NaHC03(aq> (2 ml) at -
78°C. The reaction mixture was allowed to warm to room temperature and the 
organic layer separated. The organic layer was washed with saturated aqueous 
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NaHC03 (2 ml) and brine (2 ml), dried over Na2S04, evaporated under reduced 
pressure to give a yellow residue containing the cyclic imine, which was used without 
further purification. 
3-Vinylhexahydropyrrolizine-1,1,5-tricarboxylic acid 5-ethyl ester 1,1-dimethyl 
ester (341) 
C02Me 
To a stirred solution of imine 339 (132 mg, 0.94 mmol) in DCM (10 ml) was added 
zinc bromide (106 mg, 0.47 mmol). The reaction mixture was stirred for IO min in 
which time the zinc bromide dissolved. The solvent was evaporated under reduced 
pressure to give the imine complex as an oily residue. This residue was dissolved in 
anhydrous DMSO (2 ml) and added to a stirred solution ofvinylcyclopropane 29I (86 
mg, 0.47 mmol) and tetrakis(triphenylphosphine) palladium(O) (32 mg, 0.027 mmol) 
in anhydrous DMSO (2 ml). The reaction was stirred for 17 h at 80°C under a 
nitrogen atmosphere. The reaction mixture was diluted with distilled water (I 0 ml) 
and extracted with ethyl acetate (2 x I5 m1). The combined organic fractions were 
washed with water (3 x 20 ml) and brine (3 x 20 ml), the organic was then dried over 
MgS04, and the solvent evaporated under reduced pressure to give an orange oil. 
Purification by column chromatography (Si02, 40-60 P.E:ethyl acetate; 6: I) afforded 
the pyrrolizine 341 (15 mg, I 0%) as an orange oil. Umax (thin film)/cm- 1 2917w, 
2848w (C-H str), 1732s (C=O str), I682 (C=C str); 8H (400 MHz, CDCb) 5.68-5.62 
(IH, m, 9-CH), 5.13-5.09 (lH, m, 10-C(H)H), 4.97-4.92 (IH, m, 10-C(H)H), 4.42-
4.39 (I H, m, 5-CH), 4.10-4.00 (2H, q, J 7.0 Hz, OCfuCH3), 3.67, 3.66 (6H, 2 x s, 2 
x OCH3), 3.57-3.49 (I H, m, 3-CH), 3.42-3.37 (I H, t, J 12.7 Hz, 8-CH), 2.65-2.57 
(IH, dd, J 5.8 and 13.6 Hz, 2-C(H)H), 2.22-2.10 (2H, m, 2-C(H)H and 7-C(H)H), 
2.02-1.90 (2H, m, 7-C(H)H and 6-C(H)H), 1.45-1.39 (I H, m, 6-C(H)H); 8c (I 00 
MHz, CDCb) I78.3, I78.0 (2 x C=O), 165.5 (C=O), I38.3 (9-C), II6.6 (I 0-C), 70.1 
(1-C), 68.7 (5-C), 66.9 (8-C), 61.9 (CH3.CH20), 54.1 (3-C), 53.9, 53.8 (2 x OCH3), 
41.2 (2-C), 31.5 (6-C), 29.8 (7-C), 13.5 (.CH3CH20); m/z (FAB+) 326 (86), 252 (92), 
186 
154 (37), 149 (38), 136 (34), 109 (31), 97 (34), 95 (48), 91 (36), 83 (44), 81 (51), 71 
(40), 69 (76), 67 (44), 57 (97), 55 (100), 43 (38), 41 (32); HRMS found 326.1606 
[M+Ht, [C16H23N06+Ht requires 326.1604 ; [ a]o 20 +6.8 ( c 0.011 in CHCb). 
General Procedure for the preparation of2-methyl-4,5-dihydro-1,3-oxazoles 376, 
377, 378,379,380 and 399!26 
A solution ofthe appropriate amino alcohol (1.0 equiv.) in DCM (50 ml) was added 
dropwise to a stirred solution of ethyl iminoacetate hydrochloride (1.1 equiv.) or a-
phenylacetimidate hydrochloride 398 (1.1 equiv.) in DCM at 0°C. After complete 
addition, the mixture was stirred at room temperature for 24 h and then washed with 
water, dried and the solvent evaporated under reduced pressure. Oxazoles were 
obtained as viscous oils. 
(4S)-4-Benzyl-2-methyl-4,5-dihydro-1,3-oxazole (376)126 
---Ph 
From (2S)-2-amino-3-phenylpropan-l-ol (phenylalaninol) (2.93 g, 19.4 mmol). 
Oxazole 376 was isolated as a colourless oil (2.34 g, 69%). IR (neat/cm-1) 1673s 
(C=N), 1497w, 1454w, 1386m, 1229s; oH (400 MHz, CDCb) 7.32-7.19 (5H, m, Ar-
CH), 4.40-4.32 (IH, m, 4-CH), 4.19-4.15 (IH, t, J 8.4 Hz, 5-C(H)H), 3.95-3.91 (IH, 
dd, J 8.2 and 8.4 Hz, 5-C(H)H), 3.08 (1H, dd, J 5.4 and 13.7 Hz, PhC(H)H), 2.65 
(1 H, dd, J 8.3 and 13.7 Hz, PhC(H)H), 1.97 (s, 3H); oc (75 MHz, CDCh): 165.00 (2-
C), 138.03 (iAr-C), 129.16 (oAr-C), 128.52 (mAr-C), 126.46 (pAr-C), 71.82 (5-C), 
67.44 (4-C), 41.80 (6-C), 13.93 (7C); [a]D20 -44.0 (c 5.6 in CHCh) [lit. [a]D20 -47.9 (c 
5.6 in CHCb)]. 
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4-Isopropyl-2-methyl-4,5-dihydro-1,3-oxazole (377)126 
1 
6 ----4?y' 4 9 
N 7 
3 
8 
From 2-amino-3-methylbutan-1-ol (valinol) (2.0 g, 19.4 mmol). Oxazole 377 was 
isolated as a colourless oil (1.48 g, 60%). IR (neat/cm-1) 1677 (C=N), 1386, 1230; 8H 
(400 MHz, CDCh) 4.22 (IH, dd, J 7.8 and 9.3 Hz, 5-C(H)H), 3.93-3.82 (2H, m, 5-
C(H)H and 4-CH), 1.97 (3H, d, J 1.5 Hz, 6-CH3), 1.72 (lH, dt, J 13.2, 6.8 Hz, 7-CH), 
0.97 (3H, d, J 6.8 Hz, 8-CH3), 0.88 (3H, d, J 6.8 Hz, 9-CH3). 8c (75 MHz, CDCh) 
164.3 (2-C), 72.4 (5-C), 70.3 (4-C), 32.7 (6-C), 18.8 (8-C), 18.3 (9-C), 13.8 (7-C). 
( 4S)-4-(2-methy1propyl)-2-methyl-4,5-dihydro-1 ,3-oxazole (378) 126 
From (R)-leucinol (2.27 g, 19.4 mmol). Oxazole 378 was isolated as a colourless oil 
(1.09 g, 40%). IR (neat/cm-1) 2958m (C-H), 1676s (C=N), 1386s (C-0), 1226s, 
I 044m, 984s, 905m; 8u (300 MHz, CDCb) 4.31 (I H, dd, J 8.0, 9.3 Hz, 5-C(H)H), 
4.15-4.09 (IH, m, 4-CH), 3.77 (IH, t, J 8.0 Hz, 5-C(H)H), 1.96 (3H, d, J 1.3 Hz, 6-
CH3), 1.84-1.71 (IH, m, 8-CH), 1.62-1.53 (IH, quintet, J 8.8 and 9.3 Hz, 7-C(H)H), 
1.27 (IH, dt, J 13.4 and 7.3 Hz, 7-C(H)H), 0.94 (6H, 2 x d, J 4.6 and 6.7 Hz, 9-CH3 
and 10-CH3); 8c (75 MHz, CDCb) 164.24 (2-C), 73.12 (5-C), 64.68 (4-C), 45.66 (6-
C), 25.41 (7-C), 22.88 (9-C), 22.55 (10-C), 13.96 (8-C); [a]o20 -103.8 (c 1.04 in 
CHCb). 
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(4R)-4-Phenyl-2-methyl-4,5-dihydro-1,3-oxazole (379)126 
6 0 
')'~H 
From (R)-phenylglycinol (2.66 g, 19.4 mmol). Oxazole 379 was isolated as a 
colourless oil (2.65 g, 85%). IR (neat/cm-1) 1684s (C=N); DH (400 MHz, CDCh) 7.36-
7.25 (5H, m, Ar-CH), 5.18-5.14 (1H, m, 4-CH), 4.60 (IH, dd, J 8.3, 10.3 Hz, 5-
C(H)H), 4.08 (IH, t, J 8.3 Hz, 5-C(H)H.), 2.09 (3H, d, J 1.5 Hz, 6-CH3); De (75 MHz, 
CDCh): 165.79 (2-C), 142.40 (7-C), 128.71 (8-C), 127.51 (10-C), 126.53 (9-C), 
74.66 (4-C), 69.78 (5-C), 13.91 (6-C); [a]0 20 +85.2 (c 1.60 in CHCb) [lit. [a]0 20 +98.2 
(c 1.66 in CHCh)]. 
(± )-4-Ethyl-2-methyl-4,5-dihydro-1 ,3-oxazole (380)126 
s~:z__o s 
N 4 
3 
7 
8 
From 2-aminobutan-1-ol (2.19 g, 19.4 mmol). Oxazole 380 was isolated as a 
colourless oil (0.78 g, 45%).1R (neat/cm-1) 1670s (C=N); oH (400 MHz, CDCh) 4.31-
4.26 (IH, dd, J 8.0 and 8.2 Hz, 5-C(H)H), 4.03-3.95 (I H, m, 4-CH), 3.83 (I H, t, J 8.1 
Hz, 5-C(H)H), 1.97 (3H, d, .11.5 Hz, 6-CH3), 1.69-1.58 (IH, m, 7-C(H)H), 1.55-1.44 
(1 H, m, 7-C(H)H), 0.95 (3H, t, .17.3 Hz, 8-CH3); oc (75 MHz, CDCb) 164.43 (2-C), 
72.19 (5-C), 67.72 (4-C), 28.65 (6-C), 13.89 (7-C), 10.06 (8-C). 
General Procedure for the Se02-Promoted Oxidative Rearrangement to 
oxazinones 381, 382, 383, 384, and 385.124 
A solution of oxazoline ( 1.0 equiv.) in dry dioxane (50 ml) was added to a 
suspension of selenium dioxide (1.2 equiv.) in dioxane (50 ml), and the mixture was 
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heated at reflux for 2 h. The mixture was cooled, and the yellow reaction mixture 
decanted from the selenium residue. The mixture was evaporated under reduced 
pressure, to give a yellow oil. Purification by column chromatography (Si02• iso-
hexane:ethyl acetate, 4:1) afforded oxazinones 381, 382, 383, 384, 385 and 396 (20-
65%) as colourless oils. 
(5S)-5-Benzyl-5,6-dihydro-2H-1,4-oxazin-2-one (381)124 
4 
7 HtN:t / ...... 5 ~ 
Ph 2 
6 
0 0 
1 
From ( 4S)-4-benzyl-2-methyl-4,5-dihydro-l ,3-oxazole 376 ( 1.80 g, I 0.5 mmol). 
Oxazinone 381 was isolated as an orange oil (1.19 g, 60%). IR (neat/cm"1) 2987,2972 
(C-H str), 1742 (C=O), 1651 (C=N); 8H (300 MHz, CDCh) 7.88 (IH, d, 12.4 Hz, 3-
CH), 7.38-7.30 (6H, m, Ar-CH), 4.37 (IH, dd, J 4.4 and 11.7 Hz, 6-C(H)H); 4.18 
(IH, dd, J 7.8 and 11.7 Hz, 6-C(H)H), 4.08-4.02 (IH, m, 5-CH), 3.17 (IH, dd, J 5.9 
and 14.2 Hz, 7-C(H.)H), 2.77 (IH, dd, J 8.8 and 14.2 Hz, 7-C(H)H.); 8c (75 MHz, 
CDCh): 154.35 (2C), 152.57 (3C), 136.58 (iAr-C), 129.18 (oAr-C), 128.86 (mAr-C), 
127.18 (pAr-C), 68.59 (5C), 57.77 (6C), 37.76 (7C); [a]020 +116 (c 0.15 in CHCh) 
[lit. [a]020 +112 (c 0.15 in CHCb)]. 
(± )-5-Isopropyl-5,6-dihyd ro-2H-1 ,4-oxazin-2-one (382) 12"' 
·lx~x 
0 0 
1 
From 4-isopropyl-2-methyl-4,5-dihydro-1 ,3-oxazole 377 ( 1.33 g, I 0.5 mmol). 
Oxazinone 382 was isolated as an orange oil (0.88 g, 60%). IR (neat/cm-1) 1746 
(C=O), 1630 (C=N); 8H (400 MHz, CDCI3) 7.90 (1H, d, J 2.9 Hz, 3-CH), 4.47 (1H, 
dd, J 4.4 and 11.7 Hz,), 4.26 (dd, J 9.5 and 11.7 Hz, I H), 3.53-3.48 (IH m, 5-CH), 
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1.95 (IH, td, J 13.6 and 7.3 Hz, 7-CH), 1.07 (6H, t, J 7.3 Hz, 8 and 9-CH3); oc (75 
MHz, CDCh): 154.57 (2-C), 152.31 (3-C), 68.35 (6-C), 61.54 (5-C), 30.44 (7-C), 
19.27 (8-C), 18.74 (9-C). 
(SS)-5-(2-methylpropyl)- 5,6-dihydro-2H-1,4-oxazin-2-one (383)124 
From ( 48)-4-(2-methylpropyl)-2-methyl-4,5-dihydro-1 ,3-oxazole 378 ( 1.48 g, 1 0.5 
mmol). Oxazinone 383 was isolated as an orange oil (0.52 g, 32%). IR (neat/cm-1) 
1745s (C=O), 1645w (C=N), 1457w; oH (300 MHz, CDCh) 7.86 (1H, d, J2.6 Hz, 3-
CH), 4.46-4.41 (I H, dd, J 4.0 and 11.5 Hz, 6-C(IDH), 4.18-4.11 (I H, dd, J 8.3 and 
11.5 Hz, 6-C(H)H), 3.87-3.81 (IH, m, 5-CH), 1.99-1.85 (IH, m, 8-CH), 1.64-1.54 
(1H, m, 7-C(H)H), 1.39-1.26 (IH, m, 7-C(H)H), 1.00 (6H, dd, J 1.4 and 6.7 Hz, 9 and 
10-CH3); Oc (75 MHz, CDCh) 154.48 (2-C), 152.12 (3-C), 69.75 (6-C), 54.64 (5-C), 
40.49 (8-C), 24.76 (7-C), 22.73 (9-C), 22.30 (10-C); [a]0 20 +146 (c 0.11 in CHCh). 
(5R)-5-Phenyl-5,6-dihydro-2H-1,4-oxazin-2-one (384)124 
From ( 4R)-4-phenyl-2-methyl-4,5-dihydro-l ,3-oxazole 379 ( 1.69 g, I 0.5 mmol). 
Oxazinone 384 was isolated as an orange oil (0.28 g, 15%). IR (neat/cnf1) 2971, 2901 
(C-H str), 1746 (C=O), 1670 (C=N), 1455; oH (300 MHz, CDCb) 8.07 (IH, d, J 3.0 
Hz, 3-CH), 7.46-7.40 (5H, m, Ar-CH), 4.92 (I H, ddd, J I 0.6, 4.5 and 3.0 Hz, 5-CH), 
4.62 (I H, dd, J 4.5 and I I .8 Hz, 6-C(H)H), 4.29 (I H, dd, J I 0.6 and 11.8 Hz, 6-
C(H)H); Oc (75 MHz, CDCb): 154.05 (2-C), 153.29 (3-C), 136.09 (iAr-C), 129.05 
(oAr-C), 128.53 (pAr-C), 127.07 (mAr-C), 71.11 (5-C), 59.99 (6-C); [a]020 -249.2 (c 
0.12 in CHCb) [lit. [a]o20 -252 (c 5.23 in CHCh)]. 
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(±)-5-Ethyl-5,6-dihydro-2H-1,4-oxazin-2-one (385)124 
./~(X 
0 0 
1 
From 4-ethyl-2-methyl-4,5-dihydro-1 ,3-oxazole 380 ( 1.18 g, I 0.5 mmol). Oxazinone 
385 was isolated as an orange oil (0.40 g, 30%). IR (neat/cm"1) 1732 (C=O), 1651 
(C=N); 8H (400 MHz, CDCh) 7.86 (IH, d, J 2.4 Hz, 3-CH), 4.46 (IH, dd, J 3.9 and 
11.7 Hz, 6-C(H)H), 4.20 (IH, dd, J8.3 and 11.7 Hz, 6-C(H)H), 3.70-3.65 (IH, m, 5-
CH), 1.77-1.65 (2H, m, 7-CHz), 1.11 (3H, t, J 7.3 Hz, 8-CH3). 8c (75 MHz, CDCh) 
154.32 (2-C), 153.19 (3-C), 69.50 (6-C), 54.01 (5-C), 42.32 (8-C), 24.90 (7-C). 
5-Phenyl-morpholin-2-one (387)127 
~\Y~4 
Ph"",l_ ~ 
0 0 
A solution of (R)-phenylglycinol (2.00 g, 14.6 mmol) and diisopropylethylamine (5 
ml, 29.2 mmol) in acetonitrile (70 m1) were stirred at room temperature under a 
nitrogen atmosphere for 15 min. Phenyl-a-bromoacetate (2.84 g, 13.1 mmol) was 
dissolved in acetonitrile (30 ml) and added to the reaction mixture via a side arm 
pressure equalised addition funnel over a 20 min period. The colourless solution was 
stirred at room temperature for 17 h. The solvent was evaporated under reduced 
pressure keeping temperatures below 40°C. The oil was redissolved in DCM (I 0 ml) 
and loaded onto a silica column with a sodium carbonate pre-column. Purification by 
column chromatography (Si02, 40-60 P.E:ethyl acetate; I: 1) afforded the 
morpholinone 387 (700 mg, 27%) as a colourless oil. Umax (thin film)/cm· 1 3320m (N-
H str), 1738s (C=O str), 1456m, 1405m, 1212s; 8u (400 MHz, CDCh) 7.33-7.26 (5H, 
m, Ar-CH), 4.32 ( 1 H, dd, J 4.5 and 11.5 Hz, 6-C(H)H), 4.22 (I H, t, J 11.5 Hz, 6-
C(H)H), 4.08 (I H, dd, J I 0.7 and 11.5 Hz, 5-CH), 3.93 (I H, d, J 17.9 Hz, 3-C(H)H), 
3.84 (IH, d, J 17.9 Hz, 3-C(H)!:!), 1.96 (IH, br, NH); 8c (100 MHz, CDCh) 167.7 
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(C=O), 137.5 (iAr-C), 128.9 (oAr-C), 128.7 (pAr-C), 127.0 (mAr-C), 74.4 (6-C), 56.5 
(5-C), 48.5 (3-C). 
5-Benzyl-morpholin-2-one (388)127 
Ht~4 !"" X Ph 2 
6 
0 0 
A solution of (R)-phenylalaninol (1.25 g, 8.28 mmol) and diisopropylethylamine 
(3.60 ml, 20.7 mmol) in acetonitrile (50 ml) was stirred at room temperature under a 
nitrogen atmosphere for 15 mins. Phenyl-a-bromoacetate (1.60 g, 13.1 mmol) was 
dissolved in acetonitrile (20 ml) and added to the reaction mixture via a side arm 
pressure equalised addition funnel over a 20 min period. The colourless solution was 
stirred at room temperature for 17 h. The solvent was evaporated under reduced 
pressure keeping temperatures below 40°C. The oil was redissolved in DCM (1 0 ml) 
and loaded onto a silica column with a sodium carbonate pre-column. Purification by 
column chromatography (Si02, 40-60 P.E:ethyl acetate; I: 1) afforded the 
morpholinone 388 (800 mg, 56%) as a colourless oil. Umax (thin film)/cm· 1 3325m (N-
H str), 1740s (C=O str), 1455m, 1415m, 1203s; 8H (400 MHz, CDCb) 7.27-7.11 (5H, 
m, Ar-CH), 4.29-4.26 (1 H, dd, J 3.5 and 10.8 Hz, 6-C(H)H), 4.06 (I H, t, J 11.5 Hz, 
6-C(H)H.), 3.68 (IH, d,.! 18.0 Hz, 3-C(H.)H), 3.52 (1H, d, J 18.0 Hz, 3-C(H)H.), 3.22-
3.18 (IH, m, 5-CH), 2.73-2.68 (IH, dd, J5.5 and 13.6 Hz, PhC(H)H), 2.59-2.54 (1H, 
dd, .! 8.2 and 13.6 Hz, PhC(H)H), 1.65 (I H, br, NH); oc (1 00 MHz, CDCb) 168.02 
(C=O), 136.68 (iA-rC), 129.16 (oAr-C), 128.95 (mAr-C), 127.13 (pAr-C), 73.87 (6-
C), 52.70 (5-C), 48.00 (3-C), 37.80 (PhCH2); m/z (El) 192 (88), 101 (32), 65 (45); 
HRMS found 192.1027 [M+Ht, [C 11 H 13N02+Ht requires 192.1024. 
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General procedure for the pyrrolo-oxazinones 389, 392, 394 and 395 
To a stirred solution of vinylcyclopropane 259 (100 mg, 0.54 mmol, 1 eq.) and 
tetrakistriphenylphosphine palladium(O) (10 mol%) in THF (5 ml), was added 
oxazinone (0.49 mmol, 0.9 eq.). The reaction mixture was stirred at room temperature 
for 20 h. The solvent was removed in vacuo, redissolved in ethyl acetate and washed 
with water and brine (2 x I 0 ml). The organic extract was dried over MgS04 and 
evaporated under reduced pressure to give an orange oil. Purification by column 
chromatography (SiOz: iso-hexane:ethyl acetate, 5: 1) afforded pyrrolo-oxazinones 
389,392,394 and 395 (15-75%) as an inseparable mixture of diastereoisomers. 
5-Benzyl-8-oxo-3-vinyl-hexahydro-pyrrolo[2,1-c] [ 1,4] oxazine-1 ,1-dicarboxylic 
aCid dimethyl ester (389a : 389b, syn:anti, 2:1) 
H 2 
10 ~C02Me ~- •••• ,, 1 
11 ,f/ 3 C02Me 
H 4 N g-:.. H 
Ph"'--_ .. Ys ~· 0 
12 .••• \__0 
6 7 
H 
~-- .. ,,, 
389a {syn) 389b {anti) 
From (5S)-5-benzyl-5,6-dihydro-2H-l ,4-oxazin-2-one 381 (I 02 mg, 0.54 mmol). The 
pyrrolooxazinone was isolated as a yellow oil as an inseparable mixture of 
diastereoisomers (151 mg, 75%, 2:1 syn:anti, 389a : 389b). IR (neat/cm-1) 1742s 
(C=O), 1603w (C=C), l454w, 1435w, 1267m; oH (400 MHz, CDCb) 7.31-7.14 (I OH, 
m, Ar-CH), 5.59-5.47 (2H, m, 10-C and 10-C'), 5.23-5.14 (4H, m, 11-CH2 and 11-
CH2'), 4.71 (1H, s, 9-CH'), 4.33-4.28 (2H, m, 6-C(H)H and 6-C(H)H'), 4.18-4.13 
(I H, dd, .13.4 and 11.2 Hz, 6-C(H)H), 4.04 (2H, m, 9-CH and 6-C(H)H'), 3.84 (3H, 
s, OCH3), 3.82 (3H, s, OCH3'), 3.78 (2H, s, OCH3), 3.76 (3H, s, OCH3'), 3.47-3.41 
(2H, m, 3-CH and 3-CH'), 3.32-3.27 (I H, m, 5-CtJ), 3.11-3.04 (I H, m, 5-CH'), 2.94-
2.84 (2H, m, 12-C(H)H and 12-C(H)H'), 2.75-2.67 (3H, m, 12-C(H)H, 12-C(H)H', 2-
C(H)H and 2-C(H)H"), 2.41 (IH, dd, .16.4 and 13.4 Hz, 2-C(H)H), 2.23 (IH, dd, J 
8.6 and 13.4 Hz, 2-C(H)H'); oc (75 MHz, CDC13): 170.11 (C=OOMe), 169.74 
(C=OOMe), 167.49 (8-C), 139.33 (10-C'), 137.72 (10-C), 129.33-126.67 (6 x Ar-C 
and 6 x Ar-C), 119.08 (11-C), 117.63 (11-C'), 70.87 (6-C), 68.20 (6-C'), 67.55 (3-
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C'), 63.65 (9-C), 63.45 (9-C'), 60.58 (3-C), 56.39 (5-C'), 53.44 (5-C), 53.07, 53.02 (2 
x OCH3), 39.15 (2-C), 38.56 (2-C'), 38.34 (12-C'), 30.23 (12-C); m/z (FAB+) 374 
(68), 372 (30), 372 (30), 282 (84), 167 (27), 154 (36), 153 (21), 149 (93), 137 (31), 
136 (40), 135 (38), 121 (25), 117 (29), 109 (31), 107 (28), 105 (38), 97 (33), HRMS 
found 374.16090 [M+Ht, [CzoHz3N06+Ht requires 374.16036. 
5-lsopropyl-8-oxo-3-vinyl-hexahydro-pyrrolo [2,1-c] [1 ,4] oxazine-1 ,1-dicarboxylic 
I 
acid dimethyl ester (392a : 392b, syn:anti, 5:4) 
14 
392a (syn) 392b (anti) 
From 5-Isopropyl-5,6-dihydro-2H-1,4-oxazin-2-one 382 (76 mg, 0.54 mmol). The 
pyrrolooxazinone was isolated as a yellow oil as a separable mixture of 
diastereoisomers (94 mg, 54%, 5:4 syn:anti, 392a : 392b). Anti isomer: IR (neat/cm-
1) 1741s (C=O), 1435m, 1265s, 1204m; oH (400 MHz, CDCh): 5.63-5.54 (IH, m, 10-
C), 5.20-5.08 (2H, m, 11-C), 4.65 (IH, s, 9-CH), 4.45 (IH, dd, J 4.6 and 12.0 Hz, 6-
C(H)H), 4.24 (IH, dd, 18.3 and 12.0 Hz, 6-C(H)H.), 3.80 (3H, s, OCH3), 3.76 (3H, s, 
OCH3), 3.39-3.33 (IH, q, J 7.8 Hz, 3-CH), 2.77-2.72 (IH, dd, J 7.3 and 13.7 Hz, 2-
C(H)H), 2.60-2.55 (IH, m, 5-CH), 2.25 (IH, dd, J 7.3 and 13.7 Hz, 2-C(H)H), 1.81 
(IH, td,.! 13.7 and 6.8 Hz, 12-C), 0.95-0.90 (6H, 2 x d, J 12.0 Hz, 13 and 14-C); oc 
(75 MHz, CDCb) 170.03, 169.87 (2 x C=O(OMe)), 169.23 (C=O), 139.66 (10-C), 
117.70 (11-C), 67.33 (3-C), 66.09 (6-C), 63.57 (9-C), 61.15 (1-C), 59.17 (5-C), 53.35, 
53.17 (2 x OMe), 37.79 (2-C), 29.71 (12-C), 19.22 (13-C), 18.20 (14-C); Syn isomer: 
IR (neat/cm-1) 174ls (C=O), 1435m, 1265s, 1204m; oH (400 MHz, CDCb): 5.42-5.31 
(IH, m, 10-C'), 5.14 (IH, dd,.! 1.4 and 10.0 Hz, 11-C(H)H'), 5.05 (IH, dd,.! 1.4 and 
17.0 Hz, 11-C(H)H.), 4.46 (I H, s, 9-CH'), 4.28 (I H, dd, .! 6.1 and 11.2 Hz, 6-
C(H)H'), 4.06 (IH, t, .! 11.2 Hz, 6-C(H)H'), 3.74 (3H, s, OCH3'), 3.70 (3H, s, 
OCH3'), 3.75-3.70 (I H, m, 5-CH'), 3.04 (IH, quintet, J 5.6 and 11.0 Hz, 3-CH'), 2.75 
(1H, dd, J 8.3 and 14.0 Hz, 2-C(H)H), 2.33 (1H, dd, J 5.8 and 13.8 Hz, 2-C(H)H), 
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1.81 (lH, m, (CH3)2CH), 0.86-0.81 (6H, 2 x d, J 12.0 Hz, 2 x CH3); oc (75 MHz, 
CDCh) 171.25, 169.64 (2 x C=O(OMe) '), 168.04 (C=O'), 138.64 (10-C'), 119.49 
(11-C'), 68.28 (6-C'), 64.95 (5-C'), 62.05 (9-C'), 60.26 (1-C'), 56.00 (3-C'), 53.48, 
53.07 (2 x OMe'), 36.52 (2-C'), 31.03 (12-C'), 19.30 (13-C'), 18.40 (14-C'); mlz 
(FAB+) 326 (35), 109 (22), 97 (29), 95 (38), 93 (22), 91 (30), 85 (22), 83 (39), 81 
(44), 79 (29), 77 (26), 73 (23), 71 (35), 69 (69), 67 (46), 57 (62), 55 (100), 43 (42), 41 
(43); HRMS found 326.1604 [M+Ht, [C16H23N06+Ht requires 326.1604. 
5-Ethyl-8-oxo-3-vinyl-hexahydro-pyrrolo [2,1-c] [1,4] oxazine-1 ,1-dicarboxylic 
acid dimethyl ester (394a: 394b, syn:anti, 1:1) 
;~. Ha2 COzMe 11~·,,, 
3 1 
9 C02Me 
13 4 N ~~0 
0 
7 
394a (syn) 394b (anti) 
From 5-Ethyl-5,6-dihydro-2H-1,4-oxazin-2-one 385 (67 mg, 0.54 mmol). The 
pyrrolooxazinone was isolated as a yellow oil as an inseparable mixture of 
diastereoisomers (29 mg, 17%, 1:1 syn:anti, 394a: 394b); IR (neat/cm-1) 1746s (C=O 
str), 165lm (C=C str), l604w, l496m; 8H (400 MHz, CDCh): 5.66-5.56 (2H, m, lO-
CH and 10-CH'), 5.21-5.09 (4H, m, 11-CHz and 11-CH2'), 4.66 (lH, s, 9-CH'), 4.47 
(lH, dd, J 4.2 and 11.5 Hz, 7-C(H)H'), 4.38 (1H, dd, J 3.9 and 10.8 Hz, 7-C(H)H), 
4.27 (IH, dd, J3.9 and 10.8 Hz, 7-C(H)H), 4.14-4.09 (1H, dd, J7.8 and 11.5 Hz, 7-
C(H)H'), 3.96 (lH, s, 9-CH), 3.81 (3H, s, OCH3), 3.80 (3H, s, OCH3'), 3.77 (3H, s, 
OCH3), 3.76 (3H, s, OCH3'), 3.53-3.43 (2H, m, 3-CH and 3-CH'), 2.99-2.94 (1 H, m, 
6-CH), 2.80-2.74 (IH, m, 6-CH'), 2.72-2.65 (2H, m, 2-C(H.)H and 2-C(H)H'), 2.41 
(IH, dd, J 5.9 and 13.7 Hz, 2-C(H)H), 2.23 (1H, dd, J 8.6 and 13.7 Hz, 2-C(H)H'), 
1.59-1.48 (4H, m, 12-CHz and 12-CHz'), 0.96-0.88 (6H, m, l3-CH3 and 13-CH3'); 8c 
(75 MHz, CDCh) 170.18, 170.02, 169.73, 169.64 (C=OOMe), 167.79 (C=O), 139.67 
(10-C'), 137.97 (10-C), 130.51 (1-C), 118.74 (11-C), 117.46 (11-C'), 71.04 (6-C), 
68.58 (6-C'), 66.92 (3-C'), 63.69 (9-C'), 63.64 (9-C), 61.49 (1-C') 60.68 (3-C), 60.46 
(1-C), 55.46 (5-C'), 53.38, 53.35, 53.21, 52.97 (2 x OMe and 2 x OMe'), 52.47 (5-C), 
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39.14 (2-C), 38.74 (2-C'), 24.45 (~H2CH3), 10.75 (CH2CH3), 9.86 (CH2CH3); mlz 
(FAB+) 312 (42), 155 (24), 154 (100), 138 (28), 137 (52), 136 (73), 107 (22), 89 
(21); HRMS found 312.1443 [M+Ht, [CisH21N06+Ht requires 312.1447. 
8-0xo-5-phenyl-3-vinyl-hexahydro-pyrrolo [2,1-c] [1 ,4] oxazine-1 ,1-dicarboxylic 
acid dimethyl ester (395a : 395b, syn:anti, 1:1) 
H 
~- .... ,, 
0 
6 7 
395a (syn) 395b (ant1) 
From (5R)-5-pheny1-5,6-dihydro-2H-1,4-oxazin-2-one 384 (95 mg, 0.54 mmol). The 
pyrrolooxazinone was isolated as a yellow oil as an inseparable mixture of 
diastereoisomers (48 mg, 25%, 1:1 syn:anti, 395a : 395b). IR (neat/cm-1) 1749s 
(C=O), 1605w (C=C), 1450w, 1441w, 1124m; 8H (400 MHz, CDCb): 7.38-7.31 (m, 
I OH, 5 x Ar-CH and 5 x Ar-CH'), 5.70-5.59 (IH, m, 10-C'), 5.45-5.37 (IH, m, 10-C), 
5.26 (lH, dd, J 10.0 and 1.2 Hz, 11-C(H)H'), 5.18 (IH, dd, J 17.1 and 1.2 Hz, 11-
C(H)H') 4.90 (IH, d, J 17.1 Hz, 11-C(H)H), 4.89 (lH, s, 9'-CH), 4.75 (IH, d, J 10.0 
Hz, 11-C(H)H), 4.65 (lH, dd, J 5.1 and 11.5 Hz, 6'-CH(H)), 4.45 (IH, dd, J 5.9 and 
ll.l Hz, 6-CH(H)'), 4.35 (lH, dd, J 5.1 and 11.1 Hz, 6-CH(H)), 4.28-4.23 (2H, m, 5-
CH and 5-CH'), 4.10 (IH, s, 9-CH), 4.00 (lH, dd, J 4.6 and 10.5 Hz, 6-CH(H)), 3.83 
(3H, s, OCH3'), 3.81-3.80 (9H, 2 x s, 0 CH3' and 2 x OCH3), 3.74-3.72 (3H, m, 
OCH3), 3.49 (lH, q,./7.7 Hz, 3-CH), 3.39-3.33 (IH, m, 3-CH'), 2.80-2.75 (IH, dd, J 
7.8 and 14.2 Hz, 2-C(H)H'), 2.64-2.54 (IH, dd, J 7.8 and 14.2 Hz," 2-C(H)H), 2.43 
(IH, dd, .I 6.4 and 13.7 Hz, 2-C(H)H), 2.32-2.25 (IH, dd, .1·7.8 and 13.7 Hz, 2-
C(H)H'); 8c (75 MHz, CDCb): 170.16, 170.07, 169.73, 169.37, 169.16, 168.48 (6 x 
C=O), 138.62 (10-C), 137.65 (10-C'), 135.55 (iAr-C), 128.85 (oAr-C), 128.56 (oAr-
C), 128.27 (pAr-C), 128.15 (pAr-C'), 127.92 (mAr-C), 127.67 (mAr-C'), 119.52 (11-
C'), 116.52 (11-C), 72.76 (6-C'), 71.59 (5-C'), 68.30 (6-C), 64.69 (3-C), 62.96 (9-
C'), 61.73 (9-C), 60.89 (3-C'), 60.16 (1-C), 55.22 (5-C), 53.43, 53.39, 53.29, 53.07 (4 
x OCH3), 38.49 (2-C'), 38.41 (2-C); m/z (FAB+) 361 (21), 360 (100), 359 (61), 358 
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(32), 153 (22), 136 (23), 121 (28), 105 (26), 104 (70), 91 (41), 77 (26), 69 (30), 67 
(20), 57 (41), 55 (44), 43 (26), 41 (28); HRMS found 360.1441 [M+Ht, 
[Ct9H2tN06+Ht requires 360.1447. 
a-Phenylacetimidate hydrochloride (398)128 
NH.HCI 
Ph 11 ~OEt 
Hydrogen chloride gas was bubbled through a stirred solution of benzyl cyanide (9.85 
ml, 83.8 mmol) in ethanol (5.38 ml, 92.2 mmol) at 0 °C, until the reaction mixture 
had gained 3.37 g in mass. The resulting solution was then allowed to stand in the 
freezer for 17 h before diethyl ether (75 ml) was added, and additional cooling in an 
ice bath yielded the hydrochloride salt 398 (14.2 g, 85%) as white crystals. IR 
(neat/cm-1) 3397m (N-H str), 1659 (C=N), 1448m, 1389m, 1097m; 8H (300.07 MHz, 
CDCh) 7.46-7.36 (5H, m, Ar-CH), 4.62 (2H, q, J 7.0 Hz, CfuCH3), 4.05 (2H, s, 
PhCH2), 1.98-1.95 (IH, br, NH), 1.44 (3H, t, J 7.0 Hz, CH2Cfu); 8c (75.45 MHz, 
CDCh): 177.17 (C=N), 131.27 (iAr-C), 129.55 (oAr-C), 129.13 (mAr-C), 128.34 
(pAr-C), 71.09 (PhCH2), 39.33 ~H2CH3), 13.53 (CH2CH3). 
( 4 R)-4-Phenyl-2-benzyl-4,5-dihydro-1 ,3-oxazole (399) 126 
6 0 Ph~2H 
3 : 
Ph 
From (R)-phenylglycinol (2.66 g, 19.4 mmol) and a-phenylacetimidate hydrochloride 
398 (4.25 g, 21.3 mmol) Oxazole 399 was isolated as a colourless oil (2.76 g, 60%). 
IR (neat/cm-1) 1689s (C=N); 8H (300 MHz, CDCh) 7.39-7.3I (!OH, m, Aromatic-
CH), 5.22-5.I6 (I H, t, J 9.2 Hz, 4-CH), 4.60 (I H, dd, J 8.5 and I 0.2 Hz, 5-C(H)H), 
4.08 (I H, t, J 8.5 Hz, 5-C(H)H), 3.74 (2H, s, 6-CH2); 8c (75 MHz, CDCh): I67.I8 (2-
C), I42.35'(i-Ar-C), I35.I9 (iAr-C), I29.01 (oAr-C), I28.70 (oAr-C), 128.67 (mAr-
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C), 127.52 (pAr-C), 127.08 (pAr-C), 126.56 (mAr-C), 74.93 (4-C), 69.66 (5-C), 34.91 
(6-C); [a]0 20 +53.2 (c 2.83 in CHCh) [lit., +50.7 (c 2.83 in CHCb)]. 
2-0xazoline (401)130 
Thionyl chloride (2.08 ml, 28.7 mmol) was added dropwise to N-formyl-
ethanolamine 403 (1.50 g, 16.9 mmol) at 0°C, resulting in a vigorous exothermic 
reaction. The reaction mixture was allowed to warm to room temperature over 1 h. 
The reaction mixture was then evaporated under reduced pressure to remove excess 
thionyl chloride, resulting in a colourless oil which was neutralised with aqueous 
sodium carbonate (35 ml), extracted with dichloromethane (3 x 40 ml), dried over 
sodium sulphate and evaporated so the temperature remained below 40°C. The 
resulting colourless oil was 2-oxazoline 401 (720 mg, 60%) with no need for further 
purification. IR (neat/cm-1) 1640m (C=N); oH (400 MHz, CDCh) 8.21 (1H, s, 2-CH), 
3.72-3.50 (4H, m, 4-CH2 and S-CH2);8c NMR (75 MHz, CDCh) 161.37 (2-C), 43.68 
(4-C), 39.85 (5-C). 
N-formyl ethanolamine (403)128 
0 ll OH N~ 
H 
Ethanolamine (5.00 g, 82.0 mmol) and formic acid (3.77 g, 82.0 mmol) were 
combined and heated in an open flask 4 h until the loss of weight corresponded with I 
mol of water. Boiling began at 160°C and ceased at 200°C, indicating the end of the 
reaction. Kuglerohr distillation of the viscous oil gave N-formyl ethanolamine 403 
(4.30 g, 59%) as a colourless oil, bp 225-227°C (8.3 mbar). IR (neat/cm-1) 3387, 3630 
(NH and OH str) 1756s (C=O); 811 (400 MHz, DMSO-d6) 7.98 (IH, s, NCHO), 4.70 
(IH, br, NH), 3.46-3.38 (2H, m, 2-CH2), 3.15-3.06 (2H, m, I-CH2); Be (75 MHz, 
' 
CDCh) 165.64 (C=O), 61.23 (2C), 43.98 (1 C). 
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2-(2-tert-Butoxycarbonylvinyl)-cyclopropane-1 ,1-dicarboxylic acid dimethyl 
ester (405) 
;(all A ' ~O,Me 
- o "';' \J'-co2Me 
2 
A 100 ml round bottom flask was charged with (tert-butoxycarbonylmethyl)-
triphenylphosphonium bromide (6.15 g, 13.5 mmol) in THF (50 ml) under a nitrogen 
atmosphere. n-Butyllithium (5.39 ml of a 2.5 M solution in hexanes) was added 
dropwise at ooc and the mixture stirred for 10 min. The aldehyde 292 (2.09 g, 11.2 
mmol) was added to the reaction, and the mixture was stirred for a further I 0 m in, 
upon which it was quenched with H20 (1 0 ml), and extracted into DCM (3 x 15 ml). 
The organic layer was dried over MgS04 and evaporated under reduced pressure to 
give the crude product as an orange oil which was further purified via flash 
chromatography on silica gel (petrol:ethyl acetate, 6: I) to give the product as a 
colourless oil (2.27 g, 71%). Vmax(neat)/cm-1173ls (C=O str), 165ls (C=C str), 1435s, 
1367s, 1257s, 1142s; oH (400 MHz, CDCb) 6.28 (IH, dd, J 9.6 & 15.2 Hz, 4-CH), 
5.91 (IH, d, J 15.2 Hz, 5-CH), 3.70 (3H, s, OCH3), 3.69 (3H, s, OCH3), 2.61-2.54 
(IH, m, 3-CH), 1.73 (IH, dd, J 5.2 & 7.6 Hz, 2-(H)H), 1.63 (IH, dd, J 5.2 & 9.2 Hz, 
2-C(H)H), 1.39 (9H, s, OC(Cfu)J); 8c (l 00 MHz, CDCb) 169.44 (C=O), 167.27 
(C=O), 164.98 (C=O), 141.77 (4-C), 126.25 (5-C), 80.54 (1-C), 53.01 (OMe), 52.89 
(OMe), 36.41 (OC(CH3)3), 29.81 (3C), 28.18 (OC(CH3)3, 21.46 (2-C); m/z: (Cl) 302 
([M+(NH4)t, 98%), 246 (79), 211 (33), 145 (80), 120 (54), 113 (61), 98 (40), 65 
(37), 57 (l 00) and 41 (72); HRMS found 302.1598 [M+(NH4)t; [C14Hzo06+(NH4)t 
requires 302.1598. 
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4-Bromobut-3-yn-1-ol (407)100 
3 
Br 
~OH 
To a solution of potassium hydroxide (32.0 g, 576 mmol) in H20 (300 ml) was added 
bromine (8.16 ml, 158 mmol), and the solution was cooled to 0 °C. The flask was 
covered with aluminium foil and then 3-butyn-1-ol (10.0 g, 143 mmol) was added. 
The mixture was stirred for 24 h after warming to room temperature. The mixture was 
extracted with diethyl ether (2 x 50 ml), and the organic layer was dried over Na2S04, 
and evaporated under reduced pressure to give the desired product as a colourless oil 
(19.5 g, 92%). Vmax(neat)/cm-1; 3355br (0-H str), 1417w, 1034s and 845m; OH (400 
MHz, CDCh) 3. 76 (2H, t, J 3.2 Hz, 4-CHz), 2.49 (2H, t, J 3.2 Hz, 3-CH2), 2.08-2.02 
(lH, s, OH); oc (100 MHz. CDCh) 60.80 (4-C), 40.08 (1-C), 24.04 (3-C), 15.26 (2-
C); m/z: (El) 150 ([M+H]\ Br81 , 5%), 148 ([M+Ht, Br79, 5%), 120 (95), 118 (100) 
and 69 (25); HRMS found 147.9527 [Mt, [C4H50Br79+Ht, requires 147.9523. 
4-Bromobut-3-en-1-ol (408)100 
Br 
,~OH 
2 4 
A dry 10 ml round bottomed flask was charged with 4-bromo-but-3-yn-I-ol407 (9.00 
g, 60.6 m mol) and THF/H20 (I: I, 300 ml). To this was added p-
toluensulfonhydrazide (22.5 g, 121 mmol) and sodium acetate (15.0 g, 182 mmol). 
This mixture was stirred under reflux for 4 h, after which the reaction was allowed to 
cool, and· then extracted with DCM (2 x 50 ml). The organics were dried over 
MgS04, then evaporated under reduced pressure to give the desired product as a 
colourless oil (8.5 g, 93%). Vmax(neat)/cm-1: 3335br (0-H str), 1623m (C=C str); OH 
(400 MHz, CDCb) 6.22 (IH, J 1.2 and 7.2 Hz, I-CH), 6.12 (IH, q, J7.2 Hz, 2-CH), 
3.65 (2H, t, J 6.8 Hz, 4-CHz), 2.46-2.38 (2H, m, 3-CHz); oc (100 MHz. CDCb) 
131.21 (2-C), 109.93 (3-C), 60.94 (4-C), 33.22 (3-C); m/z: (El) 152 ([M]\ Br81 , 8%), 
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150, ([Mt, Br79, 8%), 122 (49), 120 (52) and 71 (100); HRMS found 149.9678 
[MBr79t, [C4H70Br79t requires 149.9680. 
Methanesulfonic acid 4-bromobut-3-enyl ester (409)100 
A 10 ml round bottomed flask was charged with 4-bromobut-3-en-1-ol 408 (6.00 g, 
39.7 mmol) dissolved in DCM (3 ml). To this mixture was added triethylamine (4.40 
g, 43.7 mmol) and the reaction mixture was cooled to 0 °C. Methanesulfonyl chloride 
(5.00 g, 43.7 mmol) was added dropwise, and the reaction was stirred whilst allowed 
to warm to room temperature overnight. The reaction was quenched with H20 (30 ml) 
followed by a saturated sodium bicarbonate solution (20 ml). The organics were 
extracted into DCM (3 x 20 ml), dried over MgS04 and evaporated under reduced 
pressure to give the crude product which was further purified via flash 
chromatography (P.E 60-40:ethyl acetate, 6:1) to give the desired product as an 
orange oil (8.51 g, 94%). Vmax(neat)/cm-1 3087w, 3026w, 2939w (C-H aliphatic str), 
1625m (C=C str), 1470w, 1416w, 1359s, 1171s, 965s, 920s; oH (400 MHz, CDCb) 
6.30 ( 1 H, dt, J 1.2 and 6.8 Hz, 1-CH), 6.12 (I H, q, J 6.8 Hz, 2-CH), 4.23 (2H, t, J 6.4 
Hz, 4-CH2), 2.97 (3H, s, 5-CH3), 2.64-2.58 (2H, m, 3-CH2); oc (I 00 MHz, CDCb) 
128.99 (2-C), 111.45 (1-C), 67.64 (4-C), 37.68 (5-C), 29.86 (3-C); m/z: (El) 248 
([M+(NH4)t, Br81 , 98%), 246 ([M+(NH4)t, Br79, 98%), 134 (90), 118 (52), I 09 (56), 
91 ( 48), 79 (I 00) and 53 (80); HRMS found 245.9791 [M+(NH4)Br79t, 
[C5H90 3SBr79+(NH4)t requires 245.9794. 
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1-Bromo-4-iodo-but-1-ene ( 41 0)100 
Methanesulfonic acid 4-bromobut-3-enyl ester 409 (8.51 g, 37.2 mmol) and sodium 
iodide (83.5 g, 557 mmol) were added to anhydrous acetone (1000 ml) and heated 
under reflux for 24 h. The resulting precipitate was removed by filtration through a 
Celite pad, and the filtrate was evaporated under reduced pressure. The white solid 
was washed with diethyl ether (5 x 20 ml) and the solution was evaporated under 
reduced pressure a second time to give the desired product as an orange oil (8.00 g, 
82%). Ymax(neat)/cm-1 162lm (C=C str), 1422m, 1285s, 1247s, 117ls; 8H (400 MHz, 
CDCh) 6.28 (IH, dt, J 1.6 & 6.8 Hz I-CH),), 6.08 (IH, q, J 6.8 Hz, 2-CH), 3.14 (2H, 
t, J 6.8 Hz, 4-CH2), 2.75 (2H, ddt, J 1.6, 6.8 and 7.5 Hz, 3-CH2); 8c (100 MHz, 
CDCh) 132.92 (2-C), 109.62 (1-C), 33.09 (4-C), 2.16 (3-C); m/z: (El) 262 ( [Mt, 
Br81 , 98%), 260 ([Mt, Br79, 98%), 209 (35), 139 (39), 91 (100), 65 (52), 55 (61) and 
43 (91); HRMS found 259.8694 [MBr79t, [C4H6Br79It requires 259.8697. 
4-Bromobut-3-enylisoindole-1, 3-dione (411) Method A 
9 11 
12 
0 
A solution of methanesulfonic acid 4-bromobut-3-enyl ester 409 (500 mg, 2.35 
mmol), potassium phthalamide (477 mg, 2.58 mmol), potassium iodide (38 mg, 0.23 
mmol) and 18-crown-6 (55 mg, 0.21 mmol) in DMF (20 ml) was heated under reflux 
for 24 h under a nitrogen atmosphere. After cooling to room temperature, the 
resulting residue was diluted with ethyl acetate, and the solids filtered. The organic 
phase was washed with H20 (3 x 30 ml), dried over MgS04 and evaporated under 
reduced pressure to give the crude product which was further purified by flash 
chromatography on silica gel (P.E 60-40:ethyl acetate, 6: I) to give the phthalamide 
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product as a yellow crystalline solid (300 mg, 46%). Vmax(neat)/cm-1: 3460w, 1771 s, 
1712s (C=O str), 1623m (C=C str), 1467m, 1436m, 1396s, 1360s; 8H (400 MHz, 
CDCh) 7.79-7.76 (2H, m, 9 and 10-CH), 7.67-7.65 (2H, m, 11 and 12-CH), 6.16 (1H, 
dt, J 1.6 & 7.2 Hz, 1-CH), 6.08 (1H, q, J 7.2 Hz, 2-CH), 3.76 (2H, t, J 6.8 Hz, 4-
CH2), 2.55 (2H, dd, 1.6 and 7.2 Hz 3-CH2); 8c (100 MHz, CDCh) 168.34 (5 and 6-
C), 134.00 (11 and 12-C), 132.02 (7 and 8-C), 130.81 (2-C), 123.29 (9 and 10-C), 
110.65 (1-C), 36.10 (4-C), 29.22 (3-C); mp: 61.5-63.8°C; mlz: (FAB+) 282 ([M+H]+, 
Br81 , 2%), 280 ([M+Ht, Br79, 2%), 160 (39), 95 (30), 81 (.8), 69 (570, 57 (67), 55 
(100) and 41 (40); HRMS found 279.9977 [M+H]\ Br79, [C12H100 2NBr79+Ht 
requires 279.9973. 
4-Bromobut-3-enylisoindole-1, 3-dione (411i00 Method B 
A solution of 1-bromo-4-iodobut-1-ene 410 (2.60 g, 9.98 mmol) and potassium 
phthalamide (3.70 g, 20.0 mmol) in 2-butanone (50 m!) was heated under reflux for 
24 h under a nitrogen atmosphere. After cooling to room temperature, the resulting 
residue was diluted with ethyl acetate, and the solids filtered. The organic phase was 
washed with H20 (3 x 30 ml), dried over MgS04 and evaporated under reduced 
pressure to give the crude product which was further purified by flash 
chromatography on silica gel (P.E 60-40:ethyl acetate, 1: I) to give the phthalamide 
product as a white crystall~ne solid (1.50 g, 54%). Data as shown in Method A. 
4-{Bromobut-3-enyl)-[1-phenylmethylidene ]-amine ( 412) 
8 
Br 7~9 
1~N~1a 
2 4 5 11 
Phthalamide 411 (600 mg, 2.15 mmol) in EtOH (30 ml) was treated with hydrazine 
monohydrate (120 mg, 2.15 mmol). The reaction mixture was refluxed for 2 h. The 
reaction was complete upon formation of a white precipitate. To this was added 
aqueous 2 M HCI ( 10 m!) and the reaction refluxed for a further I 0 min. The reaction 
was allowed to cool to room temperature, and the solids were filtered and washed 
with water (2 x I 0 m!). The aqueous ethanol filtrate was evaporated under reduced 
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pressure, and re-dissolved in aqueous 2 M NaOH, and extracted into diethyl ether (2 x 
20 ml). The organic fractions were combined and dried over MgS04 before 
concentrating to -10 ml in vacuo, using a cool water bath. To this solution were 
added molecular sieves (2.50 g 4 A) and benzaldehyde (212 mg, 2.00 mmol). The 
reaction mixture was left to stir overnight, after which time it was filtered under 
suction and washed several times with diethyl ether (3 x5 ml). The filtrate was 
evaporated under reduced pressure to give the imine as an orange oil (380 mg, 74%). 
Vmax(neat)/cm·1 2925, 2359, 1289, 1055, 772 and 689; OH (CDCh, 400 MHz) 8.29 
(IH, s, 5-CH), 7.78-7.72 (2H, m, Ar-H), 7.49-7.43 (2H, m, Ar-H), 7.42-7.40 (IH, m, 
Ar-H), 6.30-6.22 (IH, m, I-CH), 6.19-6.10 (IH, m, 2-CH), 3.74-3.70 (2H, m, 4-CH2), 
2.62 (2H, q, J 6.6 Hz, 3-CH2); oc (CDCh, 100 MHz) 161.58 (C-12), 136.03 (C-1), 
132.27 (C-7), 130.65 (C-4), 128.56 (C-2 and C-6), 128.08 (C-3 and C-5), 109.09 (C-
11), 59.64 (C-10) and 31.29 (C-9), m/z: (FAB+) 240 ([M+Ht, Br8\ 10%), 238 
([M+Ht, Br79, 10%), 136 (27), 118 (28), 95 (37), 91 (38), 81 (38), 69 (55), 57 (50) 
and 55 (100); HRMS found 238.0234 [M+Ht, Br79, [C 11 H12NBr79+Ht requires 
238.0231. 
4-(4-Bromobut-3-enyl)-3-(2-tert-butoxycarbonylvinyl)-5-phenylpyrrolidine-1,1-
dicarboxylic acid dimethyl ester (415) 
11 
10""'-/ 7:-- 127 H:ctz COzMe 
~ .. ···"''" 3 1 CO Me 11 .... 6 4 5 2 
0 13 (N p~ H . 
sr0 14 
16 15 
415a (E-isomer) 
yO 0 
/\ y·H C02Me ~~co2Me 
( Ph 
srv 
415b (Z-isomer) 
To a stirred solution of 2-(2-tert-butoxycarbonyl-vinyl)-cyclopropane-1, 1-
dicarboxylic acid dimethyl ester 405 ( 1.16 g, 4.09 mmol) in THF (20 ml) was added 
4-(bromobut-3-enyl)-[ 1-phenylmethylidene ]-amine 412 ( 1.07 g, [91% imine 9% 
benzaldehyde], 4.09 mmol imine) then ZnBr2 (2.30 g, 10.2 mmol) at room 
temperature. This was left to stir under a nitrogen atmosphere for 10 m in before 
addition of tetrakistriphenylphosphine palladium(O) (236 mg, 0.204 mmol). The 
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reaction mixture was stirred for 24 h. The solvent was then removed in vacuo, and the 
residue dissolved in ethyl acetate (I 0 ml) and washed with water (2 x 20 ml). The 
organic fraction was then dried over MgS04 and evaporated under reduced pressure 
to give an orange oil Purification by column chromatography (Si02, 40-60 P.E:ethyl 
acetate; 20:1) afforded pyrrolidines 415a and 415b as a separable mixture of isomers 
(415a [1.24 g, 58%], 415b [0.50 g, 23%]) as yellow oils. £-isomer 415a: 
Vma'<(neat)/cm-1 2951m, 2840m (C-H aliphatic), 1732s, 1712s (C=O str), 1651m (C=C 
str), 1621w (C=C-Br), 1493w, 1455m, 1434m, 1367s, 115ls; 8H (400 MHz, CDCh) 
7.31 (2H, d, J 8.4 Hz, 2 x oAr-CH), 7.23-7.15 (3H, m, 2 x mAr-CH and 1 x pAr-CH), 
6.76 (IH, dd, J7.6 Hz and 15.6 Hz, 6-CH), 5.98 (1H, d, J6.9 Hz, 16-CH), (IH, d, J 
15.6 Hz, 7-CH), 5.82 (IH, q, J 6.9 Hz, 15-CH), 4.71 (IH, s, 5-CH), 3.72 (3H, s, 
OMe), 3.30-3.21 (1H, m, 3-CH), 3.04 (3H, s, OMe), 2.70-2.65 (2H, m, 13-C(H)H and 
2-C(H)H), 2.64-2.59 (1H, m, 13-C(H)H), 2.22 (1H, dd, J 5.7 and 13.2 Hz, 2-C(H)H), 
2.10-1.98 (2H, m, 14-CH2); 8c (100 MHz, CDCh) 171.81, 168.67, 165.55 (3 x C=O), 
147.54 (6-C), 140.28 (iAr-C), 132.48 (15-C), 128.52, 127.84 (5 x Ar-C), 124.76 (7-
C), 108.72 (16-C), 80.61 (9-C), 71.60 (5-C), 64.74 (1-C), 63.24 (3-C), 53.16 (OMe), 
52.10 (OMe), 50.46 (13-C), 38.58 (2-C), 28.16 (10, 11 and 12-C), 28.05 (14-C); m/z 
(FAB+) 524 ([M+Ht, Br81 , 11%), 522 ([M+Ht, Br79, 17%), 466 (27), 402 (100), 
346 (38); HRMS found 522.1498 ([M+Ht, Br79), [CzsH3zN06Br79+Ht requires 
522.1491). Z-isomer 415b: Vmax(neat)/cm-1 2976m, 2950m (C-H aliphatic), l733s, 
171 Is (C=O str), 1635m (C=C str), l62lw (C=C-Br), l492w, l454m, l434m, l367s, 
1268s; 8H (400 MHz, CDCh) 7.35 (2H, d, J 8.4 Hz, pAr-CH), 7.22-7.15 (3H, m, 2 x 
mAr-CH and 1 xpAr-CH), 6.24 (IH, dd, J 8.4 and 11.7 Hz, 6-CH), 5.98 (IH, d, 7.0 
Hz, 16-C), 5.84 (IH, q, J 6:9 Hz, 15-CH), 5.72 (IH, d, J 15.5 Hz, 7-CH), 4.64 (IH, s, 
5-CH), 4.43-4.35 (IH, br q, J 8.4 Hz, 3-CH), 3.69 (3H, s, OMe), 3.03 (3H, s, OMe), 
2. 70-2.64 (I H, m, 13-C(!::!)H), 2.54-2.49 (2H, m, 13-C(H)H and 2-C(H)H), 2.39 (I H, 
dd, J 6.9 and 13.3 Hz, 2-C(H)H), 2.20-2.02 (2H, m, 14-CH2); 8c (100 MHz, CDCh) 
172.47, 169.34, 165.49 (3 x C=O), 150.18 (6-C), 139.88 (iAr-C), 132.80 (15-C), 
128.90, 127.57 (5 x Ar-C), 122.94 (7-C), 108.50 (16-C), 80.63 (1-C), 72.02 (5-C), 
64.62 (9-C), 59.26 (3-C), 52.92 (OMe), 52.03 (OMe), 50.87 (13-C), 38.09 (2-C), 
28.24 (10, 11 and 12-C), 27.90 (14-C); mlz (FAB+) 524 ([M+Ht, Br81 , 13%), 522 
([M+Ht, Br79, 19%), 466 (I 00), 464 (89), 346 (57); HRMS found 522.1485 [M+Ht, 
Br79; [CzsH3zN06Br79+Ht requires 522.1491. 
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2-Amino-3-phenyl-propan-1-ol (417) 
Chlorotrimethylsilane (15.2 ml, 120 mmol) was added to. a suspension of lithium 
borohydride (1.32 g, 60.1 mmol) in dry THF (85 ml) under a nitrogen atmosphere 
over a 5 min period at room temperature. (R)-Phenylalanine (5.00 g, 30.0 mmol) was 
then added over 5 mins. The mixture was allowed to stir for 24 h before being 
quenched with methanol until there was no effervescence visible. The solvent was 
evaporated under reduced pressure, and the residue treated with 20% potassium 
hydroxide solution and extracted with DCM (3 x 30 ml). The combined organic phase 
was dried over sodium sulphate and evaporated under reduced pressure to give the J3-
aminoalcohol 417 (4.30 g, 95%) as a pale yellow solid, which was used without 
further purification. Umax (thin film)/cm-1 3659s (0-H), 3355s (N-H), 1578w, 1122m; 
oH (400 MHz, CDCh) 7.32-7.18 (5H, m, Ar-CH), 3.62 (IH, dd, J 4.00 and 10.8 Hz, 
1-C(H)H), 3.39 (IH, dd, J 7.2 and 10.8 Hz, 1-C(H)H), 3.10 (IH, m, 2-CH), 2.79 (IH, 
dd, J 5.2 and 13.6 Hz, 3-C(H)H), 2.50 (I H, dd, J 8.8 and 13.6 Hz, 3-C(H)H); Oc (1 00 
MHz, CDCh) 139.1 (iAr-C), 129.6 (oAr-C), 129.0 (mAr-C), 126.8 (pAr-C), 66.5 (I-
C), 54.6 (2-C), 41.1 (3-C). 
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4-tert-Butoxycarbonyl-(E)-methylene-1 0-phenyl-2,3, 7 ,8-tetrahyd ro-1H-
pyrrolo[1,2-a]azepine-1,1-dicarboxylic acid dimethyl ester (418a) 
15 14 
)~-~ 
To a stirred solution of 1-( 4-bromo-but-3-enyl)-5-(2-tert-butoxycarbonyl-vinyl)-2-
phenyl-pyrrolidine-3,3-dicarboxylic acid dimethyl ester 415a (I 00 mg, 0, I8I mmol) 
in DMSO (5 ml) was added tetrakistriphenylphosphine palladium(O) (22 mg, 19.0 
llr'nol). This was stirred under a nitrogen atmosphere for I 0 m in before addition of 
NaHC03 (80 mg, 0.952 mmol). The reaction mixture was heated to 80°C for I h, then 
cooled to room temperature. Water (10 ml) was added and the aqueous mixture 
extracted with ethyl acetate (I 0 ml). The aqueous fraction was re-extracted with a 
further portion of ethyl acetate (I 0 ml), and the organic fractions combined and 
washed with water (2 x I 0 ml) and saturated brine solution (3 x I 0 ml). The organic 
layer was dried over MgS04 and evaporated under reduced pressure to give an orange 
oil. Purification by column chromatography (Si02, 40-60 P .E:ethyl acetate; 20: I) 
afforded the pyrrolidine 418a (72 mg, 92%) as a white crystalline solid. mp 13I-
I340C; Vmax(neat)/cm-1:2951m, 1731s (C=O str), 1631m (C=C str), 1584w, 1434m, 
1146s; 8H (400 MHz, CDCb) 7.38 (2H, d, J 8.0 Hz, 2 x Ar-CH), 7.23-7.15 (3H, m, 3 
x Ar-CH), 6.05 (IH, br d,.! 12.4 Hz, 5-CH), 5.73 (IH, dt, J 5.3 and 12.4 Hz, 6-CH), 
5.60 (IH, s, 11-CH), 4.64 (IH, s, 10-CH), 4.40-4.34 (IH, m, 3-CH), 3.72 (3H, s, 
OMe), 2.93 (3H, s, OMe), 2.73(IH, dd, J 5.3 and 10.2 Hz, 2-C(H)H), 2.70-2.62 (IH, 
m, 8-C(H)H), 2.60-2.52 (2H, m, 8-C(H)H and 2-C(H)H), 2.28-2.15 (I H, m, 7-
C(H)H), 2.04-1.96 (IH, m, 7-C(H)H), 1.40 (9H, s, 14-CH3, 15-CH3 and 16-CH3); 8c 
(lOO MHz, CDCb) 172.08, 169.67, 165.70 (3 x C=O), 156.87 (4-C), 139.69 (iAr-C), 
135.54 (6-C), 128.43 (5-C), 128.43 (pAr-C), 127.83 (2 x mAr-C), 127.79 (2 x oAr-C), 
120.99 (11-C), 79.95 ( 13-C), 72.87 ( 10-C), 66.35 (3-C), 63.81 (1-C), 52.77, 51.97 (2 
x OMe), 47.56 (8-C), 38.99 (2-C), 33.25 (7-C), 28.16 (14, 15 and 16-C); m/z (FAB+) 
208 
442 (9), 385 (27), 384 (100); HRMS found 442.2237 [M+Ht, [C2sH31N06+Ht 
requires 442.2230. 
4-tert-Butoxycarbonyl-(Z)-methylene-1 0-phenyl-2, 7 ,8-tetrahydro-1H-
pyrrolo[1,2-a]azepine-l,l-dicarboxylic acid dimethyl ester (418b) 
16 
0 
7 
To a stirred solution of 4-(4-bromo-but-3-enyl)-3-(2-tert-butoxycarbonylvinyl)-5-
phenylpyrrolidine-1, 1-dicarboxylic acid dimethyl ester 415b (I 00 mg, 0.181 mmol) 
in DMSO (5 ml) was added tetrakistriphenylphosphine palladium(O) (22 mg, 19.0 
Jlmol). This was stirred under a nitrogen atmosphere for I 0 m in before addition of 
NaHC03 (80 mg, 0.952 mmol). The reaction mixture was heated to 80°C for 1 h, then 
cooled to room temperature. Water (I 0 ml) was added and the aqueous mixture 
extracted with ethyl acetate (l 0 ml). The aqueous fraction was re-extracted with a 
further portion of ethyl acetate ( 10 ml), and the organic fractions combined and 
washed with water (2 x 10 ml) and saturated brine solution (3 x 10 ml). The organic 
layer was dried over MgS04 and evaporated under reduced pressure to give an orange 
oil. Purification by column chromatography (Si02, 40-60 P.E:ethyl acetate; 20:1) 
afforded the pyrrolidine 418b (75 mg, 94%) as a white crystalline solid. mp 132-
l350C; Vmax(neat)/cm-1 :2951 m, 1731 s (C=O str), 1632m (C=C str), 1584w, 1434m, 
1146s; 811 (400 MHz, CDCb) 7.32 (2H, d,.! 8.0 Hz, 2 x Ar-CH), 7.23-7.15 (4H, m, 3 
x Ar-CH and 5-CH), 5.94 (IH, dt,.! 5.2 and 12.4 Hz, 6-CH), 5.64 (IH, s, 11-CH), 
4.61 (IH, s, 10-CH), 3.71 (3H, s, OMe), 3.49-3.43 (IH, br q, 3-CH), 2.99 (3H, s, 
OMe), 2.92 (I H, dd,.! 11.2 and 13.2 Hz, 2-C(H)H), 2.80 (I H, dt,.! 6.4 and 13.2 Hz, 
8-C(H)H), 2.58 (I H, ddd,.! 6.4, I 0.0 and 13.2 Hz, 8-C(H)H), 2.39 (I H, dd,.! 5.2 and 
13.2 Hz, 2-C(H)H), 2.20-2.12 (2H, m, 7-CH2), 1.43 (9H, s, 14, 15 and 16-CH3); 8c 
(100 MHz, CDCb) 172.05, 169.12, 165.76 (3 x C=O), 154.60 (4-C), 139.54 {iAr-C), 
135.57(6-C), 128.72(2xoAr-C), 127.85(2xmAr-C), 127.81 (5-C), 126.11 (pAr-C), 
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118.40 (11-C), 80.15 (13-C), 73.88 (10-C), 69.97 (3-C), 63.28 (1-C), 52.97, 52.05 (2 
x OMe), 50.81 (8-C), 39.24 (2-C), 30.43 (7-C), 28.26 (14, 15 and 16-C); mlz (El) 441 
(9), 385 (45), 384 (100), 340 (36); HRMS found 441.2159 [Mt, [C2sH31N06t 
requires 441.2151 ). 
3-(9-Benzyl-4-tert-butoxycarbonylmethyl-3,6, 7 ,8-tetrahydro-lH-azepin-2-
ylmethyl)-malonic acid dimethyl ester (420) 
14 
"fa 
16 12 
11 
6 
7 
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10 I 
8 Ph 
C02 Me 
Azepine 418a or 418b in THF (1.0 ml) and t-BuOH (7.0 Jll) was added dropwise to a 
stirred solution oflithium metal (5 mg, 7.14 mmol) in ammonia (5 ml) at-78°C. This 
was stirred for 20 m in before addition of saturated aqueous ammonium chloride ( 1 
ml). The reaction mixture was allowed to warm to room temperature, then partitioned 
between ethyl acetate (1 0 ml) and distilled water (I 0 ml). The organic layer was then 
washed with brine (I 0 ml), and dried over MgS04. Purification by column 
chromatography (Si02, 40-60 P.E:ethyl acetate; 20:1) afforded compound 420 (16 
mg, 40%) yellow oil. 8H (400 MHz, CDCb) 7.25-7.14 (5H, m, 5 x Ar-CH), 5.68 (lH, 
t, .15.8 Hz, 5-CH), 3.76-3.72 (2H, m, 3-CH and 10-C(H)H), 3.65 (3H, s, OMe), 3.65-
3.62 (IH, m, 10-C(H)H), 3.59 (3H, s, OMe), 3.11-3.02 (IH, m, I-CH), 3.00-2.91 (lH, 
m, 8-C(H)H), 2.82-2.73 (3H, m, 8-C(H)H and ll-CH2), 2.38-2.27 (I H, m, 2-C(H)H), 
2.20-2.10 (2H, m, 6-CH2), 1.81-1.70 (IH, m, 7-C(H)H), 1.38-1.29 (IH, m, 7-C(H)H); 
8c (100 MHz, CDCI3) 171.27, 170.57, 169.67 (3 x C=O), 140.06 (4-C), 137.63 (iAr-
C), 130.03 (5-C), 128.81 (2 x oAr-C), 128.12 (2 x mAr-C), 126.73 (pAr-C), 80.58 
(13-C), 63.44 (1-C), 58.80 (IO-C),52.57, 52.37 (OMe), 48.84 (3-C), 48.80 (8-C), 
44.62 (11-C), 28.73 (2-C), 28.12 (6-C), 28.08 (14,15 and 16-CH3), 21.84 (7-C); m/z 
(FAB+) 445 (24), 372 (21), 301 (21), 300 (100), 244 (65); HRMS found 445.2460 
[Mt, [C2;H3;N06t requires 445.2464. 
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4-tert-Butoxycarbonylmethyl-1 0-phenyl-3,6, 7 ,8-tetrahydro-1H-pyrrolo[1 ,2-
a]azepine-1,1-dicarboxylic acid dimethyl ester dimer (421) 
14 15-+ 13 
0 
Azepine 418a or 418b (50 mg, 0.13 mmol) in THF (2 ml) was cooled to -78°C under 
a nitrogen atmosphere. To this solution was added lithium anthracenide (O.I 0 ml, I 00 
mg Li and 2.58 g anthracene in 20 ml THF), or enough to turn the reaction mixture 
deep green. The reaction was stirred for 30 min until TLC experiments confirmed the 
-consumption of starting material. The reaction was then exposed to the air for I 0 m in, 
before concentrating under reduced pressure to give a yellow solid. Purification by 
column chromatography (Si02, 40-60 P.E:ethy1 acetate; 6: I) afforded the dimer 421 
(40 mg, 80%) as a yellow oil. 8H (400 MHz, CDCb) 7.32-7.14 (I OH, m, IO xAr-CH), 
5.38 (2H, br s, 2 x 5-CH), 4.52 (2H, s, 2 x 10-CH), 3.68 (6H, s, 4 x OMe), 3.42-3.34 
(2H, br m, 2 x 3-CH), 3.03 (6H, s, 4 x OMe), 3.02-2.82 (6H, m, 2 x 6-CH and 2 x II-
CH2), 2.72-2.58 (6H, m, 2 x 2-C(H)H and 2 x 8-CH2), 2.43 (2H, dd, J 6.0 and 12.8 
Hz, 2 x 2-C(H)H), 1,65-1.47 (4H, m, 2 x 7-CH2), 1.38 (ISH, s, 2 x [14,15 and 16 
CH3]); 8c (lOO MHz, CDCb) 171.98, 171.14, 169.16 (6 x C=O), 140.21 (4-C), 
134.98(5-C), 128.51 (4xoAr-C), l28.16(2xiAr-C), 127.83(4xmAr-C), 127.60(2 
x pAr-C), 80.51 ( 13-C), 73.68 ( 10-C), 64.45 (1-C), 63.76 (3-C), 52.92, 52.00 (8 x 
OMe), 51.04 (8-C), 43.84 (11-C), 40.07 (6-C), 38.58 (2-C), 30.55 (7-C), 27.97 (14, 
15 and 16-C); ); m/z (FAB+) 886 (46), 885 (60), 884 (49), 883 (36), 443 (40), 442 
(22), 441 (25), 387 (32), 386 (95), 385 (37), 384 (47), 342 (7I), 341 (31), 340 (lOO). 
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· 2-0xo-3-phenyl-4-vinyl-cyclopentane-1,1-dicarboxylic acid dimethyl ester (422) 
To a stirred solution of vinylcyclopropane 259 (100 mg, 0.54 mmol) in DMSO (5 
ml), was added tetrakistriphenylphosphine palladium(O) (62 mg, 0.054 mmol), under 
an atmosphere of nitrogen. This was stirred for 1 0 m in at room temperature before 
adding phenyl isocyanate (129 mg, 1.08 mmol). The reaction mixture was heated to 
80°C for 2 h, giving a deep red solution. The mixture was allowed to cool to room 
temperature, diluted with water (20 ml), then extracted with ethyl acetate (10 ml). The 
aqueous fraction was re-extracted with a further portion of ethyl acetate ( 10 ml), and 
the organic fractions combined and washed with water (2 x 10 ml) and saturated brine 
solution (3 x 10 ml). The organic layer was dried over MgS04 and evaporated under 
reduced pressure to give an orange oil. Purification by column chromatography (Si02, 
40-60 P.E:ethyl acetate; 6:1) afforded the pyrrolidinone 422 (89 mg, 54%) as a 
colourless oil. Ymax(neat)/cm-1 3063w, 2953w, 1734s, 1700s (C=O str), 1595m (C=C 
str), 1491s, 1420s, 1264s; 8H (400 MHz, CDCh) 7.41-7.28 (5H, m, 5 x Ar-C), 5.72-
5.60 (IH, ddd, .17.6 and 10.4 and 17.6 Hz, 6-CH), 5.17 (IH, d, J 17.6 Hz, 7-C(H)H), 
5.11 (1H, d, J 10.4 Hz, 7-C(H)H), 4.65 (IH, q, J 7.6 Hz, 4-CH), 3.76 (3H, s, OMe), 
3.75 (3H, s, OMe), 3.00 (1H, dd, .17.6 Hz, 5-C(H)H), 2.54 (1H, dd, J 6.0 Hz, 5-
C(H)H); oc (I 00 MHz. CDCb) 167.93, 167.50, 165.92 (C=O), 137.03 (iAr-C), 
136.28(6-C), 129.39(2xoAr-C), 128.86(pAr-C), 128.43 (2xmAr-C), 119.17(7-C), 
63.49 (1-C),60.05 (4-C), 53.79 (OMe), 53.65 (OMe), 35.07 (5-C); mlz (FAB+) 303 
(35), 212 (100), 130 (33), 77 (25); HRMS found 303.1111 [Mt, [C 19H21N06t 
requires 303.1106. 
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Table I. Crystal data and structure retinement for gpS. 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
C<:!ll volume 
z 
Calculated density 
Absorption coefficient J.l. 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
e range for data collection 
Index ranges 
Comptetene:;:; to 9"" 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Retlections with Fz>2o 
Absorp:ion correction 
tvlin. ~nd rnax, mmsmission 
Stn:cture solution 
Refinement method 
Weighting parameters a, b 
Daca I restraints I parameters 
Final R indices [i=•> 2<1] 
R ir:dices (all data) 
Goodness-of-fit on F1 
Extinction coel1icient 
Largest anu mean shift!~u 
Largcsr diff peak and hole 
gp5 
C1oHtsi2N2Zn 
485.43 
150(2} K 
MoKct, 0.71073 A 
monoclinic, P21/c 
a= 8.2835('8) A 
b = 11.0457(10) A 
c = 16.1971( 19) A 
147Ll'l(1) .A3 
4 
2.191 g!cm3 
5.840mm-1 
912 
J3 - 96. 772(9)0 
pale yellow, 0.90 x 0.78 x 0.68 mmJ 
7843 (0 range 2.23 to 28.66°) 
Bruker SMART 1000 CCD diffractometer 
w rotation with narrow frames 
2.24 to 28.86., 
h-!Oto 10,k-J4to 14,1-21 to21 
99.9% 
0% 
12336 
3500 (Rim = 0.0346) 
3090 
semi-empirical from equivalents 
OJJ77 and 0. t09 
direct methods 
Full-matrix least-squares on F1 
0.0165, 2.5157 
3500/0/139 
R 1 '" 0.0262, wR2 = 0.0560 
RI == 0.0315, wR2 == 0.0575 
1.083 
0.00171(13) 
0.00 l and 0. 000 
1.267 and -1.276 eA -l 
Table 2. Atomic coordinates and equivalent isotropic displacement par~meters (A 2) 
for gp5. U,c; is defined as one third of the trace of the orthogonalizcd uu tensor. 
X y z U.q 
Zn(l) 0.13588(5) 0.51251(3) 0.18827(2) 0.01673(9) 
I(l) 
-0.16910(3) 0.56907(2) 0.1 56297( 15) 0.02601(8) 
1(2) 0.24132(3) 0.52660(2) 0.344346( 14) 0.02422(8) 
N(l) 0.2627(3) 0.6264(3) 0.12 145(17) 0.0186(6) 
C(l) 0.2636(•~) 0.7424(3) 0.1217(2) 0.0226(7) 
C(2) 0.3671(5) 0.7963(4) 0.0621(2) 0.0325(9} 
C(3) 0.4230(5) 0.6885(4) 0.0147(3) 0.0356(10) 
C(4) 0.3681(4) 0.5792(3) 0.0609(2) 0.0251(8) 
C(S) 0.1718(5) 0.8168(4) 0.1760{3) 0.0342(9) 
N(2) 0. 1677(3) 0.3488(3) 0.13496(17) 0.0186(6) 
C(6) 0.2830(4) 0.2722(3) 0.1487(2) 0.0218(7) 
C(7) 0.2536(5) 0.1563(3) 0.1016(2) '0.0297(8) 
C(8) 0.1107(5) 0.1873(3) 0.0369(2) 0.0297(8) 
C(9) 0.0366(4) 0.2999(3) 0.0736(2) 0.0264(8) 
C(lO) 0.4317(5) 0.2923(4) 0.2076{2) 0.0291(8) 
Table 3. Bond lengths [A] and angles [0 } for gpS. 
Zn(l)-N(l) 2.031(3) Zn{l)-N(2) 2.035(3) 
Zn(l)-1(2) 2.5801(5) Zn(l)-1(1) 2.5947{5) 
N(l)--C(l) 1.282(4) N{I)-C(4) 1.482{4) 
C(I)--C(5) 1:477(5) C{l)-C(2) 1.489(5) 
C(2)-C(3) 1.518(6) C(3)-C(4) l.519(5) 
N(2)-C(6) 1.276{5) N(2}-C(9) 1.485(4) 
C(6)-qlO) 1.482(5) C(6}-C(7) 1.495(5) 
C(7}-C(8) 1.524(5) C(8}-C(9) 1.537(5) 
N(I}-Zn(l}-N(2) 102.89(11) N(1 )-Zn( I }-T(2) I 10.38(8) 
N(2)-Zn( I )-1(2) 115.06(8) N( 1 )-Zn( I }---l(l) 107.29{8) 
N(2)-Zn(l}-I(l) 107.53(8) 1(2}-Zn{ I HC I) 112.965( 18) 
C( 1 }-N{ I )--C( 4) 110.5(3) C( I )-N(l }-Zn(l) 128.4(3) 
C(4}-N(l}-Zn{l) 121.1(2) N(l)--C(I)~(5) 123.7(4) 
N(l }-C(I }-C(2) 113.6(3} C(5}-C( I }-C(2) 122.7(3) 
C(I)-C(2)--C(3) 104.4(3) C(2}-C(3}-C(4) 104.3(3) 
N(1)-C(4}-C(3) 106.3{3) C( 6)-N(2}-C(9) 11 0.5(3) 
C(6}-N(2}-l.n{l) 130.3(2) C(9}-N(2}-Zn( I) 119.1(2) 
~(2)-C(6)-C(!O) 124.1(3) N(2}-C(6}-C(7) 113.9(3) 
C( 10}-C(6}-C(7) 122.0(3) C(6)-C(7}-C(8) 103.0(3) 
C(7}-C(8}-C(9) 103.3(3) N(2}-C(9)-C(8) 105.0(3) 
..... ·-"-· ..... . 
. . • ~ .-j ,.· •• . 
A 0 ,~ O '••>'•• ~ ''''-~ ·-~ ,,,..::.. ----- ·---·'-~:_:_;~~ti~~~~;;;;.{: : 
.. -
;f;, 
le:' 
Table 4. Hydrogen coordinates and isotropic displacement parameters (N) for gp5. 
X y 
H(2A) 0.4611 0.8396 
H(2B) 0.3037 0.8535 
H(3A) 0.5427 0.6889 
H(3B} 0.3718 0.6891 
H(4A) 0.3068 0.5223 
H(48) 0.4630 0.5362 
H(SA) 0.1296 0.7648 
H(5B) 0.0811 0.8567 
H(SC) 0.2439 0.8782 
H(7A) 0.2254 0.0900 
H(78) 0.3502 0.1324 
H(SA) 0.0313 0.1201 
H(SB) 0.1479 0.2057 
H(9A) 0.0038 0.3603 
H(9B) -0.0599 0.2778 
H(IOA) 0.4377 0.3776 
H(lOB) 0.5277 0.2713 
H(IOC) 0.4279 0.2413 
Table 5. Torsion angles [0 ] for gpS. 
N(2}-Zn(l }-N( 1 }-C( I) 
I( 1 }-Zn( I }-N( 1 )-C( I) 
I(2 }-Zn( l }-N ( 1 )-C( 4) 
C(4)-N(l}-C( I )-C(S) 
C(4)-N(1}-{:(l)-C(2) 
N( 1 }-C( 1 }-C(2 }-C( 3) 
C(l}--C(2}-C(3)-C( 4) 
Zn( l )-N( 1 )-C{ 4 }-C(3) 
N( I )-Zn(l)-N(2)-C(6) 
I(l )-Zn(1 )-N(2}-C(6) 
1(2)-Zn( I )-N(2)-C(9) 
C(9)-N(2)-C( 6)-C( 1 0) 
C(9}-N(2)-C(6)-C(7) 
N(2)-C(6)-C(7)-C(8) 
C(6~(7}-C(8}-C(9) 
Zn( I )-N(2}-C(9}-C(8) 
169.2(3) 
55.9(3) 
114.4(2) 
-179.4(3) 
0.4(4) 
5.6(4) 
-8.8(4) 
172.1(2) 
85.1(3) 
-161.9(3) 
140.2(2) 
-179.3(3) 
-1.0( 4) 
13.8{4) 
-19.7(4) 
171.6(2) 
z u 
0.0919 0.039 
0.0240 0.039 
0.0153 0.043 
-0.0437 0.043 
0.0218 0.030 
0.0901 0.030 
0.2175 0.051 
0.1423 0.051 
0.2041 0.051 
0.1384 0.036 
0.0748 0.036 
0.0301 0.036 
-0.0176 0.036 
0.0296 0.032 
0.1011 0.032 
0.2243 0.044 
0.1805 0.044 
0.2568 0.044 
1(2)-Zn(l }-N(I }-C( 1) 
N(2}-Zn(1}-N(1}-C(4) 
I( 1 }-Zn( 1 }-N (I }-C( 4) 
Zn( I }-N(I }-C( 1 }-C(S) 
Zn( I }-N{ I )-C( 1 )-C(2) 
C(S)-C(l}-C(2}-C{3) 
C( l )-N( l }-C( 4 )-C(3) 
C(2}-C(3)-C{ 4 )-N( l) 
1(2)-Zn(l }-N(2}-C( 6) 
N( I )-Zn( I }-N(2}-C(9) 
I(l )-Zn{l }-N(2}- C(9) 
Zn( I }-N(2}-C( 6)-C( I 0) 
Zn(l )-N(2}-C( 6}-C(7) 
C(l0)-C(6)-C(7)-C(8) 
C( 6 }-N(2)·C(9)-C(8) 
C(7)-C(8)-C(9)-N(2) 
-67.5(3) 
-8.9(3) 
-122.1(2) 
2.4(5) 
-177.9(2) 
-174.7(3) 
-6.2(4) 
9.2(4) 
-35.0(3) 
-99.7(2) 
13.4(3) 
-3.8(5) 
174.6(2) 
-167.8{3) 
-12.3(4) 
19.7(4) 
.. .-. I 
----········---------·----·· 
C(19l 
4-tert-Butoxycarbonyl-(E)-mcthylcne-1 0-phenyl-2,3,7 ,8-tetrahydro-1 H-pyrrolo[ I ,2-
a}azepine-1.1-dicarboxylic acid dimethyl ester (458a) [gp7]. 
i ___ .....J 
Table I. Crystal data and structure refinement for gp7 
ldentitication code 
Chemical formula 
Formula •weight 
Temperature 
Radiation, wtwdcngth 
Crystal system, space group 
linit cell P"ramctcr:; 
Cell volurm: 
z 
Cah:ulated density 
Absorption coefficient ~1 
F(OOO) 
Crystal colour and size 
Retlections for cell refinement 
Data collection method 
a range for .data collection 
Index range.~ 
Completeness to 0 = 26.00° 
Intensity decay 
ReflectiOns collected 
Independent reflections 
Reflections with Fz>2cr 
Absorption curn:ction 
tv1in. and max. transmission 
Structure solution 
Rt::iinement method 
Weighting parameters a, b 
Data; restraints I paramc!crs 
Fin:tl R indices [F:>2a) 
R indices (all data) 
Gombess-of- fit on F7 
Ab~,Jiute structure parameti.'r 
Largest o:md mean shiftlsu 
Largt:sl di!T peak and hole 
gpt' 
CuHHNO~ 
441.51 
150(2) K 
MoKu, 0.71073 A 
monoclinic, P21 
a= 9.3057(8) A 
b"' 13.1079(11}.\ 
c = 9.5560(8) A 
1160.85(17) N 
2 
1.263 g/cm1 
0.090mm 1, 
472 
y= 90" 
pale yellow, 0.31 x 0.15 >< 0.14 mm3 
3096 (0 rant,.>e 2.65 tu 16.34") 
Oruker APEX 2 CCD diffractometer 
w rolation with narrow frames 
2.14to26.41° 
h -11 to 11, k -16 to 16, I -11 to 11 
100.0% 
0% 
10450 
2488 (R,., .. 0.0471) 
209·f 
semi-empirical from equivalents 
0.973 and 0.98!1 
direct methods 
Full-matrix least-squares on F2 
D 0389, 0.1009 
2488/ I /294 
RI ""0.0343, wR2- 0.0715 
R i = 0.0502. ~ R2 ... 0.0796 
1037 
ll\(10}, Friei.ld~ merged; absolute stru~:urc unknnwn. 
0 UUO and 0.00{) 
0.173 and -0.179 eA -l 
l 
.J 
Table 2. Atomic coordinates and equivalent isotropic displacement parn.meters (Al) 
for gp7. Ucq is defined as one third of the trace of the orthogonalized U'1 tensor. 
X y z u •. l 
N(l} 0.2733(2) 0. 73848( 15) -0.0190(2) 0.0205(4) 
C(l) 0.3343(3) 0.6920l(l9) 0.1119(3) 0.0207(5) 
C(2) 0.4970(3) 0.70097(19) 0.1377(3) 0.0223(5) 
C(3) 0.5862(3) 0.7501(2) 0.0372(3) 0.0274(6) 
C{4) 0.5550(3) 0.8205(2) -0,0627(3) 0.0316(6) 
C(S) 0.4180(3) 0.8738(2) -0.1087{3) 0.0310(6) 
C(6) 0.2922(3) 0. 84917(19) -0.0255(3) 0.0248(6) 
C(7) 0.1216(2) 0.70588([9) -0.0371(3) 0.0206(5) 
C(8) 0.1250(3) 0.59516{18) 0.0283{2) 0.0202(5) 
C{9) 0.2833(3) 0.58 I 98(19) 0.0885(3) 0.0233(5) 
C(IO) 0.5694{3) 0.6603(2) 0.2534(3) 0.0245(5) 
C(ll) 0.5062(3) 0.6100(2) 0.3715(3) 0.0272(6) 
0(1) 0.3833(2) 0.61989(18) 0.4025(2) 0.04!1(5) 
0(2) 0.60640( 18) 0.55093{ 15) 0.44140(19) 0.0283(4) 
C(l2) 0.5695(3) 0.4829(2) 0.5567(3) 0.0326(7) 
C(l3) 0.7114(4) 0.4289(3) 0.5942(4) 0.0560(10) 
C(l4) 0.5259(4) 0.5446(3) 0.6802(3) 0.0448(8) 
C(15) 0.4542(4) 0.4083(3) 0.5017(4) 0.0513(9) 
C(l6) 0.0588(3) 0.71297(18) -0.1882(3) 0.0210(5) 
C(l7) 0.1432(3) 0.69730(1 9) -0.2993(3) 0.0246(6) 
C(18) 0.0813(3) 0.7003(2) -0.4370(3) 0.0295(6) 
C(19) -0.0641(3) 0.7178(2) -0.4653(3) 0.0331(7) 
C(20) -0.1484(3) 0.7344(2) -0.3557(3) 0.0350(7) 
C(21) -0.0875(3) 0.7317(2) -0.2182(3) 0.0275(6) 
C(22) 0.0237(3) 0.58842{ 19) 0.1465(3) 0.0222(5) 
0(3) -0.0544(2) 0.65473(14) 0.18068(19) 0.0326(5) 
0(4) 0.03545(19) 0.49691(14) 0.20727( 19) 0.0287(4) . 
C(23) -0.0539{3) 0.4800(2) 0.3213(3) 0.0315(6) 
C(24) 0.0706(3) 0.51604(18) -0.0806(3) 0.0224(5) 
0(5) -0.0548{2) 0.49393( 16) -0.1037(2) 0.0356{5) 
0(6) 0.17617(19) 0.47742(14) -0.14906( 19) 0.0289(4) 
C(25) 0.1299(4) 0.4078(2) -0.2623(3) 0.0404(8) 
Tublc 3. Bond lengths [A] and angles[~] for gp7. 
N(l}-C(I) 1.459(3) N(I}-C(6) 1.463(3) 
N(l)-C(7) 1.470(3) C(I)-C(2) 1.517(3) 
C(l)-C(9) 1.528(4) C(2}-C(lO) 1.352(4) 
C(2}-C(3) 1.473(4) C(3)-C(4) 1.341(4) 
C(4)-C(S} 1.485(4) 
.C(5)-C(6) 1.509(4) 
C(7)-C(I6) 1.511(3) C(7)-C(8) !.579(3) 
C(8)-C(24) 1.523(3) C(8)-C(22) 1.538(3) 
C(8}-C(9) 1.542{3) C(IO}-C(I·I) 1.474(4) 
C(ll)-0(1) 1.214(3) C{ll)-0(2) 1.343(3) 
0(2)-C(l2) 1.482(3) C(l2}-C(I S) 1.511(4) 
C(l2)-C(\3) 1.512(4) C(l2)-C(l4) 1.516(4) 
C( i 6)-C(21) 1.387(3) C(l6}-C(J7) 1.392(3) 
C(I7)-C(l8) 1.389(4) C( 18)-C(l9) 1.374(4) 
C( 19)-C(20) 1.381(4) C(20)-C(21) \.383(4) 
C(22)-0(3) 1.197(3) C(22)-0(4) 1.333(3) 
0(4)-C(23) 1.446(3) C(24)-0{5) 1.203(3) 
C(24)-0(6) 1.329(3) 0(6)-C(25) l.451 (3) 
C(l)-N(l)-C(6) 1 14.3(2) C(l)-N(l )-C(7) 105.92( 18) 
C(6)-N(l)-C(7) 113.61(19) N(l)-C(l}-C(2) 114.3(2) 
N(l)-C{l)-C(9} 100.20(19) C(2}-C(I}-C(9) 112.9(2) 
C( I 0)-C(2)-C(3) 115.9(2) C(l0)-C(2)-C( I) 121.3(2) 
C(3)-C(2)-C(1) 122.8(2) C( 4 }-C(3 )-C(2) 131.8(3) 
C(3}-C(4)-t:(5) 131.3(3) C(4)--C(5)-C(6) 115.5(2) 
~(1)-C(6)-C(5) 109.6(2) N(J}-C(7)-C(16) 112.28(19) 
~(l)-C(7}-C(8) I 03.64( 18) C(l6)-C(7}-C(8) 115.3(2) 
C(24 )-C(8}-C(22) 105.95(19) C(24)-C(8)-C(9) I I 5.2(2) 
C(22)-C(8)-C(9) I I 0.4(2) C(24 }-C( 8}-C(7) 111.24(19) 
C(22}-C(8)-C( 7) 110.59(19) C(9)-C(8)-C(7) I 03.58(19) 
C( l }-C(9 )-C(8) 102.84(19) C(2)-C( l 0}-C( 11) 126.8(2) 
0(1 }-C(Il)-0(2) 124.5(2) 0(1)--C(li)--C(IO) 126.1 (2) 
0(2)--C(Il)-C(IO) 109.3(2) C(ll }-0(2}-(:(12) 121.3{2) 
0(2}-C(I2)-C(l5) I 09. 7(2) 0(2)-C(I2}-C(IJ) 101.6(2) 
C(I5)-C(12}-C(I3) ll0.9(3) 0(2)-C( 12}-C( 14) 110.7(2) 
C{l5)-C( I 2)-C(14) I 12.6(2) C(IJ)--C( 12)-C(I4) 110.7(3) 
C{21 )-C( I 6}-C( 17) 118.6(2) C(21 }-C( 16 )-C(7) 119.7(2) 
C( 17}-C( 16)-C(7) 121.6(2) C( I 8)-C( 17}-C( I 6) 120.3{2) 
C(I9}-C(l8}-C(17) 120.5(3) C( 18}-C( 19)--C(20) 119.6(3) 
C( l9)-C(20)-C(21) 120.3{3) C(20)-C(2 1 }-C( 16) 120.7(2) 
0(3}-C(22}-0( 4) 124.2(2) 0(3)-C(22)-C(8) 125.9(2) 
0(4)-C(22)-C(8). 109.9(2) C(22)-0( 4)-C(23) 115.8(~) 
0(5)-C(24}-0(6) 124.4(2) 0(5)--C(24)-C(8) 123.1(2) 
0(6)-C(24)-C(8) 112.4(2) C(24 }-0( 6)-C(25) 115. 1(2) 
Table 4. Hydrogen coordinates and isotropic displacement parameters (A 2) for gp?. 
X y 2 u 
H(J) 0.2880 0.7222 0.1928 0.025 
I-1(3) 0.6838 0.7278 0.0446 0.033 
H(4) 0.6344 0.8396 -0.1129 0.038 
H(SA) 0.3908 0.8566 -0.2085 0.037 
H(SB) 0.4355 0.9482 -0.1034 0.037 
H(6A) O.JlOO 0.8771 0.0708 0.030 
H(6B) 0.2033 0.8810 -0.0707 0.030 
H(7) 0.0643 0.7511 0.0213 0.025 
H(9A} 0.2899 0.5434 0.1779 0.028 
H(9B) 0.3405 0.5464 0.0209 0.028 
H(IO) 0.6717 0.6645 0.2593 0.029 
H(lJA) 0.7411 0.3935 0.5112 0.084 
H(IJB) ·0.6999 0.3793 0.6691 0.084 
H(l3C) 0.7852 0.4791 0.6267 0.084 
H(l4A) 0.6032 0.5926 0.7!06 0.067 
H(I4B) 0.5092 0.4986 0.7579 0.067 
H(I4C) 0.4372 0.5824 0.6519 0.067 
H(I5A) 0.3621 0.4442 0.4832 0.077 
H(ISB) 0.4443 0.3547 0.5718 0.077 
H(lSC) 0.4813 0.3774 0.4145 0.077 
H(l7) 0.2436 0.6845 -0.2808 0.030 
H(l8) 0.1398 0.6902 -0.5123 0.035 
H{l9) -0.1063 0.7185 -0.5596 0.040 
H(20) -0.2486 0.7477 ~0.3748 0.042 
H(2l) -0.1464 0.7429 -0.1435 0.033 
H(23A) -0.0216 0.5245 0.4004 0.047 
H(23B) -0.0461 0.4086 0.3512 0.047 
H(23C) -0.1546 0.4956 0.2895 0.047 
H(25A) 0.0713 0.3533 -0.2262 0.061 
H(25B) 0.2148 0.3780 -0.3004 0.061 
H(25C) 0.0725 0.4450 -0.3367 0.061 

